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EXECUTIVE SUMMARY  
 
1.  The scientific evidence for long-term and cumulative effects of GM plant cultivation 
was reviewed. Currently available risk assessment methodologies were also reviewed 
and gaps in knowledge identified.  Tools and techniques to fill these gaps have been 
identified, drawing on experience of risk assessment in other domains.  Case studies 
were used to test and develop the risk assessment approaches, and to develop examples 
of monitoring and management measures.   
2.  Some areas of potential long-term risks and benefits were identified from the scientific 
literature but in fact there have been few comprehensive studies carried out in the field 
over the long-term that directly address long-term and cumulative effects.  
 
3.  Risk assessment methodologies for release of GMOs generally follow a case-by-case 
approach based on a scientific framework of assessment of hazards, potential for 
exposure, consequences of exposure and options for risk management. Many of these 
risk assessment frameworks do require that cumulative long-term effects are considered, 
however these assessments naturally tend to focus on identifying and monitoring effects 
of the GMO that can be anticipated, based on scientific evidence.  Risk assessment 
methodologies currently in use probably do not easily lend themselves to the much 
broader, conceptual requirements of assessing unanticipated, long-term cumulative 
effects of the release of GM crops. 
 
4.  A workshop was held at CSL on 31 October 2005. A group of specialists attended the 
workshop and scoped different potential scenarios for long-term and cumulative risks 
from GM crops. Not all the risks identified in the workshop will necessarily be 
significant in practice, neither will they all be relevant to any particular release. Rather, 
together with the findings of the literature review, they show the range of possible risk 
types that assessment methodologies will need to be able to identify and evaluate.  
 
5.  Current approaches to risk assessment were identified and reviewed by contact with 
those involved in assessment of GM releases in the EU. A questionnaire was circulated 
to the competent authorities (CAs) of the Member States and other contacts supplied by 
DG Environment. A summary of their responses is given in the report, illustrating the 
diversity of approaches across the EU. 
 
6.  A risk assessment framework was developed and tested using case studies taken from 
GM plants in the pipeline for EU approval. The case studies were also used to develop 
examples of risk management strategies for monitoring and mitigation. 
 
7.  The risk assessment framework has been designed to be used by the CAs and to be 
made available to applicants.  Consideration will need to be given to ensuring that the 
effort that it requires is proportionate to the effort required for the current environmental 
risk assessment (e.r.a), and to the level of risk identified.  GM plants present inherently 
lower risk scenarios than, for example, medical products.  GM crops, their products and 
derived products are traded commodities therefore, acceptability to the European 
Commission, WTO etc, will also need to be considered.  If companies are asked to 
undertake a very lengthy risk assessment process for cumulative long-term risks, it may Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  
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not gain acceptance by them or by CAs and run the risk of not being addressed at all.  If 
the long-term risk assessments were to be undertaken at a higher EU level on a more 
generic basis, then consideration of balancing these costs may become less important. 
Also, some thought will be needed as to how the framework will fit with current ‘short-
term’ e.r.a.s, and any implications for these as the framework proposed in this report is 
more detailed than the guidance currently given. More work will therefore be required 
on the framework and its application before it can be used within the current EU 
regulatory system. 
 
8.  Areas where further work will be needed to improve the framework or fill gaps in our 
knowledge are as follows: 
 
 
•  Obtaining Baseline Data.   There is a need for good baseline data if monitoring is to 
be able to detect changes.    A study is required to advise on the best indicators of 
long-term/ cumulative changes.  There are also institutional and other practical aspects 
of implementation to be considered.  For example, who should carry out the 
baselining, and how would it relate to ecological baselining for other purposes?    
 
•  Ranking the Risks of Generic Crop-Trait combinations.  It could be more cost-
effective, for society as a whole, if some risk assessment work were to be done at a 
higher level than the release-specific ERAs.   If certain crop-trait combinations (or 
other types of scenario) could be ranked in broad order of inherent risk, this would 
help both regulator and industry to ensure proportionate levels of depth and detail in 
risk assessments.  It might also lead regulators to issue guidance indicating any broad 
classes of combinations that would be unlikely to be authorised, preventing wasted 
effort by all parties. The assessment framework could be applied in order to establish 
whether certain crop-trait combinations are inherently riskier than others.  
 
•  Introgression into and Ecology of wild relatives.  Currently, the mechanisms of 
introgression into wild relatives are not understood in sufficient detail to enable the 
likelihood of introgression to be determined with confidence.  Neither is there, in 
general, a good enough understanding of the ecology of wild relatives, and hence of 
how undesirable traits might spread in the environment.   Research is required to 
improve the understanding of introgression and of the ecology of wild relatives, in 
sufficient detail for risk assessment. 
 
•  Improved hazard identification for long-term and cumulative effects.  It is 
difficult to identify hazards that are fundamentally different from those that can occur 
in the short-term.   In most cases, the long-term and cumulative hazards identified in 
this study were the same as the short-term ones, although the degree of risk associated 
with the hazard could be greater - given a longer time or more widespread planting, 
the likelihood and extent of undesirable effects may increase.  Nevertheless, some 
genuinely different hazards can be identified.   These tend to arise from rather subtle 
and complex combinations of factors, which would only be manifested in the long-
term or as a result of widespread releases and plantings.   The process of identifying 
long-term and cumulative risks could be made more efficient and effective if standard 
hazard-identification techniques (brainstorming, failure analyses, HHA etc) could be 
enhanced to focus more quickly on such genuinely long-term and cumulative effects.  
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•  Tolerability Criteria.  The absence of explicit criteria in the Directive for judging 
whether a risk is tolerable, and the apparent variations in practice between Competent 
Authorities, point to a need to develop some more explicit guidance on criteria that 
will encourage well-founded, consistent and fair decisions.   There is a need to 
develop justifiable criteria for tolerable risk, and guidance on their application. 
 
•  Tracking, Combining and Monitoring Cumulative Risks. In considering 
cumulative risks, the EC will need mechanisms to track and combine the risk 
assessments from multiple, and in some cases apparently unrelated, releases.    There  
is a need to explore the scientific and institutional issues involved in tracking multiple 
release assessments and consents and to develop guidance for regulators.  The study 
could consider both scientific aspects (how to identify any potential for cumulative 
risk) and institutional aspects (processes and procedures, IT issues). 
 
•  Stakeholder Engagement in Risk Assessment.  In other controversial debates about 
risk and the environment, there has been a growing realisation of the importance of 
considering social and ethical aspects. Stakeholder participation in framing the 
question and defining assessment methods is being given serious consideration and 
has occurred in some cases, in addition to the more traditional model, in which 
stakeholders review and challenge assessment results and assertions.   Risk assessment 
should be used to provide a structured framework for discourse and decision-making 
under irreducible uncertainty, rather than as a technical and scientific exercise alone.  
Deliberative processes have been used in other domains, and this experience could be 
adapted and applied to the GM domain. 
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1. Introduction 
 
1.1. Background to the Study 
 
Directive 2001/18/EC of the European Parliament and of the Council on the deliberate release 
into the environment of genetically modified organisms (GMOs) entered into force on 17
th 
April 2001. The deadline for transposition of the Directive into national laws was 17
th 
October 2002, ensuring full applicability of its provisions.  
 
According to the Directive, each application for deliberate release of a GMO into the 
environment for research purposes (Part B releases) or for placing on the market (Part C 
releases) must contain a comprehensive environmental risk assessment (e.r.a.). The e.r.a. 
must be performed according to the principles as laid down under Annex II of the Directive.  
 
The objective of the e.r.a. is, on a case by case basis, to identify and evaluate potential 
adverse effects, either direct or indirect, immediate or delayed, relating to the release of a 
GMO in terms of human health and the environment. The e.r.a. should be conducted with a 
view to identifying if there is a need for risk management to be associated with the release 
and if so, the most appropriate measures to be used. A general principle of the e.r.a is that 
analysis of the ‘cumulative long-term effects’ should also be carried out.  
 
On 24
th July 2002 the Commission adopted a Decision establishing guidance notes 
supplementing Annex II of the Directive 2001/18/EC. EFSA published its draft guidance 
document on risk assessment in April 2004.   
 
The guidance provides Competent Authorities and applicants with general principles to be 
followed with respect to the objectives, elements, general principles and methodology of the 
e.r.a.  General guidance has been provided by the competent authorities, e.g. UK Defra 
guidance provided by ACRE in 2001. However, the guidance to date has concentrated on the 
concept of 10 year consents and not examined the longer-term problems which may arise if 
GM crops are grown on a large scale basis in many EU countries over many decades, or if 
many different types of Part B releases occur over a long period of time in one area. More 
specific guidance on risk assessment, and potential risk control measures is now required 
with regard to the potential cumulative long-term effects arising from GM crops on human 
/animal health and the environment. 
 
‘Cumulative long-term effects’ refer to the accumulated effects of consents on human/animal 
health and the environment, including inter alia flora and fauna, soil fertility, soil degradation 
of organic material, the feed/food chain, biological diversity, animal health and resistance 
problems in relation to antibiotics.  The availability of GM crops may also cause effects on all 
the above due to wider agricultural, land use and socio-economic changes. 
 
‘Cumulative’ could be interpreted in terms of (a) the effect of many genes/traits in the crop 
proposed for release, (b) the cumulative effect on health or the environment of multiple 
releases over time, and/or (c) the effect of extremely large scale cultivation of GM crops 
across many EU countries. 
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Long-term effects cannot always be anticipated /identified in the e.r.a. Therefore, appropriate 
measures such as case-specific and/or general surveillance monitoring plans can help in 
detecting these effects. There is also a requirement to be able to reverse any effects detected 
by management of the risks identified. 
 
 
1. 2. Objectives  
 
•  To collect  and collate existing information/studies demonstrating the existence or 
potential for long-term effects of GM crops. 
 
•  To assess and document the adequacy of existing risk assessment methodologies/ 
protocols to account for the above effects from different crops and to identify possible 
gaps/lack of knowledge and where further research is required.  
 
•  To develop specific methodology in terms of risk assessment, with associated risk 
assessment criteria (e.g. specific indicators, etc), for the potential cumulative long-
term effects from individual groups of GM crops (e.g. species) and for different 
transgenic phenotypes (e.g. herbicide tolerance, insect tolerance).  
 
•  To indicate, as appropriate, the types and extent of risk management measures 
(including monitoring activities) required to address potential long-term effects.   
 
1.3. Methodology 
 
Figure 1 provides an overview of the project methodology. The project will review the 
scientific evidence for long-term cumulative effects of GM plant cultivation. Currently 
available risk assessment methodologies will be reviewed and any gaps in knowledge will be 
identified.  Tools and techniques to fill these gaps will be identified, drawing on experience of 
(long-term) risk assessment in other domains, and approaches that are appropriate to the GM 
crops domain will be developed.   Case studies will be used to test and develop the risk 
assessment approaches, and methods to define monitoring and management measures.  Risk 
management plans will be outlined to cope with the risks from a range of current and likely 
future GM releases within the Community.  
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Figure 1.  Overview of Methodology 
 
 
 
 
 
 
 
Task 1:  Collect and Collate Information  
 
1.1 Review data on 
long-term & 
cumulative risks 
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methods for risk 
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1.5 Define user 
requirements 
Task 2:  Develop assessment methods 
 
 
. 
Task 3:  Report on risk management strategies 
 
2.1 Identify gaps between current methods and user requirements  
2.2 Identify potential tools and techniques to fill gaps 
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2.  Collection of Existing Information on Cumulative Long-term Effects of 
GM Plants 
 
Field releases of genetically modified organisms (GMOs) have grown enormously since the 
first field trial was held in 1986 (OECD, 1993).  Field trial approvals almost doubled every 
year between 1988 and 1994 and reached a peak in 1998 at 2,312.  During the nine-year 
period 1996 to 2005, the global area of biotech crops increased more than 47 fold, from 1.7 
million hectares in 1996 to 90.0 million hectares in 2005 (ISAAA, 2005).  Table 1 below 
shows global plantings of GM crops worldwide. 
 
Table 1: Global plantings of GM crops in 2004 and 2005 (Source: ISAAA) 
GM crop plantings (million ha) 
Country 2004  %  change 2005 
USA 47.6  +4.6  49.8 
Brazil 162  +5.6  17.1 
Canada 5.0  +88.0  9.4 
China 5.4  +7.4  5.8 
Paraguay 3.7  -10.8  3.3 
India 1.2  +50.00  1.8 
South Africa  0.5  >100  1.3 
Uruguay 0.5  0  0.5 
Australia 0.3  0  0.3 
Mexico 0.2  +50.0  0.3 
Romania 0.1  0  0.1 
Philippines 0.1  0  0.1 
Spain 0.1  0  0.1 
Colombia <0.1  0  0.1 
Iran -  -  <0.1 
Honduras <0.1-  -  <0.1 
Portugal -  -  <0.1 
Germany -<0.1  -  <0.1 
France -  -  <0.1 
Czech Republic  -  -  <0.1 
Total  81.0 +11.1  90.0 
 
To date, the vast majority of releases involve GM plants; bacteria, fungi, viruses and animals 
account for only 1.0%, 0.1%, 0.3% and 0.2% of releases respectively (OECD, 2000a).   
Worldwide, the principal GM crops are soybean, maize and cotton, most of these contain a 
single transgene that modifies the plant for herbicide tolerance and or insect resistance, 
although plantings of twin trait (herbicide resistant and insect tolerant) cotton and maize was 
reported in 2004 (James, 2004).  GM plants with traits that influence virus resistance, crop 
quality, male sterility and disease resistance are less common, but it is reasonable to expect 
increasing developments in these areas in the future. 
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2.1. Risk assessment: definition and requirements 
 
Environmental risk assessment is the practice of determining the nature and likelihood of 
effects of human actions on animals, plants and the natural environment; it requires estimating 
the probability of harm to plant and animal life, and to ecosystem integrity (ERMA, 2004).  
Many environmental risks fall into the low probability and high consequence category which 
means that they cannot easily be compared with other types of risk; environmental risks may 
also have long lead times between cause and effect, with the possibility of irreversible 
outcomes.  Risk assessment of GMOs aims to identify and assess all risks that could result in 
harm to human health or the environment due to the proposed dealings with the GMO. 
 
Risk assessment comprises three main steps, firstly hazard identification, which involves 
analysis of what, how, where and when something could go wrong and the causal pathway 
leading to that adverse outcome.  Hazard identification is arguably the most important 
component of any risk assessment; failure to correctly identify hazards will be carried through 
the assessment process with the likely outcome that risk will be underestimated.  Tools and 
techniques are available to assist in identification of hazards, these are mostly deductive with 
the most commonly cited approaches being comparison with previous experience, 
brainstorming and checklists, however there is interest in the use of inductive hazard 
identification techniques in connection with ecological risk assessment (e.g. Hayes 2004).  
Hazard identification is followed by consideration of the likelihood of an adverse outcome 
and the severity of that outcome, or the consequences – if it happened would it be a problem.  
In making these assessment, aspects such as the possible severity of the hazard, the likely 
spatial and temporal extent, reversibility and possible cumulative impacts must be taken into 
consideration.  The final stage is risk estimation in which the probability that the potential 
harm would be realized is determined; the risk estimate is a combination of the likelihood and 
consequences of an adverse outcome and assessment of likely interactions between the two, it 
should also incorporate consideration of uncertainty.  Risk estimation is considered in the 
context of the ease with which management and mitigation options may be implemented and 
how effective they would be. 
 
Risk estimations can be qualitative, semi-quantitative or quantitative, and if completed in a 
systematic and rigorous manner should be a valuable aid to decision making.  There is no 
universally applicable procedure for conducting ecological risk assessment, indeed a 
multiplicity of techniques and methods are available (Hayes, 2003). This is due in part to the 
relative immaturity of ecological risk assessment as a discipline, but also in part to the 
complexity of environmental management issues and the variety of possible stressors and 
measurement endpoints, and thus the widely different types of assessment that are required.  
In the years since GM crops have been entered into trials and, more recently, placed on the 
market, there has been an increasing recognition of the importance of a robust, transparent 
and statistically sound approach to risk assessment that can be applied to a range of crop / 
environment scenarios, and which enables decision makers to assess GM crops or products in 
the context of prevailing policy, consumer and economic considerations.  To achieve this, the 
scope and context of the risk assessment must be clearly defined, including the characteristics 
of the receiving environment. In addition, appropriate baselines against which to compare the 
properties and characteristics of the GM crop and the unmodified equivalent must be 
established. 
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Uncertainty analysis 
Regardless of whether qualitative or quantitative risk assessment is used, it must be based on 
evidence.  Biological systems are complex and environmental risk assessments will inevitably 
be faced with considerable uncertainty both in terms of variability of data and lack of 
information.  Analysis of these uncertainties is a critical component of ecological risk 
assessment; it distinguishes risk assessment from impact assessment and promotes 
transparency and credibility, and leads to improved decision-making (Hayes 2003).  In 
qualitative analysis, ‘linguistic uncertainty’ is particularly prominent since terms such as “low 
risk” for example are routinely used without reference to exposure, but with sufficient time or 
number of “trials”, low risk events may be more or less certain.  Contextual uncertainty can 
occur in the spatial and temporal components of the risk assessment and in its scope, 
resolution and boundaries.  Linguistic and contextual uncertainty can be reduced by carefully 
defining the terms of reference and language in the risk assessment, but ultimately they can 
only be eliminated mathematically.  Epistemic uncertainty reflects our limited knowledge of 
ecological systems; it occurs as measurement error – random (resulting from imperfect 
measuring devices) and systematic (resulting from bias), natural variation, model error, 
subjective judgement and ignorance.  Ignorance, model error and measurement error are often 
collectively known as incertitude because they can be reduced with empirical effort.  Random 
measurement error is minimised by taking additional measurements; systematic measurement 
error is minimised by careful experimental design and instrument calibration; natural 
variability cannot be reduced with empirical effort but can be described mathematically.  Risk 
assessment models will also introduce uncertainty (Ferson and Ginzberg, 1996).  When 
considering cumulative long-term impacts of GM crops our level of uncertainty is further 
increased, hence increasing the importance of transparent uncertainty analysis. 
 
Cumulative and long-term effects 
The potential long-term effects of GM crops on (agro)-biodiversity are often considered a 
major concern.  However, a central problem is to define the term ’long-term‘ (van der Meer, 
1993); it may vary from months to decades or centuries, depending on the organisms, 
environments and genes involved.  To assess any potential unintended negative impact, 
information from over 10 to 100 generations of a species may be required (Kasanmoentalib, 
1996).  An authorisation to place a GM crop on the market is generally given for 10 years; 
however Conner et  al (2003) estimate that, based on available data to date, it will take 
decades for current GM crops to have appreciable ecological consequences, if any, on a single 
agricultural site, and that it will take centuries for any appreciable ecological consequences, if 
they exist, to occur on a more global scale.  Potential cumulative effects might be expected to 
occur more rapidly if the same GM crop is grow repeatedly within a specified area, however, 
identification of cumulative effects at an early stage will be dependent on monitoring 
programmes, and in the absence of these, growers’; observations.  Hill et al, 2003 suggested 
that with GMOs (as with chemicals), poor data and confounding factors generally make it 
difficult to detect ecologically meaningful relationships, even where they do exist, and that 
the possibility of missing any effects is large because the statistical power to detect significant 
relationships is often low.  Clearly, the availability of statistically useful relevant baseline data 
for use as a comparator for detection of changes in ecological trends will be a key requirement 
for interpretation of long-term monitoring data.  In the USA where GM crops are most widely 
grown, there is no such requirement for deliberate monitoring of GM crops grown on a 
commercial scale, although any adverse or unanticipated effects must be reported to the 
regulatory authority.  In Europe the requirement and framework for post market monitoring is  Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  
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in place, but as the scale of cultivation of GM crops is limited to date, very little data has been 
gathered and it is unclear how monitoring arrangements will work in practice. 
 
2.2. A review of evidence available from the scientific literature 
 
The scientific literature was reviewed to identify any evidence that (1) effects are known to 
occur as a result of the insertion of a GM construct into plants, (2) effects have been recorded 
as the result of current long-term, large scale releases, (3) any unanticipated potential effects 
have been identified. The review concentrated on environmental effects, allergenicity effects 
of GM plants on the human population and adverse effects on animal health resulting from 
the use of antibiotic resistance genes in constructs. 
 
Effects can result from: 
Direct impacts (What the crop is): impacts which arise as a result of the modifications to the 
crop itself. These may include the effects on human health, gene flow, unintended effects on 
non-target species, and impacts on soils. 
Indirect impacts (How the crop is grown): impacts arising from the effects of GM crops 
management on the environment. These include changes to farming inputs, farm management 
practices such as tillage, and broader impacts on the water resources and pollution, and 
farming landscape. 
What the crop is used for: impacts arising from the development of new crops which may 
grown to replace non-renewable energy sources; have health benefits (such as enhanced 
vitamin content); or be used to make pharmaceuticals. 
 
Summary of scientific evidence for risks associated with GM crops 
A large number of papers have been published reviewing the anticipated effects of GM crops. 
Some experimental studies have been carried out in the laboratory or glasshouse. These are 
useful in providing indicators of possible risks but are often criticised as being artificial and 
not resembling conditions encountered in the field. 
 
The number of intensive studies carried out under field conditions has been small and they 
have generally been relatively short –term. Even the UK Farm Scale Evaluation (FSE) trials 
were only carried out over 3-4 years (possibly 6 years if the post release monitoring period is 
included). The largest scale releases of GM plants have been carried out in countries outside 
the EU, for example, the USA and China. However, there have only been few cases where 
these releases have been systematically and scientifically monitored and where the results of 
this have been published in the scientific press. 
 
During the course of this review of the literature we have identified the following as areas 
where some potential long-term/ cumulative effects of GM crops have been scientifically 
verified: 
 
Effects of the use of herbicides with herbicide tolerant (HT) GM crops on weed 
populations and seed banks:  The UK FSE trials identified effects of GM crops on the 
number and diversity of weed seeds left in the soil after the crops had been grown. The 
number of weed seeds were reduced after GM crops had been grown, presumably as a 
result of the herbicide application. The effects on weed seed levels persisted through the 
second season after the GM crops had been removed. It is anticipated that this will affect 
the number of seeds available as food for insects and birds. Effects were more substantial 
with the crops of GM HT sugar beet and oilseed rape than with GM HT maize. Studies of  Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  
risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
  13
 
long-term GM HT crop releases in the USA have shown that the weed populations within 
crops shift to those which are naturally herbicide tolerant and that herbicide tolerant forms 
of common weeds emerge in some cases. 
Effects of Bt crops on non-target insect populations: Most of the studies confirm that 
non-target insect populations remain at similar levels under GM crops. However, there are 
some studies, which suggest that fewer natural predators are present and that the 
population may be more ‘unstable’. 
Development of resistance to Bt: Monitoring of Bt crops to date has confirmed that the 
Bt resistance is holding up.  However, laboratory experiments have suggested that it is 
quite feasible that resistance will develop in the long-term if crops are grown widely.  
Effects of GM crops on soil decomposition: there are some well documented examples 
of effects of GM crops on soil decomposition and soil organisms. These are mainly from 
laboratory studies and effects appear to be transient - it is therefore not known whether 
these will contribute to long-term effects. 
Gene flow to wild relatives: There are some studies where gene flow from GM or 
conventional crops to wild relatives has been substantiated in the field. Most authors agree 
that this will occur in the field at low levels where crops are grown in close proximity to 
compatible relatives, however, there is no evidence to show whether GM genes are likely 
to become established in the population. Only genes which confer a selective advantage 
are likely to become fixed in the wild population. 
Lower usage of pesticide sprays: A number of studies have identified a reduction in the 
number of pesticide sprays applied compared to conventional crops, particularly for Bt 
crops. This could lead to better human health and less effect on non-target insects. 
 
2.3. Existing plans and methodologies used for GMO risk assessment 
 
Most developed nations producing or releasing transgenic products have put in place 
regulatory systems aimed at assessing and managing risks associated with products of 
biotechnology developments to ensure protection of human and animal health and the 
environment.  For example, the United States, Canada, New Zealand, Australia, Argentina 
and the European Union have individually enacted legislation that requires assessment of the 
ecological and human-health risks associated with the contained use and deliberate release of 
GMOs.  On a much wider scale, the parties to the Convention of Biological Diversity adopted 
the Cartagena Protocol on Biosafety in January 2000, providing an international regulatory 
framework to reconcile the respective needs of trade and environmental protection in the 
context of the rapidly growing global biotechnology industry.  The Cartagena protocol also 
bases assessments of movements of living modified organisms, (as GMOs are termed in the 
protocol) on principles of risk assessment and risk management.  Similarly, international 
organisations such as the Organisation for Economic Co-operation and Development 
(OECD), the Food and Agriculture Organisation of the United Nations (F AO), the United 
Nations Environment Programme (UNEP), the International Plant Protection Convention 
(IPPC), the Association of Southeast Asian Nations (ASEAN) to name a few, have all 
considered developments in plant biotechnology and developed frameworks for assessment of 
the risks associated with release and movement of genetically modified crops. 
 
Two general concepts have been proposed to guide ecological risk assessment in regulatory 
and associated procedures; these are the concept of familiarity and the precautionary 
principle.  The concept of familiarity is based on the fact that most genetically modified Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  
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organisms are developed from organisms such as crop plants whose biology is well 
understood (OECD, 1993a).  Familiarity allows the risk assessor to draw upon previous  
 
knowledge and experience with the introduction of similar crops, including GM crops, into 
the environment, and to use the non-GM crop as the comparator to the GM crop in order to 
highlight differences associated with the genetic modification and the subsequent 
management of the GM crop.  Some consider this concept to be too loosely defined to be very 
useful for risk assessments (Levidow et al., 1996; Regal, 1999; Torgersen, 1996), nevertheless 
it is still widely used in GMO risk assessment, particularly for assessment of food products. 
 
The precautionary principle was first introduced in the Rio Declaration of the Convention of 
Biological Diversity (CBD), stating: ‘‘where there is a threat of significant reduction or loss 
of biological diversity, lack of full scientific certainty should not be used as a reason for 
postponing measures to avoid or minimise such a threat’’ (CBD, 1992). It has since seen 
many different and much more generalised forms (Goklany, 2000).  The Cartagena Protocol 
on Biosafety (SCBD, 2000) and the EU GMO regulatory framework are both based on the 
precautionary principle. 
 
We have reviewed many risk assessment frameworks for which information is publicly 
available, paying particular attention to guidance given with respect to cumulative long-term 
effects.  A number of similar reviews have been undertaken in recent years and we have used 
these as a starting point.  Summaries have been drawn from the “Ad hoc expert group on risk 
assessment” established under the Cartagena Protocol on Biosafety
1, and a review by K. R. 
Hayes (CSIRO, Australia, 2003) entitled “Robust methodologies for risk assessment; best 
practice and current practice in ecological risk assessment for GMOs”.  Each methodology 
was reviewed in terms of its scientific principles and framework, approaches to hazard 
identification, likelihood and consequence assessment, uncertainty analysis, monitoring and 
reviewing, and finally whether cumulative long-term effects must be considered. 
 
Details of twenty eight publicly available approaches to GMO risk assessment were reviewed, 
although many more could have been found.  The key framework in use by member states of 
the EU is EU Directive 2001/18/EC (specifically Annex II)
2 and associated guidance 
documents, also guidance produced by the European Food Safety Authority (EFSA) in 
connection with regulation 1829/2003
3 on genetically modified food and feed.  Within the EU 
member states, we have also reviewed national guidance developed by the UK and Italy.  
Internationally, we identified 10 organisations presenting approaches specifically for GM risk 
assessment, these range from being extremely detailed frameworks such as that developed by 
the Australian Office of the Gene Technology Regulator (OGTR) to much broader guidelines 
such as those published by the Association of South East Asian Nations (ASEAN).  In USA, 
New Zealand and Switzerland GMO risk assessment is undertaken in the broader context of 
releasing ecological ‘stressors’ such as new organisms or hazardous substances.  Risks 
associated with plant pests and pathogens and non-native species have parallels with release 
                                                 
1 http://www.biodiv.org/biosafety/cop-mop/result.aspx?id=10787 
2 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on 
the deliberate release into the environment of genetically modified organisms and repealing 
Council Directive 90/220/EEC - Commission Declaration. OJ L 106 , 17/04/2001 p.1 – 39). 
3Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 
September 2003 on genetically modified food and feed (Text with EEA relevance) (OJ L 
268, 18/10/2003 p.1 – 23). Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  
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of GMOs and risk assessment methodologies for these were also reviewed.  To provide 
conceptual thoughts on the approach to long-term cumulative risks, we identified the US  
 
Environmental Protection Agency (EPA) framework for assessment of cumulative risks.   
Reviews of the risk assessment methodologies are in Annex 2, table 2 below summarises the 
key features of the (thirteen) most detailed frameworks. 
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Table 2: Summary of detailed risk assessment methodologies for the release of genetically modified organisms 
 
Does the method take into account these issues and are clear guidelines provided 
Method 
Specific 
to 
GMOS? 
Scientific 
principles 
Hazard 
identification 
Likelihood & 
consequence 
assessment 
Uncertainty 
analysis 
Monitor & 
review 
Long-term / 
cumulative 
effects 
EU Council Directive 
2001/18/EC 
9 
Precautionary 
principle; 6-step 
ERA framework.  
Case-by-case 
General 
guidelines, no 
specific 
techniques; 
checklists 
General 
guidelines, no 
specific 
techniques 
Uncertainties must 
be documented 
General 
surveillance 
monitoring 
required in all 
cases 
Must be 
considered in 
context of 
monitoring 
EFSA guidance for the risk 
assessment of GM plants 
and derived food and feed 
2005 
9 
Precautionary 
principle; 6-step 
ERA framework.  
Case-by-case 
General 
guidelines, no 
specific 
techniques; 
checklists 
General 
guidelines, no 
specific 
techniques 
Uncertainties must 
be documented 
General 
surveillance 
monitoring 
required in all 
cases 
Must be 
considered in 
context of 
monitoring 
UK (Defra) guidance on 
principles of risk 
assessment and monitoring 
for the release of GMOs 
9 
Precautionary 
principle; 6-step 
ERA framework.  
Case-by-case. 
General 
guidelines, no 
specific 
techniques; 
checklists 
General 
guidelines, no 
specific 
techniques 
Uncertainties must 
be documented 
General 
surveillance 
monitoring 
required in all 
cases 
Must be 
considered in 
context of 
monitoring 
Italian Ministry of 
Agriculture 
9 
Model-driven 
approach based on 
risk analysis and 
risk management.  
Science-based and 
case-by-case. 
Hazard 
identification s 
based on 
assessment of 
source, diffusion 
factors, migration 
routes and 
receptors 
Likelihood and 
consequence is 
calculated by the 
model, based on 
answers to 
electronic 
questionnaire 
Not mentioned in 
the preliminary 
document we have 
seen 
Not mentioned in 
the preliminary 
document we have 
seen. 
So far applied to 
experimental 
releases only, so 
long-term 
cumulative risks 
do not appear to 
have been 
considered yet. 
CBD: The Cartagena 
Protocol 
9 
Precautionary 
principle.  Best 
practice using 
recognised RA 
techniques should 
be used.  Case-by-
case. 
No specific hazard 
identification 
techniques 
recommended 
No specific 
techniques 
recommended.  
Receiving 
environment is 
key. 
Uncertainty to be 
managed by 
obtaining more 
information 
Monitoring is a 
means of 
managing 
uncertainty. 
Not specifically 
mentioned Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  risk assessment methodologies 
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UNEP International 
technical guidelines for 
safety in biotechnology 
9 
Familiarity is key 
concept. 3-step 
assessment, but 
not a strict 
framework. 
No specific hazard 
identification 
techniques 
recommended 
No specific 
techniques 
recommended.  
Forecasting and 
quantitative 
approaches may 
be appropriate 
Not referred to  To verify 
assumptions of 
risk assessment & 
evaluate efficacy 
of risk 
management. 
Not specifically 
mentioned 
US EPA: Guidelines for 
ecological risk assessment 
(1998) 
8 
ERA is applicable 
for chemical, 
physical and 
biological 
stressors.  3-phase 
framework - 
problem 
formulation, 
analysis and risk 
characterisation  
Conceptual model 
for use by risk 
assessors is 
provided 
Conceptual model 
for use by risk 
assessors is 
provided 
Discussed in 
detail; techniques 
for addressing 
uncertainty 
discussed. 
Not discussed 
specifically, but 
implicit through 
document 
No specific 
requirement, but 
rigorous model 
should make 
extrapolation 
possible 
Canadian FIA: Assessment 
criteria for determining 
environmental safety of 
plants with novel traits 
(2004)  9 
5-stage 
framework; 
familiarity with 
unmodified 
equivalent is key 
feature. Can 
extend ERA to 
group of similar 
GMOs. 
No specific hazard 
identification 
techniques 
recommended 
Based on practical 
experience. 
Reference made to 
seed dormancy 
model 
Not discussed  Post-release 
programme is 
required for 
unintended &/or 
unexpected 
effects. 
Not specifically 
mentioned 
Australia: Office of the 
Gene Technology 
Regulator Risk Analysis 
Framework (2005)  9 
3-stage framework 
based on best 
scientific practice. 
Case-by-case.  
Unmodified 
organisms as the 
comparator 
Techniques to be 
used are not 
specified, but 
checklists and 
techniques that 
could be used are 
provided 
Risk estimation 
matrix is provided 
with guidance on 
scale and 
terminology. 
Discussed in detail 
and is required as 
part of the ERA.  
Advice is given on 
how this might be 
approached 
Risk management 
component is 
required as part of 
framework 
Must be 
considered and 
management 
options presented. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  risk assessment methodologies 
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New Zealand ERRMA: 
Identifying Risks (1999) 
8 
5-step risk 
assessment 
framework. Case-
by-case.  
Environmental 
baseline is 
comparator. 
Must demonstrate 
thorough 
consideration of 
hazards.  
Comprehensive 
list of tools & 
techniques 
provided. 
No specific 
techniques 
recommended.  
Qualitative, 
quantitative and 
semi-quantitative 
approaches 
discussed, 
reference to NZ 
standards made. 
Discussed in 
detail.  Focuses on 
consideration of 
significance of 
variability.  Data 
used must be 
checked for 
statistical 
competence & 
have been peer-
reviewed 
Explicitly required 
in ERA 
framework.  No 
guidance on this is 
given 
Implicit 
throughout the 
document but no 
specific guidelines 
IPPC International 
Standard for Phytosanitary 
Measures #11, 2004 (ISPM 
11)  8 
Plant 
health 
3-step risk 
assessment 
framework.  Case-
by-case.  Focused 
on potential for 
entry, 
establishment and 
spread of non-
native pests 
Techniques to be 
used are not 
specified, but 
comprehensive 
checklists and 
techniques that 
could be used are 
provided 
Detailed guidance 
provided on 
assessment of 
probability and 
consequence, 
includes economic 
consequences. 
Must be 
considered and 
documented where 
main areas of 
uncertainty lie.  
No techniques 
recommended 
Conclusion of the 
PRA is whether 
risk management 
is required and 
what needs to be 
used. 
Assessment of 
potential long-
term consequences 
of pest entry is 
implicit in PRA 
EPPO Framework for Pest 
Risk Analysis (DATE?) 
8 
Plant 
health 
3-step risk 
assessment 
framework.  Case-
by-case.  Focused 
on potential for 
entry, 
establishment and 
spread of non-
native pests 
Techniques to be 
used are not 
specified, but 
comprehensive 
checklists and 
techniques that 
could be used are 
provided 
Detailed guidance 
provided on 
assessment of 
probability and 
consequence, 
includes economic 
consequences. 
Must be 
considered and 
documented where 
main areas of 
uncertainty lie.  
No techniques 
recommended 
Conclusion of the 
PRA is whether 
risk management 
is required and 
what needs to be 
used. 
Assessment of 
potential long-
term consequences 
of pest entry is 
implicit in PRA Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  risk assessment methodologies 
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UK (Defra) Standard 
Methodology to assess the 
risks from non-native 
species considered possible 
problems to the 
environment (2005)  8 
Non-
native 
species 
6-step risk assessment 
framework.  Case-by-case 
Comprehensive 
step-by-step 
guidance 
provided 
including scores 
(unlikely 
through to very 
likely).  
Electronic 
template 
available 
Comprehensive 
step-by-step 
guidance 
provided 
including scores 
(unlikely 
through to very 
likely).  
Electronic 
template 
available 
Must be taken 
into account; 
mathematical 
approach to 
calculation of 
conditional 
probability 
presented. 
Worksheets are 
provided.  
Options for 
further work in 
this area 
discussed 
Final module of 
PRA is 
dedicated to 
risk 
management 
options and 
monitoring of 
efficacy. 
Assessment of 
potential long-
term 
consequences 
of pest entry is 
implicit in PRA Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  
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Risk assessment methodologies - summary 
There is no universally adopted approach for undertaking environmental risk assessments for 
the release of GMOs.  All the risk assessment methodologies reviewed did, however, follow a 
similar approach based on a case-by-case scientific framework aimed at assessment of 
hazards, potential for exposure and consequences of exposure, followed by consideration of 
risk management.  The EU framework follows this basic approach in a six-step analysis; the 
guidance document is detailed but does not describe any tools that may be used at the various 
stages; brief guidance is provided on consideration of uncertainty, but again little guidance on 
how assessments could be made.  Outcomes of the ERA need not be quantified, but should be 
relative, e.g. to a non-GM comparator; the overall evaluation of risk of the GMO must take 
into consideration strategies employed to manage risks. 
 
The Australian OGTR ‘Risk Analysis Framework’ is the most recent publication and 
probably provides the greatest level of accessible guidance for completing all stages of the 
risk assessment.  The model used is clearly explained, clear terminology for likelihood and 
consequence assessments are provided together with matrices for assessment of risks; it also 
devotes quite a few pages to an easily understandable discussion of the role of uncertainty in 
assessment.  Assessment of long-term cumulative risks is required in the context of 
consequence assessment and is not a separate consideration per se within the framework.  The 
guidance is focussed on GMOs and is presented very clearly, including details of the 
regulatory process for GMOs in Australia and the responsibilities of the OGTR.  The New 
Zealand framework is similarly detailed (although not focussed specifically on GMOs), and 
again considers long-term cumulative risks in the context of hazard and consequence 
assessment as part of the overall process, it also asks the applicant to consider more socially-
oriented questions, for example in relation to Maori values, and future generations, which 
have relevance for longer term effects.  The US EPA has developed an extremely complex 
generic framework in which terminology is clearly defined and flow diagrams illustrate the 
process, but it may be somewhat unwieldy and daunting to the prospective risk assessor.  
While the Australian, New Zealand and USA frameworks are very much written from the 
perspective of the risk assessor, the EU framework, although comparable in concept, in 
presentation is far more focussed on science and consideration of real scenarios that may arise 
as a result of release of the GMO.  Synthesis of the two approaches might prove powerful. 
 
Throughout the documents reviewed the most common approaches to hazard assessment 
involve brainstorming and use of checklists; there is limited reference to structured tools and 
techniques which support deeper questioning of ”what happens if…?”, although the New 
Zealand guidance for identifying risks explores techniques in greater depth.  Hayes (2004) 
considers uncertainty analysis to be the very rationale of risk assessment, fundamental to 
ensuring that “we don’t have any regrets about releasing particular GMOs”, yet, apart from 
the Australian and USA approaches, there is limited attention paid to uncertainty analysis.  
With GMOs, as with chemicals, Hill et al, 2003 suggested that poor data and confounding 
factors generally make it difficult to detect ecologically meaningful relationships, even where 
they do exist, and that the possibility of missing any effects is large because the statistical 
power to detect significant relationships is often low. 
 
Most of the frameworks do not specify criteria for acceptability, or otherwise, of risks.  This 
is understandable when we think that such decisions must be taken in the context of shifting 
policy goals and, in Europe, of national regulatory frameworks.  The European Environment 
Agency reported in 1999 that “differences in acceptability of risks are evident across the  Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  
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different member states of Europe where acceptable and unacceptable risks vary widely 
between member states, leading to differences in interpretation of the deliberate release 
directive”, some evidence of this was found in this study when we undertook to assess 
competent authority(CA) requirements of the risk assessment process, this is discussed in 
more detail later in the report. 
 
Consideration of cumulative long-term effects is implicit in risk assessment frameworks 
presented by the USA, Australian and New Zealand models, but mainly in the context of 
anticipated adverse effects of the GMO under consideration.  The frameworks do not 
specifically provide guidance for assessment of effects that might be expected to arise in the 
longer term, or cumulatively due to large-scale release of a particular GMO, or interaction 
with other GMOs in the environment.  Models developed for pest risk assessment or non-
native species assessment focus on longer-term probabilities and include more detailed 
analysis of uncertainty, it is possible that some elements used in these assessments may also 
be useful for consideration of the release of GMOs.  Consideration of the broader, 
unanticipated effects of the commercial release of GM crops is covered in the European 
legislation but no specific framework for assessment is suggested, nor is clear guidance 
provided on the key issues that must be considered, the questions that should be asked.  We 
found only one reference relating specifically to assessment of cumulative long-term risks; in 
2003 the United States Environmental Protection Agency published details of an initiative to 
‘develop a simple, flexible structure for conducting and evaluating cumulative risk 
assessment’ (summarised in Appendix 2 ).  The approach is essentially similar to ecological 
risk assessment but differs fundamentally in focusing on assessing the combined effects of 
more than one agent or stressor (leading to greater need for assessment of interactions and 
uncertainty), and there is increased focus on the populations potentially affected.  This 
framework is unlikely to be applicable to the release of GMOs, but may prove conceptually 
useful as it evolves. 
 
2.4. A review of the regulatory context and needs. 
 
Formal scientific risk assessment is normally only part of a wider process of decision-making 
and risk management.  We have attempted to establish what regulators operating within the 
EU regime could appropriately expect from risk assessment in the case of long-term and 
cumulative effects of GM crops.  We directed a set of questions at EU member states’ 
competent authorities to determine the extent to which they rely upon risk assessments in their 
decision making, and the variations in the scope of what the risk assessment is expected to 
cover. 
Questionnaire responses 
The questions that were directed at the competent authorities and the replies that we received 
are listed in Table 3 below.  Of the 29 individuals approached, formal replies were received 
from twelve competent authorities, ten of which are summarised below and nine full replies 
are provided in Appendix 3 of the report.  Some member states did not feel qualified to 
answer the questions, in particular some of the new member states because they have limited 
experience of the authorisation procedure.  We are very grateful to those who were able to 
respond for providing such comprehensive answers.  Replies were provided from 
Scandinavian, Mediterranean, western, central and eastern regions of from EU-15 and some 
of the newer member states, we think this has provided a reasonably good representation of  
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views.  It is important to note, however, that none of the respondents are currently cultivating 
GM crops. 
 
A key point to emerge was that the understanding of ‘long-term’ depends on the context of 
the release, for example perennial crops have very different timeframes from fruit or forest 
trees and therefore long-term must be a variable factor set on a case-by-case basis.  There was 
general consensus that long-term is the period of time beyond the ten years of the consent, 
and can be anything up to 100 years.  Cumulative effects were generally considered as those 
due to repeated release of the same GMO or trait, or the effects of release of different GMOs 
in one area.  Many member states were unwilling to be drawn on what long-term or 
cumulative effects may occur, but most comments related to potential for gene flow leading to 
impacts on biodiversity, effects of changes in agricultural practice and allergenicity effects in 
humans.  One member state commented that effects that might be anticipated as the result of 
cultivation of a GM crop could be just as likely to occur due to the introduction of a new 
conventional crop or change in management practice.  In most cases member states have 
national environmental monitoring schemes in place and anticipate that these will be reviewed 
and adapted to enable monitoring of any potential effects of the release of GMOs; proving 
cause and effect may prove difficult.  In many cases respondents thought that current 
monitoring programmes would not be sufficient to identify long-term or cumulative effects; 
for this aspect of the review it would have been interesting to have received responses from 
those countries currently cultivating GM crops. 
 
Responses regarding the EU risk assessment framework and whether it adequately enables 
applicants to address potential long-term and/or cumulative effects varied, some suggested 
that clearer guidance to applicants from the European Commission would be beneficial, while 
others thought that monitoring aspects of applications generally needed to be improved.  None 
of the respondents had developed their own criteria for environmental impacts against which 
they assess the acceptability of the GM releases; some respondents base their judgements on 
the framework provided by directive 2001/18 (Annex II) while others are currently 
developing their own criteria.  A number of member states commented that where a crop 
offers a clear environmental benefit and/or a benefit to society, it was likely to be assessed 
less stringently than a crop that offered no clear benefits.  No models for risk assessment were 
proposed for consideration within the European context. 
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Table 3: Summary of responses to questionnaire, by respondent in no particular order.  
Full (anonymous) responses are provided in Appendix 3. 
 
Questions: 
 
•  What do you understand by ‘long-term’ - 10 years, 50 years, 100 years or other? 
•  What sort of effects do you think might emerge after this period of time?  What 
are your reasons for thinking this? 
•  What monitoring arrangements do you have in place that would support 
identification of such effects, should they occur? Do you envisage that it will be 
possible to prove cause and effect given your current monitoring arrangements? 
•  What do you understand by cumulative effects? 
•  What sort of cumulative effects do you think might emerge after what you have 
defined as the long-term in Q2?  What are your reasons for thinking this? 
•  Do you think the monitoring arrangements in place in your member state are 
adequate to identify these effects, should they occur? 
•  Do you think the current EU risk assessment framework enables applicants to 
address adequately the potential long-term cumulative effects of GMOs?  Do 
applicants generally pay sufficient attention to this aspect of applications?  What 
do you think would improve this aspect of the authorisation process? 
•  Do you have specific criteria for deciding what are acceptable and unacceptable 
risks?  If so, can you let us know what these are and why you have identified 
these? 
•  Are there any models used by other regulatory authorities worldwide that you 
would like to be incorporated into the European approach that might provide for 
a better assessment of long-term cumulative risks? 
•  Are you aware of any reports of unexpected effects of the release of a GMO? 
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Question   
1  2  3 4 5  6  7  8  9  10 
1 Not  fixed,  but 
exceeds the 
time period of 
the consent of 
a specific 
product.  Will 
be defined on 
a case-by-case 
basis – e.g. 
timeframe for 
tree is different 
to perennial 
plant.  
Intensity of 
usage also 
determines 
what is ‘long-
term’ 
Dissemination of 
GMO into different 
habitats (similar to 
experiences with 
invasive non-native 
species).  Gene 
stacking, multiple 
resistances, long-
term change in 
agricultural practice 
due to intensification, 
soil alteration, Bt 
resistant pest species, 
HR weeds, long-term 
loss/change of 
natural habitats, 
subtle elimination of 
wild species by 
cultivated GMO, 
continuous 
contamination of 
crops  
Concept for 
national 
biodiversity 
monitoring 
currently 
being 
developed – 
will be very 
difficult to 
design a 
monitoring 
programme 
that will 
foresee 
unknown 
effects. Good 
statistical 
design will be 
essential 
Cumulative 
effects are 
effects that 
arise from i) 
placing on 
market of 
several 
different 
GMOs; ii) 
introduction 
of same trait 
in several 
GMOs (e.g. 
Bt, HR), iii) 
intensification 
of agricultural 
practice due to 
the GMO 
Soil 
alterations due 
to cumulative 
use certain 
herbicides or 
GMOs; 
multiple 
herbicide 
resistance in 
weeds; 
accelerated 
selection of Bt 
resistant pest 
spp; transgene 
contamination 
in non-GMO 
crop varieties; 
change/loss of 
natural 
habitats &/or 
biodiversity 
due to 
intensification 
of agricultural 
production. 
No –not at 
the moment 
Applicants generally 
do not address long-
term or cumulative 
risks adequately; 
monitoring plans are 
in most cases 
insufficient; the 
current procedure 
only identifies short-
term effects.  Effects 
of GMOs in 
combination with 
agricultural practice 
should be analysed 
No specific 
criteria at the 
moment for 
environmenta
l aspects. 
Broadly 
speaking 
criteria are 
protectionist 
& consensus 
in society.  
For human 
health 
effects, 
assessment 
of 
toxicology, 
allergy & 
substantial 
equivalence 
are key 
criteria 
 Stem  split 
of GM 
soybean 
under stress 
conditions; 
loss of 
unripe 
cotton balls 
on GMO 
cotton; 
change of 
fat 
compositio
n in cow 
milk upon 
feeding 
with GMO 
soybean, 
gene 
stacking of 
herbicide 
tolerance 
traits in 
Canada.  
Plus 1 
reference 
provided 
2 10  years  or 
more 
Public health effects 
(allergies & toxicity) 
&/or environmental 
effects (GMO 
crossing with non-
No specific 
monitoring for 
GMOs at 
present 
Cumulative 
effects are 
indirect & 
long-term due 
to intended 
Could be both 
environmental 
& human 
health effects, 
e.g. escape of 
 General  surveillance 
plans need to be 
more detailed & 
prescriptive, & 
provide detail of 
No specific 
criteria 
No model. 
But feeding 
studies 
should be 
more 
Unexpected 
release of 
GMO 
products 
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GMO).  Under 
National law, permit 
will only be granted 
for 5 years 
release.    GMO plants 
to the wild, 
affecting wild 
flora; allergies 
or toxicity 
ling after 
being placed 
on the market 
preventive measures.  
Further assurances 
for proper 
implementation 
should also be 
sought.  The issue of 
unintended release 
should be considered 
more thoroughly.  
Needs to be 
improvements in 
accuracy & precision 
of analytical 
methods, e.g. for 
compound feeds. 
prolonged; 
need more 
thorough 
evaluation of 
substantial 
equivalence 
& need 
further 
investigation 
into long-
term 
consequences 
of GMO 
products on 
fauna & flora 
feed use on 
Japan 
3  20-50 years  Effects caused by 
characteristic of the 
organism &the 
modification; effects 
emerging fro the 
change in agricultural 
practice.  Specific 
effects may be on 
biodiversity, gene 
transfer to wild 
relatives, resistant 
pest populations, & 
changes in use of 
herbicides.  May see 
positive effects, e.g. 
reduced soil erosion, 
reduced use of 
chemical 
insecticides. Should 
be further studies to 
look at effects on soil 
Multi-year 
studies of GM 
crops in place, 
but not aimed 
at systematic 
long-term 
monitoring of 
effects of GM 
crops.  
Monitoring 
network for 
conventional 
crops been in 
place >20 
years, looking 
at agronomic 
performance 
& effects on 
pests, 
diseases, 
biogeochemist
Effects 
occurring at 
same time & 
same place or 
area.  May be 
positive or 
negative 
As in Q3.  
Will also be 
connected 
with 
increasing 
number 
cultivated GM 
crops & 
spectrum of 
new traits.  
Effects very 
difficult to 
anticipate.  
Effects are 
most likely to 
emerge from 
changes in 
agricultural 
practice rather 
than the 
genetic 
Current 
monitoring 
arrangement
s are not 
sufficient.  
Authorities 
& notifier 
should 
monitor for 
these effects.  
Methodolog
y should 
react to new 
traits & 
changes in 
agricultural 
practice 
Framework is very 
general, especially 
for long-term & 
cumulative effects.  
Notifications are 
often too brief in 
these areas.  Existing 
framework should be 
accompanied by 
specific guidelines & 
case studies focused 
on identification of 
possible long-term 
effects.  
Improvement of this 
aspect of the 
authorisation process 
is important 
Risk criteria 
used are 
those given 
in 
2001/18/EC.  
Acceptable 
risks are 
those lower 
than or on 
the same 
level as the 
risks of the 
non-modified 
crop variety.  
A risk-
benefit 
analysis 
should be 
carried out. 
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organisms  ry & soil 
microorganis
ms.  GM 
crops will be 
included in 
this network 
modification 
itself. 
4  20-50 years  More cases of 
contaminated grain; 
increase in stacked 
events, which cannot 
be detected. 
Hybridisation of GM 
OSR in southern 
Mediterranean.  
Possibility of food-
related allergies 
developing 
Current 
monitoring 
would not 
prove cause & 
effect for 
events in 
(Q2). 
Cumulative = 
events 
generated over 
time by a 
combination 
of factors 
Cannot predict  Current 
monitoring 
is not 
sufficient to 
detect 
cumulative 
effects 
Current EU 
regulatory 
framework does not 
require applicants to 
determine long-term 
or cumulative 
effects.  Applicants 
tend to focus on why 
they do not need to 
present information 
Currently 
developing 
risk criteria 
No Starlink 
5 Any  effect 
occurring after 
10 years or 
longer 
Not wise to start 
guessing about 
possible effects, need 
to stick with case-by-
case assessment. 
Only thorough risk 
assessment could 
identify possible 
long-term effects of a 
particular GMO. 
 
Many 
different 
networks exist 
that could be 
applied to the 
observation of 
long-term, 
unforeseen 
effects of 
GMOs.  
Systems exist 
for monitoring 
plant diseases, 
amphibians, 
plants, birds, 
marine life, & 
so on.  Where 
specific 
Effects that 
pile up 
Emergence of 
cumulative 
effects will 
depend on the 
GMO/s in 
question – not 
possible to 
predict them 
as we don’t 
know what 
sort of GMOs 
will be on the 
market in the 
future 
Current 
monitoring 
arrangement
s will 
possibly 
lead to 
detection of 
cumulative 
effects 
Current risk 
assessment 
framework is 
adequate to address 
potential long-term 
effects of GMOs.  
Current application 
process works well 
for these aspects of 
risk assessment 
We use the 
criteria given 
in Directive 
2001/18/EC 
to decide 
whether risks 
are 
acceptable or 
not – this 
Directive 
provides the 
framework 
for such 
decisions 
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monitoring 
requirements 
are identified, 
this will be 
specified in 
the permit for 
release.  Any 
discussion on 
cause & effect 
is purely 
theoretical – 
not possible to 
predict 
whether 
proving cause 
& effect will 
be possible; it 
will probably 
be possible 
6 Long-term 
depends on the 
context – 
species, 
environment, 
human effects 
etc.  Consider 
10 years to be 
adequate but 
e.g. for forest 
trees 10 years 
would be 
inadequate.  
Easier to focus on 
immediate effects & 
health effects, 
allergies may be 
expected in longer 
term.  Environmental 
effects have much 
longer time frame 
anyway, e.g. 
herbicide resistance 
effects could take 
much longer than 10 
years to present, so 
we much think longer 
term anyway.  
Different crops have 
different lifecycles & 
Generic 
schemes are in 
place that 
could pick up 
effects of 
growing GM 
crops, but 
these have not 
been properly 
evaluated yet.  
Monitoring 
networks will 
need clear 
instruction/ed
ucation as to 
what should 
be monitored 
Cumulative = 
sum of factors 
which 
individually 
do not have an 
effect but 
when 
combined, 
may have an 
effect. These 
scenarios 
become 
increasingly 
complex. 
Refer to 
answer given 
for Q3; again 
comes down 
to 
consideration 
on a case-by-
case basis. 
None in 
place at the, 
moment, CA 
will consider 
it when it 
becomes 
necessary. 
No, applicants do 
not generally pay 
sufficient attention 
to long-term risks.  
Very little peer-
reviewed data is 
provided, it is often 
poorly presented & 
with poor 
hypotheses, which 
makes its validity 
questionable.  Data 
is also presented 
from biased 
perspective. Makes 
assessment very 
difficult.  Not 
No specific 
indicators 
identified 
yet.  Would 
be less 
critical in 
assessment 
of a crop that 
demonstrates 
clear benefits 
for the 
country & 
society. 
No   [Referred to 
a couple, 
awaiting 
information
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rotations anyway, so 
risk assessment must 
be considered on a 
case-by-case basis.  
Greatest effects are 
expected to be gene 
flow & effects on 
seedbanks. 
when GM 
crops become 
a more 
realistic 
prospect. 
National 
agricultural 
community 
quite opposed 
to GM crops 
at present so 
prospects for 
cultivation are 
limited. 
necessarily the 
applicants fault as 
2001/18/EC does not 
provide guidance on 
data collection, 
analysis & 
presentation.  CAs 
could be more 
exacting in their 
requirements Clear 
guidance is needed, 
but this would 
require EU-wide 
agreement.  
Independent 
research in this area 
would be very 
valuable. 
7 Depends  on 
the crop – long 
time for a 
perennial crop 
is different to 
that for a 
forest crop.  
For forest trees 
even 100 years 
would not be 
unreasonable. 
Ecological 
timeframes are 
different from 
agricultural 
timeframes 
All / any 
compartments of the 
environment might 
be affected. 
See answer to 
Q7.   
The effects of 
having more 
than one 
GMO, leading 
to a change in 
potential risks; 
this also 
affects the 
long-term 
risks  
All / any 
compartments 
of the 
environment 
might be 
affected. 
Monitoring 
programmes 
are in place 
for 
conventional 
grazing & 
forestry.  
Intensive 
agriculture 
is monitored 
less. 
Tools for monitoring 
are available, lead 
CAs should use 
these & put pressure 
on companies to use 
them.  Applicants do 
generally pay 
sufficient attention 
to these & do a good 
job, but too little 
effort is put into 
monitoring. 
No specific 
criteria.  CA 
weighs 
advantages & 
disadvantage
s.  
Acceptability 
of risks is a 
national, 
internal value 
for each CA, 
not an 
economic 
consideration 
& varies crop 
to crop.  
Would be 
prepared to 
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accept 
greater risks 
for a crop 
that 
demonstrated 
real 
advantages 
for the 
environment 
or general 
public. 
8 10  years  or 
more. 
Magnitude, 
likelihood & 
timing of long-
term effect can 
change 
depending on 
receiving 
environment – 
could change 
in 10-20 years. 
Loss of biodiversity 
due to gene flow; 
changes in insect 
community structure 
& function; changes 
in soil microbial 
profile, diversity or 
community structure 
Monitoring 
specifically 
for GMOs id 
only at the 
regional level 
for research 
purposes - to 
identify bio-
indicators & 
to establish 
baselines.  
National 
environmental 
monitoring 
schemes could 
be adapted to 
monitor for 
effects of 
GMOs 
Cumulative 
effects – from 
repeated 
exposure or 
intake of non-
target 
expression of 
toxins, 
allergens, 
carcinogens.  
Synergistic 
effects - 
combinations 
of GMOs 
released in 
neighbouring 
sites give an 
adverse effect, 
or 
characteristics 
of single 
GMOs act 
together to 
produce a 
harmful effect 
Undetected 
toxins, 
allergens & 
carcinogens 
enter the food 
chain & 
accumulate; 
decrease in 
insect 
diversity by 
repeated 
exposure of 
target species 
to a toxin.  
Reduction in 
biodiversity of 
agricultural 
landscape 
Not at 
present 
because of 
lack of 
databases 
concerning 
environment
al baselines, 
lack of 
indicators; 
lack of 
GMO 
monitoring 
activities at 
National 
level 
EU framework does 
not enable applicants 
to address long-
term/cumulative 
risks.  Applicants do 
not pay sufficient 
attention to this 
aspect of 
application.  Could 
be improved by 
standard ERA 
methodology; R&D 
on gene technology, 
ecological 
interactions & 
genomic, proteomic 
& population 
dynamics 
No   The 
government 
has 
developed a 
standard 
methodology 
which has 
been 
implemented 
for Part B 
releases only 
so far. 
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9  A change that 
is not 
reversible 
within 15 
years, and / or 
a small change 
that is not 
easily 
detected, but is 
in the same 
direction for 
10 years+ 
leading to 
significant 
environmental 
change, not 
reversible in 
the short-term 
Answer is limited to 
crops that are 
currently available in 
EU or have pending 
applications.  Effects 
can be good, bad, 
neutral; effects may 
include landscape 
scale effects, e.g. 
cultivation patters, 
management 
practices, could in 
turn affect farmland 
biodiversity. Similar 
effects may be seen 
with any new or 
different agricultural 
practice.  Emergence 
of agricultural weeds 
with herbicide 
tolerance is a 
possibility.  Could 
see volunteer crop 
plants, gene flow into 
sexually compatible 
wild relatives. 
No specific 
arrangements 
in place for 
GM crops, as 
none currently 
grown.  Other 
monitoring 
programmes 
are carried out 
for certain 
indicators.  
Difficult to 
envisage 
linking and 
effect to a GM 
crop, would 
need to tested 
experimentall
y 
Combined 
inputs that 
accrue over 
time & space 
from 
cultivation of 
GM crops.  
Might be 
interactive or 
incremental 
due to 
increases in 
scale. 
Difficult to 
predict.  
Possibly 
evolution of 
herbicide 
tolerant 
agricultural 
weeds – e.g. 
through 
herbicide use 
or gene flow.  
Gene stacking 
leading to 
multiple 
herbicide 
resistance is a 
possibility - 
this could also 
arise from 
conventional 
crops. 
Yes – if they 
have adverse 
effect on 
environment 
relative to 
non-GM 
equivalent 
Current framework 
is adequate.  LTC 
effects will have to 
be dealt with 
through general 
surveillance as we 
don’t know what 
they will be.  CS 
monitoring may be 
applicable in some 
circumstances; 
clearer guidance on 
principles of CS & 
GS monitoring from 
EU would be useful. 
Risks are 
assessed in 
accordance 
with criteria 
in Annex II 
of 2001/18.  
Comparator 
is non-GM 
equivalent & 
conventional 
management 
practices 
associated 
with it. 
No Not  aware 
of any 
unsubstanti
ated 
reports. 
10 Long-term  is 
not defined, is 
subject to 
interpretation 
by expert 
assessors 
Will mainly see 
socio-economic 
effects in long-term, 
linked with 
agrochemical 
applications & IP.   
     Environmental  & 
health risks will be 
addressed 
adequately by the 
EU regulatory 
regime 
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2.5. Lessons learnt from long-term risk assessment in other domains 
 
This section considers what lessons can be learned from the assessment and management of 
long-term and cumulative risks in other domains.  
 
The main area in which research and practice have been developed is that of the disposal of 
radioactive wastes.  Most EU States, and others with nuclear programmes, have developed 
policies that require assessment of the long-term risks before authorisation can be granted.   In 
these cases, ‘long-term’ typically refers to timescales of thousands or even millions of years – 
these being the timescales over which activity is expected to emerge from (deep) underground 
repositories to the accessible environment.  These long timescales also reflect the need to 
address concerns about the loss of institutional control (security of the site, monitoring etc). 
 
Although these timescales are much greater than those which most CAs would currently 
interpret as ‘long-term’ for GM crops, and the decision contexts and nature of the risks are 
also very different, there are several lessons that are relevant.  These lessons relate to two 
main, inter-connected areas: the principle of how far into the future a risk assessment should 
look, and the treatment of uncertainty within long-term assessment.    The radioactive waste 
field has less to offer in terms of identifying hazards, since the hazard – radioactivity – is 
already known.  It may appear in different forms, according to the radioactive decay chains, 
and cause harm by different routes (ingestion, inhalation etc) but is not so variable as the very 
wide range of environmental consequences that can arise from the release and cultivation of a 
crop.  The potentially useful lessons learned are listed below:  
 
Some radioactive waste regulators set, or allow the developer of the facility to define and 
justify, a cut-off on the timescale to be considered.  This is justifiable in the radioactive waste 
domain because the inherent risk – the level of activity – generally decays over time, such that 
it is possible to evaluate when the peak risk is likely to have passed.  This is not possible for 
GM crops – once released into the environment there is a possibility, at least, that the risk will 
increase – for example if an invasive species is given an additional selective advantage.  It is 
much more difficult to understand and forecast what human or ecological mechanisms might 
eventually control it.  The lesson for the GM crop domain is that regulators should not set an 
arbitrary cut-off time on assessments – it should be demonstrated on a case-by-case basis how 
the risk is expected to change over time and when the peak risk will have passed.   
 
Over very long timescales, the effects of natural climatic cycles (as well as more immediate, 
anthropogenic climate change) will need to be considered, as well as radical changes in land 
use and human activity.  It is recognised that, as time progresses, uncertainty increases, such 
that the value of the risk assessment, as a tool for quantitative prediction diminishes and may 
ultimately become meaningless.  However, this is not to be taken as a justification for 
truncating the assessment period (see (1) above).  Rather, it shifts the emphasis away from 
quantitative predictions about what is expected to happen towards a broader, qualitative 
consideration of ‘what-if’ scenarios.   The proponent needs to demonstrate that, for a range of 
credible future scenarios, the environmental mechanisms and barriers to risk will continue to 
provide adequate assurance of safety.   It is not expected that the assessment should ‘predict 
the future’ in detail, with regard to habitats or human behaviour, but rather that safety should 
be demonstrated for a range of stylised scenarios, spanning the factors that affect risk.  Given 
that most GM risks are difficult to quantify even in the short-term, this would seem an 
appropriate model for assessing long-term GM risks – the emphasis should be on considering Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  2
the crop within the whole environmental system, and the effectiveness of barriers to harm, 
rather than detailed modelling of those aspects that can be quantified.   
 
In predicting the dispersion of radionuclides through the geosphere, computational modelling 
approaches have been complemented by work on natural analogues – the observational study 
of the migration of activity, over geological timescales, from naturally occurring radioactive 
rocks.   There could be scope for parallel approaches in the GM crop domain, considering the 
historic or palaeontological evidence for the spread and impacts of new species  
 
Very sophisticated techniques have been developed for probabilistic (stochastic) analysis, 
enhancing the basic Monte Carlo methods to allow more complex representations of future 
scenarios to be assessed, for example by allowing correlations between input parameters, and 
better statistical analysis and presentations of the outputs – for example in sensitivity analysis 
and identification of critical parameters.   These techniques are potentially applicable to GM 
crops, although the aspects of radioactive waste disposal that have been subjected to this kind 
of analysis – typically the hydrogeological dispersion and uptake of the activity in the 
geosphere and biosphere - are generally more amenable to quantitative analysis than most 
aspects  of GM crop risks.   
 
Following on from (4) above, there is increasing recognition of the need for a balance 
between quantitative and qualitative approaches – neither is sufficient by itself. 
 
The difficult of finding any politically acceptable sites in many States has led to a growing 
realisation of the importance of considering social aspects of risk.  There has been much 
research on the social construction of risk and risk perceptions.   Stakeholder participation in 
framing the question and defining methods is being given serious consideration and has 
occurred in some cases  (Smith & Collier, 2005) in addition to the traditional model of 
stakeholder review of results.   These developments underline the importance of developing 
risk assessment as a structured framework for discourse and decision-making under 
irreducible uncertainty, rather than as a technical and scientific exercise alone.    
 
Decisions about long-term disposal of waste, as against the main alternative of continued 
surface storage under controlled conditions, raise ethical issues of the responsibility of current 
generations to those in the future and of choice and consent.  Continued surface storage 
imposes a burden on future generations, in that the costs of storage and the search for and 
implementations of a longer-term solution are handed on to them.  On the other hand, it 
allows them a greater degree of control, and keeps open the possibility that better techniques 
will be developed.   There are parallels in the GM domain in deciding the balance between 
imposing a risk on future generations and denying them potential benefits.   The GM crop 
case is different, however, in that radioactive waste already exists, and a solution has to be 
found, whatever decisions are made about the future use of nuclear energy.  There is no such 
unavoidable imperative to commercialise GM crops.  These ethical issues require exploration, 
both at the policy level and in their implementation with regard to specific releases.   Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  3
 
 
3.  A Framework for Risk Assessment  
 
This section describes the development of a generic framework for the assessment of long-
term and cumulative risk.  Section 3.1 describes the high-level principles and user 
requirements adopted in designing and developing the framework.  Section 3.2 outlines how 
the framework was developed, including how the evolving framework was tested, refined and 
demonstrated by means of an initial workshop and iterative application to case studies.   
Section 3.3 outlines the proposed framework so far as it has been possible to develop it, 
outlining tools and techniques that can support it and providing guidance on its use.  Section 
3.4 reviews how well the framework satisfies the principles and requirements, and highlights 
the specific challenges that users will need to consider in applying it.  Section 3.5 identifies 
the research gaps - areas in which further work would be needed to develop a fully coherent 
and workable approach.  
 
3.1. Guiding Principles and User Requirements  
 
In order to meet regulatory needs and comply with best practice in risk assessment, the 
following principles and user requirements have been adopted in the design of the framework: 
Scientifically sound.  The framework must be conceptually sound and theoretically rigorous, 
making the best use of available science.  
Human-centred.  Risk assessment is more than just technical analysis – it should encourage, 
structure and inform discourse between stakeholders.   The process of using the framework 
can therefore be as important as its products.  The guidance presented here includes 
consideration of the ways in which the framework can be used (e.g. in whether in group 
sessions or by an individual analyst) as well as the more technical aspects.   
Usable. The user of the framework must remain in control of the process, and be aware of its 
limitations.  Conceptual models of the environment and of risk should be as easy to 
understand as possible.  The framework must be as easy to learn and use as possible, given the 
inevitably complex nature of the decisions it is intended to support.  It should be flexible, 
offering a variety of tools appropriate to different cases.   Note that ‘Users’ here includes all 
the various stakeholders in risk assessment: both those who will actually gather data and 
perform analyses, and those who will interpret and base decisions on the results.  
Transparent.  The framework should help the user to identify and document the reasoning and 
assumptions behind their judgements and any limitations.  
Proportionate.  Trade-offs often have to be made between the above principles.  For example, 
a compromise is often necessary between usability and scientific rigour.  The appropriate 
balance between conflicting principles will vary with each application, so the framework 
should be applicable at various levels of depth and detail, as appropriate to the decision stakes 
and the data available.  
 
3.2. Development of the Framework 
 
The development of the framework took as a starting point a generic risk assessment approach 
that will be familiar from other domains.  In brief, it is based around the identification of 
hazards – things that might go wrong – and the evaluation of the likelihoods and severities of 
consequences of those hazards.  At this level, the approach is relatively standard – the more Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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complex and difficult issues arise in applying it to the specific challenges posed by long-term 
and cumulative risks from GM crops. 
 
The framework was first tested in an initial workshop, described in detail in Appendix 4.  The 
workshop involved participants with experience in various scientific domains related to GM 
crops, the environment and human/ animal health, as well as risk assessment specialists.  It 
identified potential scenarios for long-term/ cumulative risks from GM crops, chosen to show 
the range of possible risk types that the framework will need to be able to address. 
  
The framework was then applied to a number of case studies of releases currently in, or likely 
to be in the regulatory pipeline within the EU.  The case studies were used to test and refine 
the approaches in the previous sections. In addition they were used to illustrate the type and 
extent of risk monitoring and mitigation measures that may be required for the commercial 
release of GM crops (Section 4).  Details of the case study assessments are given in Appendix 
6.  It is stressed that the purpose of these case studies was to help with the development of the 
framework.  They were carried out within a very limited time, and in many areas large 
assumptions had to be made rather than seeking real data.  The findings are therefore 
indicative of what might emerge from a real regulatory assessment, but must not be relied 
upon as such. They also help to indicate the range of possible risk types that the eventual 
assessment methodology framework will need to be able to identify and evaluate. 
 
Lessons learned from the workshop and case studies have been incorporated in the latest 
version of the framework, as described in Section 3.3 following 
 
3.3. The Proposed Framework 
 
The framework is intended to define a coherent, but flexible process of assessment.  It does 
not prescribe particular tools or explain their theory and use in detail, but suggests a range of 
tools that may be helpful.   It is recognised that every case will be different, and that the most 
appropriate tools will depend on: 
•  the nature of the proposed release and its environment; 
•  the specific decision context;  
•  the potential level of risk – the breadth and depth of assessment reflecting the decision 
stakes in accordance with the principle of proportionality; and 
•  the extent and quality of data available.    
 
It is also recognised that many users will already have experience in using certain tools for 
some of the steps in the framework, that they may prefer to continue using. 
 
A (non-exhaustive) catalogue of the tools and techniques that can be applied at the various 
stages of the framework is provided in Appendix 4. It summarises the uses, limitations and 
requirements of each method and provides references from which more detailed information 
can be found.  
 
Overview of the Process 
 
The steps in a generic risk assessment process can be represented as shown in Table 4 
following.  
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Table 4. The generic risk assessment process. 
 
STEP  AIM/ QUESTION TO BE ANSWERED 
1 Frame  the 
Question 
Define the question in risk terms, in a way that best informs the 
decision to be made.   Define what is meant by risk - the 
problem boundaries, types of risk measures, etc 
2  Define Criteria  Define how  it is to be decided whether the risk is tolerable 
3 Hazard 
Identification and 
Analysis  
Identify what could go wrong - intended or unintended events 
associated with the release that could lead to harm / adverse 
effects.    
4  Hazard Analysis  Identify and understand the casual and contributory factors for 
each Hazard, and its potential effects, and analyse the 
relationships between and within causes, Hazards and effects. 
5 Assess 
Likelihoods 
Consequences 
and Risks 
Assess how likely it is that each hazard will occur. 
Identify the various possible outcomes of each hazard.  For each 
outcome, assess its severity (how bad it would be) and the 
probability of that outcome actually occurring (given that the 
hazard itself has occurred) 
Assess the level of risk – this will be a function of the likelihood 
of the hazard and the severities and probabilities of its 
consequences 
6 Compare  Risk 
against Criteria 
Is the predicted level of risk tolerable, against the criteria 
devised in step 2?  
7 Consider 
Uncertainties 
What are the main uncertainties in the assessment models, data 
or assumptions?  How might they change the conclusions? In 
view of these uncertainties, is there sufficient confidence to 
make a decision?  If not, what could be done to reduce the 
uncertainties? 
8 Identification  of 
Mitigation & 
Monitoring 
Methods 
What could/ should be done to reduce the risk?  
(return to Step 3 and re-assess as appropriate – the mitigation/ 
monitoring methods may change the hazards ) 
 
 
The following sections describe each step in more detail, as applied to long-term and 
cumulative risks from GM crops.  
 
 
Step 1: Framing the Question 
 
Real regulatory decisions and questions are not always framed in terms directly amenable to 
risk assessment.  The critical, and often challenging, first step in risk assessment is therefore 
to frame the initial question in a way that informs the decisions to be made and that is 
amenable to practical risk assessment.    
 
At the highest level, the decision question about GM crops can usually be posed in terms such 
as: Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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“Is it acceptable to release [crop] modified with [gene, trait]? 
 
This can be fairly readily restated in risk terms as: 
 
“What are the risks associated with the release of the modified crop, and how do these 
compare with the agreed tolerability criteria 
 
But in order to apply risk assessment tools it will be necessary to have a more precise 
definition of the question and of the risks to be assessed.  For example: 
•  What is the decision context – an internal, commercial decision by the industry, or a 
regulatory one?  Risk assessments may be used to inform regulatory policy or strategy, 
as well as release-specific decisions. 
•  What is the geographic scale of the decision to be made -  local, State, EU or global?   
•  What types of risk are considered to be within the scope of the assessment?   The 
present study focuses on human/ animal health and the environment, but 
‘environment’ is a very broad term that is not specifically defined in Directive 
2001/18.   There are, for example, overlaps between environmental risks and agro-
economic, social and ethical ones.    
•  What measures of risk are to be used? The measure will, in broad terms, usually be the 
likelihood of the various potential harmful consequences.  But is it the risk per release 
that is of concern, or the aggregate over an (assumed) number of releases?   Is it the 
risk to individuals or the collective risk to society?  
•  What is to be assumed about other GMO releases or changes in the environment over 
the assessment timescale?  This is a particular issue for the study of long-term and 
cumulative effects.   
•  How it is it to be decided what level of risk is tolerable?  
 
The answers to all these questions will strongly affect the results.  For example, the ‘right’ 
decision from a regional point of view may be different from that for an international 
decision.  Framing of the question is critical, and the questions above should be thoroughly 
discussed in order to define the question appropriately and precisely.   In practice, the framing 
step is usually iterative with later stages of assessment - it is not until the more detailed 
assessment questions are asked that the subtleties of the overall question become apparent.    
 
Long-term and cumulative risks are the specific subject of this assessment, but these are not 
always easy to distinguish from shorter term ones.  In many cases, the hazards are the same, 
but differ in degree and in the greater level of uncertainty.  
 
 
Step 2: Defining Tolerability Criteria 
 
In order to decide whether a particular release should be allowed (at all, or with additional 
mitigation or monitoring measure) criteria must be defined for what level of risk is considered 
tolerable.   
 
Directive 2001/18 does not provide any explicit, risk-based criteria such as limits on the 
frequency of occurrence of particular effects.   Current practice (see Section 4.1.4- Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Questionnaire Responses) seems to be largely based on a comparison between the risks 
associated with the GM crop and those for its unmodified equivalent.  Most Competent 
Authorities (CAs) that responded to the questionnaire had no more specific criteria, but one 
required risks to be ‘lower than or the same level as’ those of the non-modified crop.  It would 
seem extremely difficult ever to demonstrate this robustly for long-term and cumulative risks 
- given the complexity and interconnectedness of the environment it is almost always possible 
to postulate some potential negative effect.  However this CA did also say that ‘a risk-benefit 
analysis should be carried out’ opening the possibility of trading off advantages and 
disadvantages.  Another CA stated that risks were considered unacceptable if ‘significant’  
adverse effects were revealed by the comparison, but the threshold of significance was not 
defined.   
 
The absence of explicit criteria, and the apparent variations in practice between CAs, point to 
a need to develop more explicit guidance on criteria, in order to encourage well-founded, 
consistent and fair decisions.    It may not be possible, or indeed desirable, to devise any very 
rigid criteria – the risks and benefits of GM crops are probably too complex to be 
encapsulated in, for example, simple quantitative thresholds.  And Member States will wish to 
retain some flexibility to reflect national and local concerns, as indeed Article (9) of Directive 
2001/18 explicitly acknowledges, with regard to ethical concerns.  Rather, it is important that 
guidance should ensure that all relevant factors are taken into account, and provide a 
systematic framework for the discussion about risk.    
 
Whatever criteria are adopted need to be related to the framing of the question (Step 1) – i.e. 
to the decision context and the specific definitions of risk.  The development of tolerability 
criteria is usually iterative with the identification of hazards – it may be more practical to set, 
for example, a limit on the likelihood or extent of specific hazards arising than to define 
generic limits on some aggregate measure of risk  
 
The main questions and areas for further development are noted below: 
 
•  What benchmarks or standards can be adopted?  For example tolerable levels of risk 
could be defined by reference to a comparison with the risks from the unmodified crop in 
the current environment, or against the risks from the current crop allowing for normal 
bounds of variability and mutation in that crop and its environment.   
•  Is there a need for a formal requirement to minimise risks, such as the As Low As 
Reasonably Practicable (ALARP) principle?  What should be the bias in favour of 
safety?   How is this to be related to the implementation of the precautionary principle?  
•  Should the assessment take account of the benefits as well as risks?  The necessarily 
rather risk-averse nature of a regulator’s function, and traditional,  hazard-based 
approaches to risk assessment have lead to an emphasis on potential negative aspects. 
•  As well as considering what levels of risk may be considered tolerable, an aspect of 
particular importance when considering long-term and cumulative risk is the level of 
confidence in the assessment that is required in order to make a decision.   Long-term and 
cumulative effects are by their nature uncertain, and some of the uncertainty will be 
irreducible, but quite possibly large.  What are the appropriate rules for decision-making 
under uncertainty?   
•  Any decisions about tolerability inevitably involve ethical considerations of 
environmental and social justice, the bounds of discourse and value judgements about the Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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weight given to various benefits and risks.   For long-term and cumulative risks 
additional ethical concerns of responsibility and choice arise from the potential for 
decisions taken now to affect future generations.   
  
Step 3: Hazard Identification 
 
Hazard identification is the process of identifying ‘what could go wrong’.    It should be as 
comprehensive as possible – GM crops have a very wide range of potential effects, not all of 
which will be obvious, especially where long-term and cumulative aspects are concerned.   
 
 
Hazard identification techniques 
 
Hazard identification can be conducted against a standard checklist – for example the general 
types of potentially harmful characteristics and adverse effects listed in Annex II of Directive 
2001/18.   However, such approaches are ‘closed’  - comparison against non-exhaustive lists 
does not prompt consideration of what else might occur.  It is better to complement them with 
a more open-ended brainstorming approach, and/ or with individual techniques that encourage 
more inductive thinking (see, for example, Hayes 2006) 
 
Brainstorming should be structured, and led by an experienced facilitator, to ensure that it 
remains on track and covers all the aspects.  Initially the aim should be simply to identify 
potential hazards, resisting the (time-consuming) temptation to begin to assess their likelihood 
or consequences.   Analysis can be carried out later, in Step 4, by an individual or smaller 
group of assessors, when all the results have been collated and appropriate data sources can be 
sought.   
 
The brainstorming participants should have experience covering all the potentially relevant 
disciplines, such as genetics, ecology, agriculture, veterinary science and human health.     
 
Note that a ‘hazard’ is to some extent arbitrary – it can be defined at any level of detail, and at 
any stage along the chain or network of causes and effects that leads from the release of the 
GM crop to the harm.  In brainstorming sessions, participants will usually mention ‘hazards’ 
at many different levels of detail and stages, such that some hazards will be subsets of others, 
and hazards will have interactions.  If time permits, these relationships should be explored, 
but detailed analysis of dependencies is usually better performed in Step 4.    
 
It is however important during the brainstorming session to obtain as clear an understanding 
as possible of the hazards that participants have in mind.  Hazards should ideally be stated in 
terms of specific events that either do or do not occur, rather than generic processes.  So for 
example, it is better to define hazards in terms such as ‘introgression into wild relative, giving 
herbicide-resistance ’ than simply as ‘introgression of genes’.   
 
Prompting hazard identification using Themes 
 
It is suggested that first stage in brainstorming should be designed to broaden the scope of 
what is considered.   Some forms of potential harm may be relatively obvious, such as the 
potential for a herbicide-resistant gene to enter a related weed species, conferring a selective 
advantage that allows it to become a problematic weed.   But less obvious, indirect or Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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secondary effects may be particularly important when long-term and cumulative effects are 
considered, and these are harder to identify.    
 
To encouraging thinking beyond the immediate and obvious it is recommended that the group 
should begin by considering whether the release can have any effect (positive or negative) on 
a wide-ranging list of environmental ‘Themes’.  Themes express the environmental goods and 
values that regulators aim to protect.  Those in the Table 5 following, for example, were 
developed using as a starting point the Themes from the UK Environment Agency’s draft 
corporate Vision (Environment Agency 2005), modifying them to be more specific to the 
present study.   
Table 5.  Example Environmental Themes 
 
Theme  Description 
Human health  Freedom from toxic or allergenic characteristics, from 
antibiotic resistance or other compromising of therapeutic 
techniques and from adverse nutritional effects  
Animal heath  Freedom from toxic or allergenic characteristics, from 
antibiotic resistance or other compromising of therapeutic 
techniques and from adverse nutritional effects 
Quality of life 
Knowledge of living in a healthy environment, rich in wildlife 
and natural diversity, that can be cared for, used, appreciated 
and enjoyed.   This Theme could also be extended to include 
socio-economic dimensions of environmental risk, such as the 
well-being of farming and rural communities.  
Agricultural 
sustainability 
Agricultural systems that maintain productivity, sustainability 
and resilience and ensure fair markets. 
Environment 
for wildlife 
Habitats improved in their extent and quality to sustainable 
levels for the benefit of all species.  
Air quality  Clean air – levels of pollutants below the level at which they 
can do significant harm. 
Water quality 
Clean water - levels of pollutants below the level at which they 
can do significant harm.  Water bodies sustain diverse and 
healthy ecosystems, fisheries, sports and recreational activities. 
Land use and 
soils 
Restored, protected land with healthy soils and biogeochemical 
cycles, supporting a wide range of uses, including production 
of healthy, nutritious food and other crops.  Contaminated and 
damaged land restored and protected.  Appropriate land uses – 
balancing conflicting demands to make best use of the limited 
resource.   
Greener 
business 
Sustainable business practices 
Sustainable 
resource use 
Wiser, sustainable use of natural resources, minimising waste 
production, reusing and recycling products and materials and 
making efficient use of energy and materials. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Theme  Description 
Limit and 
adapt to 
climate 
change 
Reductions in the emission of greenhouse gases and 
preparedness for the effects of changes in climate. 
Regulatory 
effectiveness  
Ability to regulate effectively, efficiently and fairly – good 
relations with those regulated and all stakeholders 
 
It is recognised that the selection of Themes involves a number of (value) judgements about 
what constitutes a health or environmental theme, as opposed to an economic, social or ethical 
ones.    The Themes used might vary according to the specific remit of the CA in each 
Member States, and the list above is intended only as an example.  It should also be stressed  
that the aim of using the list here is simply to broaden discussion, not to set out specific 
criteria.   
 
The participants in the brainstorming session should be asked to consider whether there could 
be a risk or benefit to each Theme, scoring Yes, Maybe or No for each.  At this level, there is 
no need for a metric (scale) of risk or indeed any formal definition of risk.  The aim is to 
broaden the thinking for later stages of hazard identification and risk assessment rather than to 
inform a decision directly.  
 
In pilot studies and workshops, we found that it was often possible to think of some very 
indirect or unlikely mechanism by which the system being considered could potentially 
present a risk or benefit to any of the Themes.  It is therefore suggested that some sensible 
cut-off should be set.  One way to do this is to impose a time limit on discussion – for 
example that if no-one can identify an affect on the theme after two minutes’ discussion, the 
score should be ‘No’.  While this seems to go against the general spirit of open-ended 
brainstorming, in which the aim is to identify risks as comprehensively as possible, it should 
be recalled that the aim is to widen the discussion by identifying broad classes of effects that 
could merit further analysis.  It is not required at this stage to identify detailed combinations 
of failures, errors and circumstances that may lead to an effect.    
 
Prompting hazard identification using FEP lists  
 
It has already been noted that long-term and cumulative risks are not always easy to 
distinguish from shorter term ones.  In many cases, the hazards are the same, but they differ in 
degree and in the greater level of uncertainty.  To encourage participants to identify specific 
long-term and cumulative effects that would not occur in the short-term, some specific 
prompts may be helpful.    
 
For example, in the workshop of Oct 2005 (Appendix 4) we asked participants to consider the 
various elements of a Source – Pathway - Receptor framework, and applied two sets of 
prompt words, as shown in the Table below, to help participants identify Hazards from 
changes in the source, pathway or receptor. 
 
Step 4: Hazard Analysis 
 
As already noted, hazard identification tends to produce lists of hazards at varying levels of 
detail, and that may overlap or interact to varying degrees.  The task in Step 4 is to collate Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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these hazards on a consistent basis and understand the relationships and dependencies 
between them.   
 
This analysis can often be most effectively performed using a graphical technique, such as the 
construction of a fault tree, event tree, influence diagram or other systematic representation of 
the network of causes and effects that is required for the release itself to lead to actual harm to 
the health and environmental Themes.  Examples of such presentations are provided in the 
Case Studies. 
 
The construction of such diagrams has been found to be very valuable in its own right, in 
forcing clarity of thinking about how potential harm can be realised and helping the assessor 
to identify the main pathways or contributors to risk.  And, by showing what events, errors 
and circumstances have to conspire and what barriers have to fail for harm to occur, it 
provides a systematic basis for considering where risk can be mitigated in Step 8. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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Table 6. Prompts for Identifying Long-term and Cumulative Hazards 
 
 
FEPS 
Features Events & Processes that may 
change over time and affect Source, 
Pathway or Receptor 
 
recessive genes 
dormant/ latent traits 
climate 
land use, soils 
habitats 
agricultural practices 
food consumption 
human activity 
population distribution 
regulation  
social, organisational and institutional 
structures and practices  
availability of information  
 
  Deviations 
 
ways in which the FEPs may change 
 
 
More Than/ Less than 
Earlier/later 
Not Done 
Other Than 
Used Beyond Intent 
 
  
 
Step 5: Assessing Likelihoods, Consequences and Risks   
 
In general, risk can be expressed as a combination of the likelihood of some adverse effect, 
and the severity of that effect.  For example, it could be expressed in terms of the probability 
of occurrence of certain defined hazards, or as the sum, over all hazards, of the expectation 
value of the severity of the consequences of those hazards.  The specific definition and 
measures(s) of risk, and hence the ways in which it is evaluated in any particular assessment 
will have been decided in Step 1 and may also be determined by how the hazard analysis 
(Step 4) has been constructed.  
 
Where adequate quantitative data are available, fault trees, event trees and other types of 
cause-consequence diagram as developed in Step 4 can be used to quantify likelihoods, 
consequences and risks.  For example, in a fault tree, events combine through logical AND or 
OR gates to lead to the next level up the tree.   (AND means that all events have to occur to 
pass to the next level, OR means that only one event has to occur.)  The probability of an 
event can be derived from the probabilities of lower-level events using standard rules of 
probability and Boolean logic.   For example, the probability of both event A and event B 
occurring, P(A AND B) can be evaluated as P(A) x P(B) (provided P(A) and P(B) are small).   Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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If the probabilities of the ‘base events’ are known, or can be estimated, the probability of the 
top event can be derived.   
 
 
In principle one could evaluate the risk to each Theme as the top event of a separate tree, but  
this would be very time-consuming, and there remains the problem of whether and how to 
combine the risks to each Theme into some kind of aggregate measure.  It may often be better 
to use the Themes simply to broaden the consideration of potential hazards at the early stages, 
rather than necessarily carrying them through all the detailed analytical and quantification 
stages..  
 
In most cases, a compromise has to be made between rigour and complexity.   If hazards and 
their outcomes are explored in great detail, the analysis becomes complex and there is a 
‘combinatorial explosion’ of data to be obtained and processed.  On the other hand, too 
simplistic a representation is likely to miss important features.  There are no easy rules to help 
set the balance at an appropriate point – usually it is a matter of starting with a broad-brush 
assessment and iteratively refining the analysis as the critical aspects become apparent.  
 
In a field with as short a history, and as many uncertainties, as GMOs, it is unlikely that 
robust quantitative data will exist for many elements of the risk calculation.    Assessors will 
therefore have to rely on subjective estimates in many cases, and use should be made of the 
many techniques available for ensuring that subjective data are elicited from individual 
experts or groups in ways that minimise, or at least reveal, uncertainty and bias.  
 
 Step 6: Assess Uncertainties 
 
Assessors should give ranges of uncertainty, or other appropriate descriptions of the 
uncertainty in their risk estimates.  As a minimum, the main areas of uncertainty in data, 
assumptions and models should be highlighted, and their potential to affect the evaluation 
discussed. 
 
The use of sensitivity tests, best-estimate and worst-case scoping calculations should be 
considered.  
 
If a quantitative analysis has been undertaken, formal techniques such as probabilistic or 
stochastic modelling (e.g. Monte Carlo analysis) can be applied, in which input data are 
specified using statistical distributions, rather than single point estimates, and the 
corresponding distribution of outputs (risk levels) is calculated. 
 
Step 7:  Compare Risk against Criteria 
 
The risk as assessed in Step 6 should be compared against the criteria defined in Step 2, 
taking account of the discussion of uncertainties in Step 6.   
 
The release may then be categorised as either acceptable as proposed, unacceptable, or 
requiring further work – such as a more detailed analysis, or further evaluation of mitigation 
and monitoring methods.   
 
There are special issues arise in making decisions about cumulative risks - the regulator will 
need a mechanism to track and combine the risk assessments from multiple, and in some 
cases apparently unrelated, releases.     Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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Step 8:  Identification and Evaluate of Mitigation & Monitoring Methods 
 
Dependent on the outcome of Step 7, further mitigation and monitoring methods may need to 
be identified to ensure that the risk is tolerable.     
 
Methods may include those that reduce the likelihood of the hazards, and/ or that reduce the 
probability and / or severity of their consequences.   Diagrammatic representations of how 
risks may be realised, such as fault trees (Step 4), can be helpful in providing a systematic 
framework for identifying and evaluating potential mitigations.  
 
For each identified method, its likely effectiveness (including whether it may have any 
negative effects) and its practicability should be assessed.  This can be carried out: 
by simple subjective ranking, using a matrix of effectiveness and practicability;  
by reference to fault trees etc – it may be possible to see which mitigations control the most 
critical links in the chains of cause and effect; or  
by re-running the assessment.    Note that it is necessary to return to the hazard identification 
step (Step 3) or even earlier, not just the later, analytical steps, since mitigations can introduce 
new hazards.  For example, a reactive mitigation such as control of the problem GM variant 
using a more powerful herbicide is likely to have adverse effects on other flora.  Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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4. Approaches to monitoring and management of risk 
 
EU Directive 2001/18/EC requires all applicants seeking authorisation to release a GMO 
within the EU to elaborate their plans for monitoring and reporting statements made in their 
e.r.a. in a post-market monitoring (PMM) plan.  This has two purposes, firstly to confirm 
assertions made in the ERA regarding the occurrence and impact of potential adverse effects 
of the GMO or its use, so called ‘case-specific monitoring’, and secondly to identify the 
occurrence of completely unanticipated effects of the GMO or its use on human health or the 
environment, termed ‘general surveillance’.  When consent to place a GMO on the market is 
granted, the consent holder has a legal obligation to ensure that the post market monitoring 
plan and reporting of its findings are carried out as specified.  Whereas case-specific 
monitoring is only necessary if a specific potential risk has been described, commercial 
release of all GMOs must be accompanied by a general surveillance plan that extends over the 
full life of the consent to release the GMO. 
 
4.1 Case-specific monitoring 
 
Case-specific monitoring serves to confirm that any assumption made in the ERA regarding 
potential adverse effects arising from a GMO and/or its use are correct, for example to 
confirm that a GM insect resistant crop has no different effect on non-target insects than the 
conventional crop.  Case-specific monitoring plans are therefore devised with specific 
objectives, parameters and timescales in mind and specific data will be collected to assess the 
potential impact/s. 
 
4.2 General surveillance monitoring 
 
While it is possible to predict that certain effects may occur based on risk assessments and 
scientific data, the prediction of unanticipated (direct or indirect) long-term and/or cumulative 
effects does not lend itself to the formulation of clear scientific hypotheses.  General 
surveillance therefore has its basis in long-term observation of the wider receiving  
environment, often making use of existing monitoring and stewardship programmes that will 
detect significant changes at the field, farm and landscape levels that may be related to 
specific GM releases.  This may include observing the agricultural/rural environment and 
assessing biodiversity of weed and feral crop populations, vertebrate and invertebrate 
populations, changes in behaviour of natural populations (e.g. flowering and seed set, 
breeding patterns), changes in the soil ecosystem, changes in plant pest and disease incidence, 
changes in pesticide usage and changes to general land management.  Although general 
surveillance takes a much wider view than case-specific monitoring, it is still undertaken in 
the context of what might be seen in the ten years duration of the marketing consent. 
 
Company plans for surveillance tend to focus on utilising data gathered by existing 
monitoring programmes and networks, and engaging those who work in the agricultural 
environment such as farmers, agricultural consultants and grain handlers, asking them to note 
any unusual or unexpected occurrences when growing or handling GM crops.  In designing 
the monitoring plan, the extent to which geographical areas around the GM crops must be 
included in the monitoring is also a key consideration. 
 Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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General surveillance will also be useful for monitoring effects of potential interactions 
between two genetically modified crop lines.  While these can to some degree be anticipated, 
commercial companies cannot predict which varieties of GM crops may be grown in close 
proximity to each other and what effects might arise from their interactions.  Again, this 
would only continue for the duration of the consent. 
 
4.3. Data gathering for post market monitoring 
 
The key to identifying and evaluating any changes in the receiving environment as a result of 
cultivating a GM crop is to establish the baseline status of the receiving environment for the 
component being studied.  Ideally this should be established well before the GMO has been 
placed on the market.  The consent holder must establish which networks and other routes 
they will utilise and enter into arrangements with these bodies for gathering the necessary 
data; they must then critically analyse the findings and report their conclusions to the 
competent authorities on an annual basis.  To be of value the data must be relevant to the 
question asked, of good quality, and in sufficient quantity to provide adequate statistical 
power for meaningful assessments.  Ideally, the data should be appropriately described by 
metadata and be accessible in a format suitable for direct input to statistical software. 
 
4.4. Environmental monitoring data in existence 
 
A vast quantity of environmental data currently exists, much of which is available via the 
internet.  However, the sheer volume of data and the range of methods of access can be 
barriers to efficient use of data.  The information available via the internet can be broadly 
divided into four categories, although the distinctions between these are not clear-cut and 
some sites will fall into more than one category: 
•  Web based data portals that enable users to search for and obtain data. 
•  Metadata gateways that have information and links to external sources of data, but 
no data provision. 
•  Access to data held on the site. 
•  Information about data owned by the organisation, but no access to datasets. 
 
The form in which data is presented is enormously varied and it may be freely available, or 
only accessed for a fee.  Sites that present information only rather than datasets may be of 
limited value, but may be important in terms of highlighting the existence of data which may 
be either available elsewhere or not freely available.  Many organisations make their own data 
available either on their own websites or held as part of larger collections of data.  There are 
also datasets that are gathered as part of ongoing research projects and for which little 
internet-based information is available.  Given the range of monitoring programmes being 
undertaken by different bodies, and the range of components that could be studied, it is easy 
to see that competent authorities will receive a varied collection of data and analyses from 
consent holders. 
 
4.5. Review of current means of monitoring and mitigation 
 
Methodology 
Monitoring plans submitted with applications to release GT73 oilseed rape, Bt11 maize and 
EH92-527-1 potato under EU Directive 2001/18/EC were reviewed.  Based on the applicants’ 
conclusions in the ERA, we speculated as to what monitoring might be undertaken to identify Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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long-term cumulative effects
4.  Monitoring plans were reviewed according to guidance notes 
to 2001/18
5, which state: “Potential adverse effects of GMOs will vary from case to case, and 
may include: 
•  disease to humans including allergenic or toxic effects, 
•  disease to animals and plants including toxic, and where appropriate, allergenic 
effects, 
•  effects on the dynamics of populations of species in the receiving environment and 
the genetic diversity of each of these populations, 
•  altered susceptibility to pathogens facilitating the dissemination of infectious 
diseases and/or creating new reservoirs or vectors, 
•  compromising prophylactic or therapeutic medical, veterinary, or plant protection 
treatments, for example by transfer of genes 
•  conferring resistance to antibiotics used in human or veterinary medicine, 
•  effects on biogeochemistry (biogeochemical cycles), particularly carbon and 
nitrogen recycling through changes in soil decomposition of organic material”. 
 
 
C/NL/98/11 Roundup Ready oilseed rape, event GT73 (Monsanto – updated version July 
2003). 
Trait: Tolerance to the herbicide glyphosate (‘Roundup Ready’). 
Scope: The notification covers the importation and storage of GT73 oilseed rape and its use as 
feed as well as in the processing for feed, and its industrial uses as or in products. 
Current status: European Commission decision 31 August 2005
6; consent not yet issued. 
Note: Originally submitted in 1998 under Directive 90/220/EC, which did not require 
elucidation of monitoring plans, these have been added in subsequent submissions to the lead 
CA. 
 
Proposals for case-specific monitoring 
The notifier claims that the results of the e.r.a. show effectively zero overall risk arising from 
the placing on the market of GT73, therefore case-specific monitoring is not considered 
applicable to the placing on the market of this product. 
 
Several Member States commented that the prevention of seed spillage and the consequences 
of it happening have not been sufficiently taken into account, and more information is needed.  
European Commission document 2005/637/EC
7 addressed these concerns by advising: 
“specific technical guidelines should be added to the decision to place GT73 oilseed rape on 
the market to prevent any damage to the environment in case of accidental spillage of the 
product”. 
 
Proposals for general surveillance 
The notifier will ensure that awareness of the GM crop is made widely available by providing 
key information, for example: 
•  The notifier will provide international traders with the necessary information to 
comply with statutory requirements relating to the placing on the market of the crop; 
•  Product briefings to selected networks; 
                                                 
4 It was not within the scope or resources of this project to critically assess the ERAs, or to evaluate speculative suggestions 
for monitoring against scientific evidence. 
5 Document number 2002/623/EC.  OJ L200 pp 22-33 30/07/2002. 
6 Document number 2005/635/EC.  OJ L228 pp 11-13 03/09/2005.  Section 4.2.1. Step 1: Identification of characteristics 
which may cause adverse effects 
7 OJ L228 pp 19-20 3/9/2005. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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•  Technical literature (e.g. product-specific information, company contact details). 
Further information and relevant legislation will be available from a number of sources, 
including industry and government websites, official registers and government publications. 
 
Surveillance information will be collected from 1) feedback from selected networks, and 2) 
reported potential adverse effects and other relevant information received via direct contacts 
with the notifier. Where unanticipated adverse effects are confirmed they will be investigated 
to establish if there is a correlation between the observed effect and the GM crop, and if so 
appropriate remedial action will be carried out. 
 
Suitability of monitoring plan for GT73 for identifying short and long-term cumulative risks: 
•  Short-term risks: consistent with other authorisations for import and processing. 
•  Long-term cumulative: key risks are associated with unmitigated spillage of GT73 
rapeseed along roadsides, railways, waterways, leading to establishment of localised feral 
populations of GT73 and possibly gene transfer into sexually compatible species.  Risks 
of reduced biodiversity in areas where this persists, and possible economic risks to 
commercial oilseed rape crops. 
•  Consent holder will be required to monitor spillage, and to encourage reporting of 
unexpected adverse effects as part of the general surveillance plan.  How effectively this 
will work in practice away from the port environments is yet to be tested.  Monitoring 
will only operate for the duration of the release. 
 
Table 7. Summary of ERA/Proposed monitoring and possible monitoring for GT73 0SR 
(C/NL/98/11)  
 
Risk component  In 
ERA? 
Monitor? Proposed  monitoring 
method 
What could be monitored to 
detect/mitigate long-term 
cumulative risks? 
General surveillance monitoring only 
Spillage of GT73 
oilseeds 
9  9 
Specific technical 
guidelines to be issued 
regarding prevention of 
spillage.  HACCP
8 
guidelines should 
ensure spillages are 
correctly cleared up. 
Surveys of OSR populations 
along roadsides, railways, 
waterways.  Monitor for 
presence of GT73.  Monitor 
extent of feral populations and 
monitor presence of GT73 in 
nearby weedy communities.  
For conventional OSR crops – 
monitor compliance with 
labelling thresholds, and link 
spatially with known spillages. 
Direct/indirect and anticipated and unanticipated effects: 
Human toxicity and 
allergenicity 
9  8 
Traders and bulk 
processors requested to 
inform relevant 
authorities of any 
adverse effects on the 
environment or human 
health 
Monitor for chronic toxicity 
&/or allergenicity through 
prolonged operator exposure, 
e.g. at ports and crushing 
plants. 
Potential to 
compromise human 
therapy 
9  8 None 
No antibiotic resistance in 
GT73, so unlikely to be an 
issue. 
Potential beneficial 
effect to humans  9  8  None  EU quality of life indicators. 
                                                 
8 HACCP - Hazard Analysis at Critical Control Point. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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Animal toxicity and 
allergenicity 
9  8 
Traders and bulk 
processors requested to 
inform relevant 
authorities of any 
adverse effects on the 
environment or human 
or animal health 
Monitor for chronic toxicity 
&/or allergenicity through 
feeding studies; questionnaire 
attached with feed containing 
GT73 meal. 
Compromised 
animal therapy  9  8 None 
No antibiotic resistance in 
GT73, so unlikely to be an 
issue. 
Potential beneficial 
effect to animals  9  8 None 
Would be identified by traders 
and bulk processors if have 
monitoring scheme in place. 
Disease to plants 
9  8 None 
GT73 rapeseed must only be 
transported in leak-proof 
lorries/containers.  Monitor 
closely for spillage events and 
control of volunteers at ports, 
along roadsides, railways and 
waterways to prevent feral 
populations establishing.  
Penalties on operators if they 
do not comply. 
Target organisms 
(incl. predators and 
parasitoids) 
9  8 None  Ditto  above 
Effects on non-target 
organisms  9  8  None Ditto  above 
Effects of gene-
transfer (incl. to soil 
organisms) 
9  8 None  Ditto  above 
Potential for 
increased weediness  9  8  None Ditto  above 
Altered 
susceptibility to 
pathogens 
facilitating the 
dissemination of 
infectious diseases 
and/or new 
reservoirs or vectors 
9  8  None Ditto  above 
Horizontal gene 
transfer  9  8  None Ditto  above 
Effects on 
biogeochemistry, 
particularly carbon 
and nitrogen 
recycling through 
changes in soil 
decomposition 
9  8  None Ditto  above 
 
 
 
C/FR/96/05/10 - Bt11 maize (field or sweet maize) (Syngenta Seeds SAS) 
Trait: Resistance to corn borers Ostrinia nubilalis and  Sesamia nonagrioides using the 
Cry1Ab gene. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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Scope:  For use as any other maize, including cultivation in the EU.  Bt11 also possesses 
herbicide tolerance but the scope of the notification has been limited to use without the 
application of glufosinate ammonium herbicides. 
Current status: pending. 
 
Case-specific monitoring 
Based on the e.r.a. the notifier concluded that no case-specific monitoring was necessary; 
however, in order to delay insect resistance to Bt11, an Insect Resistance Management plan 
would accompany Bt11.  The monitoring plan was divided into four parts:  
•  Maintenance of refuges (20% in the case of holdings with over 5 ha of maize); 
•  Monitoring of Bt resistance;  
•  Action plan in the event of resistance being detected;  
•  Training for producers.  
Some Member States have commented that case-specific monitoring should also be 
undertaken to consider the impact of insect resistance on non-target insects  
 
General surveillance 
The proposed general surveillance plan includes an assessment of the impact of Bt11 on non-
target arthropods and the impact of tolerance to the herbicide, but its implementation in 
practice has still to be finalized.   
 
The original proposal for general surveillance was revised in May 2004.  The revised proposal 
includes more detailed plans for surveillance ‘modules’ operating within existing surveillance 
‘nodes’ in agriculture, the environment (agro-environment and wider environment) and the 
supply chain for living Bt11 maize grains.  A detailed farmer questionnaire has been 
developed to collect relevant information from farmers relating to environmental and 
agronomic aspects of the GM crop (questions specifically cover agricultural practices, general 
observations of the crop and corn borer infestation).  Farmer data will be collected from a 
structured subset of farmers within a representative geographical area and participant numbers 
will be sufficiently large to allow for meaningful data analysis.  A questionnaire will also be 
sent to farmers in the year following cultivation on Bt11 maize.  The exact network will be 
defined in advance of commercialisation of Bt11 maize in specific regions, Syngenta will 
coordinate and report the monitoring; all data will be compiled in a  ‘general surveillance 
database‘.  It is not clear how the general surveillance monitoring will work in practice and 
how the various networks involved will be compelled to participate. 
 
Suitability of monitoring plan for Bt11 maize for identifying short and long-term 
cumulative risks: 
•  Short-term risks: currently proposals will only identify development of resistance in 
target organisms.  Will not identify any indirect effects on non-target populations.   
Farmer questionnaire will provide information regarding on-farm effects. 
•  Long-term cumulative risks: key risks are likely to be associated with target and non-
target organisms; on-farm monitoring may extend for 1 year beyond the life of the 
consent in the form of farmer questionnaire. 
 
Table 8. Summary of ERA/Proposed monitoring and possible monitoring for Bt11 
(C/FR/96/05/10) 
 Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Risk component  In 
ERA? 
Monitor? Proposed  monitoring 
method 
What could be monitored to 
detect/mitigate long-term 
cumulative risks? 
Case-specific monitoring 
Development of 
insect resistance 
3  3  Unknown. Target insect 
resistance to Bt toxin 
will be monitored as 
part of Insect 
Resistance 
Management Plan, but 
monitoring procedures 
not specified 
Measure resistance in 
populations of target insect (O. 
nubilalis and S. nonagrioides) 
in areas of Bt11 cultivation 
Effect on non-target 
organisms 
3  2  Still to be finalised. 
Predators and 
parasitoids are 
specifically mentioned 
in ERA but monitoring 
methods are not 
specified 
Monitor altered predator-prey 
interactions; altered population 
dynamics (e.g. altered 
fecundity, altered behaviour).  
Monitor populations of 
nominated indicator species in 
areas of Bt11 cultivation 
Geneflow to wild 
relatives (incl. 
production of 
‘superweeds’ 
3  2  None – there are no 
sexually compatible 
native species in 
Europe  
Not applicable 
Problem volunteers  3  2  None – maize 
volunteers are not 
considered a problem in 
Europe 
Monitor volunteer 
numbers/density; monitor 
susceptibility of volunteers to 
herbicides 
General surveillance 
Human toxicity  3  2  None  Assumed to be safe. Will be 
monitored by CAs. 
Human allergenicity  3  2  None Monitor  for  chronic 
allergenicity e.g. in farmer 
workers, processing operators 
etc.  Should be identified by 
farmer questionnaire 
Human nutrition  ￿  2  None  Assumed to be equivalent to 
conventional maize.  Will be 
monitored by CAs. 
Antibiotic resistance 
– compromised 
human therapy 
3  2  None  Will be monitored by CAs. 
Benefits to humans  3  2  None  EU quality of life indicators 
Animal allergenicity  3  2  None Grower  and  veterinary 
observation/records 
Animal toxicity  3  2  None  Mortality or morbidity of farm 
animals; animal pathology.  
Could extend questionnaire to 
feed merchants 
Animal nutrition  3  2  None  Milk yields; live weights; 
reproductive capacity; produce 
(e.g. milk or meat) quality.  
Could extend questionnaire to 
feed merchants 
Antibiotic resistance 
- compromised 
animal therapy 
3  2  None Veterinary  observation/records 
Benefits to animals  3  2  None  Extend questionnaire to feed 
merchants Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Plant pathogenicity  3  2  None – but farmer 
questionnaire could be 
extended to cover this 
Note: Two components used 
to generate the transformation 
event are derived from plant 
pathogenic sequences (tNos 
derived from Agrobacterium 
tumefaciens; p35s derived 
from Cauliflower Mosaic 
virus) 
Altered plant 
susceptibility to 
pathogens 
3  2  Farmer questionnaire 
(reduced Fusarium 
infection expected) 
Fungicide usage records; 
Grower/agronomist 
observation & records 
Altered plant 
physiology/ 
physiognomy 
  2  Farmer questionnaire  Altered growth habit; altered 
flowering time; altered seed 
viability; possible effect of 
gene recombination on GM 
gene/endogenous gene 
interaction 
Potential beneficial 
effect to plants 
3  2  None  Could be identified by farmer 
questionnaire 
Development of 
insect resistance 
3  3  Case-specific 
monitoring (detailed 
proposals not available) 
Sampling and LD50 testing of 
O. nubilalis and S. 
nonagrioides 
Effect on target 
organisms  
3  3  Case-specific 
monitoring (detailed 
proposals not available) 
Sampling and LD50 testing of 
non-target feeding Lepidoptera 
(especially any that feed on 
maize or other Gramineae) 
Effect on non-target 
organisms 
3  2  None  See case specific monitoring 
above 
Potential for 
horizontal gene 
transfer 
3  3  None   Sampling and testing soil 
micro-organisms 
Potential for 
increased weediness 
3  3  Farmer questionnaire?  Monitoring of flora in fields 
and surrounding areas; grower 
/ agronomist observation & 
records 
Effects on 
biogeochemical 
processes (incl. 
carbon and nitrogen 
cycling)  
3  2  None   Effect of Cry proteins from 
breakdown of plant parts on 
soil biota; effect of Cry 
proteins on decomposition 
rates; effects of herbicide on 
soils (soil biota, nutrient 
cycling, soil structure). 
Composition of runoff to 
water courses 
Management effects  2  2  Farmer questionnaire?  Effect of possible 
monocultures/continuous same 
species cropping on wildlife; 
altered pesticide regimes; soil 
compaction 
Demographic 
changes 
2  2  EU-wide data  Altered consumer trends; 
changes in employment 
characteristics 
 
 
 
C/SE/96/3501 Potato line EH92-527-1 (Amylogene HB) 
Trait: Modified starch content. 
Scope: Cultivation of potato clone EH92-527-1 and use for the extraction of starch for 
industrial uses, and the use of the by-products of starch extraction in animal feed. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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Current status: Pending. 
 
Case-specific monitoring  
The case-specific monitoring will focus on (1) any significant detrimental changes in the 
composition of the tubers and (2) a change in the presence of the bleomycin resistant protein 
associated with ORF4. Monitoring will comprise verification of the following assumptions of 
the risk assessment: 
•  the genes of interest remain stably inserted, 
•  the ORF 4 is not expressed at the protein level, and 
•  the starch composition and the glycoalkaloid content are stable. 
 
The assessment report of the Swedish CA states that the notifier has developed methods and 
accounted for sampling and analysis. The suggested case-specific monitoring will continue 
for five years, after which the monitoring plan will be evaluated and may be extended or 
altered.  The Swedish Board of Agriculture (SBA) concluded that in particular it is important 
to study how the glycoalkaloid content may vary depending on the place of cultivation or 
weather conditions. In addition, the SBA state there is very little reason to expect that the 
possible expression of a protein from ORF4 would result in negative health effects in animals 
that will eat the by-products of the potato. The SBA conclude that it is reasonable that 
monitoring is designed to fulfil the most important criterion in this context, that is to detect 
and avoid the unlikely scenario that ORF 4 causes a protein to occur in a significant share of 
the potatoes. 
 
General surveillance 
The general surveillance plan considers areas related to (1) growth characteristics of the plant 
(including time to flowering, abortion of flowers, and time to maturity), (2) general 
characteristics of the plants (including height, shape and colour of the foliage, size and shape 
of the plant), (3) susceptibility to disease and pests and (4) any changes in animals within and 
in proximity to the fields.  Farmers who cultivate and/or use by-products of EH92-527-1 in 
feed will be required to note all possible unexpected effects.  The notifier will supply the 
appropriate forms for this purpose.  General surveillance will also monitor the spread of 
potatoes outside the field. Management of volunteer potatoes will be carried out according to 
standard agricultural practice.  The general surveillance plan will run throughout the 10-year 
period of the consent. The base-line information consists of data that the notifier has gathered 
during previous years of cultivation and analysis.  A general surveillance questionnaire to all 
growers and handlers of the potatoes has not been proposed. 
 
Sampling plan 
The applicant has a strategy for introduction of EH92 potatoes and has developed a clear plan 
for areas of production of seed potatoes and a sampling strategy at sites of production.   
Sampling strategies must ensure homogeneity and will be undertaken according to European 
(CEN) standards, further advice will be taken from the ‘Ecological Monitoring and 
Assessment Network’, and e.g. ISTA and the EC’s Joint Research Centre. 
 
EH92 post market monitoring sampling plan: 
Object Parameters 
Seed potatoes (80 pooled samples)   PCR- identity 
Absence of ORF4 
Production potatoes (20 locations, 4 pooled 
samples each) 
Starch composition 
Glycoalkaloid level Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Carbohydrates 
Protein 
Seed potato production sites (5 per year)  Plant characteristics 
Susceptibility to pests and disease 
Production sites (20 new sites per year, 
cumulative) 
Persistence in field 
Persistence outside of the managed field 
Production sites (all sites, verification by the 
growers) 
Plant characteristics 
 
Suitability of monitoring plan for EH92 for identifying short and long-term cumulative risks: 
•  The scope of the notification includes cultivation and use for industrial purposes, and 
feeding of the by-products of processing to cattle.  It is not intended for direct human 
consumption, but it cannot be completely excluded that humans will consume the 
potatoes.  The post market monitoring plan includes a case-specific element to confirm 
the stability of the inserted genes (nptII and non-functional ORF 4) and to ensure that the 
content of starches and glycoalkaloids remain stable, general surveillance will include 
monitoring growth characteristics and pests and disease susceptibility.  The notification 
has received favourable assessments for being very thorough and for the applicant’s 
commitment to post market monitoring.  The applicant has collated 9 years of baseline 
data regarding the performance of EH92 relative to the parental variety. 
•  The biological characteristics of the potato and the relatively benign nature of the trait 
make it difficult to anticipate long-term or cumulative effects arising as a result of 
cultivation of this crop; the comprehensive post market monitoring plan is designed to 
identify any unanticipated effects of cultivation in the short-term.  Use of a farmer 
questionnaire may be advisable to identify any changes in management practice 
associated with cultivation of EH92, such as altered use of herbicides or pesticides. 
•  The main risks possibly lie in the co-mingling of EH92 with food potatoes, for which it is 
not authorised, however the strict Identify Preservation scheme should ensure against this 
and enable rapid risk management if co-mingling should occur. 
•  Longer-term cumulative impacts may lie in economic benefits, for example farmers may 
be able to secure long-term production contacts, or the increased supply of high quality 
raw materials may boost local industries with knock-on benefits to the local economy.  
There may also be potential benefits from the slight reduction in glycoalkaloid levels, 
which may improve the quality of EH92 pulp for cattle. 
 
Table 9.  Summary of ERA/proposed monitoring and possible monitoring for potato clone 
EH92-527-1 (C/SE/96/3501). 
Risk component  In 
ERA? 
Should 
monitor? 
Proposed monitoring 
method 
What could be monitored to 
detect/mitigate long-term 
cumulative risks? 
Case-specific monitoring 
The genes of interest 
remain stably 
inserted 
9  9  Event specific 
identification of 
inserted sequences 
(Southern blot or PCR) 
Continue to monitor for whole 
duration of consent. 
ORF 4 is not 
expressed at the 
protein level 
9  9  Western blot to confirm 
absence of expression 
of peptides derived 
from ORF4 
Continue to monitor for whole 
duration of consent. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Starch composition 
is stable 
9  9  Use of standard 
methods to monitor 
ratio amylose to 
amylopectin as 
indicator of quality and 
stability  
Continue to monitor for whole 
duration of consent. 
Glycoalkaloid (GA) 
content is stable. 
9  9  Use of standard method 
to monitor GA level & 
ensure it remains within 
range documented for 
starch potatoes 
Continue to monitor for whole 
duration of consent. 
General surveillance 
Human toxicity  2  2  None  N/A EH92 will not be 
authorised for food use.  Strict 
control over Identity 
Preservation scheme to ensure 
EH92 does not enter the food 
chain. 
Human allergenicity  2  2  None  N/A EH92 will not be 
authorised for food use.  Strict 
control over Identity 
Preservation scheme to ensure 
EH92 does not enter the food 
chain. 
Human nutrition  2  ?  None  Inadvertent use as food potato 
could affect insulin levels in 
diabetics if consumed over a 
long period.  Strict control 
over Identity Preservation 
scheme to ensure EH92 does 
not enter the food chain. 
Antibiotic resistance 
– compromised 
human therapy 
2  2  None  EH92 is not intended for direct 
human consumption.  Strict 
control over Identity 
Preservation scheme to ensure 
EH92 does not enter the food 
chain. 
Benefits to humans  2  2  None  Possible economic benefits to 
farmers. 
Animal allergenicity  2  3  None 
Animal toxicity  2  3  None 
Animal nutrition  2  3  None 
Antibiotic resistance 
- compromised 
animal therapy 
2  3  None 
Inclusion of specific question 
in general surveillance 
programme about possible 
adverse effects on cattle fed 
with pulp derived from EH92. 
Benefits to animals  2  3  None  Inclusion of specific question 
in general surveillance 
programme about possible 
beneficial effects on cattle fed 
with pulp derived from EH92. 
Plant pathogenicity  2  2  None  Promoters are derived from 
Agrobacterium tumefaciens; 
no viral promoters are used. 
Altered plant 
susceptibility to 
pathogens 
3  3  Seed production sites (5 
per year) and all 
production sites 
(growers to verify) will 
be monitored for 
susceptibility to pests 
and diseases 
Could derive further 
information from a farmer 
questionnaire.  Monitor for 
duration of the consent. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Altered plant 
physiology/ 
physiognomy 
3  3  Seed production sites (5 
per year) and all 
production sites 
(growers to verify) will 
be monitored for plant 
characteristics 
Could derive further 
information from a farmer 
questionnaire.  Monitor for 
duration of the consent. 
Potential beneficial 
effect to plants 
2  ? None  Any  unanticipated  beneficial 
effects to EH92 could be 
identified through farmer 
questionnaire. 
Development of 
insect resistance 
2  2  None  Trait is not related to insect 
tolerance so no need to 
monitor. 
Effect on target 
organisms  
2  2  None  There are no target organisms 
so no need to monitor. 
Effect on non-target 
organisms 
2  3  None Changes  in  glycoalkaloid 
levels may alter palatability to 
insects and other organisms 
(larvae, slugs, rodents etc), this 
may alter within-field 
populations in the long-term.  
Monitor populations of 
invertebrates and vertebrates 
feeding in and around crops of 
EH92. 
Potential for 
horizontal gene 
transfer 
2  2  None  Kanamycin resistance is 
ubiquitous in soil.  Transfer of 
gbss gene to wild relatives or 
other cultivated potatoes 
considered highly unlikely in 
northern Europe.  Widening of 
area of cultivation to southern 
Europe could lead to increased 
potential for horizontal 
transfer of gbss as potatoes can 
become weedy and wild 
relatives occur – may need to 
re-assess ERA and PMM plan 
in this case.  
Potential for 
increased weediness 
3  3  20 production sites will 
be monitored each year 
for persistence in the 
field (monitored for 4 
years) and outside of 
the field (monitored for 
2 years). 
Monitoring is appropriate; the 
20 sites must be fully 
representative of the areas in 
which the potatoes are being 
cultivated.  Monitor for 
duration of the consent. 
Effects on 
biogeochemical 
processes (incl. 
carbon and nitrogen 
cycling)  
2  ?  None  Potato does not have a 
substantial role in soil 
processes; altered starch 
composition may alter 
degradation profile in the 
long-term.  Monitor soil biota. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Management effects  3  3  General surveillance 
programme. 
Monitor herbicide use in fields 
where EH92 has been grown; 
monitor changes in cultivation 
practice.  Possible scenario: 
increased numbers of smaller 
tubers may lead to increased 
numbers groundkeepers 
following harvest.  This would 
necessitate increased use of 
herbicides where EH92 has 
been grown to control any 
volunteers.  Potential for 
adverse impacts on plant 
populations in the field and 
organisms reliant on the plants 
as a food source.  This 
scenario may also lead to 
increased cultivation of fields 
that have grown EH92, leading 
to disruption of soil integrity. 
Demographic 
changes 
2  2  None.  Map cultivation of EH92 
relative to starch production 
factories to confirm the 
applicant’s assumption that 
EH92 will only be grown in 
close proximity to these.  
Market forces will determine 
contracts for production.  EU 
socio-economic data. 
 
4.6. Summary 
 
General surveillance aspects of post market monitoring plans are intended to identify 
unanticipated effects of release of a GM crop, success here will depend on establishment of 
effective mechanisms for collating and comparing baseline data for nominated key indicators 
over a period of time, and being able to identify any significant changes in baseline values, 
these can then be further investigated for causal linkages.  Data would need to be available in 
a format that is spatially and temporally appropriate for statistical analyses.  Current post 
market monitoring programmes are focussed on identification of adverse/beneficial effects 
that may occur within the 10-year period in which the crop is marketed, monitoring by the 
consent holder in connection with a specific release will substantially cease soon after the 
consent expires.  The monitoring plans for GT73, Bt11 and EH92 confirm this; there is little 
scope for identification, by the consent holder, of any effects associated with a specific release 
once this period is completed.  Monitoring for cumulative long-term effects is expected to 
encompass even broader themes than general surveillance; it is possible that collation and 
analysis of data for identification of these effects would be more effective if undertaken by, or 
on behalf of, competent authorities as part of higher-level national environmental surveillance 
initiatives. 
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5.  Findings & Recommendations 
 
5.1. The State of the Art 
 
A review of the scientific literature on long-term and cumulative risk assessment has 
illustrated the paucity of scientific evidence in this area. Experimental evidence is largely 
based on laboratory and glasshouse experimentation, which can only tentatively be used to 
extrapolate to the field in the medium to long-term. Very few monitoring studies have been 
carried out over longer time periods. 
 
Many risk assessment frameworks are currently available for risk assessment of the release of 
GM crops.  These tend to follow a similar approach based on a case-by-case scientific 
framework aimed at assessment of hazards, potential for exposure and consequences of 
exposure, followed by consideration of risk management; very few of the frameworks 
reviewed specifically consider long-term and cumulative risks.   The EU Directive states that 
these long-term and cumulative risks must be assessed, but gives limited guidance and there is 
limited evidence that it is actually done.  The Australian Office of the Gene Technology 
Regulator (OGTR) ‘Risk Analysis Framework’ is the most recent publication and probably 
provides the greatest level of accessible guidance for completing all stages of the risk 
assessment.  The New Zealand and USA approaches are also very detailed.  However, they 
provide limited guidance specifically for consideration of cumulative long-term risks. 
 
The European approach is noticeably focussed on the GMO and the underlying science, while 
other approaches focus on the risk assessment methodology.  Methodologies for assessing 
risks of the impacts of plant pathogens or pests and non-native species tend to consider the 
longer-term cumulative impacts of the release or introduction of new species and these may 
provide some useful insight for GM crops.   
 
Of the competent authorities that responded to the questionnaire, most considered the EU risk 
assessment framework to be adequate; most also had a clear view of the meaning of 
cumulative long-term effects and how this might be approached in practice, although none 
had developed a clear monitoring strategy.  In this respect it was unfortunate that none of the 
countries that are currently growing GM crops could be contacted.  Gaps in regulators’ stated 
requirements were identified, particularly with respect to presentation of monitoring plans 
following the release of a GMO, however this was generally thought to be due to lack of 
precedent, and possibly not always the applicant's fault (i.e. better guidance is needed).  None 
of the respondents had developed their own risk acceptability criteria and most abide closely 
by the criteria set in 2001/18 while also taking national policy goals into consideration.   
  
5.2. The Proposed Risk Assessment Framework  
 
A risk assessment framework has been developed, refined and demonstrated in a number of 
case studies.  The steps in the framework follow a standard risk assessment methodology.  It 
begins by framing the question: defining the boundaries of system to be assessed and the 
types and measures of risk to be considered.  Criteria for judging the tolerability of the risk 
are then defined.   Hazards are identified and analysed, and the risk evaluated and compared 
against the criteria.  Additional risk mitigation and monitoring measures can then be identified 
and evaluated, if seen to be required.   Tools and techniques have been identified that can 
support the various steps in the framework.  These are available at different levels of depth Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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and detail, allowing users to select a method appropriate to the decision stakes and the data 
available.   
 
The assessment structure and the tools and techniques suggested are thus firmly based on 
approaches that have been extensively used and proven in other domains.  Experience with 
the case studies suggests that the proposed approach is intelligible and usable, given the 
inevitably complex nature of the risks it assesses, and that it does help to clarify discussions 
about long-term and cumulative risks.  
 
The real value of the framework may be more in terms of process  than  product.  The 
framework provides a structure for a systematic discussion between stakeholders that leads to 
better understanding and insight, in addition to its more obvious ’results’ in terms of risk 
evaluations.   It should be seen as an aid to decision-making under uncertainty rather than a 
clear-cut procedure to test a proposed release against prescribed criteria.    
 
It is anticipated that the framework would be used by the CAs and made available to 
applicants, so that everyone is working to the same procedures, and that therefore all parties 
should come out with the same (or similar) assessment. Long-term & cumulative risk 
assessment is in effect only one aspect of the e.r.a., therefore, the effort that the risk 
assessment requires needs to be proportionate to the effort required for the preparation of the 
current e.r.a. and to the level of risk identified. Thought needs to be given to implications for 
the ‘short-term’ e.r.a. as the framework proposed in this report is more detailed than the 
existing, relatively general guidance on ‘short-term’ e.r.a. 
 
5.3. Key Issues in Applying the Proposed Framework 
 
Although elements of the framework have already been used in some GM risk assessments, 
it’s the systematic application of the full approach is relatively new and uncommon.    While 
the tools and techniques will be familiar to most risk assessment practitioners, their 
application to the GM domain does raise specific challenges, as follows, that will need to be 
kept in focus when applying it.   
 
Once released into the environment there is a possibility that the risk from a GM crop could 
increase – for example if an invasive species is given an additional selective advantage.  It is 
difficult to identify, understand or forecast what human or ecological mechanisms might 
eventually control the risk.  Regulators should not set an arbitrary cut-off time on assessments 
– it should be demonstrated on a case-by-case basis how the risk is expected to change over 
time and when the peak risk will have passed.   
 
There is extreme uncertainty in the prediction of the nature, likelihood and severity of long-
term and cumulative effects.  The environment is a complex, highly interactive system and, 
almost by definition, we can have no direct means to verify the predictions about long-term 
and cumulative risks before a decision has been made.  Tools such as stochastic analysis are 
available to manage and analyse the effects of such uncertainties within the confines of the 
risk assessment itself, but wider issues are raised regarding the use of risk assessment within 
decision-making.  
 
Over very long timescales, uncertainty increases, such that the value of risk assessment as a 
tool for quantitative prediction diminishes and may ultimately become meaningless.  This 
shifts the emphasis away from quantitative predictions about what is expected to happen 
towards a broader, more qualitative consideration of ‘what-if’ scenarios.    The applicant Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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needs to demonstrate that, for a range of scenarios spanning the range of credible futures, the 
environmental mechanisms and barriers to risk will continue to provide adequate assurance of 
environmental safety.   The emphasis should be on considering the crop within the whole 
environmental system, and the effectiveness of barriers to harm, rather than detailed 
modelling of those aspects that can be quantified.   
 
5.4. Research Gaps and Possible Future Work 
 
There are a number of significant outstanding issues that would make practical application of 
the assessment framework problematic.  With the current state of knowledge, it is unlikely 
that risk assessments can be performed with sufficient confidence to support robust regulation 
and decision-making.  A number of further work packages (WPs) have therefore been 
identified that would help to close these gaps, as follows: 
 
WP1: Obtaining Baseline Data.   There is a need for good baseline data if monitoring is to 
be able to detect changes.    A study is required to advise on the best indicators of long-term/ 
cumulative changes.  There are also institutional and other practical aspects of implementation 
to be considered.  For example, who should carry out the baselining, and how would it relate 
to ecological baselining for other purposes?    
 
WP2: Ranking the Risks of Generic Crop-Trait combinations  It could be more cost-
effective, for society as a whole, if some risk assessment work were to be done at a higher 
level than release-specific e.r.a.s.   Ranking crop-trait combinations (or other types of 
scenario) in broad order of inherent risk, would help both regulator and industry to ensure 
proportionate levels of depth and detail in risk assessments.  It might also lead regulators to 
issue guidance indicating any broad classes of combinations that would be unlikely to be 
authorised, preventing wasted effort by all parties. This WP would apply the assessment 
framework in order to establish whether certain crop-trait combinations are inherently riskier 
than others.  
 
WP3:  Introgression into and Ecology of Wild Relatives  Currently, the mechanisms of 
introgression into wild relatives are not understood in sufficient detail to enable the likelihood 
of introgression to be determined with confidence. Neither is there, in general, a good enough 
understanding of the ecology of wild relatives, and hence of how undesirable traits might 
spread in the environment.   Research is required to improve the understanding of 
introgression and of the  ecology of wild relatives, in sufficient detail for risk assessment. 
 
WP4: Improved hazard identification for long-term and cumulative effects.  It is difficult 
to identify hazards that are fundamentally different from those that can occur in the short-
term.   In most cases, long-term and cumulative hazards identified in this study were the same 
as the short-term ones, although the degree of risk associated with the hazard could be greater 
- given a longer time or more widespread planting, the likelihood and extent of undesirable 
effects may increase.  Nevertheless, some genuinely different hazards can be identified.     
These tend to arise from rather subtle and complex combinations of factors, which would only 
be manifested in the long-term or as a result of widespread releases and plantings.   The 
process of identifying long-term and cumulative risks could be made more efficient and 
effective if standard hazard-identification techniques (brainstorming, failure analyses, HHA 
etc) could be enhanced to focus more quickly on such genuinely long-term and cumulative 
effects.  
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WP5:  Tolerability Criteria.  The absence of explicit criteria in the Directive for judging 
whether a risk is tolerable, and the apparent variations in practice between Competent 
Authorities, point to a need to develop some more explicit guidance on criteria that will 
encourage well-founded, consistent and fair decisions.   The aim of this WP would be to 
develop justifiable criteria for tolerable risk, and guidance on their application. 
 
WP6: Tracking, Combining and Monitoring Cumulative Risks   In considering 
cumulative risks, the EC will need mechanisms to track and combine the risk assessments 
from multiple, and in some cases apparently unrelated, releases.    There is a need to explore 
the scientific and institutional issues involved in tracking multiple release assessments and 
consents and to develop guidance.  The study could consider both scientific aspects (how to 
identify any potential for cumulative risk) and institutional aspects (processes and procedures, 
IT issues)  
 
WP7: Stakeholder Engagement in Risk Assessment  In other controversial debates about 
risk and the environment, there has been a growing realisation of the importance of 
considering social and ethical aspects. Stakeholder participation in framing the question and 
defining assessment methods is being given serious consideration and has occurred in some 
cases, in addition to the more traditional model, in which stakeholders review and challenge 
assessment results and assertions.   Risk assessment should be used to provide a structured 
framework for discourse and decision-making under irreducible uncertainty, rather than as a 
technical and scientific exercise alone.  Deliberative processes have been used in other 
domains, and this experience could be adapted and applied to the GM domain. 
 
Appendix 7 provides some further details for each of these WPs.  For each, we have 
documented why it is needed, given an initial specification of the objectives and scope, 
indicated the tasks and outputs and provided indicative timescales and costs.   
 
Many of the WPs suggested above would also have benefits in improving the quality of 
current, ‘short-term’ risk assessments – the same difficulties arise, although not always with 
such severity. 
 
Decisions about these WPs and their priorities will need to be made in the light of wider 
considerations of EU policy and EC research programmes.   However if the priority were, for 
example, to issue some guidance to industry and regulators as soon as possible (accepting that 
may scientific and risk management challenges remain to be solved), we would suggest that 
WP 4 and WP5 deal with the most urgent needs and would provide the greatest value in the 
short-term.  WP4 would help to resolve the difficulty of identifying long-term and cumulative 
effects, which are often subtle and hidden.  WP5 would address the current absence of any 
clear criteria for judging the tolerability of risks, and so encourage well-founded, consistent 
and fair decisions.   
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Weaver & Morris (2005) have presented a comprehensive annotated bibliography of peer-
reviewed scientific research highlighting the human health, animal health and environmental 
risks associated with GM. They identified two potential risk categories: 
 
Risks associated with expression of the gene e.g. Bt toxin.  
Unpredictable effects of the GM construct on the plant genome 
 
It is also clear that there are risks which are not related to the GM plant itself but are part of 
the management practice required for agricultural use of the GM crop. 
 
1.1. Risks associated with expression of the transgene 
 
1.1.1. GM plants containing Bt toxin 
 
Insect resistance 
GM crops containing the genes for Bacillus thuringiensis (Bt) toxin have been grown widely 
since 1996. The cumulative area of these crops grown over the years is now > 80 million 
hectares worldwide. Originally, the biggest concern was that insect resistance to Bt would 
appear as quickly in the field as it had done in laboratory experiments (Agi et al, 2001; 
Alyokhin et al 1999; Cannon 2000; Cao et al 1999). Insect resistance management (IRM) 
strategies were therefore put in place to try and mitigate this anticipated problem.  
 
As part of their requirements, companies selling Bt plants are mandated by the US EPA to 
implement an annual resistance monitoring program, the goal of which is to detect changes in 
resistance levels in pest population. The most widely used method is diagnostic or 
discriminating dose incorporated into an artificial diet. Bates et al (2005) have reviewed the 
management of insect resistance over the last 8 years of Bt releases in the USA and have 
found no reports of increased insect resistance developing to the Bt crops in the field. 
 
 
In their review, Bates at al (2005) suggested that IRM strategies can do much to delay the 
development of resistance to Bt plants but that the most effective use of Bt crops will be as a 
component of overall IPM programs. For example, the use of Bt crops in conjunction with 
cultural or biological methods, that have limited efficacy on their own, may help increase the 
feasibility of large refuges or help suppress local pest populations in the near or long term.  
Although treating Bt crops as a silver bullet for pest management will almost certainly hasten 
the evolution of resistance in the long term, incorporation of transgenic crops with traditional, 
integrated approaches to pest management should help ensure their long-term sustainability 
and maximize their environmental and human health benefits. 
 
Tabashnik et al (2005) monitored pink bollworm (Pectinophora gossypiella) resistance levels 
over 8 years and 10-17 fields of Bt cotton annually, using bioassays, and found no evidence of 
increased resistance to Cry1Ac in populations. Wu & Guo (2005) report that no trend towards 
Bt resistance has been observed in cotton bollworm (Helicoverpa armigera) in Bt cotton 
crops in China. In their paper, Tabashnik et al comment that most common type of Bt 
resistance (‘Mode 1’) is characterized by recessive inheritance, 500-fold resistance to at least 
one Cry1A toxin, negligible cross-resistance to Cry1C, and reduced binding of Bt toxins to 
midgut membrane target sites. Mutations affecting a Cry1A binding midgut cadherin protein 
are linked to laboratory selected Mode 1 resistance in Heliothis virescens and Pectinophora 
gossypiella. Baxter et al (2005) have shown that field evolved Mode 1 resistance in the Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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diamondback moth, Plutella xylostella, has a different genetic basis, indicating that screening 
for resistance in the field should not be restricted to a previously proposed DNA-based search 
for cadherin mutations.  Tabashnik et al (2005) tested this using a unique model system 
composed of broccoli plants transformed to express different Cry toxins (Cry1Ac, Cry1C, or 
both) and a synthetic population of the diamondback moth (Plutella xylostella) carrying genes 
for resistance to Cry1Ac and Cry1C at frequencies of 0.10 and 0.34, respectively. After 24–26 
generations of selection in the greenhouse, the concurrent use of one- and two-gene plants 
resulted in control failure of both types of Bt plants. When only two-gene plants were used in 
the selection, no or few insects survived on one- or two-gene Bt plants, indicating that 
concurrent use of transgenic plants expressing a single and two Bt genes will select for 
resistance to two-gene plants more rapidly than the use of two-gene plants alone. The results 
of this experiment agree with the predictions of a Mendelian deterministic simulation model 
and have important implications for the regulation and deployment of pyramided Bt plants 
(Zhao et al, 2005). Thus there are still concerns that if the hectarage in Bt crops increases 
further resistance may yet develop. 
 
Effects on non-target arthropods 
Non-specificity is another issue of transgenic insecticidal crops, e.g. the Monarch butterfly 
study which demonstrated a toxic effect of GM pollen to the Monarch butterfly (Hansen et al 
2000, Losey et al 1999, Sears et al, 2001, etc). Debate has raged on with a variety of rebuttals 
of these types of studies. Other non-target effects have also been documented on 2-spot 
ladybirds, green lacewing, etc. (see Weaver et al 2005 refs, p166). Many of these studies were 
carried out in the laboratory under artificial conditions and these are therefore open to 
interpretation.  
 
An EPA report (USEPA 1999) reported that the toxin CryIAb caused significant mortality and 
reduced reproduction of the soil-dwelling collembolan, Folsomia candida. Despite its own 
finding of an adverse effect on a non-target species, the EPA concluded that there is a 200-
fold “safety factor” in the levels of toxin present in the field. The meaning of this EPA safety 
factor is not entirely clear, though perhaps it signifies that the concentration of Bt toxin in 
corn residue or soil is less than 1/200
th of the concentration needed to kill Collembola 
(Obrycki, 2001). 
 
Lozzia (1999) reported a two-year survey in two North Italian locations (near Pavia) during 
1997-98, which revealed no significant differences in the abundance of non-target 
entomofauna in transgenic and isogenic corn crops.  The authors concluded that transgenic Bt 
176 maize (Novartis product) appeared to have no deleterious effects on non-target abundance 
or biodiversity, although they also suggested that longer term and larger scale field trials are 
needed to confirm these findings.   
 
A study carried out in the USA in order to collect information on ecological risks, as part of 
the regulatory process, has been published by McKee et al (2003). The reported studies found 
no ‘unacceptable’ adverse effects of GM crops on a range of arthropod populations in plot or 
farmscale trials in the USA, including trials of Bt corn and Bt cotton. 
 
Pons & Stary (2003) found no differences in aphid-parasitoid associations on Bt maize and 
isogenic maize for aphid species composition and associated parasitoid guild, in an irrigated 
area in Catalonia, Spain.  
 
De la Poza et al (2005) found no detrimental effect on any predatory taxa or on the functional 
group as a whole in studies on Bt maize expressing the Cry1Ab toxin from Bacillus Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  3
thuringiensis. As part of a Spanish specific monitoring program for Bt maize, a farm-scale 
study was initiated in 2000 to assess the potential impacts of Bt maize on predatory 
arthropods. The trials were conducted at two maize growing areas (Lleida and Madrid) over 3 
years. In each locality three treatments (each with 3–4 replicates of 0.4–0.7 ha) were arranged 
in a completely randomised block design, Bt-maize (cv. Compa CB) being compared with the 
isogenic cv. Dracma under conventional farm practices, with or without the insecticide 
(imidacloprid) seed treatment. Predator abundance was monitored from late May to mid 
September in Lleida and from mid June to mid September in Madrid by visual surveys and 
pitfall traps. Anthocoridae, Coccinellidae, and Araneae represented about 90% of the total 
number of predators recorded in visual samplings whereas Carabidae and Araneae were the 
two prevalent predator groups (85–90% of the total predators) collected in pitfall traps. Their 
abundance varied from year to year and between locations, but no clear tendencies related to 
Bt maize was recorded. Insecticide treatment reduced anthocorid numbers occasionally but no 
consistent effects were found for the rest of predators.  
 
A set of comprehensive studies of the insect populations in Bt corn and Bt cotton in the USA 
and Australia have recently been published as a series in the journal Environmental 
Entomology during 2005. The study concluded that there are no substantial negative effects of 
Bt on non-target insects (Naranjo et al 2005). Studies were carried out over a minimum of 
three site years in either controlled moderate sized research plots or commercial fields and 
were subjected to typical grower production practices.  
 
Studies have been carried out in China on Bt cotton e.g. Men et al (2003) who published a 3 
year investigation in Henan Province which concluded that the use of Bt cotton can increase 
the diversity of arthropod communities and pest sub-communities but that natural enemy 
communities may be decreased. Similar results were obtained by Liu et al (1996) who were 
concerned that lower numbers of natural enemy arthropods under Bt cotton may mean that 
populations are unstable. Ma et al (2003) also suggest that the insect community under the 
GM crop is less stable and there is therefore more chance that minor insect pests could 
develop into major ones.  
 
Men et al  (2004) did find reductions in some groups of insects on Bt cotton in China due to 
sprays of pesticide. The effects of pesticide applications on pests (aphids and acarid mites) 
and predators (ladybeetles and spiders) were investigated in transgenic Bt  cotton and 
nontransgenic cotton agroecosystems in 1999, 2000 and 2001. Although transgenic cotton did 
not cause changes in populations of acarids and did not reduce numbers of predators 
significantly; its effects on aphids were inconsistent. Although insecticides were not applied 
against the main pest – cotton bollworm – on transgenic cotton, the total number of 
insecticide applications in 3 years was no less than the total applied on nontransgenic cotton, 
because additional applications were required against sucking pests on transgenic Bt cotton. 
Pesticide applications decreased the numbers of aphids, acarids and predatory spiders 
significantly on both transgenic and nontransgenic cottons.  
 
 
Effect of Bt toxin on soils 
Stotsky (2000) reported that Bt toxin can bind to soil and therefore persist in the soil. They 
found evidence that the Bt corn biomass decomposed more slowly in soil when compared to 
its non-GM equivalent. However, they found no evidence of effects of the Cry1Ab protein on 
earthworms, nematodes, protozoa, fungi, bacteria and concluded this was an effect of lignin 
content in the GM crop not Bt toxin per se. 
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In a review by Liu et al (2005), they reported that CryIIA Bt cotton produce the protein at a 
level of 34 ug Cry11A protein/g of fresh weight of tissue prior to harvest. If the transgenic 
cotton plant matrix is uniformly incorporate into 7.6cm of soil, then the estimated maximum 
content of Cry11A protein is 1.6 ug/g dry soil (Sims and Ream, 1997).  When purified Bt 
toxin was added to non-sterile soils, activity against the larvae of the tobacco hornworm 
(Manduca sexta) was still detected after 234 days. A high soil clay content and low soil pH 
increased the persistence of Bt toxin in soil (Saxena & Stotzky, 2000). These results suggest 
that the transgenic protein can remain in soil for a long time. It is still not known whether 
continuous planting of transgenic plants over many years will lead to increasing accumulation 
of transgenic proteins, or what impact this might have on soil microorganisms or the soil 
fauna.   
 
Wu et al (2004) have reported that soil dehydrogenase activity in the soil amended with 
transgenic rice straw was significantly higher compared with the soil amended with non 
transgenic rice straw, but the difference disappeared after incubation for 63 days.  
 
The overall general conclusion is that effects of Bt toxin on soils were minor compared to 
natural variations found between soils anyway. However, there could potentially be stronger 
effects with other types of GM plant. 
 
Benefits 
 
It is suggested that Bt crops can produce proportionately higher yield gains in developing 
countries due to a combination of high pest pressure and poor chemical control in traditional 
crops.  Pest-related crop losses of 50% and higher are quoted.  It is suggested that such crops 
could substantially reduce the current gaps between attainable and actual yields, especially in 
smallholder farming systems.  Qaim & Zilberman (2003) carried out on-farm field trials with 
Bt cotton in seven different Indian states demonstrated substantial reduction in pest damage 
and yield increases (up to 80%).  A total of 395 plants grew three adjacent 646 m
2 plots: 1) Bt 
cotton hybrid; 2) non-Bt cotton counterpart; and 3) local non-Bt hybrid. Farmers managed the 
trials according to customary practices.  Bt  crops were sprayed (especially against H. 
armigera) on average, three times less often than were the non-Bt counterparts; however there 
was no significant difference in the number of sprays applied against sucking pests (aphids, 
jassids and whitefly).  Nevertheless, “insecticides amounts on Bt plots were reduced by 
almost 70%”.  A saving of about $US30 per ha.  In terms of yields, the benefits were even 
more sizeable: 80-87%.  The bollworm pressure in India was exceptionally high in 2001, but 
even over a 4-year period (1998-2001) Bt hybrids showed an average advantage of 60%.  In 
other words, the yield is directly related to a reduction in the high pest damage (about 60%) 
caused by bollworms in the conventional plots. 
 
Huang et al (2002) carried out a survey of the use of plant biotechnology in China. The list of 
GM plants being used included: rice, wheat, potatoes and peanuts.  Poor farmers in China are 
cultivating more areas of GM plants than are small farmers in any other developing countries.  
A survey of agricultural producers demonstrated that Bacillus thuringiensis cotton adoption 
increases production efficiency and improves farmer health.  Research on GM cotton began as 
a response to rising pesticide use and the emergence of pesticide-resistant bollworm 
populations in the late 1980s.  Bt cotton farmers reduced pesticide use by an average of 13 
spray applications (or c. 50 kg) per hectare per season, which reduced costs by $762 per ha. 
Total number of pesticide applications per ha decreased from c. 20 (without Bt cotton) to c. 7 
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The use of GM crops with Bt insect resistance is reported to lead to less application of 
insecticides to agricultural crops and therefore cause less impact on the environment and 
fewer direct effects on non-target species. There are documented reports of reduction in 
pesticide usage as a result of use of Bt crops, for example, Pray et al (2001) surveyed cotton 
farmers in Northern China in 1999. Farmers that used cotton engineered to produce the Bt 
toxin substantially reduced the use of pesticide without reducing the output/ha or quality of 
cotton. This resulted in substantial economic benefits for small farmers, also farmers using Bt 
cotton reported fewer pesticide poisonings than those using conventional cotton. Yang et al 
(2005) carried out a similar survey in 2002 and found that although farmers had adopted Bt 
crops in an effort to increase yields and reduce sprays and were willing to reduce sprays, lack 
of technical knowledge still led to some overspraying.  
 
Gregory et al (2002) surveyed thus use of Bt cotton varieties expressing the Bollgard gene 
which were first commercialised in South Africa in 1998.  Farmers in the Makhathini Flats 
region of KwaZulu Natal - where chemical control of pest infestations on cotton had proved 
inadequate – were early adopters.  The product provides effective control of the main 
lepidopterous pests (H. armigera, Earias spp. and Diparopsis castanea).  Cotton in this area is 
usually grown on 3-10 ha plots.  Chemical control usually involves 6-10 applications of 
carbamate and pyrethroid insecticides per growing season.  Theses spray applications also 
require considerable quantities of water, and it can take up to 20 km of walking to collect 
enough water to spray 1 ha using knapsack sprayers.  The adoption of Bt cotton on these plots 
has reduced (by 5-8 sprays per season) the need to chemical pesticides and resulted in a 2-
fold yield increase in some areas (1999/2000).  Although little or no spraying is required to 
control bollworm pests on Bt cotton, jassids and other hemipterans (such as Dysdercus) can 
cause problems and need to be scouted for.  One or two sprays with systemic compounds 
have proved effective against these secondary pests.  Low sales of cotton have ensured that 
there are areas of conventional cotton in place to act as refugia. 
 
Qaim et al (2003) reported that transgenic Bt cotton can halve pesticide application rates in 
Argentina while significantly increasing yields. Yield effects are bigger than in other 
countries due to the current low levels of insecticide use. Although smallholder farmers are 
not currently using the technology, gross benefits are predicted to be highest for them. 
Biological model simulations suggest that rapid resistance buildup in pest populations appears 
to be unlikely if minimum non-Bt refuge areas are maintained.   
 
A more sceptical view is presented by the NW Science and Environmental Policy Centre 
(Idaho, USA) (Benbrook, 2001) where it is argued that Bt cotton has reduced insecticide use 
in several states, whereas Bt corn has had little if any impact on corn insecticide use (Cannon, 
2000).  The author argues that asking whether GM crops reduce pesticide use is not the 
important question, we should be “asking how biotechnology can lead toward prevention-
based biointensive pest management systems that rest largely on low-impact ways to manage 
natural biocontrol processes and interactions”.  The greatest long-term management benefits 
from agbiotech may well be process- and management-based.  Biotech will make it possible 
for farmers to subtly tip the competitive balance within agricultural systems towards 
beneficial organisms, at the expense of pests. 
 
 Phipps et al (2002) used published data to estimate the effects of GM crops on pesticide use 
on a global basis. They concluded that, overall, GM technology reduced pesticide use 
globally, with the size of the reduction varying between crops and the introduced trait.   
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grown on 50% GM basis in the EU, pesticide use would decrease by 14.5 m kg of formulated 
product (4.4. m kg a.i.) per annum. 
 
 
1.1.2. GM herbicide tolerant plants  
 
The second type of GM crop grown widely at present is herbicide tolerant (HT).  
 
Effects of HT plants on biodiversity 
Results of the UK Farm scale evaluation trials (Firbank et al 2005) have demonstrated that 
GM herbicide tolerant crops and their cropping systems could influence farmland biodiversity 
because of their effects on the weed biomass and seed production. Effects persisted at least 
two years after the crops were grown. Weed seed banks were significantly higher following 
GMHT maize and significantly lower following GMHT spring oilseed rape (SOSR). 
 
Owen & Zelaya (2005) report that the widespread adoption of GM herbicide resistant crops in 
the USA has resulted in a change in the weed populations. Both weed population shifts and 
the evolution of herbicide resistant types has occurred. For example, Commelina comminus 
L.(Asiatic dayflower), Chenopodium album (common lambsquarters) and Polygonum 
convolvulus L (wild buckwheat) are reported as increasing in prominence in agricultural 
systems because of increased herbicide application. The evolution of herbicide resistant weed 
populations of horseweed (Conyza canadensis (L) Cronq) resistant to glyphosate was also 
identified.  
 
Both of the above effects are likely to be due to the effect of the herbicide application directly 
not the GM plant per se. 
 
Evidence for gene transfer from GM plants to wild relatives 
The possibility that GM constructs from crop plants might be transferred into related wild 
plants or feral weed populations has been identified as a risk for some time. One of the major 
concerns is that herbicide tolerance will be transferred to weedy relatives making them more 
able to survive weed control practices than their non-tolerant forms and providing an invasive 
species, which could interfere with agricultural practices or invade the natural environment. 
For this to occur several stages need to take place, first an F1 hybrid must be formed, then 
there must be introgression of the gene into the population, then there must be spread to 
secondary populations.  
 
The oilseed rape (OSR) (Brassica napus) to Brassica rapa (Bargeman’s cabbage) model has 
been most intensively studied in the UK. Wilkinson et al (2003) measured and modelled 
introgression of OSR genes into B.rapa populations where these populations occurred 
together and estimated that around 32,000 hybrids occur between OSR and B. rapa per year. 
This gives some indication of the potential levels of transfer of GM genes likely to occur if 
GMHT OSR was grown in close proximity to B. rapa. 
 
Daniels et al (2005) carried out a comprehensive screening of wild relatives around the UK 
Farm scale OSR crops over a three year period and identified one instance of gene flow from 
OSR to a wild relative, Sinapsis arvensis. This illustrates that gene flow to wild relatives can 
occur from GM crops at low levels in normal agricultural scenarios. 
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Hedge & Waines (2004) have reported that natural hybrids between GM herbicide resistant 
wheat and the weed Aegilops triuncialis can be created in the glasshouse but have not yet 
observed this in the field. 
 
Bartsch & Schuphan (2002) have suggested that the transgenic form of sugar beet had no 
difference in competitiveness and winter hardiness and possibly a much safer performance 
due to its higher resistance to early pre-bolting than the isogenic control. Studies on Beta 
populations have shown that a century of gene flow from commercial beet (Beta vulgaris ssp. 
vulgaris) seed production has had little effect on the wild beet populations of Beta vulgaris 
ssp. maritima in Italy (Bartsch et al., 2003). 
 
Betz (2005) reviewed gene transfer from cotton.  Cotton has only two wild relatives that occur 
in the United States, Gossypium thurberi in Arizona and G. tomentosum in Hawaii, that could 
possibly outcross with commercial varieties of cotton (Fryxell, 1979; Stephens, 1964). 
Cultivated cotton is an allotetraploid, whereas G. thurberi is a diploid, so they are 
incompatible and would not produce fertile off-spring. G. tomentosum is morphologically and 
temporally incompatible with commercial cotton varieties. There is, therefore, no reasonable 
mechanism for out-crossing of the genes introduced into wild cotton relatives in the United 
States (Funchs et al., 1993). The US EPA has precluded the culture of Bt cotton in Hawaii for 
this reason. Unfortunately, the culture of non-modified cotton poses a threat to the biological 
diversity of this species and introgression of sequences from G. barbadense and G. hirsutum 
have likely occurred previously. As G. tomentosum may bloom at the same time as domestic 
cotton, there is no guarantee of either geographic or temporal isolation. For these reasons, 
EPA imposed stringent sales and distribution restrictions on the registration for cotton 
expressing the Cry1Ac delta-endotoxin grown in Hawaii. The Agency required the following 
labelling statement to mitigate the potential for the cry1Ac gene to move from cultivated 
cotton to G. tomentosum: "Not for commercial sale or use in Hawaii.” (EPA, Biopesticides 
Regulation Action Document 15, 2001) 
 
Hails & Morley (2005) have used mathematical models and integrated field data in an attempt 
to assess the relative fitness of hybrids. For example, to identify the key properties of B.rapa 
which if changed would make the plant more fit. The work has suggested that populations are 
restrained by competition with other vegetation. It then becomes more unlikely that even if 
the hybrid plants could produce more seed that they would be able to find a niche to 
germinate and grow in competition with the current flora. 
 
It is therefore, generally accepted that gene flow will occur (although possibly at very low 
levels) but what effect this will have is more difficult to assess (Jenczewskski et al 2003). The 
levels of gene flow will depend on breeding systems, ploidy levels, etc and are relatively easy 
to assess for any plant/wild relative combination. More difficult to assess are the fitness costs 
of the transgene and benefits conferred to the wild relative, which will be key to its spread in 
the population. There is therefore a need to assess long-term establishment of the transgene in 
populations and this is limited at present by our lack of knowledge of the ecology and 
dynamics of weed and feral populations, how factors affect fitness and how they interact with 
each other and population genetics generally. The GM question has challenged some of the 
assumptions held in the past on introgression of genes into populations. Strategies to reduce 
gene flow from GM crops being developed will also have to be assessed in future. 
 
GM introgression into landraces 
Some examples of introgression of GM genes into traditional landraces have received a lot of 
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which has since been discredited both because of the non-specific test used and because only 
gene flow, not introgression , was shown (Metz, 2002). However, it is still perfectly feasible 
for this to occur although current awareness of the problem means that it is less likely to occur 
in practice. 
 
Effects of GM HT plants on arthropod populations 
McKee et al (2003) reported that no differences between GM HT soybean and conventional 
soybean crops were identified during 1-2 year trials at the plot or farmscale level.  
 
The UK farm scale evaluation trials carried out a comprehensive assessment of the effects of 
growing HT forage maize, sugar beet and winter and spring oilseed rape under commercial 
practices on various insect groups. In beet crops, butterflies and bees were all less abundant in 
the HT crops than the conventional crop, whereas in general other groups were not 
consistently affected. In forage maize crops, there were few effects of the GM crop observed, 
although there were more ground dwelling detritivores and seed feeding carabids in the HT 
crops. Visits by honey bees were also consistently higher in the boundaries of HT maize 
crops. In spring oilseed rape there were few effects related to the GM crop, although 
butterflies were less frequent in HT crops and carabids were more frequent in conventional 
than HT crops. The results for winter oilseed rape were similar to spring oilseed rape although 
more springtails were recorded in the HT than in the conventional crop. 
 
Effects of GM plants on soil microflora and soils 
A useful review of the evidence to date on effects of GM plants on soil microorganisms has 
been produced by Liu et al (2005). GM plants have been found to have significant effects on 
soil populations of non-target bacteria and fungi, soil enzyme activities, colonisation of roots 
by mycorrhizal fungi and the structure of the soil microbial community. Some of these effects 
are transient, occurring only when viable plants are present, or only at certain periods of the 
plant lifecycle. In some cases no effect is seen at all. Some effects are clearly related to the 
type of GM construct, e.g. if the construct produces an anti-microbial protein, such as T4 
lysozyme. There is some evidence that unintentional changes in the composition of root 
exudates may be responsible for some changes in microflora (e.g. Siciliano et al 1998). 
 
Siciliano & Germida (1999) carried out a study on the effect of HT (EPSPS) oilseed rape on 
soil microorganisms. Approximately 2300 bacteria were isolated from roots of HT and non-
transgenic OSR plants. According to the results, fewer Bacillus, Microccocus, Variovarax 
isolates, and more Flavobacterium and Pseudomonas isolates were found on the roots of the 
transgenic cultivar compared with the non-transgenic cultivar.  The bacterial root-endophytic 
community of the transgenic cultivar exhibited a lower diversity compared with the non-
transgenic cultivar  
 
A 2-year multiple site field study (transgenic canola and non-GM canola/ a conventional 
canola variety : six times sampling) was carried out by Dunfield & Germida (2003).The 
results showed that there were significant differences between the rhizosphere microbial 
communities associated with the two oilseed rape lines that were observed at several times 
throughout the growing season; however, there were no differences between microbial 
communities from field plots containing harvested transgenic line and field plots containing 
no oilseed rape during the field season after winter. This means that differences between the 
rhizosphere microbial communities associated with the transgenic plants were temporary and 
depended on the presence of the viable plant. 
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Possible inhibition of decomposition in GM tobacco expressing proteinase inhibitor 1 has 
been reported by Donegan et al (1997, 1999). Hopkins et al (2005) reported  significant 
effects of lignin modified plants (e.g. reduced COMT lignin GM plants) on decomposition in 
laboratory studies with tobacco. 
 
Evidence for horizontal gene transfer to bacteria 
It is known that bacteria routinely exchange genetic material amongst themselves by 
conjugation, transduction and transformation (Panoff & Chuiton, 2004). De Vries & 
Wackernagel (2003) have identified a list of 87 bacterial species where natural transformation 
is possible.   
 
Gay and Gillespie published a review of this area in 2005.  As part of the safety assessment of 
genetically modified plants, a number of expert committees have examined whether the nptII 
gene in Calgene’s FalvrSavr or the ampicillin resistance marker in Norvatis’s Bt176 maize 
could be transferred from GM plants back to bacteria, thus becoming an additional source of 
antibiotic-resistance pathogens (Gay & Gillespie, 2005). Schubbert et al. (1998) showed that 
plasmid and bacteriophage DNA introduced into mice by oral gavage at very high 
concentrations was not totally degraded in the intestinal tract. Fragments of DNA of hundreds 
to thousands of base pairs, enough to include the open reading frame of an antibiotic 
resistance gene, were found in the intestine of the mice. Although surviving DNA represented 
less than 4% of that ingested, this was still a substantial amount of genetic material available 
for transfer to gut bacteria. 
 
Gay and Gillespie concluded that whereas there is no evidence that antibiotic resistance from 
GM crops is being transferred to bacteria, this does not exclude the possibility that it might 
occur. However, the evidence suggests that, if it occurs at all, the contribution to the burden of 
antibiotic resistance from GM plants is low, and is dwarfed by inappropriate prescribing of 
antibiotics in medical practice and their use as animal growth promoters in agriculture. 
Antibiotic-resistance markers do not pose a substantial risk to human health because the 
contribution that recombinant bacteria might make--should the enormous barriers to transfer 
be overcome--is so small that any contribution to antibiotic resistance made by GM plants 
must be overwhelmed by the contribution made by antibiotic prescription in clinical practice.  
 
In principal DNA from GM plants will be available for the transformation of bacteria but the 
likelihood that this could happen successfully is considered to be small. 
 
 
1.2. Unpredictable effects of the GM construct on the plant genome 
 
Many of the obvious effects of the GM construct on the plant are evident during the selection 
process and these lines are discarded. However, there are still concerns that the GM construct 
may interfere with plant genes and that this may not be identified early in the selection 
process. The need to demonstrate substantial equivalence in order to get products approved 
means that such plants would not be approved. However, there are a range of papers 
published which do demonstrate such effects (Weaver, 2005).  There are no specific reports of 
field examples where this type of effect has been verified. 
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1.3. Human allergenicity 
 
The health risk assessment of GM foods currently relies on the testing of the toxicity of single 
chemicals (Bskshi,2003). However, food is a complex mixture of thousands of chemicals.  
According to the World Health Organization (1995), the safety of whole GM foods can be 
assessed by comparing the toxicity of the safety of whole GM foods to the food or food 
constituent from which is derived. From the standpoint of the FDA, the important thing for 
consumers to understand about these new foods is that they are likely to be as safe as the 
foods now on store shelves. All foods, whether traditionally bred or genetically engineered, 
must meet the provisions of the Federal Food, Drug, and Cosmetic Act. Decisions regarding 
safety should be based on the nature of the product, rather than on the method by which it was 
modified. It is important to bear in mind that many of the crop plants used contain natural 
toxins and allergens. The potential for human toxicity or allergenicity should be kept under 
scrutiny for any novel proteins produced in plants with the potential to become part of human 
food or animal feed. 
 
Allergenic reactions to foods such as cereals, nuts, milk and eggs can be life-threatening in 
hypersensitive people. Both conventional and GM manipulations could result in production of 
more allergenic plants. It is also possible to use both techniques to reduce the allergenicity of 
plants, where sufficient scientific knowledge is available, for example gene silencing could be 
used to remove toxins. It is difficult to check for potential allergenicity to novel proteins, 
using current testing techniques, when the human population has not been exposed to these 
allergens to a large extent before. The science of prediction of allergenicity is in its infancy so 
there is no easy way to predict the likely effects of novel GM proteins. 
 
WHO and FAO have described a hierarchical approach to evaluate the allergenicity of GM 
foods and crops. The three main approaches that can be utilized to identify allergen sources 
include 1) amino acid sequence characterization-that method would increase the number of 
allergenic sequences in the data bank, 2) identification of the amino acid sequences that define 
allergenic epitopes to develop more precise sequence-screening criteria; and 3) development 
of an animal model that can recognize food allergens in a manner similar to that which occurs 
in human disease (Bskshi, 2003). 
 
One clearly documented case of increased allergenicity involving a GM plant is described by 
Nordlee  et al (1996). Methionine rich 2S albumin from brazil nuts was transferred to 
soyabean to improve the nutritional quality of the soyabean. Allergenic effects were picked up 
during the testing regime and the product was withdrawn. In retrospect, this was a predictable 
scenario as Brazil nuts are known to be allergenic to humans. 
 
A second example was the Starlink maize event when traces were found in taco shells in 
2000. The FDA investigated 28 consumer complaints related to this, where consumers had 
complained of adverse reactions to the product. Analysis of sera from consumers, using 
ELISA to Cry9C–specific IgE antibody, found no trace of this suggesting that the allergenic 
responses were not specific to the GM product. 
 
There is a significant potential for PR proteins to be human allergens as they comprise of the 
order of 25% of the proteins on the Official Allergen Database of the International Union of 
Immunological Societies (Hoffman–Sommergruber, 2002). 
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1.4. Other reported indirect effects of GM plants on human health 
 
Wu et al (2004) suggest that decreased insect damage on Bt corn leads to lower levels of 
mycotoxins. For example, Munkvold & Hellmich (1999) carried out field studies on Bt11 and 
MON 810 and found that levels of fumonisin were lower in GM crops. This should provide 
some benefit for human health from growing GM crops. 
 
Gay & Gillespie (2005) have analysed the likelihood of antibiotic resistance markers from 
GM plants becoming incorporated into human microbes, thus conferring resistance. They 
conclude the contribution of this is likely to be negligible compared to use of antibiotics in 
clinical therapy. 
 
1.5. Animals and antibiotic resistance 
 
The usefulness of antibiotics in the prevention of animal diseases needs to be preserved so 
that we don’t need to use those currently used in human treatment. The use of antibiotic 
resistance genes as a selectable marker for GM crops has raised concerns about the potential 
for transfer of these genes to gut or soil bacteria, causing bacteria to become resistant to these 
antibiotics. The antibiotic resistance genes of most concern are the kanamycin resistance – 
nptII or hygromycin B resistance – hpt genes, normally driven by plant promoters, as well as 
the aadA genes (spectinomycin and streptomycin resistance) which are driven by bacterial 
promoters. This has led to the regulatory authorities recommending that the use of these 
markers be phased out, e.g. the US FDA has recommended that GM plant producers do not 
use valuable antibiotics in selections. 
 
Reviews by Droge et al 1998; Neilsen et al 1998; FAO/WHO 2000, Smalla et al 2000 and 
Thompson 2000 have concluded that gene transfer from GM plants to bacteria is likely to be a 
rare occurrence. 
 
More recently, Miki et al 2004 have concluded that the selectable markers commonly in use 
are not likely to increase the chance of resistance occurring naturally. Their rationale is that 
the genes are common in soil bacteria anyway so their use in plants is not likely to increase 
the available gene pool significantly. Van den Eede et al (2004) have also ranked hpt, nptII 
and aadA genes as being (1) already widely distributed in soil and enteric bacteria and, (2) 
conferring resistance to antibiotics which are of limited therapeutic value to animal and 
human medicine.  
 
There appear to be few studies, if any, where this has actually been measured. 
 
Plant-made Pharmaceuticals(PMP) 
 
A recent more novel application of GM plants is in the production of vaccines. Transgenic 
plants are proving to be an ideal means by which to produce oral vaccines enabling intact 
antigen to reach the gut associated lymphoid tissue. For example, the Prodigene company has 
produced an edible vaccine for transmissible gastroenteritis virus in pigs which has been 
shown to be effective and has been patented. Plant-made vaccines have prevented the onset of 
disease in animal models and have proven to be safe in human clinical trials. One major issue 
is the risk of contaminating the general food supply. Few studies have been done in these 
types of GM plant to date, but this is likely to prove a controversial area for the future. 
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2.1. EU regulatory framework and guidelines for use 
2.1.1 EU Council Directive 2001/18/EC on the deliberate release into the environment of 
genetically modified organisms and the relevant annexes and guidance documents 
 
Availability: http://europa.eu.int 
This Directive repeals the earlier Council Directive 90/220. The scope of the directive is, inter 
alia, to provide a common European wide methodology for ecological risk assessment and 
common objectives for monitoring GMO releases to the environment. It requires an 
ecological risk assessment prior to any deliberate release of GMOs.  Many of the countries 
that comprise the EU have ratified the Cartagena Biosafety Protocol, as such much effort has 
been expended in the EU to ensure that Directive 2001/18/EC is compliant with the Annex III 
of the protocol with respect to risk assessment. 
 
With respect to risk assessment key parts of the directive or related documents are: 
a) Annex II: Principles for the Environmental Risk Assessment.  Describes principles and 
methodology, including specific information on risks to be considered for GM plants, and for 
GMOs other than plants.  Note: superseded by European Food Safety Authority Guidance 
(discussed below). 
b) Commission Decision of 24 July 2002 establishing guidance notes supplementing annex II 
of Directive 2001/18/EC (Decision 2002/623/EC), provides detailed information on general 
principles and methodology. 
Scientific principles and framework of risk assessment under 2001/18/EC 
In accordance with the precautionary principle, the potential direct and indirect (immediate 
and delayed) effects of GMOs are to be accurately assessed, on a case-by-case basis in the 
environmental risk assessment (ERA).  A general principle of the ERA is also that an analysis 
of the cumulative long-term effects relevant to the release and the placing on the market is 
carried out.  Releases are to be carried out in a stepwise fashion and must be field-tested in 
ecosystems that could be affected by their use.  A differentiated procedure is permitted for 
GMOs that are well known and well characterised.  The directive specifies a six-stage risk 
assessment process starting with hazard identification; followed by an evaluation of potential 
consequences and likelihood of each potential adverse effect, and an estimation of the risk. 
The estimation of risk is to be made as far as possible given the “state of the art”.  The fifth 
step identifies management options, followed by an evaluation of the overall risk taking 
management into account. 
 
Hazard identification 
The directive does not identify or recommend any inductive hazard assessment techniques. It 
notes that potential adverse effects will vary from case to case and lists five generic hazards 
such as diseases and toxic effects, impacts on population dynamics in the receiving 
environment with potential to affect biodiversity, altered susceptibility to pathogens and 
effects on biogeochemistry. 
 
Likelihood and consequence assessment 
The directive does not identify or discuss any specific techniques to assess the likelihood or 
consequences or adverse effects. It notes that the environment into which the GMO is released 
and the manner of the release are major factors. An estimation of the risk to human health or 
the environment posed by each identified characteristic of the GMO which has the potential to 
cause adverse effects should be made as far as possible given the state of the art, by Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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combining the likelihood of the adverse effect occurring and the magnitude of the 
consequences, if it occurs.  The rationale for reaching estimation of the risk should be clearly 
presented and justified.  Assessments of risk need not be quantitative but should be relative, 
e.g. to a non-GM reference. 
 
Uncertainty analysis 
The directive requires that the overall uncertainty for each identified risk should be described 
in relation to assumptions and extrapolations made throughout the ERA, different scientific 
assessments and viewpoints, uncertainties, the known limits of the mitigation measures; 
conclusions that can be derived from the data.   
 
Monitor and review  
The directive details the objectives, principles and design requirements of a monitoring plan. 
The objective of the plan is to confirm the assumptions made in the risk assessment and to 
identify the occurrence of adverse effects that were not anticipated in the assessment. The 
plan is to incorporate general surveillance for unanticipated effects as well as specific 
monitoring for those effects identified in the assessment. The latter must be continued for a 
sufficient period of time to identify delayed and indirect effects. The plan must be 
implemented in a systematic manner and consider mechanisms for identifying and confirming 
any observed effects. 
 
Cumulative long term effects 
The directive closely links the environmental risk assessment (era) and monitoring; 
monitoring requirements for placing on the market are intended to provide data for long-term 
potentially adverse effects of GMOs.  Monitoring results can be used to confirm the ERA, or 
lead to its re-evaluation.  The ERA must consider: 
•  long-term effects in terms of the long term interactions of the GMO and the receiving 
environment;  
•  the characteristics of the GMO which become important on a long-term basis; repeated 
deliberate releases or placings on the market over a long period of time; and 
•  the GMOs deliberately released or placed on the market in the past. 
Further information may be required on long-term effects, e.g. multiple herbicide resistances, 
and there must be adequate research (partly within monitoring plans), which can provide data 
for assessing cumulative long-term effects.  Guidance on monitoring plans for case specific 
monitoring and general surveillance have been developed, but general surveillance monitoring 
in particular is still only a very vaguely developed concept that has yet to be put widely into 
practice. 
 
The following guidance documents have also been published with respect 2001/18/EC: 
 
c) Annex VI (Guidelines for the Assessment Reports) to Directive 2001/18/EC, lists the 
information required by the Directive 
d) Annex VII (Monitoring Plan) to Directive 2001/18/EC; describes aspects of the principles 
and design of monitoring plans 
e) Council Decision of 3 October 2002 supplementing annex VII to Directive 2001/18/EC 
(Decision 2002/811/EC).  Provides a detailed description of the objectives, general principles, 
strategy, methodology, and analysis of monitoring plans. 
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2.1.2 European Commission Guidance Document for the Risk Assessment of Genetically 
Modified Plants and Derived Food and Feed (6-7 March 2003) 
 
Prepared for the Scientific Steering Committee by the Joint Working Group on Novel Foods 
and GMOs 
Availability: http://europa.eu.int/comm/food/fs/sc/ssc/out327_en.pdf 
Key Characteristics: Scope is genetically modified plants and derived food and feed.  The 
guidance provides a description of the comparative approach to risk assessment and discusses 
the detail that must be provided.  This covers the molecular characteristics of the GMO and 
data on comparative analysis (choice of comparator, field trial data, agronomic traits and 
analysis of the products), together with a detailed description of specific information 
requirements related to the environmental risk assessment (geographical relevance of data, 
impact on wild plants, impact on non-modified crops, impact on organisms and ecological 
processes).  The document does not discuss uncertainty or statistical analysis, nor does it 
consider how cumulative or long-term effects.  This document has been superseded by the 
EFSA guidance for the risk assessment of GM plants and derived food and feed published in 
March 2005. 
2.1.3 European Food Safety Authority 
 
Guidance Document of the Scientific Panel on Genetically Modified Organisms for the Risk 
Assessment of Genetically Modified Plants and Derived Food and Feed.  Adopted 24 
September 2004 (published March 2005). 
Availability: http://www.efsa.eu.int/science/gmo/gmo_guidance/660_en.html 
Scientific principles and framework 
The scope of the guidance is commercial releases of genetically modified plants and derived 
food and feed submitted within the framework of EU Directive 2001/18/EC and Regulation 
(EC) 1829/2003 on GM food and feed.  Risk assessment is described as “a process of 
evaluation including the identification of attendant uncertainties, of the likelihood and 
severity of an adverse effect(s)/event(s) occurring to man or the environment following 
exposure under defined conditions to a risk source(s)” (EC, 2000a).  It provides a description 
of the comparative approach to risk assessment based on the principles of familiarity and 
substantial equivalence, and consideration of intended and unintended effects.  A formal 
framework for risk assessment is not provided or recommended.  Risk assessments must be 
demonstrably based on good scientific data and it must be clear the assumptions that have 
been made during the risk assessment process and what are the boundaries of the assessment. 
 
Hazard identification 
No hazard assessment techniques are identified or recommended, but a detailed description of 
information required to undertake the risk assessment is provided. 
 
Likelihood and consequence assessment 
A comprehensive risk characterisation should be carried out, based on data gathered from 
hazard identification and exposure assessment.  Where there is an absence of data this should 
be discussed and taken into account in the final risk analysis.  Assumptions and extrapolations 
should be clearly stated.  Risk estimation may be qualitative and where possible, quantitative; 
terms for definition of risks and associated uncertainties are not prescribed. 
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Uncertainty analysis 
Any uncertainties inherent in the different steps of the risk assessment should be highlighted 
and quantified as much as is possible.  The guidance requires that estimation of uncertainties 
in experimental data should be handled by proper statistical analysis; probabilistic methods 
can be used.  Quantification of uncertainties in extrapolations from laboratory or experimental 
studies should be highlighted.  .  Where possible, statements in essentially qualitative risk 
assessments such ‘low risk’, medium risk’ etc should be quantified in terms of probability of 
exposure and/or occurrence of adverse effects. 
 
Monitor and review 
The document defines monitoring as “the systematic measurement of variables and processes 
over time and assumes that there are specific reasons to collect such data, for example, to 
ensure certain standards or conditions are being met or to examine potential changes with 
respect to certain baselines”.  Guidance on developing case specific and general surveillance 
monitoring plans is provided; EFSA has also issued a separate guidance document for general 
surveillance of GM crops. 
 
Long term and cumulative effects 
These are considered throughout the document in the general context of the risk assessment, 
and in particular with respect to case-specific monitoring and general surveillance monitoring.  
However the document does not specifically address long-term cumulative effects. 
 
2.1.4  European Commission: DG Health and Consumer Protection 
First report on the harmonisation of risk assessment procedures part 1: Report of the Scientific 
Steering Committee's Working Group on Harmonisation of Risk assessment Procedures in the 
Scientific Committees advising the European Commission in the area of human and 
environmental health 26-27 October 2000. 
Availability:  http://europa.eu.int/comm/food/fs/sc/ssc/out84_en.pdf 
This very comprehensive report was commissioned to outline approaches to risk assessment 
used by the EC’s different Scientific Advisory Committees and to identify issues of interest 
across these Committees.  It considers the different approaches and tries to identify areas of 
common interest and areas where progressive harmonisation might be achieved.  In the report 
risk assessment is defined as “a process of evaluation including the identification of the 
attendant uncertainties, of the likelihood and severity of an adverse effect(s)/events(s) 
occurring to man or the environment following exposure under defined conditions to a risk 
source(s)”.  The report defines risk assessment as comprising hazard identification, hazard 
characterisation, exposure assessment and risk characterisation.  The report is not intended to 
provide guidelines, but it does identify recommend that a guidance document be developed by 
the Steering Committee to harmonise some aspects of risk assessment in the EC, including a 
glossary of terms and a common language to describe different levels of risk.  The report also 
recommends introduction of requirements for monitoring and surveillance for an increasing 
range of risk sources, in particular issues for which there is a high degree of uncertainty – GM 
crops may be considered to fall within this.  It is unclear whether any progress has been made 
subsequent to publication of this report, or whether any of the recommendations have been 
adopted.  We have not been able to identify any subsequent reports from this Working Group. 
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2.2. Guidance documents produced by individual member states 
2.2.1 United Kingdom 
Availability: http://www.defra.gov.uk/environment/acre/biodiversity/guidance/06.htm 
The UK Department for Environment, Food and Rural Affairs (Defra) guidance on the 
principles of risk assessment and monitoring for the release of GMOs were developed to 
assist applicants during the introduction of EC Directive 2001/18/EC.  Draft guidelines to 
accompany Directive 2001/18EC were published in November 2002. 
 
Scientific principles and framework 
The guidelines state that, in accordance with the precautionary principle, the risk assessment 
should be transparent, scientifically sound, carried out on a case-by-case basis and re-
examined if new information becomes available. The precautionary principle, however, is not 
defined in the guidelines. The risk assessment is to consider the direct, indirect, immediate 
and delayed effects of the GMO release; each of these terms is defined.  The assessment 
should also be compared to the risks presented by the use of the unmodified organism in 
corresponding situations.  The guidelines specify a six-step risk assessment procedure.  The 
first four steps consisting of hazard identification, consequence and likelihood assessment and 
risk calculation.  The latter should be made, as far as possible, given the current ‘state of the 
art’.  The fifth step requires the analyst(s) to identify risks that need to be managed and how 
best to manage them.  The analyst is then required to re-calculate the overall risk of releasing 
the GMO taking into account any proposed management strategies. 
 
Hazard identification  
The guidelines do not identify or recommend any inductive hazard assessment techniques.  
They do, however, provide a comprehensive checklist of potential GMO hazards.  They also 
stress that potential adverse effects are not to be discounted on the basis that it is unlikely to 
occur. 
 
Likelihood and consequence assessment  
The guidelines do not identify or discuss any specific techniques to calculate the consequence 
or likelihood of adverse effects following the release of the GMO.  They state that the 
characteristics of the environment into which the GMO is released, and the manner of the 
release, will be major factors in the consequences and likelihood of adverse effects.   
 
Uncertainty analysis  
The guidelines do not refer to uncertainty in the risk assessment process, or the significance of 
the risk estimates. 
 
Monitor and review  
The applicant is required to submit a monitoring plan as part of the application to market a 
GMO, designed to confirm the assumptions made in the risk assessments and identify the 
occurrence of any unanticipated effects.  Monitoring must be systematic and continue long 
enough to identify delayed and indirect effects, and give consideration to mechanisms for 
identifying and confirming any observed effects. 
 
Long-term and cumulative effects 
Monitoring requirements described above are intended to identify these.  There is no clear 
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effects, or cumulative effects, however Defra has commissioned a study to explore how this 
might be best achieved, in preparation for when the commercial release of GM crops might be 
expected in the UK. 
2.2.2 Italy 
Availability: http://bch.minambiente.it/bch.html 
The Italian Ministry for the Environment and Territory (Directorate for Environmental 
Safeguard) has developed a standard methodology for environmental risk assessment for use 
with the deliberate release of GMOs under EU Directive 2001/18/EC.  To date the model has 
only been applied to experimental releases, but it is the intention that it will also be 
implemented for assessment of commercial releases. 
 
Scientific principles and framework 
Based on application of risk analysis and risk management procedures.  Risk analysis is 
classified as hazard identification followed by risk assessment.  Risk assessment is described 
as the evaluation of the likelihood of the hazard occurring, associated with the presence of the 
receptor in the receiving environment and determination of the potential exposure to the 
hazard.  The process must be science based and applied on a case-by-case basis.  An expert 
group has developed a method for evaluation of the environmental safety of the deliberate 
release of GMOs.  The method is available for use by regulators, applicants and other 
stakeholders alike.   
 
The model is based on a logic scheme founded on the assumption that a risk related to release 
of a GMO into the environment will only occur if the source, diffusion factors migration 
routes and receptors are present.  The model operates via an electronic questionnaire that 
leads to a qualitative evaluation of risk.  Questions refer to the biology of the plant, properties 
of the trait, agricultural and horticultural practices, the receiving environment etc. 
 
No further information is available at the time of writing the report. 
 
 
2.3. Summary of guidance documents produced by international organisations 
2.3.1 Cartagena Protocol on Biosafety  
Availability: http://www.biodiv.org/biosafety/The Parties to the Convention of Biological 
Diversity adopted the Cartagena Protocol on the 29th January 2000.  Annex III of the protocol 
describes the general principles, methodology and points to consider when conducting a risk 
assessment for GMOs intended for direct use as food or feed, or for processing (Articles 11 
and 15). 
 
Scientific principles and framework  
The risk assessment is to be carried out in a scientifically sound manner, in accordance with 
Annex III and taking into account recognised risk assessment techniques, expertise of, and 
guidelines developed by, relevant international organisations. The risk assessment is to be 
carried out on a case-by-case basis and should be compared to the background risk posed by 
the equivalent non-modified recipients or parental organisms. The protocol specifies the 
precautionary principle thus: lack of full scientific certainty should not prevent a party to the 
protocol from taking an “appropriate” decision.  The protocol defines a six-step risk 
assessment procedure. The first step is hazard identification followed by an assessment of the 
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environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  7
a recommendation as to whether or not the risks are acceptable or manageable. Finally, where 
there is uncertainty about the level of risk this should be addressed by obtaining more 
information and/or by management and/or monitoring. 
 
Hazard identification  
The protocol does not recommend or detail any specific hazard identification techniques. It 
simply states that the analyst(s) identify adverse effects on human health and biological 
diversity associated with novel genotypic and phenotypic characteristics of the organism 
concerned. 
 
Likelihood and consequence assessment  
The protocol does not recommend or identify any specific techniques to identify or quantify 
the likelihood or consequences of adverse effects. It does, however, state that the likelihood 
assessment should be based on the level and kind of exposure in the likely potential receiving 
environment. It recommends that the receiving environment be described in terms of its 
location, climate, ecological characteristics, biological diversity and centres of origin. 
 
Uncertainty analysis 
The protocol does not recommend or identify any techniques to analyse uncertainty, other 
than obtaining more information or managing/monitoring the problem. The significance of 
risk is only expressed in terms of how acceptable or manageable they are. 
 
Monitor and review  
The protocol does not discuss monitoring techniques other than as a means to deal with 
uncertainty in the level of risk (see above). It does, however, recommend that the risk 
assessment take account of the specificity, sensitivity and reliability of methods used to detect 
and identify the GMO. 
 
Cumulative / long term effects 
The protocol does not specify consideration of long term or cumulative effects and does not 
discuss timescales of releases. 
 
 
2.3.2 United Nations Environment Programme (UNEP) 
 
International Technical Guidelines for Safety in Biotechnology 1995 
These were launched by UNEP in December 1995, four years before the Cartagena Protocol 
was adopted.  The guidelines were developed to provide a common framework for 
biotechnology safety assessment without prejudice, but as a complement, to the protocol. 
Availability: http://www.unep.ch/biosafety 
 
Scientific principles and framework 
Familiarity features prominently in the UNEP guidelines. They suggest, for example, that the 
extent and length of the risk assessment should depend on the analyst(s) familiarity with the 
organism concerned.  Initially risk assessments should be conducted on a case-by-case basis, 
but as knowledge and experience evolve, the assessment may serve for a functionally 
equivalent group of organisms.  The assessment should be carried out in a scientifically sound 
manner. The guidelines anticipate that, in most cases, the ecological risks will be low from 
well-known crop plants (that have been modified by altering or adding only a few genes) Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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introduced into arable environments. Risks that are identified should be compared to the 
background risks associated with non-modified organisms.  The guidelines go on to state that 
the risk assessment can range from a routine ad hoc judgement by the analyst to adherence to 
a formalised procedure. It specifies a three-step risk assessment procedure starting with 
hazard identification. If hazards are identified the assessment proceeds by calculating risk as 
the combined effect of the consequences and likelihood of the hazard being realised. Finally 
management strategies, commensurate with the level of risk, should be designed and 
implemented. 
 
Hazard identification  
The guidelines do not identify or recommend any hazard identification techniques. 
 
Likelihood and consequence assessment  
The guidelines do not identify or discuss any specific techniques to assess the likelihood or 
consequences of hazards identified. They do, however, state that forecasting models could be 
developed in the future that may help the assessment, and that international databases help in 
the development of models, possibly implying that quantitative approaches might be 
appropriate.  More explicitly they only suggest that full regard be given to experience with the 
organism elsewhere, relevant literature and consultation with available experts and public 
authorities. 
 
Uncertainty analysis 
The guidelines do not refer to uncertainty within the risk assessment process, or the 
significance of the risk estimates. 
 
Monitor and review  
The guidelines state that monitoring (that may vary from a very simple observation to an 
extensive research programme) may be used to verify the assumptions of the risk assessment, 
and should be used to evaluate the efficacy of risk management measures. No further 
information is given. 
 
Cumulative / long term effects 
We could find no reference in the document to either long-term effects or cumulative effects. 
United Nations Environment Programme – Global Environment Facility (UNEP-GEF) 
Developing countries and countries with economies in transition: UNEP-GEF Biosafety 
projects 
Availability: UNEP/GEF website http://www.unep.ch/biosafety/parcountrieslist.htm 
•  Provides information on all countries that have previously, or are currently participating 
in UNEP-GEF Biosafety projects (pilot phase, development, implementation or capacity 
building). 
•  Country links provide details of progress within each country, and in some instances 
regulatory framework documents are provided, e.g. Argentina, Bangladesh.  In excess of 
100 countries are listed. 
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2.3.3 Organisation for Economic Co-operation and Development (OECD) 
 
The Organisation for Economic Co-operation and Development (OECD) is an 
intergovernmental organisation in which representatives of 30 industrialised countries in 
North America, Europe and the Pacific, as well as the European Commission, meet to co-
ordinate and harmonise policies, discuss issues of mutual concern, and work together to 
respond to international problems. Most of the OECD’s work is carried out by more than 200 
specialised Committees and subsidiary groups composed of Member country delegates. 
 
The OECD published its “Safety Considerations for Biotechnology” in 1986 and 1992.  The 
1986 report was the first attempt to set international safety guidelines for industrial, 
agricultural and environmental applications of biotechnology. It presented scientific principles 
that could underlie risk management for the release of GMOs into the environment; the 1992 
report follows on from this and inter alia defines “Good Development Principles” for the 
design of safe, small-scale field trials of GM plants and microorganisms.  These have now 
largely been superseded by European guidance document, and developments with the 
Cartagena Protocol.  The reports did not identify or recommend any inductive hazard 
assessment techniques or discuss uncertainty within the risk assessment process or the 
significance of the risk estimates.  With respect to monitoring, the 1992 report states that 
scientifically acceptable and environmentally sound field research requires: “formulation of 
an hypothesis and statement of objectives; development of specific methodologies to 
introduce, monitor and mitigate the organisms; a precise description of the design of 
experiments, including planting density and treatment pattern; and a description of specific 
data to be collected, and of methods for analysis to test for statistical significance”. 
 
The Working Group for Harmonization in Biotechnology was established in 1995 at a 
time when the first commercial transgenic crops were being considered for regulatory 
approval in a number of OECD Member countries. From the beginning, one of its primary 
goals was to promote international regulatory harmonisation in biotechnology among member 
countries. Regulatory harmonisation is the attempt to ensure that the information used in 
risk/safety assessments, as well as the methods used to collect such information, are as similar 
as possible. 
 
Series on Harmonisation of Regulatory Oversight in Biotechnology No. 32:  An Introduction 
to the Biosafety Consensus Documents of OECD’s Working Group for Harmonization in 
Biotechnology 
Availability: http://www.oecd.org 
This document explains the background and scope of OECD consensus documents developed 
by the working group.  The Working Group recognised that national authorities and others 
undertaking risk assessments for GM crops would be going through similar procedures and 
that much of the information related to the biology of crop plants would be the same.  They 
decided to compile information common to the risk/safety assessment of a number of 
transgenic products focused on the biology of the host species or crop and traits used in 
genetic modifications.  The aim was to encourage information sharing and prevent duplication 
of effort among countries by avoiding the need to address the same common issues in each 
application involving the same organism or trait.  These documents therefore compile 
information relevant to risk/safety assessment of several transgenic products, and focus on 
either (a) the biology of particular host species or crops, or (b) traits used in genetic 
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of products of biotechnology and are intended to be mutually accepted among OECD Member 
countries. 
 
The following consensus documents have been published, and others are in the development 
phase: 
•  General Information concerning the Biosafety of Crop Plants Made Virus Resistant 
through Coat Protein Gene-Mediated Protection (1996) 
•  Information Used in the Assessment of Environmental Applications Involving 
Pseudomonas (1997) 
•  The Biology of Brassica napus L. (Oilseed Rape) (1997) 
•  The Biology of Solanum tuberosum subsp. tuberosum (Potato) (1997) 
•  The Biology of Triticum aestivum (Bread Wheat) (1999) 
•  General Information Concerning the Genes and their Enzymes that Confer Tolerance to 
Glyphosate Herbicide (1999) 
•  General Information Concerning the Genes and their Enzymes that Confer Tolerance to 
Phosphinothricin Herbicide (1999) 
•  The Biology of Picea abies (L.) Karst (Norway Spruce) (1999) 
•  The Biology of Picea glauca (Moench) Voss (White Spruce) (1999) 
•  The Biology of Oryza sativa (Rice) (1999) 
•  The Biology of Glycine max (L.) Merr. (Soybean) (2000) 
•  The Biology of Populus L. (Poplars) (2000) 
•  The Biology of Beta vulgaris L. (Sugar Beet) (2001) 
•  Information used in the Assessment of Environmental Applications Involving 
Baculovirus (2002) 
•  The Biology of Picea sitchensis (Bong.) Carr. (Sitka Spruce) (2002) 
•  The Biology of Pinus strobus L. (Eastern White Pine) (2002) 
•  The Biology of Prunus sp. (Stone Fruits) (2002) 
•  Module II: Herbicide Biochemistry, Herbicide Metabolism and the Residues in 
Glufosinate-Ammonium (Phosphinothricin)-Tolerant Transgenic Plants (2002) 
•  The Biology of Zea maize subsp.mays (Maize) (2003) 
•  The Biology of European White Birch (Betula pendula Roth) (2003) 
 
Safety Considerations for Biotechnology: Scale-Up of Crop Plants. 1993 
Availability: http://www.oecd.org/dataoecd/26/26/1958527.pdf 
•  Considers specific risk pathways and associated management options for GM crop 
plants.  Preceded Biosafety consensus documents, provides conceptual background. 
 
Environmental Risk Assessment of Transgenic Plants: A Comparison of International Pre-
Market Data Requirements. 2004 
Availability: Not yet available – classified. 
•  This document could not be reviewed because it is not yet declassified. 
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2.3.4 Food and Agricultural Organization of the United Nations (FAO) 
 
The FAO of the United Nations leads international efforts to defeat hunger.  FAO supports a 
science-based evaluation to objectively determine the benefits and risks of individual GMOs 
on a case-by-case basis prior to release.  FAO strives to determine the potential benefits and 
possible risks associated with the application of modern technologies to increase plant and 
animal productivity and production, and often acts as an ‘honest broker’ by providing a forum 
for discussion.  For example, the FAO provides the Secretariat to the Codex Alimentarius 
Commission (together with the World Health Organisation), which has established an 
intergovernmental task force on foods derived from biotechnologies. 
 
FAO/World Health Organisation Expert Consultation on the Safety Assessment of Foods 
Derived from GM Animals, including Fish (FAO Food and Nutrition Paper 79, 2003) 
Availability:http://www.fao.org/documents/show_cdr.asp?url_file=/DOCREP/006/Y5316E 
•  Describes general principles and considerations relevant to risk/safety assessment of GM 
animals and derived foods, including fish 
 
Working Principles for Risk Analysis for Application in the Framework of the Codex 
Alimentarius, 2003 
Availability:http://www.fao.org/documents/show_cdr.asp?url_file=/DOCREP/006/Y4800E/y
4800e0o.htm 
•  Includes general principles and key elements of risk assessment and risk management in 
the context of food safety and human health 
 
 
 
2.4 Summary of specific guidance documents developed by countries outside of the 
European Union 
2.4.1 United States of America.  Environmental Protection Agency (US EPA) 
 
In 1998, the US EPA published its finalized ‘Guidelines for Ecological Risk Assessment’.  
The final guidelines expand upon and replace an earlier framework (1992), and included input 
from stakeholders within and outside the EPA.   
 
a) Guidelines for Ecological Risk Assessment, (EPA/630/R-95/002F, April 1998) 
Availability: http://www.epa.gov/ncea 
•  Detailed discussion of general principles and considerations associated with risk 
assessment methodology 
•  Scope is any ecological stressor (chemical, physical or biological) 
 
Scientific principles and framework of risk assessment 
These guidelines encompass a wide diversity of environmental stressors including those that 
are chemical, physical and biological in nature.  The guidelines codify principles, terminology 
and process used in ecological risk assessment by describing the individual components 
(hazard, exposure, assessment endpoint selection, uncertainty, roles of risk managers and risk 
assessors etc.) within a logical framework that is useful for decision-making. 
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Hazard analysis 
The guidelines divide ecological risk assessment into three primary phases: problem 
formulation, analysis, and risk characterization.  In problem formulation, risk assessors 
evaluate goals and select assessment endpoints, prepare a conceptual model and develop an 
analysis plan. During the analysis phase, assessors evaluate exposure to stressors and the 
relationship between stressor levels and ecological effects. In the risk characterization phase, 
assessors estimate risk through integration of exposure and stressor-response profiles and 
describe risk by discussing lines of evidence and determining ecological adversity. 
 
Likelihood and consequence assessment 
The analysis phase includes characterization of exposure and characterization of ecological 
effects.  Both activities evaluate available data for scientific credibility and relevance to 
assessment endpoints and the conceptual model. Exposure characterization describes sources 
of stressors, their distribution in the environment, and their contact or co-occurrence with 
ecological receptors.  Ecological effects characterization evaluates stressor- response 
relationships or evidence that exposure to stressors causes an observed response. The bulk of 
quantitative uncertainty analysis is performed in the analysis phase, although uncertainty is an 
important consideration throughout the entire risk assessment. The analysis phase products 
are summary profiles that describe exposure and the stressor-response relationships. 
 
Uncertainty analysis 
There is substantial attention given to the evaluation of uncertainty through all stages of the 
model, and recommendations are given on how to identify uncertainties in the problem 
formulation and analysis phases and how to deal with it.  There is also clear focus on the 
importance of statistical evaluation of data at all stages of the assessment process. 
 
Monitor and review  
As the model is not specific to GM crops, there is no specific reference to monitoring.   
However, it is implicit in the approach described that it is flexible with respect to temporal 
assessments and reviewing of inputs. 
 
Cumulative / long term effects 
In the USA there is not usually a requirement to monitor once the crop has been deregulated.  
The model is so detailed and rigorous, that extrapolation to consider longer-term scenarios 
should be possible. 
 
2.4.2 Canada.  Food Inspection Agency (FIA) 
Environmental releases of GM plants in Canada are regulated by the Canadian Food 
Inspection Agency (CFIA) under powers granted by Part V of the Seed Act and the Canadian 
Environmental Protection Act.  Directive 94-08 of October 2004 (Assessment Criteria for 
Determining Environmental Safety of Plants With Novel Traits) describes the information 
used by the CFIA to identify potential adverse environmental impacts associated with the 
unconfined release of GM plants. 
 
Availability: http://www.inspection.gc.ca/english/plaveg/bio/pbobbve.shtml 
•  CFIA conducts a case-by-case, environmental safety assessment for all plants with novel 
traits (PNTs) prior to authorising confined field trials and unconfined releases 
•  The document describes a five-step, customised approach to environmental safety 
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environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  13
 
Scientific principles and framework  
PNTs are defined as plants derived from recombinant DNA technology or conventional 
breeding techniques that are neither familiar nor substantially equivalent to plants that are in 
use and generally considered as safe in Canada. The environmental safety assessment consists 
of five components. The first two require a description of the plants, its modification and 
novel traits. The third interaction assessment compares the biological characteristics of the 
modified plants with its unmodified “counterpart”, including a post-harvest, residual effect 
analysis on any three of five indicator species (forage grass, legumes, annual cereal, corn or 
oilseed). The fourth stage requires an environmental impact assessment for natural and arable 
ecosystems addressing the degree of change, geographic scope, duration and relative impact 
on plants, animals, microbes, substance presence/persistence, sustainability, agronomic 
practice, resource conservation, other concerns and overall environmental quality. Finally, the 
guidelines require species replacement / competition and seed dormancy studies if there is 
reason to believe that the behaviour of the plant has been altered in unpredictable ways.  
 
Hazard identification  
The guidelines do not identify or recommend any formal hazard identification techniques. The 
environmental impact and interaction tables provide de facto checklists.  
 
Likelihood and consequence assessment  
Applicants considering commercialising GM plants are encouraged to include experiments, 
during confined field trials, designed to meet the regulatory requirements of directive 94-08. 
Data provided by the applicant to support the interaction, environmental impact assessment 
and species replacement/competition and seed dormancy studies must be generated using 
statistically valid experimental designs and protocols.  The significance of environmental 
impacts is addressed in terms of duration, geographical scope and relative impact of the GM 
plant.  The guidelines identify three examples of replacement and seed dormancy analysis in 
the scientific literature: Crawley et al, 1993; Linder and Schmitt, 1994; and, Rissler and 
Melon, 1993. 
 
Uncertainty analysis 
The guidelines do not refer to uncertainty within the environmental safety assessment.  
 
Monitor and review 
The applicant must submit a post release monitoring programme to monitor for unintended or 
unexpected environmental effects of an authorised product.  This is reviewed during the 
environmental safety assessment of the novel plant in question. The applicant must propose 
appropriate indicators to evaluate any effects, and these should be based on the characteristics 
of the PNT.  A stewardship plan may be considered sufficient. 
 
Cumulative / long term effects 
There is no specific mention of cumulative long-term effects in the document. 
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2.4.3 Australia.  Office of the Gene Technology Regulator (OGTR) 
In Australia, the Gene Technology Regulator is responsible for protecting human health and 
safety of the environment by identifying and managing risks posed by, or as a result of, gene 
technology under the Gene Technology Act 2000 and the Gene Technology Regulations 2001 
and corresponding state law.  The Risk Analysis Framework provides guidance on how the 
Office of the Gene Technology Regulator (OGTR) will approach the risk analysis of GMOs 
under the legislation.  The second framework was finalised in January 2005.  The guidelines 
conform to the requirements of the Australian and New Zealand standard on risk management 
(AS/NZ 4360:2004) 
 
Availability: http://www.ogtr.gov.au/ 
•  Risk analysis = risk assessment + risk management + risk communication. 
•  Detailed discussion of the steps and elements of risk assessment. 
•  Discussion of risk management measures and the relationship between assessment and 
management. 
•  Discusses and attributes importance to consideration of some issues in risk assessment 
such as dealing with uncertainties. 
•  Clearly defines terms that are used in the risk analysis framework. 
 
Scientific principles and framework  
The risk assessment is to be scientific and transparent to applicants and the broader 
community alike. It will be conducted on a case-by-case basis and will consider short and 
long-term risks.  The OGTR will use ‘best practice’ risk assessment methodologies when 
conducting the assessment.  The risk will be compared to the risks posed by the unmodified 
organisms, and they will be re-examined in the light of new information.  The Regulator will, 
however, assess the significance of incomplete or absent information, and if uncertainty about 
the environmental impact remains a licence will not be granted. Similarly, if a risk cannot be 
managed a licence will not be granted.  
 
Within the framework, the first step in risk assessment is establishing the risk context, i.e. the 
scope and boundaries of the risk assessment.  The next step is to assess the risks in terms of 
“what might happen”, “how might it happen” “will it be serious if it happens”, “how likely is 
it to happen” and finally “what is the risk”.  This requires a hazard identification step in which 
sources and causal pathways of harm are identified, and the level of certainty in the hazard 
identification process.  The second risk assessment step addresses the probability of harm and 
consequences following exposure to the hazard, the level of certainty in the risk estimate and 
the significance of the risks.  The framework also identifies management options and 
communication of risk.  The final step develops and implements the risk management plan 
including monitoring during and after the release where necessary 
 
Hazard identification  
Defined as the process of analysing hazards and the events that give rise to harm.  The 
framework does not detail specific techniques that should be employed to identify hazards, 
but lists techniques employed by the OGTR.  Hazards are identified by consideration of 
causal pathways that result in harm; a list of potential hazards is provided that will be 
specifically considered by the OGTR.  The possibility of synergistic, additive, antagonistic, 
cumulative or aggregate effects should be considered.  The end point of this step is 
identification of hazards that warrant detailed estimation of likelihood and consequence. 
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Likelihood and consequence assessment  
The consequence of adverse outcomes or events is considered in terms of severity, effect on 
baseline conditions, spatial and temporal extent, potential for cumulative adverse impacts and 
reversibility, and describes a scale by which these are to be assessed.  The likelihood of the 
event occurring is then assessed based on available evidence; again, a scale is described.  Risk 
estimation is presented in a matrix whereby the likelihood of an adverse effect occurring is 
mapped against the consequences of the event and given a value (negligible to high). 
 
Uncertainty analysis 
The aim of the risk assessment is to apply a structured, systematic, predictable approach to the 
evaluation of risk, and the relative merits of qualitative and quantitative risk assessments are 
presented.  The framework requires the applicant to address the level of certainty in their 
likelihood and consequence assessments and provides guidance on how to approach it and 
how to reduce uncertainty in certain areas of the risk assessment. 
 
Monitor and review  
The risk analysis framework includes a risk management component that includes options to 
reduce or mitigate any identified risks.  The requirement for monitoring can be incorporated at 
this stage. 
 
Cumulative / long term effects 
The regulations require the OGTR to consider the GMO in terms of the short and long term, 
and the possibility of cumulative effects.  Management options might include the requirement 
for monitoring in response to identified potential risks. 
 
2.4.4   New Zealand, Environmental Risk Management Authority (ERMA) 
Availability: http://www.ermanz.govt.nz/The New Zealand ‘Hazardous Substances and New 
Organisms Act 1996’ (HSNO) is to protect the environment, and the health and safety of 
people and communities, by preventing or managing the adverse effects of hazardous 
substances and new organisms.  Section 25 of the 1996 prohibits the import, development, 
field-testing or release of new organisms, including inter alia GMOs, without prior approval 
of the Environmental Risk Management Authority (ERMA).  Technical guides ER-TG-01-1 
9/99 and ER-TG-03-1 7/00 produced by ERMA discuss techniques for identifying risks and 
preparing information on risks, costs and benefits for applications under section 25 of the 
HSNO Act. 
 a) Identifying risks for applications under the Hazardous Substances and New 
Organisms Act.  ERMA, 1999 
Availability: http://www.ermanz.govt.nz/resources/publications/pdfs/ER-TG-01-1.pdf 
•  Detailed guidance on the process of identifying potential risks 
 
b) Preparing information on risks, costs and benefits for applications under the 
Hazardous Substances and New Organisms Act. ERMA, 2000 
Availability: http://www.ermanz.govt.nz/resources/publications/pdfs/ER-TG-03-1.pdf 
•  Description of the components of risk and options for risk characterization (e.g., 
qualitative versus quantitative, etc.) 
•  Consideration of risks in a decision-making context 
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Scientific principles and framework 
Section 7 of the HSNO Act requires ERMA to take into account the need for caution in 
managing adverse environmental effects when there is scientific and technical uncertainty 
about those effects. ERMA will use recognised risk identification, assessment, evaluation and 
management techniques when evaluating applications under Part V of the Act. Information 
provided by applicants must be “necessary and sufficient” for decision-making.  Assessments 
should be conducted on a case-by-case basis and the results compared to the baseline, i.e. 
what would happen if the application were refused.  The guidelines adhere to the Australian 
and New Zealand risk management standard (AS/NZS 4360: 1999).  The risk assessment 
consists of five steps: establish the context; hazard identification; calculate risk by combining 
estimates of likelihood and consequence; and treat risks. Monitoring and reviewing occurs at 
each step, together with consultation and communication with interested parties. 
 
Hazard identification  
The guidelines encourage applicants to demonstrate that they have conscientiously considered 
the widest possible range of obvious and non-obvious risks. The hazard identification must 
examine all possibilities of harm regardless of the likelihood of occurrence. The analysis must 
be thorough and systematic and may include stakeholders and interested parties. The 
guidelines provide a comprehensive list of hazard identification techniques, including: 
informal brainstorming, analogy to known cases and failure analysis, the Delphi technique, 
checklists, fault and event trees and HAZOP analysis. 
 
Likelihood and consequence assessment  
Neither of the guidelines discusses specific methods to estimate the likelihood or 
consequences of hazards. They do, however, contrast qualitative, semi-quantitative and 
quantitative approaches. Qualitative measures of likelihood, consequence and overall risk 
based on AS/NZS 4360: 1999 are provided as examples. The guidelines note that quantitative 
approaches may include various forms of statistical analysis, fault and event tree analysis, and 
extrapolation. The quality and validity of these approaches depends on the availability of data, 
and on the accuracy and completeness of the numerical values and methods (e.g. experiments, 
models) used to derive the data.  
 
Uncertainty analysis 
The guidelines distinguish between variability and uncertainty. They suggest that probability 
or frequency distributions can be used to analyse variability.  Two sources of uncertainty are 
identified: sampling error and lack of knowledge (about the consequences or likelihood of 
risk). They recommend checking information for bias, statistical competence and peer review, 
and obtaining further information where appropriate. The guidelines encourage applicants to 
consider the significance of adverse environmental effects, specifically their distribution over 
time and space, and whether they are acute, chronic or irreversible. 
 
Monitor and review  
Monitoring and reviewing are explicitly highlighted in the risk assessment framework but 
these components are not discussed further in the guidelines. 
 
Cumulative / long term effects 
Consideration of these is implicit in the document, particularly as it is a generic document 
covering risks to humans of exposure to hazardous substances.  However, there are no 
specific guidelines with respect to monitoring for these. 
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c) Decision Making: A Technical Guide to Identifying, Assessing and Evaluating 
Risks, Costs and Benefits, ERMA, March 2004.  ER-TG-05-1 03/04 
Availability: http://www.ermanz.govt.nz/resources/publications/pdfs/ER-TG-05-01.pdf 
 
This guide has been developed to provide guidance to the ERMA and to Agency staff, and to 
provide stakeholders with assurance that the ERMA is adopting best practice approaches.  
The Guide is applicable to all decisions made by the Authority and therefore covers import, 
manufacture, release or development of hazardous substances and new organisms including 
GMOs.  The guide states that “At present there is no published technical guide to ecological 
risk assessment, and the best reference is to the United States Environmental Protection 
Agency ‘Guidelines for Ecological Risk Assessment (1998) (reviewed in 2.3.1 above), which 
is a refined version of the ERMA framework. 
 
The guide addresses the elements of the decision making process, and includes definition of 
the overall process, and the individual steps within the process, i.e. identification, assessment, 
and weighing-up of adverse and beneficial effects (risks, costs and benefits).  It is a best 
practice guide and contains details of the particular tools or techniques that ERMA will apply 
to the different tasks required by the decision making process.  Techniques to ensure risks, 
costs and benefits are fully and realistically identified, and generic descriptors to represent 
likelihood, magnitude and risk/benefit are described.  Calculation of the level of risk and 
assessment of uncertainty are covered in detail.  Consideration of long-term and cumulative 
effects is referred to throughout the document; estimates of risk must take account of these 
components.  The document states that risk treatment and review and monitoring are “not 
applicable to applications for new organisms for full release”, implying that if these are 
required the release is not acceptable. 
 
 
 
 
2.5. Other National and Regional guidance documents 
 
ASEAN (Association of Southeast Asian Nations) – ASEAN Guidelines on Risk 
Assessment of Agriculture-Related GMOs, 1999 
Availability: http://www.aseansec.org/6226.htm 
•  Intended to ensure a common framework among ASEAN member countries for 
assessment of risks associated with the transboundary movement of agriculture-related 
GMOs 
•  These Guidelines provide a common framework for assessment of risks of agriculture-
related GMOs to human health and the environment; and scientific basis for decisions 
relating to the release of agriculture-related GMOs in ASEAN Member Countries.  They 
address issues related to food safety 
•  Includes description of information requirements related to risk assessment and risk 
management, including for numerous specific types of GMOs including plants, fish, 
other vertebrates, invertebrates, several categories of microorganisms, foods 
•  No reference to long term and/or cumulative risks, or uncertainty analysis. 
 
Singapore Guidelines on the Release of Agriculture-Related GMOs. Genetic 
Modification Advisory Committee 
Availability: http://www.gmac.gov.sg/guidelines/agriculture.html 
•  These guidelines are virtually identical to the guidelines developed by the Association of 
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•  Includes description of information requirements related to risk assessment and risk 
management, including for numerous specific types of LMOs including plants, fish, other 
vertebrates, invertebrates, several categories of microorganisms, and foods 
 
BIO-EARN (East African Regional Programme and Research Network for 
Biotechnology, Biosafety, and Biotechnology Policy Development) – Resource Book for 
the Implementation of Biosafety in East Africa 
Availability: http://www.bio-earn.org/resource%20book/Home.htm 
•  Risk assessment must be science-based, case-by-case, distinguish between need-to-
know and nice-to-know information, an iterative process, that allows the reviewers to 
obtain additional information from the applicant as it is needed 
•  Risk assessment entails identification of characteristics associated with the GMO that 
may result in potential risks; evaluation of the likelihood and degree of harm; 
consideration of the consequence should the hazard be realised and identification of risk 
management strategies to minimise harm 
•  Detailed list of scientific and technical information that should be provided in the risk 
assessment.  No specific tools or techniques for hazard analysis etc provided; no mention 
of uncertainty analysis. 
 
Switzerland – Ordinance on the Release of Organisms into the Environment.  
Availability  http://www.environnement-
suisse.ch/imperia/md/content/stobobio/biotech/odeb/14.pdf 
•  Not specific to GMOs 
•  Lists considerations for determining the probability and extent of potential damage due to 
release of organisms into the environment, as well as considerations for determining 
required safety measures 
 
 
 
2.6. Risk assessment approaches used in other areas 
International Organization for Standardization (ISO) 
General guidance on risk assessment and risk management 
Availability: http://www.iso.org 
Environmental Management: The ISO 14000 Family of International Standards (2002) 
•  Various standards related to Environmental Management; the specific standards were not 
obtained for review. 
 
2.6.1 International Plant Protection Convention 
Pest risk analysis for quarantine pests including analysis of environmental risks and 
living modified organisms (LMO), International Standard for Phytosanitary Measures 
#11, 2004 (ISPM 11) 
Availability: http://www.ippc.int/IPP/En/default.jsp 
ISPM 11 is applicable to any LMO that meets the definition of a quarantine pest, namely any 
LMO that is a potential plant pest (any species, strain or biotype of plant, animal or 
pathogenic agent injurious to plants or plant products), which is of economic importance to 
the area endangered thereby and not yet present there, or present but not widely distributed 
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•  First stage in the pest risk analysis (PRA) is to identify the pest(s) and pathways that are 
of quarantine concern and should be considered for risk analysis.  The context of the 
need for the PRA must be clearly stated.  The actual PRA process consists of pest 
categorisation, assessment of the probability of introduction and spread, assessment of 
the potential economic consequences, including environmental impacts. 
•  Detailed discussion of the elements of methodology is provided, in particular estimating 
the probability and potential economic consequences, including environmental impacts, 
of introduction and spread.  Assessment of the degree of uncertainty should be 
documented when concluding the PRA stages, but no specific guidance is given. 
•  Includes detailed discussion of pest risk management options.  The context of these 
assessments are consideration of future likelihood of entry and establishment of specific 
pests, so in some ways are considering potential long term effects more directly that 
some GMO risk assessment approaches. 
 
2.6.2 European and Mediterranean Plant Protection Organisation (EPPO) 
Availability: http://www.eppo.org/QUARANTINE/quarantine.htm 
EPPO has developed “Guidelines on Pest Risk Analysis - a decision support scheme for 
quarantine pests”.  This standard is based on ISPM 11 and was approved and adopted by 
EPPO in September 2005. 
•  It provides a simple scheme based on a sequence of questions for deciding whether 
an organism has the characteristics of a quarantine pest, and if appropriate to identify 
potential management options. 
•  Stages of pest risk analysis (PRA) for quarantine pests are: initiation, pest 
categorization, probability of introduction, assessment of potential economic 
consequences and pest risk management.  Detailed guidance is provided on each of these 
stages. 
•  Assessment of the degree of uncertainty should be documented when concluding the 
PRA stages but no specific guidance is given. 
•  Includes detailed discussion of pest risk management options and provisions for 
monitoring and review.  The context of these assessments are consideration of future 
likelihood of entry and establishment of specific pests, so in some ways are considering 
potential long term effects more directly that some GMO risk assessment approaches. 
•  The scheme can also be used for PRAs initiated by the identification of a pathway or 
the review of a policy. Expert judgement may be used in answering the questions. 
 
2.6.3 UK Department for Environment Food and Rural Affairs (Defra) 
 
Standard Methodology to assess the risks from non-native species considered possible 
problems to the environment (2005). 
Availability: http://www.defra.gov.uk/wildlife-countryside/resprog/findings/non-native-
risks/index.htmIn the UK this scheme has been adopted for assessment of the risks posed by 
any non-native organisms to species, habitats or ecosystems in all or part of the UK. 
•  Provides the first structured framework for evaluating the potential for any non-native 
organisms, whether intentionally or unintentionally introduced, to enter, establish, spread 
and cause significant impacts in all or part of the UK. 
•  Based on a six-module approach – i) assessment of invasive attributes, ii) pathway risk 
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summarising risks and uncertainties leading to the final risk assessment; vi: risk 
management module. 
•  Detailed guidance on application and setting the scope and boundaries of the assessment 
is provided; terms used throughout the scheme are established at the outset; descriptors 
for values for risk assessments are given.  Uncertainty is considered in detail and 
guidance is provided on its assessment; the model proposes further work in this area. 
•  Spreadsheets for summarising the level of risk and uncertainty, invasive attributes and 
economic impact have been created, and new methods for quantifying economic impact 
and summarising risk and uncertainty have been developed. 
•  The model has already been used in real assessments for a number of scenarios in the 
UK. 
 
2.6.4 Codex Alimentarius Commission 
The scope of all guidance produced by the Codex Alimentarius Commission is food safety; 
guidance does not cover environmental risks. 
Availability: http://www.codexalimentarius.net/web/index_en.jsp 
 
a) Principles for the Risk Analysis of Foods Derived from Modern Biotechnology, 
2003 
•  Lists principles for risk assessment and risk management related to food safety of 
genetically modified foods, including some elements of annex III of the Protocol 
 
b) Guideline for the Conduct of Food Safety Assessment of Foods Derived from 
Recombinant DNA Plants, 2003 
•  Describes considerations for the assessment and management of risks associated with 
foods consisting of, or derived from, genetically modified plants 
 
c) Guideline for the Conduct of Food Safety Assessment of Foods Produced Using 
Recombinant-DNA Microorganisms, 2003 
•  Describes considerations and approaches for the safety assessment of foods produced 
using recombinant-DNA micro-organisms 
 
2.6.5 North American Plant Protection Organization 
Regional Standard for Phytosanitary Measures #14: Importation and Release (into the 
environment) of Transgenic Plants, in NAPPO Member Countries (October 2003) 
Availability: http://www.nappo.org/Standards/Std-e.html  
•  Guidance on evaluation of risks to plant or plant health associated with import and 
release of transgenic plants 
•  Divided into three modules on (1) importation into contained facilities, (2) confined 
release into the environment, and (3) unconfined release into the environment 
•  Lists information requirements regarding the transgenic plant, risk management 
measures, assessment criteria, potential for reproduction and survival, potential for 
interactions with sexually compatible relatives, and potential for effects on non-target 
organisms 
 Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  21
Scientists’ Working Group on Biosafety 
Manual for Assessing Ecological and Human Health Effects of Genetically Engineered 
Organisms. 1998. Publication of The Edmonds Institute 
Availability: http://www.edmonds-institute.org/manual.html 
•  Detailed flowchart-based approach for hazard identification and for consideration of 
specific risk pathways 
•  Risk management options also discussed 
•  Includes some case-studies 
 
International Organization for Biological Control 
Global Working Group on Transgenic Organisms in Integrated pest Management and 
Biological Control, and the Scientific and Technical Advisory Panel of the Global 
Environment Facility: Series on Environmental Risk Assessment of Genetically Modified 
Organisms – Volume 1, A Case Study of Bt Maize in Kenya 
Availability: CABI Publishing (orders@cabi.org) 
•  Detailed case-study development of the methodology for a risk assessment, focusing on a 
particular trait in a particular receiving environment 
•  Includes detailed chapters on risk pathways related to (a) impacts on non-target 
organisms, (b) gene flow and its consequences, (c) insect resistance 
•  Includes a component that helps to frame the risk assessment in the broader context of 
decision-making, taking into account risks of alternatives, and incorporating public and 
stakeholder inputs 
 
2.6.6 Framework specific for cumulative risk assessment 
Availability: http://www.epa.gov/osa/spc/2cumrisk.htm 
•  The US Environmental Protection Agency published the “Framework for cumulative risk 
assessment” in May 2003 in response to increasing focus placed on combined risks from 
aggregate exposure to multiple agents or stressors, primarily in the context of exposure to 
chemicals.  The framework document defines cumulative risk assessment as “analysis, 
characterisation and possible quantification of the combined risks to human health or the 
environment from multiple agents or stressors”.  The 2003 report was intended to a first 
step in the development of clear guidelines for cumulative risk assessment in the USA. 
•  The framework is conceptually similar to the approach used in ecological risk 
assessments, but it is distinctive in several areas: 
i.  Its focus on the combined effects of more than one agent or stressor makes it 
different from many assessments, in which, if multiple stressors are evaluated, 
they are usually evaluated and presented individually; 
ii.  Because multiple stressors are affecting the same population, there is increased 
focus on the specific populations potentially affected rather than on 
hypothetical receptors; 
iii.  Consideration of cumulative risks may generate interest in a wider variety of 
non-chemical stressors than do traditional risk assessments. 
•  The framework describes three main phases to a cumulative risk assessment: (1) 
planning, scoping, and problem formulation, (2) analysis, and (3) risk characterization. 
•  In the first phase, a team of risk managers, risk assessors, and other stakeholders 
establishes the goals, breadth, depth, and focus of the assessment. The stressors and the 
health or environmental effects to be evaluated and the relationships among various 
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approach to be taken, and the types of results expected during the analysis phase are 
developed. 
•  The analysis phase includes developing profiles of exposure, considering interactions (if 
any) among stressors, and predicting risks to the population or populations assessed. It is 
in this phase that difficult technical issues such as the toxicity of mixtures, the 
vulnerability of populations, or the interactions among stressors that may be chemical or 
non-chemical are addressed and, hopefully resolved. The end of this phase is an analysis 
of the risks associated with the multiple stressors to which the study population or 
populations are exposed. 
•  The risk characterisation phase puts the risk estimates into perspective in terms of their 
significance, the reliability of the estimates, and the overall confidence in the assessment. 
•  Hazard analysis should be quantitative where possible and different techniques for 
achieving this are discussed.  However, there is acknowledgement that cumulative risk 
assessment need not necessarily be quantitative, providing analysis and characterisation 
are effectively carried out.  The difficulty of creating a ‘common metric’ for dissimilar 
risks is also discussed and it is acknowledged that there is a need for further work in this 
area. 
•  The framework places great emphasis on making sure assumptions made in the 
assessment are clear, and consideration of the different types of uncertainty and their 
analysis.  The framework does not consider approaches for management or mitigation. 
•  This framework is aimed primarily at cumulative risks due to chemical exposure, and 
may be too complex and far-removed in its scope for application to GM crops, however 
it may offer some useful ‘conceptual’ guidance. 
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Respondent 1 
 
1)  What do you understand by “long term” – 10, 50, 100 years or other? 
The term “long term” is not interpreted as a fixed period but rather as a time period that 
exceeds the time period of the consent on a specific product. Therefore it can be used in 
order to broaden the view in the risk assessment to the time period after the consent. The 
term “long term” will be defined on a case-to-case basis. For example, the placing on the 
market of a genetically modified tree will require a different approach of the definition of 
“long term” than the placing of the market of a perennial plant. The term “long term” 
generally implies more than one generation cycle of a GMO. “Long term” can also be 
influenced by intensity of usage of a certain GMO, or a specific trait in various GMOs. 
 
2)  What sort of effects do you think might emerge after this period of time? What are 
your reasons of thinking this? 
•  Expansive dissemination of the GMO in different habitats (reason: see experience 
with invasive species) 
•  Accumulated effects (e.g. gene stacking, multiple resistances) due to combination 
of traits 
•  Uncontrolled dissemination of transgenes 
•  Long-term change of agricultural practice due to intensification of cultivation 
•  Soil alterations due to long term use of certain GMOs or change of agricultural 
practice 
Bt-resistant pest species, due to selective pressure of long-term use of Bt-GMO 
varieties 
•  HR weeds due to selective pressure of application of HR-GMO varieties and 
herbicides, or transmission of HR-transgenes 
•  Long-term change/loss of natural habitats/ecosystems 
•  Subtle elimination of a wild species by a cultivated GMO (e.g. wild apple replaced 
by cultivated apples in certain habitats); loss of non-GMO varieties used in 
agriculture 
•  Continuous contamination of crops (e.g. experience in USA with Pharm crops and 
experiences with unwanted contamination events in other countries) 
 
3)  What monitoring arrangements do you have in place that would support 
identification of such effects, should they occur? Do you envisage that it will be 
possible to prove cause and effect given your current monitoring arrangements? 
Concept for National Biodiversity Monitoring being currently developed 
 
Concept for General Surveillance of GMOs; see 
Traxler A., Heissenberger A., Frank G., Lethmayer Ch. & H. Gaugitsch (2001). 
Ecological monitoring of genetically modified organisms. Umweltbundesamt 
Monographien; Band 147, Vienna 2001, pp 87. 
 
It will be difficult enough to monitor the effects mentioned above with such an intensity 
that in case an effect occurs it will be detected. If an effect will be detected or not 
depends on the statistical design of the monitoring approach. Any monitoring system 
must foresee that the effects that it wants to monitor, i.e. the hypotheses that are 
formulated, are detected by the statistical design chosen. In order to prove a cause-effect 
relationship all variables that influence a certain parameter have to be “co-monitored”. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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However, as this is in most cases not possible, the main variables have to be chosen in 
order to possibly establish a cause-effect relationship. However, there will be variables 
that influence a certain parameter, which we don’t even know.  
 
4)  What do you understand by cumulative effects? 
•  Effects that arise from the introduction/placing on the market of several different 
GMOs 
•  Effects that arise from the introduction of the same “plant protection system” in 
several GMOs (e.g. same Bt or HR trait in several plants) 
•  Effects that arise due to intensification of agricultural practice by the use 
 
5)  What sort of cumulative effects do you think might emerge after what you have 
defined as the long term in Q2? What are your reasons for thinking this? 
•  Soil alterations due to cumulative use of certain herbicides/GMOs 
•  Development of multiple herbicide resistance in weed species 
•  Accelerated selection of Bt resistant pest species 
•  Transgene contaminations in non-GMO crop varieties 
•  Change/loss of natural habitats and/or biodiversity due to intensification of 
agricultural production 
 
6)  Do you think the monitoring arrangements in place in your member state are 
adequate to identify these effects should they occur? 
At the moment, no. 
 
7)  Do you think the current EU risk assessment framework enables applicants to 
address adequately the potential long-term cumulative effects of GMOs? Do 
applicants generally pay sufficient attention to this aspect of applications? What do 
you think would improve this aspect of the authorisation process? 
No, applicants do not at all address adequately the potential of long-term cumulative 
effects of GMOs! Monitoring plans accompanying applications must be considered 
insufficient in most cases. 
In the current step-by-step procedure in the risk assessment of GMOs only short-term 
effects with few individuals and under few environmental conditions are tested. In most 
cases no special restrictions on the general use of GMOs are introduced upon consent; 
although in specific cases such restrictions (time of use, place of use) were considered as 
measures against adverse long term effects when drafting Dir 2001/18/EC. 
The current approach is to analyse the GM plant itself, however effects of GMOs in 
combination with the agricultural practice should be analysed. 
 
8)  Do you have specific criteria for deciding what are acceptable and unacceptable 
risks? If so, can you let us know what these are and why you have identified these? 
 
For environmental effects – at the moment, no. Definition is dependent on protection 
goals and on consensus in society. 
For Human health effects, specifically the assessment of toxicology, allergology as well 
as substantial equivalence see: 
Spök A., Hofer H., Lehner P., Valenta R., Stirn S. & H. Gaugitsch (2005). Risk 
Assessment of GMO Products in the European Union. Toxicity assessment, allergenicity 
assessment and substantial equivalence in practice and proposals for improvement and 
standardisation. Umweltbundesamt Bericht Band 253, Vienna 2005, pp 131. 
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Spök A., Gaugitsch H., Laffer S., Pauli G., Saito H., Sampson H., Sibanda E., Thomas 
W., van Hage M. & R. Valenta (2005). Suggestions for the Assessment of the Allergenic 
Potential of Genetically Modified Organisms. Int. Arch. Allergy Immunol. 137: 167-180 
 
9)  Are the any models used by other regulatory authorities worldwide that you would 
like to be incorporated into the European approach that might provide for a better 
assessment of long-term cumulative risks? 
No 
 
10)  Are you aware of any reports of unexpected effects of the release of a GMO? 
 
See for example: 
Tappeser, B., Eckelkamp, C. & B. Weber (2001). Analysis of observed adverse effects 
from the release of genetically modified organisms. Umweltbundesamt Monographien 
Band 148, Vienna, 2001, pp 71. 
 
Other published or unpublished reports, e.g.: 
Stem split of GM soybean under stress conditions 
Loss of unripe cotton balls on GMO-cotton 
Change of fat composition in cow milk upon feeding with GM-soybean 
Gene stacking of herbicide tolerance traits in Canada 
 Cumulative long-term effects of genetically modified (GM) crops on human/animal health 
and the environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  4
 
Respondent 2 
 
1)  What do you understand by ‘long term’ - 10 years, 50 years, 100 years or other? 
“Long –term” effects could entail a span of 10 years and more. 
 
2)  What sort of effects do you think might emerge after this period of time? What are your 
reasons for thinking this? 
Effects could occur on public health (allergies and toxicity)  and/or the environment (GMO 
cross with on GMO). The provision in the national law is to grant a permit for five years, 
maximum.  
 
3)  What monitoring arrangements do you have in place that would support identification of 
such effects, should they occur? Do you envisage that it will be possible to prove cause 
and effect given your current monitoring arrangements? 
The monitoring arrangements included in the national law have been set according to Directive 
2001/18/EC. In this country no notification has been submitted or examined for a GMO to be 
placed on the market, therefore there is no hands-on experience on such issue. 
 
4)  What do you understand by cumulative effects? 
Cumulative effects are the indirect and at the same time long-term effects caused by the 
intended release or placing on the market of GMOs. These could be both environmental and 
health effects. 
 
5)  What sort of cumulative effects do you think might emerge after what you have defined 
as the long term in Q2? What are your reasons for thinking this? 
The cumulative effects which might emerge could involve the following: 
•  Escape of GMO plants to the wild and affecting the wild flora. 
•  Health effects occurring long after the placing on the market of GMO products such as 
allergies or toxicity. 
 
6)  Do you think the monitoring arrangements in place in your member state are adequate 
to identify these effects, should they occur? 
As no application has been submitted to our CA for the placing on the market or cultivation of 
GMO products the answer could only be theoretical: in case of such an event (placing on the 
market, or cultivation of GMO products) the monitoring plan should be very detailed and 
control by the authorities very rigorous.  
 
7)  Do you think the current EU risk assessment framework enables applicants to address 
adequately the potential long-term cumulative effects of GMOs? Do applicants generally 
pay sufficient attention to this aspect of applications? What do you think would improve 
this aspect of the authorisation process? 
The general surveillance plan should become more detailed and prescriptive concerning the 
measures which need to be taken, as well as more demanding on the necessary preventive 
measures. Additionally further assurances for its proper implementation should be provided by 
the applicant. 
 
The need to have a case specific monitoring plan should become more urgent taking into 
consideration the event (no matter how unlikely) of accidental release into the environment. Cumulative long-term effects of genetically modified (GM) crops on human/animal health 
and the environment:  risk assessment methodologies 
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The issue of unintended release into the environment should be examined more thoroughly 
both in the general surveillance plan and the case specific monitoring. There should be 
improvements of the accuracy and precision of methods of analysis and their adoption and 
publication as official methods. Problems are particularly faced with the analysis of compound 
feeds. 
 
8)  Do you have specific criteria for deciding what are acceptable and unacceptable risks? If 
so, can you let us know what these are and why you have identified these? 
We did not so far develop such criteria. 
 
9)  Are there any models used by other regulatory authorities worldwide that you would like 
to be incorporated into the European approach that might provide for a better 
assessment of long-term cumulative risks? 
The following issues are considered as significant: 
•  The feeding studies should become more prolonged instead of the time span presented by 
the notifiers. 
•  More thorough evaluation of substantial equivalence. 
•  Further investigation on the long term consequences of GMO products on flora and fauna. 
 
10)  Are you aware of any reports of unexpected effects of the release of a GMO? 
The event of the unexpected release into the environment of GMO products destined for feed 
use occurring in Japan. There are also other reports alerting for the need for further 
investigation of the effects of GMO products. 
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Respondent 3 
 
1)  What do you understand by ‘long term’ - 10 years, 50 years, 100 years or other? 
We can hardly expect specific information on the detected “long term” effects of any GM 
crop in a notification to be provided for a period longer than 10 years, because the first GM 
crops started to be commercially cultivated only 10 years ago. The risk assessment as a part 
of the notification under part C of Directive 2001/18/EC is usually based on the data 
available from field trials and, if possible, the experience gained in other countries where the 
GMO has already been placed on the market. 
However, the assessment of possible effects that may appear during the longer period, 20 to 
50 years, should be taken into consideration in the risk assessment and in the monitoring 
plan.  The post-market monitoring should cover such a “long term” period. 
 
2)  What sort of effects do you think might emerge after this period of time? What are 
your reasons for thinking this? 
The possible effects of GM crops could be of two types: 
•  effects caused by the characteristic of the organism and the modification 
•  effects emerging from the change of agricultural practices used 
Some of the risks are common for agronomical practices using either modified or non-
modified plants, e.g. the development of resistance of pests (insects, weeds). 
Potential long-term effects may include: 
•  effect on biodiversity, e.g. changes in the populations of weeds and consequently 
organisms feeding on weeds (insects, birds – see the UK farm scale trials), changes in 
the populations of target and non-target organisms. 
•  gene transfer leading to the spreading of the herbicide resistance trait to the wild 
relatives of the crop and thus creating persistent weeds 
•  development of resistant pests populations, like the European corn borer, which can 
cause first an economic damage, but in a long term also means the increase in pesticide 
use 
•  changes in the use of herbicides, e.g. focus on one or two types of herbicides, and 
consequent changes in the spectrum of weeds or emergence of resistant weeds 
Positive long-term effect of herbicide tolerant crops could be the decrease of soil erosion 
resulting from the post-emergent application of the herbicide. 
Positive effect of insect resistant (Bt) crops is the reduction of the use of chemical 
insecticides. 
Effects on soil organisms can be positive or negative, that should be a subject of further 
studies. 
 
3)  What monitoring arrangements do you have in place that would support identification 
of such effects, should they occur? Do you envisage that it will be possible to prove 
cause and effect given your current monitoring arrangements? 
Some multi-year studies with GM crops are carried out in this country, but they are not 
aimed at systematic long-term monitoring of environmental and health effects. Cumulative long-term effects of genetically modified (GM) crops on human/animal health 
and the environment:  risk assessment methodologies 
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A monitoring network for non-modified crops has been in place for more than 20 years in 
this country. Besides agronomical performance and quality also long-term effects of used 
agronomical practices in different agroecological conditions are monitored in trials funded 
by the Ministry of Agriculture. The developed methodology for studying long term effects of 
the crop and agricultural practices on pests, diseases, biogeochemistry and soil 
microorganisms can be applied to the GM-crops as well. Monitoring of GM crops should be 
included in this network or a new GM network should be established in EU member states. 
 
4)  What do you understand by cumulative effects? 
Directive 2001/18/EC, Annex II: PRINCIPLES FOR THE ENVIRONMENTAL RISK 
ASSESSMENT. 
Definitions: "Cumulative long-term effects" refers to the accumulated effects of consents on 
human health and the environment, including inter alia flora and fauna, soil fertility, soil 
degradation of organic material, the feed/ food chain, biological diversity, animal health 
and resistance problems in relation to antibiotics. 
 
Cumulative effects are - in our opinion - effects occurring at the same time and at the same 
place or area. These are, of course, not just negative effects, but also positive or indifferent 
ones. 
 
5)  What sort of cumulative effects do you think might emerge after what you have defined 
as the long term in Q2? What are your reasons for thinking this? 
Cumulative effects may consist of the effects given under 3), in the future cumulative effects 
will probably be connected also with an increasing number of cultivated GM crops and a 
spectrum of new traits. These effects are very difficult to anticipate at present.  
Cumulative long-term effects of cultivation of GM crops are most likely to emerge from the 
change in agronomic practices (e.g. different application of herbicides in case of herbicide 
tolerant crops) than from the genetic modification itself. According to the Annex II of the 
Directive 2001/18/EC, such effects have to be considered in the environmental risk 
assessment in case of placing of GMOs on the market. 
 
6)  Do you think the monitoring arrangements in place in your member state are adequate 
to identify these effects, should they occur? 
No, the monitoring arrangements are not sufficient (see 4). The monitoring of possible 
effects of GM crops should be carried out both by the authorities and the notifier. The 
methodology should be developed in accordance with the obtained data and should react 
flexibly to the new traits and connected changes in the agronomic practice. 
 
7)  Do you think the current EU risk assessment framework enables applicants to address 
adequately the potential long-term cumulative effects of GMOs? Do applicants 
generally pay sufficient attention to this aspect of applications? What do you think 
would improve this aspect of the authorisation process? 
The EU legislative (Directive 2001/18/EC, Annex II and Commission Decision 
2002/623/EC) sets only a general framework for the risk assessment, especially as potential 
long-term cumulative effects are concerned. Consequently the corresponding parts of the Cumulative long-term effects of genetically modified (GM) crops on human/animal health 
and the environment:  risk assessment methodologies 
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notifications are usually quite brief. To facilitate the more detailed risk assessment in this 
respect, the existing framework should be supplemented by specific guidelines, case studies 
etc., focused on the identified possible long-term effects.  
The improvement of this aspect of the authorisation process is an important task not only for 
the applicants, but also for the Authorities. The applicants should provide the assessment of 
potential long-term effects of the notified GMO, but they are not in a position to provide an 
analysis of the cumulative effects caused by the overall GM crops use (rate of the acceptance 
of biotechnology applications in agriculture, different crops, traits). 
The output from this project will surely contribute to the improvement of addressing the 
long-term risk assessment as well.  
 
8)  Do you have specific criteria for deciding what are acceptable and unacceptable risks?  
If so, can you let us know what these are and why you have identified these? 
The environmental risk assessment of a GM crop and its use should be based on comparison 
to the use of the corresponding non-modified crop (see Directive 2001/18/EC, Annex II B. 
General Principles: “In accordance with the precautionary principle, the following general 
principles should be followed when performing the e.r.a.: 
  - identified characteristics of the GMO and its use which have the potential to cause 
adverse effects should be compared to those presented by the non-modified organism from 
which it is derived and its use under corresponding situations; …”) 
The acceptable risks are the risks lower or on the same level as the risks of non-modified 
crop variety. A risk / benefit analysis should be made as well. 
 
9)  Are there any models used by other regulatory authorities worldwide that you would 
like to be incorporated into the European approach that might provide for a better 
assessment of long-term cumulative risks? 
- 
 
10)  Are you aware of any reports of unexpected effects of the release of a GMO? 
No, as far as we know, all the published effects of releases of GMOs were the effects taken 
into consideration in the appropriate risk assessments. 
 
 Cumulative long-term effects of genetically modified (GM) crops on human/animal 
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Respondent 4 
 
1)  What do you understand by ‘long term’ - 10 years, 50 years, 100 years or other? 
Between 20 - 50 years. 
 
2)  What sort of effects do you think might emerge after this period of time? What are 
your reasons for thinking this? 
During this period of time possible effects would be: 
•  More cases of contamination of grain with unauthorised grain (similar to the Bt 
maize in the Starlink case). As companies develop more GMOs with stacked genes 
and traits, the inherent weaknesses in current PCR-based systems to differentiate 
between combinations of hybrids will appear. So for example, current PCR methods 
will NOT differentiate between a separate consignment of NK603 maize and MON 
810 maize or a hybrid of the two or even the presence of a third unauthorised hybrid 
crossed with the two parents. 
 
•  For the Southern Mediterranean region we would predict cases of hybridisation and 
introgression of GM oilseed rape (if approved for cultivation) with concomitant 
glyphosate resistance appearing in weeds. Various factors would increase the chance 
of this occurring in this region: it shares pollination windows with various important 
agricultural weeds, rubble walls prevent the implementation of the usual weed control 
methods and the plant has a history of hybridisation. 
 
•  In a worse case scenario, there could be unexpected health problems in sectors of the 
EU population exposed to a particular modification.  Our current health risk 
assessments are based on our current knowledge of what constitutes an allergy-
generating food and our current databases. Given the varied eating habits of humans 
it would take time to make the particular links. 
 
3)  What monitoring arrangements do you have in place that would support 
identification of such effects, should they occur? Do you envisage that it will be 
possible to prove cause and effect given your current monitoring arrangements? 
Current monitoring techniques are not sufficient to prove cause and effect for points one 
and three mentioned above. 
 
4)  What do you understand by cumulative effects? 
The effects generated over time and by a combination of factors. 
 
5)  What sort of cumulative effects do you think might emerge after what you have 
defined as the long term in Q2? What are your reasons for thinking this? 
These are difficult to predict. 
 
6)  Do you think the monitoring arrangements in place in your member state are 
adequate to identify these effects, should they occur? 
No, current monitoring effects are not sufficient to detect cumulative effects. 
 
7)  Do you think the current EU risk assessment framework enables applicants to 
address adequately the potential long-term cumulative effects of GMOs? Do Cumulative long-term effects of genetically modified (GM) crops on human/animal 
health and the environment:  risk assessment methodologies 
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applicants generally pay sufficient attention to this aspect of applications? What do 
you think would improve this aspect of the authorisation process? 
No, the current EU regulations concentrate on determining whether a negative event will 
occur but are not strong on determining potential long-term effects. In our experience 
applicants often concentrate on proving why they do not have to present information and 
not on providing information. 
 
Some improvements to the current system could be: 
•  to streamline the requirements for approval for food and feed. So for example feeding 
tests on chickens and sub-chronic toxicity tests should be standard to support a food 
and feed request. 
•  lengthen the time of feeding tests. 
•  carry out a study to determine how relevant the current animals used in such tests are 
to the human dietary habits. 
•  use independent bodies not linked or paid by companies to provide critical data 
linked to safety or nutritional qualities of GMOs. 
•  provide further guidelines on what constitutes substantial equivalence. For example if 
a potato shares the same fatty acids, amino acids, minerals, vitamins and levels of 
glycoalkaloids as the non-transformed variety BUT there is evidence that the levels of 
other glycosylated compounds vary would this still constitute substantial 
equivalence? 
•  monitor closely results from sub-chronic toxicity tests.  We have been provided with 
tests where there were aberrations seen in the liver, yet the company stated that there 
were no macroscopic changes. 
 
8)  Do you have specific criteria for deciding what are acceptable and unacceptable 
risks? If so, can you let us know what these are and why you have identified these? 
We are in the process of developing these. 
 
9)  Are there any models used by other regulatory authorities worldwide that you 
would like to be incorporated into the European approach that might provide for a 
better assessment of long-term cumulative risks? 
We are not aware of any of these. 
 
10)  Are you aware of any reports of unexpected effects of the release of a GMO? 
The Starlink case – where a type of maize not intended for human consumption entered 
the human food chain in taco shells and other snack foods. 
 Cumulative long-term effects of genetically modified (GM) crops on human/animal health 
and the environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  11
 
Respondent 5 
 
1)  What do you understand by ‘long term’- 10 years, 50 years, 100 years or other? 
Long term would be any effect occurring after 10 years or longer. 
 
2)  What sort of effects do you think might emerge after this period of time? What are your 
reasons for thinking this? 
Because of the specificity of effects of genetically modified organisms (GMOs) it is not wise 
to start guessing in a general way about possible long-term effects. Every GMO is different 
and should be assessed on a case-by-case basis. Only a thorough risk assessment could shed 
light on the possible long-term effects of a particular GMO. If potential hazardous long-term 
effects are identified in the risk assessment for this specific GMO, specific monitoring is 
required as part of the permit. 
 
3)  What monitoring arrangements do you have in place that would support identification of 
such effects, should they occur? Do you envisage that it will be possible to prove cause 
and effect given your current monitoring arrangements? 
In this country many different monitoring networks exist that could be applied for the 
observation of potential long-term effects of GMOs that are unforeseen in the risk assessment. 
It would be too lengthy to describe them all. Briefly, systems exist for the monitoring of plant 
diseases, amphibians, plants, birds, marine life, etc. Specific monitoring requirements for 
GMOs, based on potential hazards identified in the risk assessment, are included in the permit 
for release into the environment.  
 
A discussion on proving cause and effect in the case of GMOs is at this moment purely 
theoretical in case of unexpected long-term effects of GMOs. It is therefore not possible to 
predict whether proving cause and effect in practice will in all cases be possible. It is not likely 
that this will be impossible. Lots of experience exists for proving cause and effect for other 
organisms than GMOs. 
 
4)  What do you understand by cumulative effects? 
Cumulative effects are effects that pile up.  
 
5)  What sort of cumulative effects do you think might emerge after what you have defined 
as the long term in Q2? What are your reasons for thinking this? 
The emergence of cumulative effects, if they occur, depends on the GMO in question. It is not 
possible to predict these possible cumulative effects if it is not clear what sort of GMOs will be 
on the market in the future.  
 
6)  Do you think the monitoring arrangements in place in your member state are adequate 
to identify these effects, should they occur? 
If an adverse effect occurs, current monitoring arrangements in this country, or the monitoring 
requirements as stated in the permit, will possibly lead to the detection of this effect. 
 
7)  Do you think the current EU risk assessment framework enables applicants to address 
adequately the potential long-term cumulative effects of GMOs? Do applicants generally 
pay sufficient attention to this aspect of applications? What do you think would improve 
this aspect of the authorization process? Cumulative long-term effects of genetically modified (GM) crops on human/animal health 
and the environment:  risk assessment methodologies 
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Yes, the current EU risk assessment framework enables applicants to address the potential 
long-term cumulative effects of GMOs in an adequate manner. Applicants have to assess these 
effects in the risk assessment. The current application process works well for these aspects. 
 
8)  Do you have specific criteria for deciding what are acceptable and unacceptable risks? If 
so, can you let us know what these are and why you have identified these? 
We use the criteria given in directive 2001/18/EC to decide whether risks are acceptable or 
not. Directive 2001/18/EC provides a framework to make such decisions.  
 
9)  Are there any models used by other regulatory authorities worldwide that you would like 
to be incorporated into the European approach that might provide for a better 
assessment of long-term cumulative risks? 
No. 
 
10)  Are you aware of any reports of unexpected effects of the release of a GMO? 
No. 
 Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Respondent 6 
 
1)  What do you understand by ‘long term’ - 10 years, 50 years, 100 years or other? 
Depends on the context – species, environment, human effects etc.  Consider 10 years to 
be adequate but e.g. for forest trees it would be inadequate.  Very complex question to 
answer. 
 
2)  What sort of effects do you think might emerge after this period of time?  What are 
your reasons for thinking this? 
It is easier to focus on immediate effects and health effects, which are relatively short 
term, allergies might be one longer-term effect we could expect to see.  Environmental 
effects are much longer term anyway, e.g. herbicide resistance effects could take much 
longer than 10 years to be detected in the environment, therefore it is necessary to think 
longer term anyway.  Forestry, fruit trees, forage grasses, horticultural and agricultural 
crops all have different rotations and life cycle therefore need to consider on case-by-case 
basis.  Having said that, gene flow and its consequences are expected to be the greatest 
anticipated effects, also effects on seedbanks. 
 
3)  What monitoring arrangements do you have in place that would support 
identification of such effects, should they occur? Do you envisage that it will be 
possible to prove cause and effect given your current monitoring arrangements? 
No monitoring programmes are in place at the moment specifically for GMOs; the 
generic schemes that are in place could pick up effects of growing GM crops, but not 
really been evaluated yet.  The monitoring networks in place when we approach 
commercial release of GM crops will need to be instructed and/or educated on what to 
look for.  The Biotech Advisory Board has reviewed the monitoring that is currently 
going on, but no results yet.  GM crops are currently a long way off at the moment.   
 
The agricultural community is quite opposed to GM crops at the moment so the prospects 
for cultivation of GM crops is currently limited.  At the National level, authorisations are 
reviewed after the EC decisions, and a decision is then made as to suitability for the 
country. 
 
4)  What do you understand by cumulative effects? 
A sum of factors which individually do not have an effect but when combined may have 
an effect.  These scenarios become increasingly complex.   
 
5)  What sort of cumulative effects do you think might emerge after what you have 
defined as the long term in Q2?  What are your reasons for thinking this? 
Again, comes back to consideration on a case-by-case basis. 
 
6)  Do you think the monitoring arrangements in place in your member state are 
adequate to identify these effects, should they occur? 
There are none in place at present, but CA will look deeper into this when it becomes 
necessary. 
 
7)  Do you think the current EU risk assessment framework enables applicants to 
address adequately the potential long-term cumulative effects of GMOs?  Do Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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applicants generally pay sufficient attention to this aspect of applications?  What do 
you think would improve this aspect of the authorisation process? 
We do not think the applicants generally pay sufficient attention to long term risks; 
notifications present very little in the way of peer-reviewed data, often data to support 
risk assessments is poorly presented and with poor hypotheses, making its validity 
questionable.  This makes it difficult to critically review the data.  We also believe that 
the notifications present risk from a biased perspective.  However, the framework for 
2001/18/EC does not provide guidance on data collection, analysis and presentation so it 
is not necessarily the applicants’ fault; there needs to be clear guidance on what should 
be collected, possibly focussing on key areas of interest, but this would require an EU-
wide agreement.  CAs could be much more exacting in their requirements for the risk 
assessments.  Possibly there is a need for a review of the roles of the CA and the 
applicants. 
 
Independent research in these areas would be very valuable - currently we are too reliant 
on information provided by the notifiers.  But there may be difficulties getting the 
companies to cooperate (the UK’s farm scale evaluation trials were thought to be a good 
example). 
 
8)  Do you have specific criteria for deciding what are acceptable and unacceptable 
risks?  If so, can you let us know what these are and why you have identified these? 
We do not have specific criteria, and again it comes back to case-by-case assessments.  
No specific indicators have been identified yet.  We would be much more critical about 
assessment for crops that are likely to be grown in this country.  Benefits to society and 
the country must be demonstrated – we would be less stringent about a crop for which 
clear benefits can be demonstrated.   
 
9)  Are there any models used by other regulatory authorities worldwide that you 
would like to be incorporated into the European approach that might provide for a 
better assessment of long-term cumulative risks? 
No. 
 
10)  Are you aware of any reports of unexpected effects of the release of a GMO? 
The Network Biosafety Service has identified a couple of reports [awaiting info about 
these from the interviewee]. 
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Respondent 7 
 
1)  What do you understand by ‘long term’ - 10 years, 50 years, 100 years or other? 
This country wants to see no effects, irrespective of time, therefore long term refer to 
very long way into the future.  Any risks that are identified for the short term should be 
extrapolated and considered in the long term in the ERA.  Also depends on the crop you 
are looking at – the standard life time for a forest tree is very different from an 
agricultural crop, therefore for forest species the long term is 100 years plus.  Also 
ecological timeframes are different from agricultural timeframes. 
 
2)  What sort of effects do you think might emerge after this period of time?  What are 
your reasons for thinking this? 
All compartments of the environment might be affected, cannot focus on just one area. 
 
3)  What monitoring arrangements do you have in place that would support 
identification of such effects, should they occur? Do you envisage that it will be 
possible to prove cause and effect given your current monitoring arrangements? 
See answer to Q7 below. 
 
4)  What do you understand by cumulative effects? 
Cumulative effects are the effects of having more than one GMO, which leads to a 
change in the potential risks; this also affects the long-term risks. 
 
5)  What sort of cumulative effects do you think might emerge after what you have 
defined as the long term in Q2?  What are your reasons for thinking this? 
All compartments of the environment might be affected, cannot focus on just one area. 
 
6)  Do you think the monitoring arrangements in place in your member state are 
adequate to identify these effects, should they occur? 
Monitoring programmes are in place for conventional grazing, forestry, intensive 
agriculture is monitored less. 
 
7)  Do you think the current EU risk assessment framework enables applicants to 
address adequately the potential long-term cumulative effects of GMOs?  Do 
applicants generally pay sufficient attention to this aspect of applications?  What do 
you think would improve this aspect of the authorisation process? 
The tools for monitoring are available.  The lead CAs should use the tools and put 
pressure on the notifier to use these tools.  CAs should make their own assessments and 
see if they agree with the notifier.  Checklists are provided in the Directive.  RAs are 
slightly ad hoc; it is difficult to formalise the risk assessment process because of the risk 
identification step (risk perception differs depending on who is doing the RA). 
 
Applicants do generally pay sufficient attention to these risks and do a good job, but too 
little effort is put into monitoring; they need to do more on monitoring. 
 
8)  Do you have specific criteria for deciding what are acceptable and unacceptable 
risks?  If so, can you let us know what these are and why you have identified these? Cumulative long-term effects of genetically modified (GM) crops on human/animal 
health and the environment:  risk assessment methodologies 
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We do not have any specific criteria for acceptable/unacceptable risks, there is no 
EU-wide guidance on this therefore it is up to National legislation.  Ethical reasons 
come into play at this point.  Acceptability of risks is a philosophical, internal value 
for each CA, not an economic consideration and will differ from crop to crop. 
CA weighs disadvantages versus the advantages.  If the GM crop offers clear advantages 
for the CA, i.e. for the environment or the general public, the CA would be prepared to 
accept greater risks.  This is not an exact science!  Unaware of how things are done in 
other MSs; quality of assessments varies MS to MS, UK (ACRE) is generally of very 
high quality, we do not have a similar group, we have a group that is half scientists, half 
politicians.  We believe that assessments should not be blurred by politics.  Influence of 
politics should be at the end of the scientific assessment process, to bring in concept of 
ethical assessment of level of acceptability of risks.   
 
9)  Are there any models used by other regulatory authorities worldwide that you 
would like to be incorporated into the European approach that might provide for a 
better assessment of long-term cumulative risks? 
No. 
 
10)  Are you aware of any reports of unexpected effects of the release of a GMO? 
No, there is no monitoring for this – should look at the USA for reports of these! 
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Respondent 8 
 
1)  What do you understand by ‘long term’ - 10 years, 50 years, 100 years or 
other? 
In reference to environmental issues, 10 years or more. 
The magnitude, likelihood and timing of a long-term effect can change 
depending on the stability of the receiving environment that could drastically 
change in 10 or 20 years. 
 
2)  What sort of effects do you think might emerge after this period of time? 
What are your reasons for thinking this? 
•  Loss of biodiversity due to gene flow to sexually compatible plants or 
establishment of the engineered plant as an invasive species in the receiving 
environment; 
•  Changes in insect community structure and function due to reduction of 
complexity in agricultural landscapes by reducing plant (crop and weed) 
diversity. It can affect the ecosystem stability by top-down or bottom-up 
effects; 
•  Changes in soil microbial profile, diversity or community structure that could 
lead to loss of soil biodiversity and thus changes in biogeochemical cycles 
and reduced soil fertility; 
•  Further potential and specific effects could be identified performing a case-
specific environmental risk assessment and/or analysing the results of 
monitoring activities of the  GMOs’ releases present at the moment 
worldwide. 
 
3)  What monitoring arrangements do you have in place that would support 
identification of such effects, should they occur? Do you envisage that it will 
be possible to prove cause and effect given your current monitoring 
arrangements? 
Monitoring activities set up for the identification of GMOs effects (long and short 
term) are only at regional level and they are related to:  
•  Research activities to identify bio-indicators and define experimental 
standard protocols (most of them on soil ecosystems). 
•  Research activities and data collection finalised to the definition of baselines. 
While the monitoring activities at national level are not directly built up 
for the monitoring of effects related to GMOs and their release into the 
environment, we consider that they are suitable to be modified and 
adapted for this object. 
 
4)  What do you understand by cumulative effects? 
In this framework we distinguish between cumulative and synergistic effects. 
•  Cumulative effects: Engineering of organisms could lead to a non-target 
expression of genes such as toxins, allergens and carcinogens. The repeated 
exposure or intake of such elements can determine adverse effects that are 
detectable only over long periods. 
•  Synergistic effects: They can arise when a combination of GMOs is 
released in neighbouring sites concurring to an adverse effect or when Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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different characteristics of a single GMO (linked to the genetic modification 
and/or to the biological features) act together resulting in a harmful effect. 
 
5)  What sort of cumulative effects do you think might emerge after what you 
have defined as the long term in Q2? What are your reasons for thinking 
this? 
•  Undetected toxins, allergens and carcinogens can enter in the food chain 
with cumulative effects; 
•  Decrease in insect diversity can be determined by repeated exposure of a 
target species to a toxin or reducing the agricultural landscape diversity, 
which is likely to result from developments such as herbicide resistance. 
 
6)  Do you think the monitoring arrangements in place in your member state 
are adequate to identify these effects, should they occur? 
Not at the moment because of the lack of databases concerning environmental 
baselines, lack of indicators, lack of monitoring activities on GMOs at national 
level. 
 
7)  Do you think the current EU risk assessment framework enables applicants 
to address adequately the potential long-term cumulative effects of GMOs? 
No 
 
Do applicants generally pay sufficient attention to this aspect of 
applications? 
No 
 
What do you think would improve this aspect of the authorisation process? 
•  Environmental Risk Assessment standard methodology; 
•  Further research activities not only related to gene technology but to 
ecological interactions, genomic, proteomic and population dynamic; 
•  Results of monitoring activities (Case Specific and General Surveillance) of 
the GMOs’ releases present at the moment worldwide. 
 
8)  Do you have specific criteria for deciding what are acceptable and 
unacceptable risks? If so, can you let us know what these are and why you 
have identified these? 
No. 
 
9)  Are there any models used by other regulatory authorities worldwide that 
you would like to be incorporated into the European approach that might 
provide for a better assessment of long-term cumulative risks? 
The government has promoted a project for the development of an ERA standard 
methodology. This methodology has been implemented on the deliberate release 
of Genetically Modified Higher Plants for experimental purpose. The next step of 
the project will be the implementation of the methodology to the deliberate release 
of Genetically Modified Microrganisms for experimental purpose and to the 
deliberate release of Genetically Modified Higher Plants for commercialisation. 
 
10)  Are you aware of any reports of unexpected effects of the release of a GMO? 
No 
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Respondent 9 
 
1)  What do you understand by “long term” – 10, 50, 100 years or other? 
Two types of effect. A change that is not reversible within 15 years. A small 
change which is not easily detected but is in the same direction over many (10 
plus years) building up a significant environmental change that is not reversible 
in the short term. 
 
2)  What sort of effects do you think might emerge after this period of time? 
What are your reasons for thinking this? 
In answering this question, we are limiting our consideration to this country and 
to the range of GM crops which are currently available for cultivation  in the EU 
or have pending applications for marketing consents for cultivation. We do not 
intend to speculate about the impact of GMOs, which at some point may receive 
marketing approval but which are not in the regulatory pipeline. We also note 
that an effect could be good, bad or neutral. 
 
In the foreseeable future, herbicide tolerance is the only trait that will be bred 
into varieties suitable for cultivation in this country. The insects targeted by Bt 
genes in approved GM crops and those with pending applications do not 
currently have pest status in this country.  GM crops containing these genes are 
therefore unlikely to be grown here. 
 
Effects that might emerge over a long timescale include those on a landscape 
scale, such as changes in cultivation patterns and management practices. This in 
turn could affect certain species directly and affect the balance of farmland 
biodiversity, depending on how these changes are managed. However similar 
effects are likely to be found arising from the introduction of any new or different 
agricultural crop or crop management system and the possibility of such effects is 
not restricted to GM crops. The emergence of agricultural weeds with herbicide 
tolerance to broad spectrum herbicides is possible in certain rotations. This is 
most likely to occur through the emergence of volunteer crop plants and repeated 
herbicide usage. There could be gene flow from oilseed rape to sexually 
compatible ‘wild relatives’. The effect of this will depend on the availability and 
use of herbicides that are used as an alternative. The outcome of the UK farm 
scale evaluations are an example of indirect effects due to new weed 
management practices made possible by GM HT crops. 
 
3)  What monitoring arrangements do you have in place that would support 
identification of such effects, should they occur? Do you envisage that it will 
be possible to prove cause and effect given your current monitoring 
arrangements? 
This country does not have specific environmental monitoring arrangements for 
GM crops, because none are yet grown here. But there are other environmental 
and agronomic monitoring programmes that are carried out in this country for 
certain indicators. It is possible that large effects, for example in cultivation 
patterns on a regional scale might be attributable to GM cropping, but for the 
most part, it is very difficult to envisage being able to link an effect identified Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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through general surveillance to a particular GMO or to GM crops more generally. 
Conventional agriculture already has such a gross effect on farmland 
biodiversity, this is likely to swamp any effects due to GM crops. Hypothetical 
links would need to be tested experimentally. 
 
4)  What do you understand by cumulative effects? 
The combined impacts that accrue over time and space from the cultivation of 
GM crops. This might include the interactive effects of different GMOs as well 
as to incremental changes resulting from increases in the scale (over time and 
space) of a particular GMO. 
 
5)  What sort of cumulative effects do you think might emerge after what you 
have defined as the long term in Q2? What are your reasons for thinking 
this? 
Cumulative effects are difficult to predict but could include the evolution of 
herbicide-tolerant agricultural weeds (through herbicide usage in particular but 
possibly through gene flow). Gene stacking could result in GM crops with 
tolerance to a number of broad-spectrum herbicides. Such tolerances could also 
arise in conventional (non-GM) crops. 
 
6)  Do you think the monitoring arrangements in place in your member state 
are adequate to identify these effects, should they occur? 
Yes, if these effects have an adverse effect on the environment as compared to 
the effects associated with the cultivation, management and use of their non-GM 
equivalents. 
 
7)  Do you think the current EU risk assessment framework enables applicants 
to address adequately the potential long-term cumulative effects of GMOs? 
Do applicants generally pay sufficient attention to this aspect of 
applications? What do you think would improve this aspect of the 
authorisation process? 
The current framework presents applicants with adequate opportunity to address 
long-term cumulative effects of GMOs. Potential long-term cumulative effects of 
GMOs for the most part will have to be dealt with by general surveillance 
because of the difficulty in predicting them. Case-specific monitoring may also 
be pertinent if the risk can be identified but not dealt with in the environmental 
risk assessment (e.g. due to scale). A clearer understanding of the principles of 
case-specific monitoring and general surveillance at Member State level would 
be advantageous. We also consider that the interaction between 2001/18/EC and 
91/414/EC in the regulation/monitoring of pesticide use on herbicide tolerant 
crops needs clarification. 
 
8)  Do you have specific criteria for deciding what are acceptable and 
unacceptable risks?  If so, can you let us know what these are and why you 
have identified these? 
Risks to human health and the environment are assessed in accordance with the 
criteria laid out in Annex 2 of Directive 2001/18/EC.  The risk of an adverse 
effect on human health or the environment as a result of a particular GM crop 
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to those associated with equivalent non-GM crops and the conventional 
management practices associated with them.  A risk is judged to be unacceptable 
if comparisons under realistic conditions reveal a significant adverse effect on 
human health or the environment and measures can not be put in place to 
sufficiently prevent such events occurring.  Adverse effects identified in lower-
tier testing (for example effects on non-target insects in no-choice bioassays) 
may be acceptable if subsequent field testing has found that the effect does not 
occur under realistic conditions.  In such cases there would normally be a 
requirement for case-specific monitoring to check that the assumptions of the 
environmental risk assessment.   
 
9)  Are there any models used by other regulatory authorities worldwide that 
you would like to be incorporated into the European approach that might 
provide for a better assessment of long-term cumulative risks? 
We are not aware of any models of this nature. 
 
10)  Are you aware of any reports of unexpected effects of the release of a GMO? 
We are not aware of any substantiated reports of unexpected effects resulting 
from the release of GMOs. 
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CSL, Sand Hutton, York 
 
Attendees: 
 
CSL:  
1.  Christine Henry 
2.  Vicky Jackson 
3.  Andrew Cuthbertson 
4.  James Blackburn 
5.  Steven Parker 
6.  Nigel Boatman 
7.  Theo Allnutt  
8.  Sarah Hugo 
 
Newcastle University: 
9.  Prof Faith Williams 
 
VLA: 
10. Chris Teale (by videolink) 
 
RM Consultants Ltd: 
11. David Nicholls 
12. Agnieszka Stachowicz 
 
 
The aim of the workshop was to identify the range of potential long term and 
cumulative risks to human/animal health and the environment from GM crops, by 
bringing together experts in various aspects of the topic in facilitated brainstorming.   
 
The following notes record the findings in terms of both potential risks identified, and 
features, events and processes that may change and hence affect risks.  
I   
II  Breakout Groups 1 – Scenarios  
 
This session was intended to start participants thinking and talking freely about the 
topic.  The participants divided into three groups of three or four and spent 20 minutes 
imagining (based on evidence or realistic speculation) some scenarios in which long 
term or cumulative effects could occur.  No specific structure was imposed on their 
discussions, although a Source-Pathway-Receptor model (Figure 2) was suggested as 
a possible framework for prompting discussion and structuring the results.    
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III  Figure 2   Source-Pathway-Receptor model - prompts for Scenarios 
 
Each group then outlined the scenario and the risks they envisaged, with the following 
results: 
 
13. Effects on jobs in chemical industry if demand for agrichemicals is reduced/ 
increased 
14. Effects on research employment and priorities; 
15. Climate change – exotic pests become native pests – this could change the need 
for and effectiveness of (both conventional and) GM crops 
16. Larger field margins needed to provide a buffer around GM crops – various  
secondary ecological and agricultural effects  
17. Fewer insects & spiders – effects on food chain for birds; 
18. Monitoring becomes more difficult if there is widespread GM cultivation - costs 
of covering large areas vs spatial sampling problems 
19. There may be greater land cover by particular crops that give the best economic 
rewards for farmers (cf Oil Seed Rape in 1970s) – effects on biodiversity and 
agricultural markets 
20. Interactions with climate change – may lead to greater or lesser propensity to 
grow crops that are more likely to be GM - e.g. maize may become more viable 
in N Europe due to warmer climate 
21. Long term effects may be independent of the GM construct itself – more to do 
with the scale of cultivation of that crop 
22. More (different?) proteins about in the environment – more risk of sensitisation 
to allergies 
23. Gene stacking – possible increase in toxicity  
24. ‘Superweed’ scenario: introgression of pest/ herbicide-resistance into a wild 
plant, taking it beyond current, equilibrium population to become an invasive 
weed 
25. Increased proportion of land used for GM – greater pressure on non-GM growers 
• crops
• modifications
•t r a i t s
• volunteers
• pollen/ seed
•v e c t o r s
• agricultural 
processes e.g. 
ploughing, silage
• markets, trade
• feed/food chain
• ingestion /inhalation/ 
contact
•a i r
•w a t e r  
•s o i l
• other crops
• wild flora and fauna
• soil: fertility, structure
• water: resource, quality
• biodiversity 
• animal/human health: 
toxicity, allergenicity, 
antibiotic resistance
• agricultural sustainability
• co-existence
• society: equity, 
employment
• economics: incomes fair 
& free markets 
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26. Antibiotic-resistance genes used in the construction of GM plants could 
theoretically be passed to bacteria in the environment or to bacteria in farm 
animals.  For example GM maize could be eaten either as silage or in animal 
feed, and this could impact on the animals’ gut bacteria.  This might, if it   
became widespread in the long term or led to the dissemination of new types of 
resistant bacteria, compromise the effectiveness of  the antibiotics whose 
resistance genes were used in the GM constructs. These antibiotics in general 
remain very useful for the treatment of many animal diseases, and the use of 
these older antibiotics for animal treatment, allows the reservation of more 
advanced antimicrobials for humans.    
27. Possibility of passage of antibiotic resistance genes originating from GM plants 
to bacteria from animals or the environment and then to human bacteria via the 
food chain or other routes.  Would new codes of practice be required in abattoirs 
to prevent such events happening? 
28. More maize may be grown, due to its GM-related advantages.  Maize harbours 
Fusarium, which can then be passed to wheat – a problem for wheat growers; 
 
IV  Brainstorming – Long Term Effects 
 
Participants were asked to identify what could change in the long term that might 
affect the source, receptor or pathway.   This following prompts were applied: 
 
Features, Events, Processes (FEPs) that may change over time and affect S, R or P 
29. recessive genes  
30. dormant/ latent traits  
31. climate change 
32. land use, soils, habitats 
33. agricultural practice 
34. food consumption 
35. behaviour and activities 
36. population distribution 
37. regulation 
38. organisational structures 
39. information availability  
 
Deviations: how the FEPs might change, or what might go wrong 
40. More/Less 
41. Early/Late 
42. Not Done 
43. Beyond Intent 
 
The results, under each of the FEP prompts are shown below.  
 
IV.i.1  Recessive genes/dormant/latent traits 
 
In general, these may lead to harmful (or beneficial) effects that are not noticed during 
the consent period.  They could result from a modification of an existing recessive 
gene or from a GM that is itself recessive. 
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44. Suppression of dormant traits may be removed in long term by (i) natural 
mutation or (ii) changes in the environment; 
45. Polymorphisms (human mainly, not animal)  
46. ‘Silent spread’:  almost by definition, recessive genes will not be noticed until 
expressed, unless there is specific genetic monitoring.  It may be possible to 
calculate the probability of occurrence of expression (if the recessive gene/ trait 
is known about in advance).  Probably more likely to occur in wild relatives than 
in GM crop itself.  
 
IV.i.2  Climate change 
 
Climate change and its many secondary effects may alter the vulnerability of the 
environment to the effects of GM crops.  It is important to notice that GM is only part 
of the climate change issue.  
 
47. There are long lead-in times for R&D – we may be focussing on the wrong 
issues now 
48. GM crops could give a benefit in enabling society to adapt to climate change – 
we may be able to design crops that cope better with the new conditions.  But 
there are dangers in seeking and relying on such quick ‘technical fixes’ - we have 
a poor understanding of interactions.   
49. Market acceptability of GM may increase if it becomes seen as a solution to a 
major issue - e.g. how to adapt to climate change – rather than just for the 
commercial gain of the industry; 
50. Danger of becoming dependent on a narrow genetic base.    But on the other 
hand, GM crops could lead to greater diversity: since traits can be passed 
between species it may enable farmers to grow a wider variety of crops in one 
area.  
51. Cultivation of large areas of the same crop with a narrow genetic base could lead 
to increased vulnerability to new plant diseases or new strains of old plant 
diseases that have become particularly adapted to infect plants with this narrow 
genetic base. 
 
Note: as well as designing-in specific traits, GM can also be used to increase the rate 
of natural mutations, then screen for and select the useful ones.   This may be seen as 
ethically more acceptable. 
 
IV.i.3  Land use, soils, and habitats  
 
52. Urbanisation – less land available – GM and conventional crops will be forced 
into closer proximity, hence greater risk of contamination/ transfer.  But a 
potential advantage of GM is in allowing us to use limited land resources more 
effectively. 
53. There are two co-existent but opposite directions in animal husbandry: the 
organic/ extensive trend and the intensification trend.  Intensification is likely to 
dominate on balance, though the organic/ extensive movement may also increase 
– the distribution will be bimodal.     
54. Greater vulnerability to e.g. epidemics  of plant diseases that might be able to 
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cross-border trade (but environmental concerns may lead to reduction in food 
miles) 
55. Possible reduction in need for crop rotation due to GM properties – e.g. 
resistance to soil –borne pests and diseases.  This could have long term effects on 
soil structure. 
56. Effects of planting another crop on land that has previously been used for a GM 
crop? 
 
IV.i.4  Organisational factors 
 
57. Control of technology.  GM technology will not necessarily be concentrated in 
hands of a few companies – for example India is starting to see small scale GM 
(cf also the growth of small scale producers of pharmaceutical generics)  
58. Note: We are not asked in this study to assess the risks of what happens outside 
the EU, or of the imports of such crops into the EU.   But we may the same trend 
in the EU – bringing a potential issue of regulating many small producers – and 
their ability to do robust risk assessments.   There is also an issue of 
responsibility where EU industries are marketing the technology into the 
developing world 
59. Acquisitions and mergers of companies – how will regulators maintain control? 
60. Greater liaison between plant breeders and agri-chem industry.  Farmers may 
tend to buy seed and chemicals as a package.  
 
IV.i.5  Human behaviour and activities  
 
61. Trend has been to greater choice of foods and greater diet awareness.  But 
environmental and energy use concerns may limit this – desire to reduce food 
miles 
62. Use of pesticides – may go up or down.  Risks from pesticides include spray drift 
to neighbours. 
 
IV.i.6  Regulation and institutional monitoring/control 
 
63. Currently the regulator grants licence to the industry that develops and markets 
the GM crop.  What if this changes, such that the licence goes with the farmer, or 
with the land? (Not likely in foreseeable future so far as we are aware) 
64. Could GM crops be admitted as organic – if GM enables them to be grown 
without artificial fertilisers, pesticides? This would have various impacts on 
markets, uptake of GM 
65. Interacting environmental legislation – e.g. Water Framework Directive, Waste 
Directive(s). 
66. What about farm seed that is kept beyond the consent period?  
 
V  Brainstorming - Cumulative Effects: 
 
The consideration of cumulative risks was similar in structure to that for long term 
risks.  Participants were asked to identify potential risks by considering the additive, 
synergistic or antagonistic effects of 
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68. multiple traits  
69. multiple releases 
70. large scale cultivation 
 
The results are shown below.  
 
V.i.1  Multiple genes/ traits in the GM crop(s)  
 
71. Multiple genes are no more likely to ‘escape’ together than the product of their 
individual escape probabilities  - unless they are on the same chromosome.   That 
should be a designed-in factor that it is known about in advance, and hence that 
can in principle be monitored for. 
72. Multiple traits, however, may act synergistically to give the plant a greater than 
additive advantage in the wild. 
 
V.i.2  Multiple releases of different/same GMO 
 
73. More opportunities to sensitise people to allergenic traits (second stimulus more 
likely to be encountered); 
74. Because modifications tend to be (on) the same genetic sequence – more chance 
of ‘genetic meltdown’. 
 
V.i.3  Large scale cultivation 
 
75. How to monitor? – Spatial sampling problems – and who will interpret data – 
possible need for controlled, generic monitoring by regulator, not just leaving it 
to each industry; Possible need for comprehensive genetic library of current 
position, to provide baseline data against which changes can be detected. 
76. Greater vulnerability to disease if there is a trend to monoculture or fewer 
varieties and possible diminution of the wider pool of genetic diversity available 
in currently grown crops. 
77. Will GM lead to monoculture or diversity?  Will legislation be needed to prevent 
monoculture.  How will market demand affect this? 
78. More choice of viable crops to grow, due to GM, may lead to greater volatility in 
what farmers choose to grow from year to year.  
VI   
VII  Breakout Groups 2 - Mitigation & Monitoring 
 
 
 
 
 Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  7
This session aimed to identify possibilities and issues in monitoring and mitigation   
Participants worked in groups of three/ four, and spent approximately 15 minutes 
identifying (based on evidence or realistic speculation) mitigation and monitoring 
measures for four example scenarios, chosen from the preceding sessions. 
 
Monitoring was defined as detection of changes or risks, mitigation as–proactive 
measures to reduce likelihood, or reactive measures to minimise consequences 
 
Participants were asked to consider both technical aspects of mitigation (how) and the 
organisational/societal aspects (who) 
 
The worksheet shown in Figure 3 below was used as a prompt/aid to discussion.  
 
Figure 3 :  Worksheet for Mitigation and Monitoring Session 
 
1.  ‘Superweed’ scenario: Introgression into wild plant, taking it beyond current 
pest-controlled population to become an invasive weed. 
 
79. One would hope and expect to do most mitigation pre-release – e.g. assessment 
of hybridisation potential and weediness of crop, barriers, and male sterility. But 
pre-release trials – may not be economic or safe to do on a scale that gives you 
usable numbers that can be scaled up to commercial release.   
80. There is a need for careful baselining if we are to monitor effects - for many 
things there are no good baselines. 
81. May need to do specific monitoring e.g. of gut bacteria in animals. 
82. Post-consent – often too late by time it is noticed. 
83. Need to develop good indicators in the pre-release period (e.g. adjacent 
hedgerows) in order to focus monitoring effectively.  
 
Silent spread of recessive genes/dormant traits  (harmful trait in GM crop itself, 
or vulnerability in interacting species) 
 
84. The general problem will be that you do not know what you are looking for! 
Mitigation & Monitoring Worksheet
Pre-release                 During consent                   Post-consent
Monitoring:
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85. Genomics may be able to help predict when to expect an expression of the 
recessive gene, and there may also be some historic data from analogous cases.  
It really needs generic surveillance monitoring.  This could be of the 
environment or of the final products. 
86. Current regulatory system assumes that it will ensure that there are no unsafe 
effects on human health before allowing a release, so monitoring for such effects 
might be considered anathematic.  
 
Antibiotic-resistance genes in plants– passed to environmental bacteria  – hence 
to animal bacteria – compromising wish to keep simple antibiotics for animals, 
complex ones reserved for humans 
 
87. Note antibiotic –resistance is a marker used to help select plants that have picked 
up the intended but undetectable gene.  The use of antibiotic-resistance as a 
marker is already being withdrawn, but EC had specifically asked about it. 
88. How do vets pick up growth of antibiotic-resistance in animals?  Are there 
effective mechanisms for sharing and analysing such information? Antimicrobial 
resistance in bacteria from food-producing animals is monitored on an ongoing 
basis by Defra and results are published annually. There is also periodic 
monitoring of resistance in intestinal bacteria recovered from cattle, sheep and 
pigs after slaughter for human consumption. 
89. Reactive mitigations, could include limiting the crop use to non-food purposes, 
and issuing appropriate animal husbandry guidance where possible and 
supported by relevant research findings. 
 
More maize grown, due to its GM-induced advantages.  It harbours Fusarium, 
which can then be passed to wheat – problem for wheat growers 
 
90. Need to look for good indicators of trends and changes, taking account of 
seasonality.   
91. Will be very expensive to monitor during consent period if not well focussed. 
92. May also need to consider limiting locations for release 
VIII   
IX  General Remarks 
 
93. While the general regulatory principle is that industries should take responsibility 
for risk-assessing their own activities, and providing assurance of their 
acceptability, long term and cumulative effects raise bigger 
social/political/ethical & economic questions.   Is it right/reasonable to ask 
industry to assess effects beyond the scope of any individual release? 
94. Are we designing assessment methods for industries, or for regulators?  Who 
should be doing assessment? 
95. What powers does the regulator have to require impose monitoring beyond the 
consent period? Need to check original Directive(s) and national legislation. 
96. If there are adverse effects with consequential losses what mechanisms are in 
place to offset these? Does the “polluter pays” principle apply? 
IX.i.1.1.1.1.1   Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  0
 
 
 
 
 
 
 
 
Appendix 5 
 
Toolbox catalogue 
 
 
 
 
 
 
 
 
 
This Appendix lists the main tools and techniques that may be helpful at various 
stages in the assessment of long term and cumulative risks from GM crops.    
 
For each step in the assessment framework (Section 3.3) that requires supporting 
tools, the table lists the potential tools, outlining their specific uses and advantages 
within the overall aim of that step, and limitations on their capabilities or constraints 
on their use.   
 
The tools are listed under each step in generally increasing order of sophistication and 
time required.  
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STEP  (numbers as 
in Section 3) 
AIM  TOOLS  SPECIFIC USES  LIMITATIONS / 
CONSTRAINTS 
REFERENCES 
Checklists   Initial, high-level identification 
of general types of potentially 
harmful characteristics and 
adverse effects  
Checklist approaches are 
‘closed’ and non-exhaustive.  
The method does not prompt 
consideration of what else 
might occur.   
For a typical list of 
characteristics and 
effects see Annex II of 
Directive 2001/18.    
3 Hazard 
Identification  
Identify intended or 
unintended events 
associated with the 
release that could 
lead to adverse 
effects.    
 
Analytical/ Inductive desk 
study methods such as:  
 
Holistic Holographic 
Analysis (HHA) 
 
Failure Modes and 
Effects Analysis (FMEA) 
Structured breakdown of the 
system into physical 
elements, processes etc, by 
reference to which an 
individual analyst can be 
prompted to identify hazards.   
The process is more open-
ended than a checklist, 
because the analyst is 
required to think inductively 
about what could go wrong in 
each element, rather than 
simply assessing whether a 
particular characteristic or 
harm may arise.  
Time consuming, requiring a 
detailed, methodical approach  
Hayes 2003, 2004 
FMEA:  many 
standard texts and 
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STEP  (numbers as 
in Section 3) 
AIM  TOOLS  SPECIFIC USES  LIMITATIONS / 
CONSTRAINTS 
REFERENCES 
Structured Brainstorming  Open-ended approach, using 
interactions between group 
members with different 
perspectives to encourage 
creative thinking  
Brainstorming needs to be 
carefully structured, and led by 
an experienced facilitator, to 
ensure that it remains on track 
and covers all the aspects.  The 
balance between  breadth and  
detail needs careful 
management, as time available 
is often a major limitation. 
 
Preparation should involve both 
the design of an overall 
structure that will be 
comprehensive, and maintain 
attention and interest, and the 
development of suitable 
prompts – cf Themes, FEPs as 
described in main text  
 
Participants should have 
experience in all the potentially 
relevant disciplines, such as 
genetics, ecology, agriculture, 
veterinary science and human 
health, and be open to creative 
‘what-if’ thinking.   Finding a 
time suitable for all required 
participants can be a practical 
difficulty. 
  
 
There are many 
standard textbooks 
and articles on 
brainstorming, but a 
good description of 
the general technique, 
although written for 
application to a 
different domain, can 
be found in the 
guidance to the 
Eurocontrol Safety 
Assessment 
Methodology:  
Functional Hazard 
Analysis.  This is 
available from the 
Eurocontrol website: 
www.eurocontrol.int Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  risk assessment methodologies 
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STEP  (numbers as 
in Section 3) 
AIM  TOOLS  SPECIFIC USES  LIMITATIONS / 
CONSTRAINTS 
REFERENCES 
4 Hazard Analysis  Identify and 
understand the 
casual and 
contributory factors 
for each Hazard, 
and its potential 
effects, and 
analyse the 
relationships 
between and within 
causes, Hazards 
and effects. 
Graphical techniques to 
represent the network of 
causes and effects  
 
Fault trees work back from 
a ‘top event’ to show how 
causal factors (base 
events) combine to lead to 
a top event 
 
Event trees work forwards 
from a defined event to 
show its potential 
outcomes. 
 
Bow tie diagrams link a 
fault tree to an event tree 
 
Cause-consequence 
diagrams and Influence 
diagrams represent 
linkages between events 
with more flexibility  
As well as providing a basis 
for evaluating risks in Step 5, 
the construction of such 
diagrams is valuable in its 
own right, in forcing clarity of 
thinking about how potential 
harm can be realised and 
helping the assessor to 
identify the main pathways or 
contributors to risk.   
 
By showing what events, 
errors and circumstances 
have to conspire and what 
barriers have to fail for harm 
to occur, it provides a 
systematic basis for 
considering where risk can 
be mitigated in Step 8. 
These diagrams are most easily 
applied to ‘binary’ events – 
events that either do occur or 
do not.    
 
Fault trees are a specific, rather 
limited, instance of using the 
rules of probability and Boolean 
logic 
 
It is not straightforward to 
represent events that are  
matters of degree rather than 
binary.  Time-dependence and 
feedbacks are also difficult to 
represent.  More sophisticated 
variants of the basic tools may 
need to be obtained/ developed 
and a higher level of analytical 
experience and is required to 
do this.  
Many standard 
textbooks and articles 
available – also 
several commercial 
software packages.   Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  risk assessment methodologies 
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STEP  (numbers as 
in Section 3) 
AIM  TOOLS  SPECIFIC USES  LIMITATIONS / 
CONSTRAINTS 
REFERENCES 
5  Assess 
Likelihoods, 
Consequences and 
Risks 
Assess how likely it 
is that each hazard 
will occur. 
 
Identify the various 
possible outcomes 
of each hazard.  
For each outcome, 
assess its severity 
(how bad it would 
be) and the 
probability of that 
outcome actually 
occurring (given 
that the hazard 
itself has occurred) 
 
Assess the level of 
risk – this will be a 
function of the 
likelihood of the 
hazard and the 
severities and 
probabilities of its 
consequences 
Subjective elicitation 
Many techniques are 
available for ensuring that 
subjective data are elicited 
from individual experts or 
groups in ways that 
minimise, or at least reveal, 
uncertainty and bias.  
These include for example, 
Extreme Values 
consensus, Delphi 
Technique and Paired 
Comparisons.   
 
Experimental evidence  
e.g. from Farm Scale Trials  
 
Computational l 
prediction/ simulation 
  
Natural analogues – 
evidence from history or 
palaeontology about the 
impacts of introduction or 
evolution of variant species 
in the past. 
 
Complex systems 
analysis   
Where adequate quantitative 
data are available, fault 
trees, event trees and other 
types of cause-consequence 
diagram as developed in 
Step 4 can be used to 
quantify likelihoods, 
consequences and risks.   
 
 
 
Require general experience in 
mathematical modelling and in 
each specific technique.   
 
Ayyub 2001 
(elicitation) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(complex systems) 
Stolk, 2003 and 2005.   Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  risk assessment methodologies 
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STEP  (numbers as 
in Section 3) 
AIM  TOOLS  SPECIFIC USES  LIMITATIONS / 
CONSTRAINTS 
REFERENCES 
Worst case scoping 
calculations  
 
 
 
Adequate if, for example, the 
release can be shown to be 
acceptable even with 
extreme worst-case 
assumptions.  
Identifying the worst-case 
combination of input 
parameters may not be 
obvious, for complex 
environmental systems 
 
Sensitivity tests 
 
Provide a richer picture of the 
potential range of outcomes 
than simple best-estimate/ 
worst-case calculations 
Identifying which parameters/ 
processes are critical  
Time-consuming when there 
are many inputs to be varied. 
 
Danger of missing a critical 
combination of parameter 
values that leads to high risk, 
because of the difficulty of 
understanding complex system 
behaviour 
 
7  Consider 
Uncertainties 
What are the main 
uncertainties in the 
assessment 
models, data or 
assumptions?  
How might they 
change the 
conclusions? In 
view of these 
uncertainties, is 
there sufficient 
confidence to make 
a decision?  If not, 
what could be done 
to reduce the 
uncertainties? 
Probabilistic or 
stochastic modelling (e.g. 
Monte Carlo analysis) Input 
data are specified using 
statistical distributions, 
rather than single point 
estimates, and the 
corresponding distribution 
of outputs (risk levels) is 
calculated.   
Provides a much richer, and 
truer, picture of the variability 
and critical parameters than 
sensitivity testing, and can be  
less labour-intensive in the 
long run, because the 
selection of cases to be 
considered is automated.  
 
  
Requires experience of 
mathematical modelling and 
statistics. 
 
Gathering input data 
distributions is more time-
consuming than single-point 
estimates.   
Commercial software 
packages include 
@RISK and 
CrystalBall Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  risk assessment methodologies 
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STEP  (numbers as 
in Section 3) 
AIM  TOOLS  SPECIFIC USES  LIMITATIONS / 
CONSTRAINTS 
REFERENCES 
8  Identification of 
Mitigation & 
Monitoring Methods 
What could/ should 
be done to reduce 
the risk?  
(return to Step 3 
and re-assess as 
appropriate – the 
mitigation/ 
monitoring 
methods may 
change the 
hazards ) 
Tools for identifying 
potential mitigations mirror 
those for hazard 
identification – including 
simple checklists , through 
desk based, systematic 
consideration of each 
element of the system 
(diagrams produced in Step 
4 can provide a structure 
for this)  and structured 
brainstorming.     
 
 
Systematic and 
comprehensive identification 
and evaluation of potential 
measures to reduce the 
likelihood of the hazards, 
and/ or reduce the probability 
and / or severity of their 
consequences.    
 
As for Hazard Identification   Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the environment:  risk assessment methodologies 
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STEP  (numbers as 
in Section 3) 
AIM  TOOLS  SPECIFIC USES  LIMITATIONS / 
CONSTRAINTS 
REFERENCES 
  For each identified method, 
its effectiveness (including 
consideration of any 
negative effects) and 
practicability should be 
assessed.  This can be 
carried out: 
• by  simple  subjective 
ranking, using a 
matrix of 
effectiveness and 
practicability; 
• by  reference to the 
hazard analysis– it 
may be possible to 
see which mitigations 
control the most 
critical links in the 
chains of cause and 
effect;  
• or  by  re-running the 
assessment.    Note 
that it is necessary to 
return to the hazard 
identification step 
(Step 3) since 
mitigations can 
introduce new 
hazards.   
    
1 Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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6.1. Case Study 1 
C/NL/98/11 Roundup Ready oilseed rape, event GT73 (Monsanto – updated 
version July 2003). 
Trait: Tolerance to the herbicide glyphosate (‘Roundup Ready’). 
Scope: The notification covers the importation and storage of GT73 oilseed rape and 
its use as feed as well as in the processing for feed, and its industrial uses as or in 
products. 
Current  status: European Commission decision 31 August 2005
9; consent not yet 
issued. 
Note: Originally submitted in 1998 under Directive 90/220/EC, which did not require 
elucidation of monitoring plans, these have been added in subsequent submissions to 
the lead competent authority. 
 
Scenario 1: Spillage and introgression of GT73 to feral OSR leading to decline in 
numbers of organic farms and consequent loss of biodiversity 
 
Background information for scenario 1: 
Oilseed rape frequently forms feral populations outside cultivated areas in man-
made and semi-natural habitats, and such populations are particularly widespread 
in field margins, on disturbed ground and along roadsides throughout oilseed rape 
growing countries. Such feral populations often result from seed shed in the field 
at harvest, spread by contractors and lost during transport (e.g. to crushing plants). 
In agricultural situations this seed can germinate and emerge in subsequent crops 
as ‘volunteer’ weeds, populations of which can persist in fields for over 10 years 
after the oilseed rape crop had been harvested. The typical seedbank population 
density of feral oilseed rape is 100 seeds m
-2, which although small compared to 
the total weed seedbank in an arable soil (commonly 1000 to 10,000 m
-2) is 
similar to the established stand density of oilseed rape crops. According to 
agronomic experiments, even if only 1/100th of the feral OSR seedbank 
germinated in a ‘break’ year (oilseed rape is commonly grown as a break crop 
every two to four years), it would have a large impact as an impurity in the oilseed 
rape crop. Simulations have shown that when no attempt is made to control feral 
OSR populations in field situations it can take around 16 years for impurity in 
yield to fall below 1% (see report ‘The potential for oilseed rape feral (volunteer) 
weeds to cause impurities in later oilseed rape crops’ (2003)
10. The application to 
market GT73 oilseed rape is restricted to import and processing. This first 
scenario addresses the possibility of spillage of GT73 leading to the establishment 
of feral or ‘escaped’ populations and consequent geneflow to non-GM oilseed 
rape crops. The scenario is based on the premise that at least some of this spilled 
seed is not cleaned up and goes on to germinate. (In actual fact European 
Commission Decision 2005/465/EC requires the consent holder to put in place 
appropriate measures in case of accidental grain spillage of GT73. However for 
                                                 
9 Document number 2005/635/EC.  OJ L228 pp 11-13 03/09/2005. 
10 http://www.defra.gov.uk/environment/gm/research/pdf/epg_rg0114.pdf Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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the purposes of this risk assessment it is assumed that no prior risk analysis has 
been carried out). 
 
Framing The Question: 
In order to make a well-informed decision regarding the risk of a product (or a 
process) it is important to adequately frame the question that is being asked. This 
question must be defined in risk terms, in a way that best informs the decision to 
be made. In the case of commercialisation of GT73, the following question is 
advanced: 
“What are the risks that long-term and cumulative effects of GT73 
commercialisation will result in serious harm to the environment (and to human 
and animal health)?”  
 
Once the risks have been elucidated (and quantified) it leads on to the following 
secondary question:  
“Given the risks associated with GT73 commercialisation, are there satisfactory 
measures that can be put in place to prevent, detect and mitigate the harm?” 
 
Clearly mitigation is not possible in the case of irreversible harm, and this 
potential outcome must be taken into account in the analysis. 
Once the above questions have been answered it must be decided whether the 
risks are tolerable, and whether or not commercialisation of GT73 can go ahead 
(with or without conditions to prevent, detect and mitigate any perceived harm). 
It should be noted that the above questions are generic and can be applied to any 
GM crop seeking authorization. Depending on the type of GMO and the 
particular hazards associated with it, additional specific questions could be 
asked to better disclose and pinpoint the risks. 
 
 
Framing The Risks: 
Criteria are used to determine whether a risk is tolerable. Criteria may, therefore, 
be defined in terms of hazard type; for example, commercialisation of a GMO 
may be deemed as unacceptable if geneflow leads to contamination of crops (e.g. 
seed crops) with unauthorized trait. Criteria may also be in the form of severity. 
For example, it may be considered acceptable to have a low level of 
contamination. Of course what is considered an acceptable low level by one 
individual or body may be considered unacceptable by another. In addition criteria 
presented by a notifier are likely to be different from those put forward by the 
regulator and the types of criteria used are likely to dependent upon the types of 
hazard that have been identified for the different crops. In the case of GT73 
spillage leading to contamination of crops, the risks we are concerned about are 
those affecting organic crops (although equally conventional or other GM crops 
could be considered as well). In this case measures of risks may include economic 
risks (will GT73 contamination result in a reduction in profit; if so, for whom?), 
employment risks (will contaminated organic crops be unmarketable, leading to 
unemployment of farm workers?), risk to wildlife (will widespread contamination 
result in organic farms converting back to conventional farming practices, with Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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consequent loss of wildlife habitats) or environmental (will campaigns to eradicate 
feral populations of GT73 lead to destruction of wildlife habitats).  
 
Defining Criteria: 
In the case of GT73 spillage leading to the contamination of conventional crops, 
one of the primary defining criteria may be the level of crops rejected for having a 
GT73 presence (the application for commercial release of GT73 does not include 
cultivation). Regulators may decide, in consultation with the industry, that the 
possible rejection of 0.1% of seed crops, for example, is an acceptable risk to take. 
In terms of food/feed the primary criteria may be that less than 0.3% of 
conventional food/feed crops require labelling. Similar (perhaps more stringent) 
thresholds may be applied to organic crops. The exact values would need to be 
carefully considered from an economic, environmental (human health, if 
applicable) and perhaps consumer choice/ethics point of view. 
 
 
Hazard Identification: 
This scenario is concerned with the risk implications of spillage, and introgression 
into feral OSR crops by the GT73 herbicide-tolerance gene, such that it has the 
potential to cross-pollinate with OSR crops (both conventional and GM). Table 1 
shows the possible effects of GT73 contamination on a number of human health 
and environmental themes. It should be noted that this contamination of crops in 
this scenario is not seen as having direct human health effects, but that other 
separate scenarios could be envisaged GT73 (e.g. the silent spread of recessive 
genes) that lead to potential direct effects.    
  
Table 1 - Potential consequences if the hazard is realised. 
Potential effect (give brief rationale or example if not obvious) 
Theme  Positive effect? 
(benefit) 
Negative effect (harm) 
Human 
health 
None  envisaged.  Increased pesticide use due to 
conversion of organic farmland to 
conventional may lead to negative health 
effects on the public (pesticide residues) 
and farm workers (pesticide poisoning). 
Animal 
health 
None envisaged.  More intensive farming (less organic 
farms) may lead to reduced animal 
welfare in some instances. 
Quality of 
life 
None envisaged.  May result in more expensive non-GM 
food/feed (and less choice if organic 
products are in short supply). This may 
be more problematical for families on 
low incomes. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Potential effect (give brief rationale or example if not obvious) 
Theme  Positive effect? 
(benefit) 
Negative effect (harm) 
Environment 
for wildlife 
None envisaged.  May result in the use of more 
environmentally harmful herbicides to 
control Glyphosate-resistant feral OSR 
plants/volunteers. 
Air   None envisaged.  None envisaged. 
Water 
None envisaged.  Detrimental effect if more/stronger 
herbicides are used to eradicate GT73 
volunteers/feral plants. 
Land 
None envisaged.  Restricts potential uses of the land (e.g. 
for seed crops) if cannot be controlled. 
 
If crops (e.g. seed crops) are disposed to 
landfill it reduces the volume available 
for other waste and adds to the 
environmental burden.   
Greener 
business 
None envisaged.  Possible use of more harmful herbicides; 
more landfill  
Sustainable 
resource use 
None envisaged.  Energy and resources will have to be 
expended to control GT73 volunteers/ 
feral weeds – though a small effect in 
terms or the big sustainability picture; 
more organic produce may have to be 
sourced abroad.  
Limit and 
adapt to 
climate 
change 
None envisaged.  Secondary effect of energy use (above) 
and possible CO2 emission from landfill. 
Flood risk 
Very small effects due to changes in field margin vegetation 
(affects slope stability, runoff, hydraulic resistance of flooded 
channel etc. relative to current flora). Could be good or bad, 
depending on location and hydrology. 
Effectiveness 
of regulation 
None  envisaged.  If the problem of crop contamination 
arises, it could be a relatively high 
profile issue, diverting funds from 
elsewhere. 
 
 
 
Assess Likelihood of the Hazard  
Context is very important in helping to characterise and provide a meaningful 
assessment of likelihood, and it may be necessary to include some type of 
‘threshold’ (or grading) as far as magnitude of events is concerned. For Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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example, the question may be asked “what is the likelihood of geneflow 
occurring between a GM crop and a wild relative?” (although geneflow is not 
necessarily a hazard in itself, it can lead to a hazard). If scientific studies show 
that 1 plant in a whole population will be fertilized by GM pollen, does this 
mean that the likelihood is ‘high’. Presumably if half the population was 
fertilized the likelihood must also be deemed ‘high’. Clearly it is necessary, 
therefore, to express likelihood in terms of the effect. Directive 2001/18 
requires that an appropriate safety and emergency response should be included 
in the technical dossier submitted to the national competent authority, for 
example, to facilitate the control of GMOs or their retrieval in the event of 
severe risk. It may be appropriate, therefore, to apply the risk assessment 
procedure to the proposed emergency response in order to ensure it will not 
have any detrimental long-term effects itself. For example, if it was found that 
the crop had a deleterious effect on on-target insects the emergency plan may 
involve applying herbicide to the crop. However this in itself may have a 
devastating effect on weed populations and hence on the insects that feed on 
them. A more environmentally benign emergency treatment may then be 
sought. 
 
It should be borne in mind that the information used to assess the likelihood of 
the hazard being realised is necessarily based on a best estimation of the 
events and conditions existing during the period of the consent. It is not 
possible to verify all the data used for this scenario because not all of the 
required information is public knowledge (some information will only be 
known to the notifier e.g. transport information), and hence not all the 
associated inferences will be strictly accurate. However the cause/consequence 
diagram presented below (figure 1) does give a useful overview of the 
processes and interactions that must be considered in order to produce an 
overall assessment of likelihood. When an actual risk assessment is being 
carried out the notifier can include this specific information in their own 
assessment of likelihood (or the Competent Authority can request this type of 
information) and it can be put forward as evidence to support any conclusions.  
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Figure 1: Cause/consequence diagram showing steps neededfor spillage and introgression of GT73 to feral OSR leading to 
contamination of OSR crops 
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1 
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pollen 
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1there is, potentially, an increased 
likelihood of glyphosate use in field 
margins of OSR seed crops (where 
weeds are kept to a minimum) 
compared to OSR food/feed crops 
where purity is less stringent. 
 
2GT73 in seed crops may not be 
detected by the seed production 
company if it is below 0.1% (the 
currently accepted limit of PCR 
detection). Above 0.1% seed company 
testing is likely to detect the presence, 
in which case the crop have to be 
destroyed (GT73 is not for cultivation) 
or labelled as GM and sent for 
crushing.  K 
M 
Key:
Events dependant on long 
timescale or cumulative effects 
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Likelihood scores: 
Spillage of GT73 on roadsides – likelihood assessment: MEDIUM 
Reasoning: Spillage of OSR on roadsides is a regular occurrence, particularly at 
harvest time when the crop is being transported from field to farm, and from farm 
to crushing plant. Oilseed rape seed especially is prone to spillage, due to its small 
size and spherical shape. The fact that spillage occurs is not only evident visually 
from the number of OSR plants that can be seen growing along many roadsides in 
OSR producing countries, it is also confirmed by research conducted in the 
showing that roadside feral oilseed rape populations are constantly replenished by 
seed spilling from vehicles on their way to oilseed crushing plants (Crawley, 
Brown 1995). Such studies have led some researchers to conclude that significant 
losses of GM OSR seed are likely to occur along seed transport routes. It must be 
stated, however, that because the consent application for GT73 is limited to import 
and processing, spillage on roads is less likely than for OSR crops that are 
cultivated in the EU. In the case of GT73, then, the possibility of harvested seed 
being shed during transportation from fields is nil (assuming, of course, that there 
are effective procedures in place to prevent unauthorised cultivation). One means 
by which GT73 seed may be spilled onto roads is through seed transport from 
ports to crushing plants. However, due to the relatively high costs associated with 
road transportation, most GT73 is likely to be processed at crushing plants based 
near to the port of entry; because such crushing plants are generally based in the 
port area there should be little need to use public roads. It follows, therefore, that 
very little GT73 is likely to be moved on public roads, if it is transported in this 
way some is likely to spill. Consequently there is deemed to be a medium risk of 
spillage. As stated earlier, however, this assessment is based on a best-estimate 
basis. The most detailed information concerning the supply chain is likely to be 
held by the notifier and may include, for example, the precise locations of the 
crushing plants that will be used, the length of the supply chain from port to 
crushing plant (including any need for transhipment and the use of public roads), 
and the likelihood of diverting GT73 seed to less robust transport networks (e.g. if 
there happened to be mechanical breakdown at the primary crushing plant). All 
this information can be included in the assessment of likelihood to provide a more 
accurate measure of final risk. 
 
Spillage of GT73 at ports/docksides – likelihood assessment: MEDIUM 
Reasoning: Spillage of grain at ports and on docksides is an inevitable result of 
moving large quantities of a small-sized, free-flowing particles from ships and 
thence to the final destination (possibly via interim holding areas) and it is a 
virtual certainty that if a port handles any reasonable quantity of oilseed rape seed 
some will be spilled. In a study of looking at the origin of feral oilseed rape plants 
at docks in Scotland, for example, it was concluded that the origin of the seed was 
from lorries taking seed to large warehouses, and probably from seed blown from 
operations at the warehouse itself (see Defra report ‘The potential for oilseed rape 
feral (volunteer) weeds to cause impurities in later oilseed rape crops’ (2003), 
http://www.defra.gov.uk/environment/gm/research/pdf/epg_rg0114.pdf). Whilst 
the seed in this case was of conventional varieties, it would seem that spillage is 
equally likely for GT73 seed. Having established that at least some seed is likely 
to be spilled at docks, further consideration must be given to the possible amounts 
of seed spillage, and how to take this into account in the assessment of likelihood. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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For example, the likelihood that a small quantity of seed spillage will take place is 
‘high’, whereas the likelihood of that a large amount of seed spillage occurs may 
be considered ‘low’. In this assessment we have considered the two extremes and 
on balance decided that a ‘medium’ risk is appropriate. 
 
Conditions suitable for germination/establishments (roads) –  likelihood 
assessment: HIGH 
Reasoning: The high numbers of feral OSR plants along roadsides has been 
presented as evidence of the spillage of seeds on roads in step A). The fact that 
these plants have grown up and are often seen to flower and set seed is evidence 
of germination and to some extent establishment. The fact that feral populations 
are constantly replenished may indicate that in the longer term these populations 
are not self-sustaining, but this is somewhat irrelevant if the criteria we are 
looking at is the propensity to flower and spread pollen, hence the likelihood 
assessment is ‘high’.  
 
Conditions suitable for germination/establishments (docks) –  likelihood 
assessment: HIGH 
 Reasoning: The presence of feral oilseed rape populations is well documented 
around ports and docksides (and along riverbanks). Rich (Rich 1991), for 
example, includes docks in a list of habitats of feral oilseed rape for Great Britain 
and Ireland (‘A common… crucifer of roadsides, waste and cultivated ground, 
docks, cities and towns, tips, arable fields, riverbanks, etc.’). Oilseed rape is an 
opportunist species whose seed can remain dormant for many years and then 
rapidly germinate, grow and flower when conditions become favourable. In this 
way it can rapidly colonise new habitats and maintain stable, self-sustaining 
populations. 
 
No clean-up of spilled seed (roads) – likelihood assessment: HIGH. 
Reasoning:  It is very difficult to ensure that bulk containers are adequately sealed 
to prevent the escape of material as small as OSR seed, whilst still maintaining an 
adequate ease of handling. It is reasonable to assume, therefore, that if GT73 is 
transported by road (see above for likelihood), the most significant source of 
spillage will be from lorries travelling to crushing plants. Such spillage may result 
from an ill-fitting or inadequately fastened tailgate, from careless loading or 
simply from seed picked up in the treads of tyres when in the loading area. In such 
instances the loss of seed is likely to be in small but steady amounts, thus leading 
to a low density of seeds along the length of the transport route. In such a case it 
will be very difficult to clean up the spilled seed, even if the loss is discovered 
once the vehicle reaches its destination.  
 
No clean-up of spilled seed (docks) – likelihood assessment: MEDIUM. 
Reasoning: Due to the quantity of material transported through ports/docks each 
day it is inevitable that some spillage will occur. In addition, by their nature, 
docksides are very difficult places to keep clean. This results from a combination 
of large area, the fact that bulk quantities of material are being moved around, and 
the constant tracking of machinery through them. It is likely, then, that during 
their standard operations GT73 seed will be spilled and a quantity of this will not 
be adequately cleaned up. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Established feral population(s) of GT73 on roadsides  – likelihood assessment: 
HIGH 
Reasoning: Establishment of feral populations of GT73 on roadsides is a function 
of seed spillage, lack of clear-up and the existence of suitable conditions for 
germination and growth, thus we have already acknowledged that GT73 has the 
potential to establish. Because Glyphosate herbicide is licensed for control of 
weeds on road verges its use is likely to result in selection pressure that will 
favour the establishment of feral populations of GT73. Local authorities are likely 
to have information on the extent of use of this herbicide on roadsides. 
 
Established feral population(s) of GT73 at ports/docksides  –  likelihood 
assessment: HIGH 
Reasoning:  In a similar way to roadsides, establishment of feral populations of 
GT73 at ports and on docksides is a function of seed spillage, lack of clear-up and 
the existence of suitable conditions for germination and growth. If these factors 
are favourable then GT73 has the potential to establish. Glyphosate herbicide is 
licensed for use on roadsides its use is likely to result in selection pressure that 
will favour the establishment of feral populations of GT73. Glyphosate herbicide 
is licensed for control of weeds on industrial sites its use is likely to result in 
selection pressure that will favour the establishment of feral populations of GT73. 
Port authorities are likely to have information on the usage of this herbicide at 
ports, etc. 
 
Feral populations of GT73 close enough to non-GM feral OSR… – likelihood 
assessment: HIGH.  
Reasoning: The agricultural landscape is traversed by numerous roads of differing 
size and usage, many in close proximity to fields. It follows then, that any feral 
populations of GT73 on roadsides will have a high likelihood of being in close 
proximity to feral oilseed rape in field margins. In addition, oilseed rape can be 
described as a high-risk crop in terms of crop-to-crop (and crop to wild relatives) 
gene flow.  Based on the experience of the seed industry regarding separation 
distance versus seed purity, the Supply Chain Initiative on Modified Agricultural 
Crops (SCIMAC), a voluntary body of the UK seed industry set up to police the 
large scale trial and commercial planting of GM crops, has established separation 
distances for planting GM crops near non-GM crops. In the case of OSR, the 
following isolation distances apply: Certified seed crops (same species) - 200m; 
Registered organic crops (same species) - 200m; Non-GM crops (same species) - 
50m. At the landscape scale low levels of geneflow have been documented at long 
distances, and thus genetic isolation of feral OSR is unlikely to be maintained. 
 
Feral populations of GT73 close enough to non-GM crops… –  likelihood 
assessment: MEDIUM. 
Reasoning: Investigations into geneflow from OSR has shown that pollination 
declines rapidly over short distances, but then remains at low levels over long 
distances from source. A 2003 investigation into OSR geneflow found that male-
sterile plants positioned up to 26km from the nearest known pollen source were 
still fertilised, albeit at low levels. The study concluded that placing an upper limit 
on the distance over which this gene flow occurs is not possible (see ‘Quantifying Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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landscape-scale gene flow in oilseed rape’, DEFRA Project RG0216, published 
2003). This suggests that some level of geneflow is inevitable between feral 
populations and oilseed rape crops. It is thought that insects, particularly 
honeybees (Apis mellifera), bumblebees (Bombus sp.) and (possibly to an even 
greater extent) pollen beetles, play a major role in the transfer of pollen over these 
long distances. Given the evidence for long range insect-mediated geneflow it 
seems reasonable to conclude that geneflow from feral populations of GT73 OSR 
on roadsides to will non-GM crops will occur to a greater or lesser degree 
depending on distance, hence a likelihood assessment of medium.   
 
Introgression of GT73 cassette into feral OSR in field margins -  likelihood 
assessment: MEDIUM. 
Reasoning: The backcrossing of GT73 hybrids in field margins, leading to the 
stable integration of the new gene into the wild population, is likely to be affected 
by the rate of pollen flow (which is in turn affected by distance between donor 
plants, pollen viability, outcrossing rate, etc) and the level of the gene in the feral 
population. It will also be influenced by selection pressure (see L)). Studies show 
that feral OSR populations decline rapidly during their first two years but they 
then persist as a residual in many fields at a typical density of 100 m
-2 (e.g. 
http://www.royalsoced.org.uk/enquiries/gm_debate/gm_squire.pdf). 
 
Selection pressure – Glyphosate herbicide use in field margins -  likelihood 
assessment: LOW. 
Reasoning: Where glyphosate herbicide is used to treat field margins it is likely to 
result in greater selection pressure and lead to the more rapid introgression of the 
GT73 epsps and gox gene cassette into the population. Currently there is a lot of 
emphasis on the wildlife management of field margins, which reduces the 
likelihood of herbicide use on them. However herbicide treatment may be more 
likely where seed crops are concerned, due to the strict purity standards that apply 
as far as weed seed are concerned. This may lead to greater selection pressure in 
the margins of fields used for seed production. 
 
Feral OSR in field margins close enough to non-modified OSR crops – 
Glyphosate herbicide use in field margins - likelihood assessment: MEDIUM. 
Reasoning: Where glyphosate herbicide is used to treat field margins, however, 
this is likely to result in greater selection pressure and lead to the more rapid 
introgression of the GT73 cassette into the population. At the present time there is 
a lot of emphasis on the wildlife management of field margins, which reduces the 
likelihood of herbicide use, however such treatment may be more likely where 
seed crops are concerned, where strict purity standards apply and weeds must be 
controlled. 
 
Contamination of organic crops (incl seed crops) with GT73 cassette - likelihood 
assessment: MEDIUM. 
Reasoning: Contamination of organic crops with the GT73 cassette may take 
place from feral oilseed rape populations in field margins or (more directly) feral 
populations on roadsides. These two sources can be quantified separately in terms 
of likelihood or could be combined to calculate an overall assessment of 
likelihood. Roadside populations, for example, are likely to be at a greater Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
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distances from crops than field margin populations, but the route for geneflow is 
more direct. Consequently the two sources of geneflow will have different 
likelihood values allocated to them. 
 
Decline of organic farms leading to loss of wildlife habitats -  likelihood 
assessment: LOW. 
Reasoning: It is relatively easy to imagine, perhaps even in the short term, the 
rejection of conventional seed crops due to the adventitious presence of GT73 (the 
application for commercialisation of GT73 does not include cultivation). It is also 
relatively easy to imagine food and feed crops becoming contaminated due to 
geneflow from feral GT73 populations, although presumably levels would 
generally be below labelling thresholds. It follows then, that contamination of 
organic crops is also likely to occur, especially if farms are located near docks or 
transport routes. If this situation does occur, then the consequences for organic 
farmers are likely to be more serious than for conventional farmers because 
thresholds for GM contaminants are likely to be lower (perhaps even zero).  
 
 
 
Identify Potential Consequences of the Hazard and Assess Their Severities and 
Probabilities 
Hazards associated with contamination of crops with GMOs have been widely 
considered and are well documented. In the case of conventional oilseed rape 
grown for food or feed a GM presence may lead to rejection of the crop (with 
consequent financial consequences) at the crushing plant or may result in a lower 
market price if the crop requires labelling as GM. In the case of seed crops there is 
also the possibility of rejection, and in addition the scope for labelling the seed as 
GM may be limited because GT73 would not be authorized for sowing in the EU.  
In the case of organic crops, similar factors apply, although the financial penalties 
in the case of rejection or labelling may be more severe due to the generally higher 
production costs and the higher unit price. In addition the possibility of rejection 
may be greater due to potentially lower acceptable threshold values for organic 
crops (assuming any threshold for GM contamination is acceptable to the organic 
sector). Organic crops with an adventitious GM presence below 0.9% may well 
have to be marketed as conventional crops, because they will not reach the correct 
organic specifications. Who will the carry the burden of this is not clear, but it 
could be the farmers themselves if no compensation scheme is in place. If this is 
the case then, over time, organic farmers may come under increasing financial 
pressure, and this may ultimately lead to a reduction in the number of organic 
farms as organic farming ultimately becomes unviable. These farms may then 
revert back to conventional farming methods, leading to a reduction in wildlife 
habits and a reduction in the biodiversity associated with organic farming 
methods. Co-existence arrangements may help to ameliorate this situation, 
although they are likely to concentrate on avoiding crop to crop geneflow rather 
than geneflow from feral populations. 
As well as growers facing problems when marking the crop there may be also 
consequences for agronomic practice. Feral OSR populations containing the GT73 
cassette may cause problems in other crops where they may manifest themselves Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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as difficult-to-control weeds. This may require different, potentially more 
expensive and/or more harmful herbicide usage or mechanical control methods.  
If GM varieties of an oilseed rape crop were to be given commercial approval for 
cultivation in the EU, and were grown widely, then the possibility exists that ‘gene 
stacking’ (the accumulation of transgenes encoding different traits) would occur 
due to cross-pollination between feral GT73 and the cultivated GM crop(s). This 
might involve transgenes conferring resistance to several herbicides, raising the 
possibility of multiple herbicide resistance (Orson, Crawley and Brown) and 
(Beckie, Hall and Warwick). Gene stacking has already been documented in 
Canada where both glyphosate resistance and glufosinate resistant oilseed rape 
(canola) are grown. In addition the possibility of generating feral GM plants that 
are invasive of semi-natural habitats as a result of transgene stacking is 
conceivable in the long-term, especially if a range of GM crop varieties with 
resistance to different pests, diseases or other environmental stresses are grown on 
a commercial scale in the EU
11.   
 
 
Assess Risk 
The likelihood of hazard being realised is combined to form a measure of the risk 
using the basic equation: 
 
Risk = SUM (Likelihood x Hazard) 
 
Both likelihood (or probability) and hazard are measured on a scale of 0 (no 
possibility or no hazard) to 5 (certainty or extreme hazard). The output therefore 
ranges from 0 (zero risk) to 25 (extreme risk). Table 2 illustrates how the overall risk 
is assessed. 
 
 
Table 2 – Assessing the overall risk. 
Hazard:  Decline of organic farms leading to loss 
of wildlife habitats 
Effect  Likelihood  Hazard  Risk Level   
= (LxH) 
Human health  2  2  4 
Animal health  1  2  2 
Quality of life  2  2  4 
Environment for wildlife  3  3  9 
Air   0  0  0 
Water 2  3  6 
Land 2  2  4 
Greener business  1  2  2 
Sustainable resource use  1  2  2 
Limit and adapt to climate change  1  1  1 
Flood risk  1  1  1 
                                                 
11 see, for example, http://www.gmsciencedebate.org.uk/report/pdf/gmsci-report1-
pt5.pdf Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Effectiveness of regulation  3  3  9 
 
 
Compare Risk Against Criteria 
With the current example it has been suggested that possible criteria to decide how a 
risk is tolerable may be defined in terms of percentage contamination of conventional 
crops. An integral component when comparing risk against criteria is the severity of 
the hazard.  
 
 
Consider Uncertainties 
In the scenario outlined there are many uncertainties that must be considered, ranging 
from unknowns regarding the transportation and spillage of GT73 to incomplete 
information on OSR geneflow (formulae showing fertilization rate with distance but 
be extremely helpful), likely distance between feral GT73 populations and 
conventional OSR (feral and crops) and possible introgression rates. 
 
 
Identification of Prevention, Monitoring and Mitigation Methods 
Following the assessment of risk consideration must to be given to methods of 
monitoring and mitigating that risk. Table 3 shows potential monitoring and 
mitigation measures for the various events identified in the scenario. 
 
 
Table 3 – Prevention Monitoring and Mitigation Methods 
  Event  Possible prevention 
measures 
Possible monitoring 
methods 
Possible mitigation 
measures 
A Spillage  of 
GT73 on 
roadsides 
Prevent or reduce 
the transport of 
GT73 by road; 
Use adequately 
sealed lorries when 
road transport is 
necessary. 
Random testing of 
roadside OSR 
plants along 
transport routes 
(e.g. by spray 
treatment with 
Glyphosate) will 
provide evidence as 
to whether there has 
been spillage of HT 
OSR (although this 
requires prior seed 
germination). 
Analytical testing 
(i.e. PCR would be 
required for 
positive 
identification of 
GT73 seed/plants).  
Standard Operating 
Procedure (SOP) 
for reporting and 
clearing up spillage; 
Monitor areas 
where seed has 
been spilled (and 
control any OSR 
plants that 
germinate – see C). 
 
B Spillage  of 
GT73 at ports/ 
Reduce the 
possibility of 
Random testing 
(see above 
SOP for reporting 
and clearing up Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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  Event  Possible prevention 
measures 
Possible monitoring 
methods 
Possible mitigation 
measures 
docksides  spillage (e.g. by 
fitting appropriate 
guards to 
conveyors); 
Wheel washing of 
vehicles exiting 
‘high risk’ dock 
areas.  
methods) of OSR 
plants/seeds in the 
vicinity of ports 
(including roads 
leading from the 
port). 
spillage; 
Monitor areas 
where seed has 
been spilled; 
Control of OSR 
plants growing in 
the port area (e.g. 
by spray treatment 
with herbicide other 
than Glyphosate). 
C Conditions 
suitable for 
germination/ 
establishments 
(roads) 
Environmental 
conditions along 
roadsides are fixed 
and it is unlikely 
that proactive 
measures could be 
carried out to make 
conditions less 
conducive to OSR 
germination/ 
establishment.  
Use of Glyphosate 
herbicides to test 
whether growing 
feral OSR plants are 
tolerant to the 
herbicide.  
Use of non-
Glyphosate 
herbicides to 
control Glyphosate 
tolerant feral OSR 
identified-by 
monitoring in A).  
D Conditions 
suitable for 
germination/ 
establishments 
(ports/ 
docksides) 
At the local scale it 
may be possible to 
alter some of the 
environmental 
conditions at ports 
to make them less 
conducive to OSR 
germination/ 
establishment. The 
most practical way 
of doing this may 
be to ensure general 
cleanliness to 
prevent the build-up 
of organic matter 
suitable for plant 
growth.  
Monitoring for 
general port 
cleanliness and the 
growth of OSR. 
Use of non-
Glyphosate 
herbicides to 
control Glyphosate 
tolerant feral OSR 
identified by 
monitoring in A).  
E  No clean up of 
spilled seed 
(roadsides) 
Requirement by the 
consent holder to 
inform operators 
and users of 
appropriate 
management 
measures in event 
of spillage; 
SOP for the clean 
Possible statutory 
monitoring of 
roadsides use for 
transportation of 
GT73. 
Routine control of 
oilseed rape 
populations 
growing on 
roadsides. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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  Event  Possible prevention 
measures 
Possible monitoring 
methods 
Possible mitigation 
measures 
up of spilled seed.  
 
F  No clean up of 
spilled seed 
(ports/docks) 
Requirement by the 
consent holder to 
inform operators 
and users of 
appropriate 
management 
measures in event 
of spillage; 
SOP for the clean 
up of spilled seed.  
Possible statutory 
monitoring of 
ports/docksides 
where GT73 is 
imported. 
Routine control of 
oilseed rape 
populations 
growing in 
ports/docksides. 
G Established 
feral 
population(s) of 
GT73 on 
roadsides 
Clean up of spilled 
seed - see above 
Sampling and 
testing (by 
glyphosate 
application or PCR 
analysis) of feral 
populations on 
roadsides. 
Notifiers and 
regulators may need 
to consider where 
responsibility lies 
for control of feral 
populations on 
roadsides, and 
whether additional 
legislative/ 
organisational 
structures need to 
be put in place to 
facilitate this. 
H Established 
feral 
population(s) of 
GT73 at 
ports/docksides 
Clean up of spilled 
seed - see above 
Sampling and 
testing (by 
glyphosate 
application or PCR 
analysis) of feral 
populations on 
roadsides. 
Control of feral 
populations of 
GT73 (using 
herbicides other 
than glyphosate) 
before flowering 
and/or seed set. 
I Feral 
populations of 
GT73 close 
enough to non-
modified feral 
OSR in field 
margins for 
airborne spread 
of pollen 
Control of feral 
populations before 
flowering and/or 
seed set; 
Removal of OSR 
plants in close 
proximity that may 
be recipients of 
pollen.  
Survey of 
roadside/field 
margin OSR 
populations to 
provide possible 
modelling and 
mitigation 
information. 
Control of feral 
populations of 
GT73 on roadsides 
and in field margins 
before flowering 
and/or seed set. 
J Feral 
populations of 
GT73 close 
enough to OSR 
crops for 
airborne spread 
Control of feral 
populations of 
GT73 before 
flowering.  
Survey of feral 
OSR populations in 
field margins to 
provide possible 
modelling and 
mitigation 
Control of feral 
populations of 
GT73 in field 
margins before 
flowering. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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  Event  Possible prevention 
measures 
Possible monitoring 
methods 
Possible mitigation 
measures 
of pollen  information. 
K Introgression  of 
GT73 cassette 
into feral OSR 
in field margins 
Control of feral 
populations of 
GT73 in field 
margins before 
flowering – see 
above. 
Sampling and 
testing of feral OSR 
populations in field 
margins. 
Control of feral 
OSR with 
herbicides other 
than glyphosate 
L Selection 
pressure – 
glyphosate 
herbicide use in 
field margins 
Restrict the use of 
glyphosate in areas 
known to harbour 
feral GT73 
populations 
Sampling and 
testing of feral OSR 
populations in field 
margins. 
If GT73 in field 
margins is found to 
be a problem, 
information notices 
could be issued to 
farmers suggesting 
limiting the use of 
Glyphosate. 
M  GT73 feral OSR 
in field margins 
close to OSR 
crops for 
airborne spread 
of pollen 
Control of feral 
populations of 
GT73 in field 
margins before 
flowering. 
Pollen trapping and 
analysis in fields 
considered 
vulnerable to GT73 
pollen influx. 
Control of feral 
OSR before 
flowering with 
herbicides other 
than glyphosate 
N Contamination 
of OSR crops 
with GT73 
cassette 
Border rows of 
male sterile OSR to 
act as pollen taps in 
vulnerable fields 
(e.g. fields next to 
docks/transport 
routes) 
PCR testing of 
crops. 
Compensation 
scheme for growers 
whose crops are 
financially affected 
by GT73 
contamination.  
 Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Decision making: 
The above scenario is just one of the possible consequences of commercialisation for 
import and processing of GT73 oilseed rape. A full risk assessment would go through 
the above process for a range of potential hazards and would determine a level of risk 
for each one. Scenario 2 is provided as an abridged example of a potential additional 
hazard that can be envisaged for GT73, with figure 2 showing the events leading to 
this hazard in the form of a cause/consequence diagram. Once the full range of 
hazards has been assessed the resulting risk values could then be integrated into an 
overall level of risk for the GMO. Based on this overall risk a decision would be made 
as to whether commercialisation could go ahead, and if so whether any additional 
prevention, monitoring or mitigation measures would need to be put in place.      
 
 
Scenario 2: Introgression of GT73 herbicide tolerance gene into wild relatives 
leading to reduced biodiversity on banksides. 
 
Background information: 
There are 17 species from the family Brassicaceae that are native to the UK and 
are able to hybridize with cultivated oilseed rape (Brassica napus) (Scheffler and 
Dale, 1994). Of these, Brassica rapa is the species most likely to receive 
transgenes directly from B. napus on a regular basis. The “wild” form of B. rapa 
(wild turnip, bargeman’s cabbage) is a plant of riversides and canal banks  (Rich, 
1991). This scenario looks at the potential of introgression of GT73 epsps and gox 
gene cassette into B. rapa on banksides, leading to a decrease in biodiversity. 
 
Assess Likelihood of the Hazard  
As examples, likelihood scores for two of the main events leading to reduced 
biodiversity on banksides by introgression of the GT73 herbicide tolerance gene 
into wild relatives.  
 
Likelihood scores: 
Introgression of GT73 cassette into B. rapa on banksides – likelihood assessment: 
MEDIUM  
Reasoning: It has been estimated that across the UK around 32,000 hybrids form 
annually in waterside B. rapa exposed to oilseed rape pollen (Wilkinson et al.). 
However, the majority of this geneflow is likely to originate from cultivated OSR, 
rather than from feral populations, therefore in order to accurately estimate the 
probability of geneflow we would need to know the area of feral OSR and 
compare it to the area of cultivated OSR. A Royal Society report, ‘Outcrossing 
among crops and feral descendents – geneflow’, states that feral OSR populations 
persist in many fields at a typical density of 100 m
-2, therefore this figure could be 
used in any estimate of geneflow and introgression. 
 
Reduced fitness of GT73 B. rapa in the absence of selection pressure - likelihood 
assessment: HIGH  Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Reasoning: In the absence of selection pressure (in this case glyphosate use), 
transgenic tolerance to herbicides is predicted to reduce persistence (David 
Claessen, Christopher A.Gilligan, Frank van den Bosch 2005). Although 
glyphosate is licensed for aquatic weed control it is harmful (dangerous) to fish 
and other aquatic life, and in the UK the Environment Agency or Local River 
Purification Authority must be consulted before use in or near water. It seems 
reasonable to suppose, therefore, that glyphosate will not be used on B. rapa 
populations near water, and this may result in decreased fitness due to the extra 
burden of carrying the gene for glyphosate tolerance. 
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Figure 2: Cause/consequence diagram showing steps needed for GT73 spillage and introgression  wild relatives leading to reduced diversity 
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airborne spread of pollen
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1 there is, potentially, an 
increased likelihood of 
glyphosate use in field 
margins of OSR seed crops 
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minimum) compared to OSR 
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banksides (permission is 
required for Glyphosate use near 
watercourses) 
AND
2 this assumes that there is a 
burden on the plant in 
carrying the genes for 
Glyphosate tolerance 
without the positive selection 
pressure of Glyphosate use Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Identify Possible Consequences of the Hazard and Assess their Severities and 
Probabilities 
Although the hazards of crop-to-crop geneflow are fairly clear-cut and well-
documented (i.e. adulteration of harvested seed and novel traits in volunteer weeds) 
there is less consensus about the hazards of gene flow to wild relatives. Some people 
have ethical concerns, considering gene flow to wild plants to be ‘genetic pollution’ 
(Daniels and Sheail, 1999). Other hazards are the potential for changes in the 
persistence, abundance or distribution (i.e. ‘weediness’) of wild relatives, which might 
alter the composition of plant communities, and effects on non-target organisms. It is 
likely that herbicide tolerance will not increase the weediness of plants in non-
agricultural habitats where herbicides are not applied. 
 
Following feedback from the case studies involving scenarios 2 and 3, the risk 
assessment framework was further revised to make the procedure more intuitive and 
easy to use. Scenario 3 was then used to test this updated framework. 
 
 
 
 
6.2. Case Study 2  
C/FR/96/05/10 - Bt11 maize (field or sweet maize) (Syngenta Seeds SAS) 
Trait: Resistance to corn borers Ostrinia nubilalis and Sesamia nonagrioides using 
the Cry1Ab gene. 
Scope:   For use as any other maize, including cultivation in the EU.  Bt11 also 
possesses herbicide tolerance but the scope of the notification has been limited to use 
without the application of glufosinate ammonium herbicides. 
Current status: pending authorisation. 
 
 
Scenario 3: Development of resistance by ECB to Bt11 leading to the decline of 
predators and parasitoids by exposure to the Cry protein.  
 
Background 
Infestation of maize plants by the stem-boring larvae of European Corn Borer 
(Ostrinia nubilalis) can cause significant loss in yield in maize crops. As a means of 
controlling ECB, Bt11 maize has been engineered to express an insecticidal Cry 
protein from the bacterium Bacillus thuringiensis. Despite early predictions that 
target pests increasingly exposed to Bt maize would quickly build up resistance to 
the Cry endotoxin, to date there is no scientific evidence of European Corn Borer 
(ECB) developing such resistance in the field. This is despite the widespread 
commercial use of this pest control method and the fact that some laboratory studies 
show a rapid build up of resistance. Nevertheless, it is widely accepted by the 
scientific community that the occurrence of insect resistance is a distinct possibility 
and this has led to the development of Insect Resistant Management strategies 
which include using high dose rates and non-Bt refuge strategies. For Bt11, refuge 
areas of 20% for planting areas over 5ha have been proposed. A key 
biological/behavioural element for the effectiveness of refuges is reliance on the Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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fact that the adult form of ECB is highly mobile, resulting in a high level of 
interaction between crop and refuge populations. The following scenario aims to 
quantify the likelihood of Bt11 resistance in ECB and the possible consequences for 
predators and parasitoids. The advent of resistance is based on the premise that 
either 1) a more sedentary strain of ECB develops, resulting in less interaction 
between the two populations, or 2) there will be large areas of the EU where refuges 
will not be required. The consequences for predators and parasitoids are based on 
the hypothetical concept of resistant ECB passing the toxic Cry protein to higher 
trophic levels. 
 
Framing The Question: 
For this scenario we will assume it is a regulatory authority that is posing the 
question, perhaps due to specific concerns raised by new experimental research. 
These hypothetical research results are a combination of modelling data showing 
hitherto unidentified mechanisms operating in support of ECB resistance, and 
laboratory experiments that highlight toxic food-chain effects in resistant 
laboratory-bred ECB fed to predators).  
 
In the case of commercialisation of Bt11 the regulatory authority poses the 
following question: 
“What are the risks that the development of Bt resistance in European Corn Borer 
will lead to a reduction in species diversity through toxic food chain effects?” 
 
In terms of geographic scale the assessment is concerned with all EU Member 
States having a ECB problem (and consequently all EU Member States likely to 
grow Bt11). In terms of risk type the assessment is concerned with risk to the 
environment, specifically to higher trophic levels that predate ECB. The 
(hypothetical) research concerns toxic food chain effects, but the regulatory 
authority is also concerned that chronic effects must not be overlooked. With this in 
mind timescale becomes increasingly important, as chronic effects often take a long 
time to materialise. The development of resistance itself is likely to take a long time 
to materialise; hence the assessment is concerned with long-term and cumulative 
effects that cannot necessarily be confirmed in laboratory or field experiments. This 
makes the scenario an ideal candidate for risk assessment. 
 
Framing the risks: 
For the purposes of this scenario we are assuming that the criteria adopted by the 
regulatory authority is that any toxic effects on ECB predators and/or parasitoids 
must be no greater than those currently caused by conventional maize cultivation. In 
actuality this criteria may be difficult to determine, because different management 
regimes have different effects on different insect groups. Another way of setting 
tolerability criteria may be to lay down defined population (or density) limits for 
different insect groups or species; for example, toxic effects may be expected to be 
most pronounced for a parasitic species of wasp that lays its eggs within ECB 
larvae, therefore an population density of 1 wasp per m
-2 may be considered 
acceptable (perhaps judged to be equivalent to the density found in conventional 
maize). Any lower and the hazard may be considered to be unacceptable. 
Alternatively, certain carabid beetles may be considered to be essential to the food Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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web in maize, in which case a decline of over 5% would be deemed unacceptable. 
Defining precise tolerability criteria is probably one of the most difficult tasks of 
the risk assessment, but it is also one of the most essential because it is against this 
that the risk is measured and the decision made as to whether that risk is tolerable. 
 
 
Defining Criteria: 
The current scenario is concerned with the toxic effects of the Cry protein on 
predators and parasitoids following the development of resistance in ECB.  Table 4 
shows the possible effects of the decline of these non-target insects on key themes.  
 
Table 4 - Potential consequences if the hazard is realised. 
 
Potential effect (give brief rationale or example if not obvious) 
Theme  Positive effect? (benefit)  Negative effect (harm) 
Human 
health 
None  envisaged.  The hazard is unlikely to have direct negative 
effects on human health. A conceivable indirect 
effect may be exposure to Cry toxins through 
food chain effects (e.g. via game birds that have 
eaten insects with high levels of the toxin), 
however the Cry protein in non known to have 
toxic effects on humans. 
Animal 
health 
None envisaged.  No direct negative effects are envisaged. Indirect 
effects are conceivable, but unlikely (see above). 
Quality of 
life 
None envisaged.  Reduction in diversity may be seen as a negative 
effect on quality of life by many; 
Loss of maize crops may result in more 
expensive non-GM food/feed (and less choice if 
organic products are in short supply). This may 
be problematical for families on low incomes. 
Agricultural 
sustainability 
None envisaged.  Development  of  resistance in ECB is likely to 
reduce agricultural sustainability. Likewise loss 
of predatory insect will reduce sustainability by 
increasing reliance further on chemical 
pesticides. 
Environment 
for wildlife 
None  envisaged.  Disruption to the food web and a lack of 
arthropod prey is likely to result in a decline in 
insectivorous species, including predatory 
arthropods, small mammals and birds. 
Air quality  None envisaged.  Possible burning of maize crops to halt spread of 
resistant ECB may result in air pollution. 
Water 
quality 
None envisaged.  Increased pesticide use is likely to result in lower 
water quality and the decline in some aquatic 
invertebrates. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Potential effect (give brief rationale or example if not obvious) 
Theme  Positive effect? (benefit)  Negative effect (harm) 
Land use and 
soils 
Loss of maize crops to resistant ECB will result in longer-term movement away 
from growing maize. This may have positive or negative effects. 
Greener 
business 
None envisaged. 
 
More pesticides used to control resistant ECB. 
Sustainable 
resource use 
None envisaged. 
 
More resources used in control and eradication 
programmes. More pesticides and fossil fuels 
used. 
Limit and 
adapt to 
climate 
change 
None envisaged. 
 
None envisaged (except as secondary effect of 
resource use above). 
 
Regulatory 
effectiveness  
None envisaged. 
 
Monitoring, control and eradication programmes 
for resistant ECB are likely to divert funds and 
human resources from other areas. 
 
 
Hazard Analysis: 
The cause/consequence diagram presented below represents the convergence of a 
number of disparate events, which, together with widespread and continuous 
cultivation of Bt11, result in a potentially serious hazard to the environment. 
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Figure 3: Cause/consequence diagram showing steps needed for the development of resistance by ECB to Bt11 leading to the decline of 
predators and parasitoids by exposure to Cry toxins. 
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Assess Likelihood of the Hazard 
 
For each of the events leading to the proposed hazard likelihood scores are identified 
as follows: 
 
A. Continuous and widespread cultivation of Bt11 maize – likelihood assessment: 
HIGH 
Reasoning: There is a high likelihood that in certain areas of the EU where corn 
borer is endemic there will be continuous and widespread cultivation of Bt11 
maize. Evidence for this can be seen in parts of N. America, where conditions 
favour the growing of maize. As a consequence growers tend to keep growing it as 
there are higher returns compared to growing less well-suited crops.   
B. Small field sizes (<5ha) resulting in large areas of Bt11 without refuges – 
likelihood assessment: MEDIUM 
Reasoning: Throughout the EU there are many types of arable farming systems in 
operation, from very intensive farms with large field sizes to small smaller-scale 
farms with consequently small field sizes. Many of these smaller farms are located 
in the newer Member States, some of which have very large geographic areas, 
including areas where ECB is endemic. Because of the good pest control afforded 
by Bt11, coupled with the expected savings in pesticide use and associated 
equipment, it seems likely that growers in these areas will be keen to adopt this 
technology. Many of these fields are likely to be less than 5ha in size, and this 
could result in large areas of Bt11 with no refuges. According to the Insect 
Resistance Management plan field of less than 5ha are likely to benefit from the 
presence of non-Bt maize on bordering farms, however this may not always be the 
case. 
C. Geographically isolated ECB population – likelihood assessment: MEDIUM 
Reasoning: It is likely that in some parts of the EU there are small maize growing 
areas where ECBs are geographically isolated from other ECB populations. This 
isolation may be due to climatic and/or geographic factors, (genetically isolated 
plant and insect populations are documented in isolated Swiss valleys surrounded 
by tall mountains, for example) or may be due to cultural reasons. In these cases 
where there is a restricted gene pool it can lead to high phenotypic plasticity and 
rapid evolutionary change.   
D. Selection pressure leading to evolution of sedentary strain of ECB – likelihood 
assessment: LOW 
Reasoning: Above it has already been determined that there is the possibility of 
isolated populations of ECB, for example, in geographically isolated valleys. Such 
populations may be compared to island populations, in that comparatively small 
evolutionary stimuli can lead to large evolutionary changes. One such change that 
has been documented with island populations of insects is reduced ability to 
disperse (e.g. reduction of wings in insects and birds and dandelions without a 
"parachute"). This occurs because there is a selective pressure against the ability 
to disperse off the island: if the organism leaves the island they are unlikely to 
return to mate and contribute to the gene pool of the next generation, so gradually 
only less-mobile individuals remain to pass on their genes. It is conceivable that 
ECBs living in an isolated area (e.g. surrounded by inhospitable mountains) may, 
over a long time period, be subject to this same selection pressure, thus leading to 
more sedentary forms. Flightlessness also has an energetic advantage because it Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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requires less energy expenditure (although it becomes unfavourable when 
predation is a factor). 
  E. Lack of interaction between ECB in Bt11 crop and ECB in refuge 
populations – likelihood assessment: MEDIUM 
Reasoning: Both A) and B) combined, and C), D) and E) combined, result in a 
lack of interaction between ECB populations in the Bt11 areas and those in refuge 
areas. The likelihood of this scenario is a product of combining the individual 
likelihood scores. In reality, because there are two possible routes to achieving the 
same outcome, we should have two separate likelihood scores, but for the 
purposes of this case study, which is simply to illustrate the process, we have 
determined a single overall likelihood value.   
F. Strong selection pressure for Cry resistance – likelihood assessment: HIGH 
Reasoning: Survival of a few Bt11-dwelling ECB larvae and a lack of interaction 
between them and refuge-dwelling ECB will result in strong selection pressure as 
far as Cry resistance is concerned. Currently it is widely accepted that resistance 
to Bt crops is a rare event and is genetically recessive. The concept behind refuges 
is that rare resistant homozyotes and the few surviving heterozygotes will mate 
randomly with the high numbers of susceptible homozygotes, thereby delaying the 
evolution of resistance. This strategy relies on there being an adequate ratio of 
refuge to crop, and the fact that the adult ECB moth is highly mobile between the 
two areas. Clearly, if either (or both) of these conditions are not met it provides 
the opportunity for the resistant homozygotes and the surviving heterozygotes to 
breed together resulting in introgression of the Bt resistance gene into the 
population. 
G. Development of resistance in European Corn Borer – likelihood assessment: 
MEDIUM 
Reasoning: In order to operate evolution requires not only selection pressure, it 
requires the presence of an appropriate gene in the population. As has already 
been stated, expert opinion considers that Cry resistance is a rare event in ECB 
populations. Nevertheless, resistant populations have been bred in the laboratory 
after several generations, and it would appear credible therefore to predict that Cry 
resistance will appear in the field given the appropriate selection pressure and 
enough time. Given the lack of interaction between Cry-resistant and Cry-
susceptible ECB individuals, individuals homozygous for resistance are likely to 
appear in the population with increasing frequency over time. 
H. Decline in European Corn Borer populations – likelihood assessment: HIGH 
Reasoning: The continuous, widespread, cultivation of Bt11 maize is likely to 
cause a steep decline in ECB numbers due to the fact that it is a highly effective 
control method compared to conventional pesticides. This is, of course, the 
intention behind the planting of Bt11.  
I. Decline in ECB predator and parasitoid populations – likelihood assessment: 
MEDIUM 
Reasoning: The decline ECB numbers is likely to be mirrored by a decline in 
predator and parasitoid numbers due to a reduction of their food supply. These 
declines are likely to be offset by predation on corn borers living in refuge areas, 
although how effective this will be in preventing a decline in numbers is 
unknown.  
J. Lack of predator and parasitoid pressure on ECB –  likelihood assessment: 
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Reasoning: Predator and parasitoid pressure is often one of the limiting factors 
that keep insect populations at a reasonably low level. Take away this pressure 
and the population can in some instances explode. In the case of ECB this is 
unlikely due to the fact that the toxin in Bt11 maize has a more severe limiting 
effect on population size. However, if this limiting factor is taken away (due to Bt 
resistance, for example) there would be very little to prevent a population 
explosion.  
K. Resistant ECB not detected by resistance monitoring plan –  likelihood 
assessment: LOW 
Reasoning: The Resistance Management Plan put forward by the notifier includes 
a monitoring plan aimed at detecting any development of insect resistance. 
However, the scale of the plan and the frequency of monitoring is not clear, and 
without these details it is difficult to make an assessment of the likelihood of 
resistance going undetected. Given the predicted large-scale cultivation of Bt11 it 
is not inconceivable that resistance will go undetected at least in the early stages 
of development. Because of the uncertainties regarding the monitoring plan the 
likelihood is scored as ‘low’. If resistance does develop in an area and it is not 
detected it may quickly spread to other areas due to natural processes or by 
inadvertent distribution by humans. 
L. Remedial plan not effective in preventing spread of resistant ECB – likelihood 
assessment: LOW 
Reasoning: An integral part of the remedial action plan is the implementation of 
alternative control measures to target pest populations in affected areas. The 
details of these control measures are not clear, and it is likely that elimination of 
resistant ECB will be difficult. The primary reason that Bt maize has been 
developed is because corn borers are particularly difficult to kill with conventional 
pesticides, since chemical sprays cannot reach boring pest larvae, living as they do 
in the stems of the plant. An alternative method may be the destruction of the 
crop, but spraying large areas with herbicide is unlikely to be popular with 
growers or the public. In addition, this would have to be carried out before the 
larvae begin to pupate and turn into adult moths. Spraying to kill the adults 
themselves is unlikely to be practical. Crop burning may be an alternative control 
method, but this is likely to be unpopular and may require derogation at the EU. 
M. Population increase and spread of resistant ECB –  likelihood assessment: 
MEDIUM 
Reasoning: If Bt resistance develops in ECB and the monitoring and control plans 
are not effective in the area where the new forms have arisen, then it is possible 
that there will be a rapid population increase due to a ready food source (Bt maize) 
and a lack of predators and parasitoids. A large population of resistant ECB will 
increase the likelihood and rate of spread, thereby leading to the colonisation of 
new areas. Dispersal is likely to be due to a combination of natural processes and 
inadvertent human assistance (the latter cause is more likely in the spread of a 
sedentary strain). Undoubtedly the frequency of resistant homozygous individuals 
will decline as resistant individuals colonise new areas and interact with 
susceptible populations, but selection pressures in Bt11 areas will continue to 
favour the spread of the resistant forms. 
N. Feeding and parasitism of resistant ECB by predators and parasitoids – 
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Reasoning:  An increase in the numbers of resistant ECB will result in an increase 
of feeding and parasitism by natural enemies. Natural enemies of ECB include 
Orius spp. (Anthocoridae: pirate bugs), carabids (e.g. Poecilus cupreus, Metallina 
lampros, Pseudophonus rufipes, etc), spiders, parasitic wasps, etc. Feeding on (or 
in the case of parasitoids, laying eggs within) resistant ECB larvae or adult moths 
may result in exposure of natural enemies to high levels of Cry toxin.    
 
O. Acute or chronic toxic effects of Cry protein on predators/parasitoids – 
likelihood assessment: MEDIUM 
Reasoning: Many independent scientific studies have shown Bt toxins to be 
specific for particular insect groups such as moths, and this specificity is often 
cited as an important safety factor because non-target beneficial insects (honey 
bees, ladybirds, parasitic wasps, etc.) will not be harmed. However, this 
assumption may not be strictly valid for all insects, particularly when trophic level 
effects are taken into account. Tri-trophic laboratory studies have shown some 
evidence that predatory lacewing larvae exhibit increased mortality when fed on 
caterpillars that had in turn been feeding on Bt maize leaves (Hilbeck, Moar, 
Pustzai-Carey, Filippini, Bigler 1998). Other insects may exhibit the same 
response. It is possible, therefore, that widespread Bt11 cultivation could lead to a 
decline in predators, parasites and pathogens, firstly as corn borer populations 
decline, and secondarily through toxic food-chain effects caused by feeding on 
surviving corn borers. Over time such effects may result in a significant decrease 
in species diversity. Refuge areas may moderate these indirect effects, but at 
present little data on this subject exists. 
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Identify possible consequences of the hazard and assess their severities and 
probabilities 
In the scenario presented above there are many areas where there is a theoretical 
likelihood of an event occurring, but there is very little hard scientific evidence to 
quantify this likelihood. Certainly there is data for flightlessness in island populations 
(one of the key criteria proposed for development of Cry resistant ECB), but 
extrapolating this to remote corn borer populations without solid evidence may be 
stretching the bounds of scientific credibility. Nevertheless, even though this is just a 
theoretical hazard, it is important to explore such dangers in order to ascertain that the 
risk is indeed as low as was thought.   
 
Assess Risk  
The likelihood of hazard being realised is combined to form a measure of the risk 
using the basic equation: 
 
Risk = SUM (Likelihood x Hazard) 
 
Both likelihood (or probability) and hazard are measured on a scale of 0 (no 
possibility or no hazard) to 5 (certainty or extreme hazard). The output therefore 
ranges from 0 (zero risk) to 25 (extreme risk). Table 5 displays the overall risk in 
terms of combined probability and severity. 
 
Table 5 – Assessing the overall risk 
Hazard:  Decline of predators and parasitoids by 
exposure to the Cry protein 
Likelihood of Hazard occurring, H   
Effect  Probability, 
P 
Severity, S  Risk Level   
=  f(H,P,S) 
Human health  2 2 4 
Animal health  1 1 1 
Quality of life  2 3 
 
6 
Agricultural sustainability  4 4 16 
Environment for wildlife  4 5 20 
Air quality  1 3 3 
Water quality  2 3 6 
Land use and soils  2 2 4 
Greener business  2 2 4 
Sustainable resource use  2 3 6 
Limit and adapt to climate change  1 1 1 
Regulatory effectiveness  3 5 15 
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With the current example it has been suggested that possible criteria to decide how a 
risk is tolerable may be defined in terms of comparisons with conventional crops. 
 
 
Identification and Evaluation of Mitigation and Monitoring Methods 
Once the assessment of risk has been carried out it is appropriate to consider the type 
and extent of monitoring and mitigation measures that could be put in place to negate 
or reduce that risk. Table 6 shows potential monitoring and mitigation measures for 
the various events leading from resistant ECB to a decline in predators and 
parasitoids. 
 
Table 6 showing possible monitoring and mitigation methods (key control points are 
shown in bold)  
  Event/ 
control point 
Possible 
prevention 
measures 
Possible 
monitoring 
methods 
Possible mitigation 
measures 
A) Continuous  and 
widespread 
cultivation of 
Bt11 
The continuous and widespread cultivation of maize is not in 
itself a problem, but it could lead to problems. To reduce 
potential problems associated with continuous Bt11 cultivation 
the consent holder could instigate a grower education 
programme aimed at introducing rotation into crop 
management. Grower surveys by the consent holder could be 
used to monitor for effectiveness of the grower education 
programme. 
B)  Small field sizes 
(<5ha) resulting 
in large areas of 
Bt11 without 
refuges 
Reduce the 
threshold that 
exempts fields of 
5ha or less having 
a non-Bt maize 
refuge. 
Conduct surveys 
to determine the 
likelihood of large 
areas being 
exempt from 
having refuges, 
and use this to 
inform the IRM 
policy;  
Ensure that all 
fields that are not 
exempt comply 
with the requisite 
area of refuge 
(currently 20%). 
Adjust local refuge 
requirements in 
areas where they are 
inadequate refuges.   
C)  Geographically 
isolated ECB 
population 
There are very few measures that could be put in place to 
avoid the geographic isolation of remote corn borer 
populations. The most obvious means to limit isolation is to 
reduce the cultivation of maize (Bt and conventional) in 
remote areas, but this approach is likely to far outweigh the 
risk of such populations becoming problematic. 
D)  Selection 
pressure 
leading to 
evolution of 
There is very little that can be done to prevent or mitigate 
evolution of sedentary ECB. ‘Normal’ ECB could be brought 
into a region to mate with the sedentary forms and dilute the, 
but this has its own risks and is likely to be unpopular. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  32
  Event/ 
control point 
Possible 
prevention 
measures 
Possible 
monitoring 
methods 
Possible mitigation 
measures 
sedentary 
strain of ECB 
Sampling and testing may detect the evolution of less mobile 
forms of ECB in isolated populations (testing could be in the 
form of laboratory studies or even simple morphological 
analysis measuring wing area). If sedentary forms are found an 
eradication programme could be instigated. 
E)  Lack of 
interaction 
between Bt11 
crop and 
refuge 
populations 
Since a lack of interaction between Bt11 and refuge ECB 
populations is a product of several disparate events coming 
together, effective prevention and mitigation measures can 
only be applied to the root causes. It may, however, be 
possible to monitor the degree of interaction between corn 
borer populations by setting up moth traps in the Bt11 areas 
and refuge areas and conducting mark and recapture 
experiments. 
F)  Strong 
selection 
pressure for 
Cry resistance 
Selection pressure is a product of survival of some Bt11-
dwelling ECB larvae and lack of interaction with refuge-
dwelling ECB. The notifier has already addressed survival rate 
by ensuring that Bt11 produces a high dose rate of Cry toxin, 
and it is difficult to envisage what more could be done. Lack 
of interaction between populations has been dealt with above.   
G) Development  of 
resistance in 
European Corn 
Borer 
Bt resistance is a 
product of several 
events coming 
together and the 
only way of 
preventing it is to 
address each of the 
root causes. 
Resistance 
monitoring for 
changes in the 
baseline 
susceptibility of 
ECB already 
forms part of 
notifier’s the IRM 
plan. 
The notifier has 
outlined a remedial 
action plan in the 
event that resistant 
ECB is detected. 
This plan includes: 
informing 
customers and 
agents of resistance; 
increased 
monitoring; 
implementing 
alternative control 
measures; and 
possible cessation 
of Bt11 sales. 
H)  Decline in 
European 
Corn Borer 
populations 
N/A - this is an 
expected result of 
growing Bt11 
maize. 
Monitoring may 
be appropriate to 
determine if there 
is a link between 
ECB decline and 
the decline of 
other species.  
N/A - this is an 
expected result of 
growing Bt11 
maize. 
I)  Decline in ECB 
predator and 
parasitoid 
populations 
Non-Bt refuges 
will help to lessen 
the decline of ECB 
predators and 
Insect trapping 
techniques can be 
used to monitor 
ECB 
Increased refuge 
areas will help to 
arrest the decline in 
predator/parasitoid Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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  Event/ 
control point 
Possible 
prevention 
measures 
Possible 
monitoring 
methods 
Possible mitigation 
measures 
parasitoids. 
Ensuring other 
wildlife friendly 
areas may also 
provide alternative 
prey sources. 
predator/parasitoid 
numbers. 
numbers.  
J)  Lack of 
predator and 
parasitoid 
pressure on 
ECB 
The lack of predator and parasitoid pressure on ECB 
populations is a product of several events and effective 
prevention and mitigation measures can only be applied to the 
root causes.  
K)  Resistant ECB 
not detected by 
resistance 
monitoring 
plan 
Increasing the scale and frequency of the monitoring 
programme will help to ensure resistance is detected but will 
cost more. The risk (of not detecting the occurrence) must be 
balanced against cost of wider monitoring.  
K) Remedial plan 
not effective in 
preventing 
spread of 
resistant ECB 
The remedial 
action plan should 
specify a range of 
control measures 
to enable growers 
and consent holder 
operatives to use 
alternative control 
methods if the 
initial ones do not 
work. 
Sampling and 
resistance testing 
may be carried out 
to determine the 
effectiveness of 
the remedial 
action plan. 
The remedial action 
plan is not specific 
with regard to 
alternative control 
measures, but it 
seems likely that 
pesticide sprays will 
be a major control 
method. If this is 
ineffective 
alternative pest 
management 
techniques will 
have to be used.  
M) Population 
increase and 
spread of 
resistant ECB 
More robust 
monitoring and 
control methods 
may help to 
prevent the 
increase and 
spread of resistant 
ECB.   
Additional 
sampling and 
resistance testing 
would document 
the increase and 
spread of 
resistance. 
Use of conventional 
pesticides will help 
control resistant 
ECB populations to 
some degree, 
although chemical 
control is difficult 
because chemical 
treatments are 
effective only 
during the short 
period between 
eggs hatching and 
larvae boring into 
stems. Targeted 
campaigns (using Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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  Event/ 
control point 
Possible 
prevention 
measures 
Possible 
monitoring 
methods 
Possible mitigation 
measures 
monitoring data) 
should aid the 
elimination of 
resistant strains.  
N)  Feeding and 
parasitism of 
resistant ECB 
by predators 
and parasitoids 
Larger refuges or 
wildlife margins 
may help to 
provide a more 
diverse range of 
prey items for the 
natural enemies of 
ECB.  
Sampling of field 
arthropods could 
be used to 
determine the 
number of 
alternative (non-
ECB) prey items.  
If sampling results 
show a scarcity of 
non-ECB prey 
items an increase in 
refuge area or 
wildlife margins 
may help to 
compensate in 
future years.  
O)  Acute or 
chronic toxic 
effects of Cry 
protein on 
predators/ 
parasitoids 
Diluting the 
number of 
resistant ECBs by 
providing a greater 
proportion of non-
Bt11 habitat may 
help to ameliorate 
any toxic effects 
of Cry proteins. 
Sampling and 
laboratory testing 
(tri-trophic tests) 
will help to 
determine the 
level of toxicity of 
resistant ECB to 
predators and 
parasitoids.  
See above 
 
 
Decision making: 
During a full risk assessment it will be necessary for the assessor to work through the 
above framework for each of the risks identified in the hazard analysis section. By 
determining the level of risk for each one it is then possible to combine these risk 
values, for example using a Boolean combination, to determine the overall risk. 
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6.3. Case Study 3  
 
 
C/SE/96/3501 - GM Potato clone EH92-527-1 (BASF)  
Organism: Potato variety ‘Prevalent’ genetically modified for altered starch 
composition; 
Trait:  Enhanced amylopectin content (>98% starch); reduced amylose; NptII 
(resistance to kanamycin); 
Scope: For use as any other industrial starch potato (including cultivation in the 
EU); 
Application: Industrial starch processing; feed use (pulp by-product used as 
cattle feed) (not evaluated for human consumption); 
Current status: pending authorisation. 
 
 
Background information for case study 3: 
In assessing the environmental and feed safety of potato clone EH92-527-1 there is a 
general consensus amongst official advisory bodies that notification C/SE/96/3501, 
including the risk assessment and monitoring plans, is a robust application and poses 
little risk to the environment and human and animal health. In some ways the potato 
plant, due to its general characteristics, would appear to be an ideal candidate for 
genetic modification in terms of environmental risk. Potatoes have no sexually 
compatible wild relatives in Europe, they produce virtually no pollen (any that is 
produced has a limited dispersal of around 3m), and the seeds are contained in 
poisonous fruits making dissemination by animals highly unlikely. Experiments 
conducted by the notifier have shown that viruses, fungi and bacteria attack the EH92-
527-1 clone with same frequency as the mother clone, and both the starch and 
glycoalkoloid content are stable. In addition to these favourable characteristics, EH92-
527-1 appears to have an increased vitamin C content and a decreased glycoalkaloid 
content (i.e. solanine), compared to the mother clone. Both these characteristics may 
offer health benefits to animals that are fed the pulp by-product. In terms of case-
specific monitoring, the notifier has presented plans for testing to determine if any 
detrimental changes in tuber composition occur (including stability of genes, starch 
composition and glycoalkaloid content), and to detect any change in the presence of 
bleomycin resistance associated with open reading frames. General surveillance will 
monitor growth characteristics, changes in phenology, susceptibility to pests and 
disease and changes in animals in and around fields. Both plans have been assessed as 
being generally appropriate and sufficient by the relevant regulatory bodies.  
 
Given the above assessment it would appear that potato clone EH92-527-1 poses very 
little risk to human health and the environment, certainly in the short term. However, 
as with any new release to the environment there is always the possibility that not all 
potential risks have been fully characterised or quantified, especially those that are not 
immediately obvious. In order to reveal any long-term and cumulative risks and assess Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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the probability and hazard, we will apply the methods outlined in the risk assessment 
framework to notification C/SE/96/3501. 
 
 
 
Framing The Question: 
In the case of commercialisation of potato clone EH92-527-1 the following 
general question is posed: 
 
“What are the risks associated with the commercialisation of GM potato clone 
EH92-527-1; are these risks acceptable?” 
 
In order to focus more precisely on the nature of the applied risk assessment the 
above question is defined in terms of the following criteria:  
 
The decision context: in this instance we will assume that question has been posed 
by the notifier who wishes to quantify the risk of any potential deleterious effects 
and determine possible prevention and mitigation measures. 
The geographic scale of the decision to be made: in terms of geographic scale, the 
assessment is concerned with all EU Member States where EH92-527-1 may be 
grown in the long term. Erring on the side of caution, and considering the 
potential effect of a possible abolition of the starch quota system, any Member 
State could in future grow starch potatoes, thus the scale has been increased to 
cover most of Europe (certain small Mediterranean countries are unlikely to grow 
EH92-527-1). 
The type of risk being considered: in terms of the nature of the risk, the 
assessment is concerned with deleterious effects on the environment, human and 
animal health.  
Measures of risk: for this example risk is assessed as the percentage decrease in 
insect species diversity over a given time period, as compared to analogous fields 
that have grown conventional potato varieties and similar subsequent crops.  
The timescales under investigation: potato volunteers can overwinter in the soil 
from one year to the next, especially if winters are mild, thus giving rise to 
daughter tubers; true seed can remain viable for at least 7 years (Askew, 1993) 
before germinating. Both these traits may result in the persistence of volunteers 
for many years if there is inadequate control; nevertheless it is likely to take a long 
time for a significant volunteer problem to arise, hence the assessment is 
concerned with long-term and cumulative effects that will not necessarily be 
evident in the first few years of commercialisation. 
 
 
Defining Tolerability Criteria: 
As has been stated in the risk assessment framework guidance notes, defining 
tolerability criteria for a particular risk is not always straightforward, especially 
given the complexity and interrelated nature of the environment. Various 
benchmarks and standards exist for GM crops (and crops in general), including Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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environmental stewardship schemes, codes of practice and independent farm 
assurance schemes. In addition there are various statutory rules concerning the 
cultivation of crops and farming practice in general (e.g. in England: the Wildlife 
and Countryside Act 1981; the Conservation Regulations 1994 and The 
Hedgerows Regulations 1997). However there is still a need to develop clear 
criteria for GM crops so that risks can be judged against them.  
 
 
Ultimately risk assessment comes down to quantifying the likelihood of a 
particular hazard and the severity of that hazard. If sufficient data are available 
then likelihood can generally be calculated on a probability basis, from 
impossibility to certainty. Putting a value on hazard severity, however, is not 
always a straightforward proposition, especially when it involves environmental 
concerns, because ethical considerations are an important part of the equation. 
Growing any type of crop will inevitably have environmental consequences, and 
whether those consequences are seen as acceptable or not depends on the 
viewpoint of the individual or the body concerned. Somehow, then, a defined limit 
needs to be placed on the consequence, so that any effect above this specified limit 
is considered unacceptable and elicits a particular action (e.g. implementation of 
mitigation measures or even withdrawal of the consent). Clearly, for limits to be 
set on severity, a clear understanding of what that the hazard is, or may be, is 
required. This therefore leads us to the next step in the framework, that of hazard 
identification. 
 
Hazard Identification: 
As mentioned above, existing assessments of consent C/SE/96/3501 conducted by 
expert committees have concluded that, on the whole, potato clone EH92-527-1 is 
unlikely to have an adverse effect on human health, animal health or the 
environment. In some instances, however, these committees have highlighted 
aspects of the consent application that could, at least theoretically, have the 
potential to cause problems in these areas. Taking these factors as a starting point, 
and focussing on potential long-term and cumulative effects, a focussed 
brainstorming session involving experts in potato biology was used to supplement 
information obtained at the primary brainstorming session. Analysis of the consent 
application dossier and consideration of the characteristics of the potato led to the 
identification of a number of areas where there is potential for long-term and 
cumulative adverse effects from the cultivation of potato clone EH92-527-1. Some 
of these effects are likely to be specific to EH92-527-1 and some are of a more 
generic nature. The potential hazards were been identified are as follows: 
 
Allergenic effects: One of the major health concerns expressed for GM food is its 
potential to increase allergies in the human population either directly or through the 
food chain (i.e. via animals that have consumed the GM product). The possibility, 
therefore, of fatal anaphylaxis in sensitised individuals after unwitting exposure to 
allergenic proteins is a real danger (Gasson, M.J., 2003). Bioinformatic analysis 
shows that potato clone EH92-527-1 contains an open reading frame that could 
theoretically produce a protein (designated ‘ORF4’) with homology to two proteins 
that are known to be toxic or allergenic (EFSA Journal (2006), 323, 1-20), namely Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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the bleomycin (ble) resistance protein together and the ornithine cyclodeaminase 
protein of Agrobacterium (which is also a mite allergen). In their advice of 14 
January 2005 the Advisory Committee on Releases to the Environment (ACRE) 
recommended that case-specific monitoring should examine the male fertility of 
potato clone EH92-527-1 to determine if there is any increase in pollen production. 
Although EH92-527-1 male fertility has been documented as low in trials, ACRE 
argue that if significant, unexpected pollen production is detected then the presence 
of ORF4 protein should be examined. The danger of high levels of pollen containing 
the ORF4 protein is that it could trigger allergic reactions in some people, such as 
farm workers and members of the public. Such effects may not be evident 
immediately and may require people to have a period of sensitisation. 
Increased numbers of volunteers: During potato harvesting some small tubers are 
invariably left in the ground after harvest (groundkeepers) and these may give rise to 
volunteer plants in the next crop. Volunteers may also arise from true seeds, and 
studies have shown a return of up to 30 million seeds per hectare following a crop of 
potatoes, with up to 90% viability (SAC 1999). Although many groundkeepers are 
killed by climatic conditions (e.g. frost and drought) their control can be 
problematical in some areas and relies on a combination of careful harvesting, 
cultural and husbandry techniques, and herbicide treatment. In seed potato crops the 
presence of volunteer plants arising from ‘rogue’ tubers can lead to the rejection or 
downgrading of seed potato crops (the dossier is not clear as to whether fields that 
have been used for the production of EH92-527-1 will subsequently be used for 
production of conventional seed potatoes, and if so the length of time separating the 
two events); another crop that can be affected by potato volunteers is vining peas, 
which are automatically rejected if contaminated with potato berries. Volunteer 
potatoes can be carriers of various potato diseases, act as a major reservoir of viruses 
and can act as a ‘green bridge’ for pests and diseases that cannot persist in the 
absence of the host. In addition they can be very competitive with other crops, and 
control of disease and pest problems on volunteers in other crops may be virtually 
impossible as label-approved recommendations do not exist. In evaluating potato 
clone EH92-527-1 the notifier has assessed the potential for the genetic modification 
to result in a change of agronomic performance, and considered the likelihood of this 
occurrence to be low. The ERA did concede, however, that the period and scale of 
field trials (245 sites over 9 years) may not be considered long enough to reveal 
subtle and cumulative effects, and that volunteer management under different 
agricultural conditions could become more complex. It is possible then, that EH92-
527-1 may exhibit a subtle difference in some aspect compared to the recipient clone. 
Such a difference may only become apparent after several years of cultivation or 
following cultivation under different climatic conditions. Theoretical examples of 
altered characteristics that could lead to an increased number of volunteers are: 
•  Increased numbers of smaller tubers, resulting in more tubers left in the 
ground after harvest; 
•  Increased frost resistance of tubers leading to enhanced over-wintering 
capacity (for example the higher levels of mono- and disaccharides 
documented for EH92-527-1 may result in an antifreeze effect; or the 
anhydrous properties of amylopectin could result in less water in the tissues). Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Whilst the above attributes have not been documented in EH92-527-1, it is possible 
that they may only manifest themselves under certain environmental conditions 
and/or over a long time period. 
Increased weediness: Weediness describes a plant’s potential to successfully 
colonize an ecosystem, especially when it may also lead to the displacement of other 
species. Generally, weediness depends on the selective advantage of many genes 
functioning in combination, which are unrelated to the genes usually introduced for 
agronomic reasons. However, traits which enhance tolerance to environmental 
stresses such as drought, cold or dormancy have the potential to increase the survival 
and distribution of the plant in managed and unmanaged ecosystems. Additionally, 
traits which provide for resistance to biotic stresses that play a significant role in the 
ecology of the plant (e.g., insect or pathogen resistance) could permit the plant to 
become persistent and/or invasive within and outside of the agricultural ecosystem. 
Baker (1965) described a number of key characteristics of weeds, including: 
discontinuous germination and long-lived seeds (and/or tubers in the case of 
potatoes); rapid growth to reproductive stage; high seed (and/or tuber) output under 
favourable conditions; high tolerance or plasticity of climatic and edaphic variation; 
and good competitiveness achieved through, for example, allelochemicals or choking 
growth.  In northern Europe potatoes are only found in cultivated areas, whereas in 
southern Europe they can also be found in the wild (although they are rarely seen as a 
‘nuisance’ plant in natural ecosystems). At present starch potatoes are grown in 
Nordic countries, Eastern Europe, Germany, Holland, Belgium and France, but there 
is a possibility that the quota system could be revised or even abolished in future, 
leading to the cultivation of EH92-527-1 elsewhere in Europe, including southern 
Member States. For EH92-527-1 to become invasive the modification would need to 
result in some (possibly significant) change in its nature compared to other potatoes, 
resulting in EH92-527-1 displaying ‘weedy’ characteristics.  Whilst clone EH92-527-
1 has not been reported as displaying any such characteristics, the notifier, in 
addressing potential changes in competitive behaviour, states that “it cannot be 
excluded that a long-term effect will only be measurable after a certain period, e.g. 
after different culture cycles”.   
Pleiotrophic effects: Pleiotrophy, when one gene is responsible for the development 
of several features and characteristics, can lead to unforeseen changes during the 
development of both transgenic and non-transgenic organisms. Pleiotrophic and 
positional effects (the influence of the gene’s position on its activity) are often 
concentrated on cell metabolism and can lead to phenotypic changes including 
altered agronomic characteristics and variations of gene expression levels. If such 
effects occur during the development of the transgenic organism they are usually 
addressed successfully, however if they are undetected, perhaps because they are 
expressed only under certain conditions, such effects can pose a risk if they increase 
the potential for the spread of transgenes (e.g. increased pollen production), or result 
in the production of toxic or allergic compounds (Lips, 1998) In a study of transgenic 
fructane-building potatoes, for example, different flowering behaviour has been 
observed compared to the donor plants (Becker et al, 1998). Such effects may only 
come to light after long-term cultivation under a range of different growing 
conditions. 
Development of antibiotic resistance: Potato clone EH92-527-1 is one of a number 
of transgenic crops that employs the NptII gene as a selectable marker, by conferring Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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resistance to the antibiotic kanamycin. There is concern among some scientists that 
the use of such marker genes could potentially lead to increased resistance to 
antibiotics in humans and animals as a result of gene transfer from genetically 
modified plants to bacteria. These concerns have been well documented and the 
EFSA has issued scientific advice on the use of antibiotic resistance marker genes in 
genetically modified plants, with the aim of phasing out the practice. Whilst there is a 
theoretical potential for such adverse effects associated with EH92-527-1, due to 
cattle being fed the by-products, the risk is thought to be remote. 
Effects on human health: Intolerance to amylopectin is known to occur in some 
people due to a congenital lack of the appropriate enzymes, and people suffering this 
condition (especially children) sometimes have to limit their intake. The accidental 
consumption of potato with 100% amylopectin may have unwanted and unexpected 
effects on such people, although the notifier maintains that such consumption will 
have no practical consequence since starch from normal potatoes also causes the 
problem. There may however be a dose-response effect that is yet to be documented. 
The Swedish Board of Agriculture, in their statement of 15 April 2004, raised a 
concern that, because amylopectin is digested more rapidly than amylose, this could 
result in undesirable effects in diabetics, who could experience a swifter increase in 
blood glucose levels than would normally be expected from consuming potatoes. The 
Board acknowledged that it is very unlikely that potato clone EH92-527-1 will enter 
the human food chain, but stated that this cannot be completely ruled out. As time 
goes on this risk is likely to increase. 
Effects on non-target organisms: Observation of the effect of growing EH92-527-1 
on a range of organisms that interact with potatoes (including viruses, fungi, bacteria, 
insects, snails and worms) has been carried out by the notifier, and no adverse effects 
have been noted. However it is not unreasonable to expect that the altered starch 
composition of EH92-527-1 may have an effect on certain soil-dwelling micro-
organisms, leading to alterations in the populations of microflora. This in turn could 
lead to altered decomposition rates and possible perturbations in chemical and 
nutrient cycling. In addition there is evidence that the level of glycoalkaloids (toxic 
and anti-nutritional compounds that occur mainly in the above-ground parts of the 
plant) in potato clone EH92-527-1 is lower than that in the mother variety Prevalent. 
Whilst a lower concentration of compounds such as solanine may be beneficial for 
animal health, it may also make EH92-527-1 more liable to attack by herbivorous 
insects and invertebrates, particularly larvae and snails (Johnston, 1989). Although 
the notifier could find no evidence for more serious attacks, a subtle increase could, 
over a long timescale, see a significant increase in the amount of pesticides used on 
the crop, with concomitant effects on non-target insects and wildlife in general. It is 
also theoretically possible that glycoalkaloids may be a limiting factor for some 
insects, such as Colorado Potato Beetle. If glycoalkaloid concentrations in leaves are 
lower this could lead to rapid growth of this insect pest, a possible extension in its 
climatic range, and over time result in wider outbreaks in conventional potato crops.   
 
To broaden the scope of the above hazards in relation to the environment and further 
explore the possible consequences the theme-based approach has been employed. The 
results are shown in table 7. 
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Table 7 - Potential consequences if the hazard/or hazards are realised. 
 
Potential effect (give brief rationale or example if not obvious) 
Theme  Positive effect (benefit)  Negative effect (harm) 
Human health 
None envisaged  
(potato clone EH92-527-1 is not for human 
consumption, although the lower 
glycoalkaloid and higher vitamin C content 
may actually enhance the nutritional content 
if it does accidentally enter the human food 
chain). 
Horizontal gene transfer of the kanamycin 
resistance gene in EH92-527-1 to bacteria in the 
guts of humans, resulting in antibiotic resistant 
bacteria and compromised human therapy; 
Some people exhibit intolerance to amylopectin; 
Glycaemic effects on diabetes sufferers who 
might accidentally consume EH92-527-1; 
Acute or chronic toxicity on people who might 
accidentally consume EH92-527-1; 
Allergenic effects may manifest themselves in 
some people. 
Animal health 
Lower glycoalkaloids and higher vitamin C 
content may enhance the nutrition of cattle 
fed the by-product. 
Horizontal gene transfer of the kanamycin 
resistance gene in EH92-527-1 to bacteria in the 
guts of animals, resulting in antibiotic resistant 
bacteria and compromised animal therapy. 
Quality of life 
Potato starch is perceived to have a higher 
quality than maize starch (thus commanding 
a higher price), possibly leading to higher 
economic returns for growers (and better 
quality products for consumers). 
Chronic allergenic effects of pollen may afflict 
some people. 
Agricultural 
sustainability 
May increase the resilience of the agro-
economy due to a wider range of cropping 
choices.  
May cause perturbations in soil-dwelling micro-
organisms, potentially leading to disruption in 
biochemical processes; 
May decrease the resilience of the agro-economy 
due to potential volunteer problems in 
subsequent crops; 
Increase in pests (phytophagous insects) due to 
lower glycoalkaloid levels in plant tissues. 
Environment 
for wildlife 
There may be benefits for wildlife compared 
to growing other crops that have higher 
pesticide inputs or are less wildlife-friendly 
than potato  
Reduction in invertebrates and their predators if 
more herbicides are used to control volunteers; 
Reduction in invertebrates and their predators if 
more pesticides are used to control higher pest 
numbers. 
 
Air quality  None envisaged. None  envisaged. 
Water quality 
None envisaged (although ‘greener’ 
processing may benefit water quality – see 
Greener business). 
Detrimental effect if more herbicides/insecticides 
are used to eradicate EH92-527-1 volunteers. 
Land use and 
soils 
Increased opportunity for growers to 
diversify. 
Restricts potential uses of the land (e.g. for 
potato seed crops) if volunteers are more 
frequent and persistent; 
If seed/ware potato crops are contaminated and 
are disposed to landfill it reduces the volume 
available for other waste and adds to the 
environmental burden.   Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Potential effect (give brief rationale or example if not obvious) 
Theme  Positive effect (benefit)  Negative effect (harm) 
Greener 
business 
A reduction in imported (e.g. maize) starch 
may reduce the number of ‘product-miles’; 
Fewer chemicals may be required during the 
processing of EH92-527-1 starch.  
Possible greater use of harmful herbicides 
Sustainable 
resource use 
None envisaged.  Energy and resources will have to be expended 
to control EH92-527-1 volunteers 
Limit and 
adapt to 
climate 
change 
None envisaged.  Secondary effect of energy use (see above). 
Regulatory 
effectiveness  
None envisaged.  If the problem of conventional seed or ware 
potato contamination arises, it could be a 
relatively high profile issue, diverting funds from 
elsewhere. 
 
 
 
To further test and refine the proposed risk assessment methodology in relation to 
long-term and cumulative effects it is necessary to select a scenario from the list of 
hypothetical hazards. In this case it has been decided to examine more closely the risk 
of increased numbers of volunteers leading to reduced wildlife diversity due to an 
increase in herbicide application. 
 
Scenario 4: Increased numbers of volunteers  
In this hypothetical scenario we have chosen to assess the risk to the environment 
posed by a potential increase in the number of potato volunteers due to possible 
phenotypic (tuber size) and physiological (frost resistance) changes resulting from the 
modification. We assume that the increase in the numbers of volunteer plants, 
although slight, has been calculated to be significant over the lifetime of the consent, 
and this has presented the notifier with the option of either extending the rotation 
period for EH92-527-1 or increasing the frequency of herbicide use. For economic 
reasons we anticipate that the notifier has chosen to recommend to contracted growers 
an increase in herbicide use. An expert committee have assessed the proposal and 
concluded that an increase in the use of broad-leaved herbicides will in turn impact on 
native weed populations and have possible knock-on effects for other wildlife. The 
notifier wishes to quantify this effect. 
 
As this particular scenario is focussing on the potential consequences of an 
increase in the number of potato volunteers it is appropriate to revisit the initial 
question and make it more specific to the identified hazard. In this case the 
following specific question is posed concerning the commercialisation of potato 
clone EH92-527-1: 
“What are the risks that the increased potato volunteers will result in a decrease 
in species diversity due to increased herbicide use?” 
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Having restricted the focus of the question it is appropriate to look again at how 
the question is framed. In the case of the risk to wildlife diversity the following 
criteria are considered important:  
 
The decision context: again we will assume that question has been posed by the 
notifier wishing to quantify the risk of any potential deleterious effects on the 
environment and determine possible prevention and mitigation measures. 
The geographic scale of the decision to be made: In the first instance this may be 
restricted to Nordic counties where commercial cropping will first be introduced. 
The type of risk being considered: in terms of the nature of the risk, the 
assessment is concerned with deleterious effects on wildlife diversity. This could 
be in terms of numbers of organisms, species diversity or species richness.  
Measures of risk: for this example we will assume that risk is assessed as the 
percentage decrease in wildlife numbers over a given time period, as compared to 
analogous fields that have grown conventional potato varieties and similar 
subsequent crops.  
The timescales under investigation: potato volunteers can overwinter in the soil 
from one year to the next, especially if winters are mild, thus giving rise to 
daughter tubers; true seed can remain viable for at least 7 years (Askew, 1993) 
before germinating. Both these traits may result in the persistence of volunteers 
for many years if there is inadequate control; nevertheless it is likely to take a long 
time for a significant volunteer problem to arise, hence the assessment is 
concerned with long-term and cumulative effects that will not necessarily be 
evident in the first few years of commercialisation. 
 
 
Hazard Analysis 
In order to understand the factors that lead to the perceived hazard, and to 
understand the relationships between the contributing factors, graphical analysis 
has been employed. Figure 4 is a rationalised fault tree showing the different 
interrelated events that have to combine for the hazard to be realised. Probability 
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Figure 4: Cause-consequence diagram showing how an increase in potato volunteers 
could elicit a decrease in wildlife diversity due to increased herbicide use over time. 
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The cause/consequence diagram in figure 4, above, provides a systematic description 
of the combinations of possible occurrences in the agro-ecosystem which can result in 
a decline in wildlife diversity (the Top Event). The tree has been constructed by 
deducing each of the preconditions for the top event and then successively for the next 
level of event, until the basic causes are identified. The probabilities are calculated 
using ‘AND’ and ‘OR’ logic gates. At an OR gate the probabilities are added to give 
the probability of the next event; at an AND gate the probabilities are multiplied. 
 
For each of the events leading to the anticipated hazard, probability values have been 
ascribed to give the likelihood of a particular outcome. Assigning probabilities in 
itself, however, is not a straightforward process, because most of the events that must 
occur for the hazard to be realised do not simply have a ‘yes’ or ‘no’ outcome: in 
nature things are generally a lot more complicated than this. In fact, for most events 
considered there are different gradations of effect. If we look at the first event 
(‘Increased numbers of smaller potato tubers’), we could ask the question ‘how many 
smaller tubers must there be for the effect to merit concern?’. Would a 5% increase or 
a 50% increase in the number of smaller tubers be significant? Presumably, if the 
tubers are only slightly smaller they will not pass through the harvesting machinery, 
and the problem will be negated. This begs the question ‘how much smaller do the 
tubers need to be before they are considered problematical?’. In the case of this 
scenario it has been decided that 20% is a realistic threshold value for each effect, 
thus each probability value has been assigned on the basis that the event will cause a 
20% change (this can be an increase or a decrease) in the factor under consideration. 
The rationale behind each probability values is as follows: 
 
A. Increased numbers of smaller potato tubers – Probability: 0.1 
Reasoning: The notifier has reported that the yield of EH92-527-1 is significantly 
lower (statistically speaking) than Prevalent. Lower yield can manifest itself either 
as fewer tubers or the same number of tubers of a smaller size (or a combination 
of the two). The notifier has not stated which of these factors is responsible, 
therefore for this scenario we will assume an increase in the number of smaller 
tubers is the reason for the drop in yield. In this instance it is not possible to put an 
absolute probability value on this event due to lack of data, however it seems 
reasonable to consider the likelihood of a greater number of smaller tubers as 
‘probable’ (P=0.1). 
 
B. Higher levels of mono- and disaccharides in tuber – Probability: 1.0 
Reasoning: Compositional analysis of EH92-527-1 by the notifier has confirmed 
that the levels of fructose and saccharose are higher in the modified clone 
compared to the donor plant.  Due to the fact that this increase in sugar levels is 
statistically significant, the probability is given as 1. 
 
C. Anhydrous properties of amylopectin in tuber – Probability: 1.0 
Reasoning: Compositional analysis of EH92-527-1 has confirmed that it has a 
higher amylopectin content than the parent plant, consisting of almost 100% of 
amylopectin. Due to the configuration of the amylopectin molecule this type of 
starch is known to have increased anhydrous properties compared to amylase 
starch. Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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D. Carbohydrate ‘antifreeze’ effect – Probability: 0.1 
Reasoning: Increased sugar content could theoretically result in greater freezing 
resistance, giving tubers an increased ability to survive over the winter.    
 
E. Less tissue water in tuber – Probability: 0.1 
Reasoning: The anhydrous properties of amylopectin are likely to result in less 
water in the tissues of EH92-527-1 potato tubers. 
 
F. Enhanced frost resistance of tubers – Probability: 0.2 
Reasoning: A lower tissue-water content, or an antifreeze effect caused by a 
higher sugar content, could lead to enhanced frost resistance in EH92-527-1 
tubers. Frost tolerance studies have been performed by the notifier and did not 
show any difference compared with Prevalent. However the field trials only 
appear to have been conducted in a single year, and laboratory trials are unlikely 
to duplicate all of the conditions existing in commercial cultivation over time. 
 
G. More tubers left in the ground after harvest – Probability: 0.1 
Reasoning: Given an increased number of small tubers it is likely that there will 
be a greater number of tubers left in the ground following harvesting, as not all 
will be removed by potato harvesting machinery. A frequent (1 in 10) chance of 
this happening would seem realistic, although field observations could be used to 
increase the accuracy of this estimate. 
 
H. More potato groundkeepers survive in the soil – Probability: 0.21 
Reasoning: With the potential for greater number of tubers being left in the 
ground, or the possibility of enhanced frost resistance, there is an increased 
likelihood of larger numbers of groundkeepers surviving from one year to the 
next. The probabilities of the two separate branches are added together at the OR 
gate to calculate the overall likelihood of the event taking place. With a larger 
number of groundkeepers surviving in the soil from 1 year to the next it is highly 
likely that there will be a larger number of potato volunteers in the subsequent 
crop 
 
I. Increased herbicide application – Probability: 0.1 
Reasoning: Given the agronomic problems associated with the control of potato 
volunteers it is highly likely that growers will increase their herbicide applications 
to deal with the higher numbers in subsequent crops, hence the likelihood of 
increased herbicide application is assumed to be a frequent.  
 
J. Decrease in numbers of broad-leaved weeds – Probability: 0.1 
Reasoning: Increased herbicide application to kill potato volunteers in subsequent 
crops is highly likely lead to a decrease in the numbers of common broad-leaved 
weeds (e.g. Brassica rapa, Chenopodium album, Fumaria officinalis, Papaver 
rhoeas etc.) in the field, hence this has been given a probability of 0.1.  
 
Due to the inherent complexity of biological systems, assessing the probability 
values relating to decreased numbers of insects, birds and mammals (events K to 
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In such cases a population modelling approach is likely to provide the most 
accurate probability estimates, and this requires high quality data relating to the 
environment of concern. As this is beyond the remit of this project we are unable 
to attach probabilities to the following events. 
 
K. Decreased numbers of phytophagous insects 
Reasoning: A great many insects (and other invertebrates) in arable fields rely on 
broad-leaved weeds as a primary food source. These include sap-sucking insects, 
such aphids and froghoppers and shield bugs, as well as foliage-eating insects and 
invertebrates including leaf cutter bees, caterpillars, slugs and snails, etc. Fewer 
broad-leaved weeds are very likely to have a detrimental effect on the numbers of 
these insects and invertebrates in the field of concern.  
 
L. Decreased numbers of nectar/pollen gathering insects 
Reasoning: In the same way that phytophagous insects rely on broad-leaved 
weeds, many nectar and pollen-gathering insects are dependent on flowering 
broad-leaved weeds in the arable environment to provide them with a food source. 
Examples of such insects are bees, butterflies and pollen beetles. A decrease in the 
number of such weeds is likely to have a direct effect on these insects, although it 
must be noted that bumble bees and butterflies can fly long distances and a decline 
in weeds may have little immediate impact on them. However, if weeds die over 
large areas and over several years, the effects on nectar resources would become 
more important. Such was an important conclusion of the UK Farm Scale 
Evaluation (FSE) trials. 
 
M. Decreased numbers of predatory insects 
Reasoning: Predatory insects, such as carabids spiders, lacewings, ladybirds, 
wasps and centipedes all feed on other smaller insects. With a reduction in their 
prey items their numbers are also likely to decrease. 
 
N. Decreased insectivorous/granivorous birds/mammals 
Reasoning: A number of birds and small mammals (and amphibians such as frogs) 
feed on insects and invertebrates, and often this is their primary food source or is 
an important food source at a particular life stage. Many birds require a regular 
supply of insects in order to feed their chicks the high protein diet they require for 
rapid development. Grey partridges are especially susceptible to variations in 
insect food supply, and studies have shown that partridge density is inversely 
related to the number of herbicide applications, and positively related to the 
number of broad-leaf weed groups (Campbell et al., 1997). Broad-leaved weeds 
also provide a useful source of seeds for granivorous birds and mammals.  
 
O. Decreased numbers of higher trophic level predators 
Reasoning: A decrease in the number of insectivorous and granivorous birds and 
mammals may lead to a decrease in the numbers of higher trophic level predators, 
such as owls, raptors, foxes, weasels, etc. that prey on small mammals and birds. 
This conclusion is supported by the FSE results, which show that a decline in 
arable weed populations is likely to result in adverse effects on organisms at 
higher trophic levels, compared with conventionally managed crops (although the Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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FSE trials did not involve GM potatoes, the effects of weed management practices 
can be extrapolated to other crops).  
 
Top Level Event: Decreased species diversity. As has already been described, the 
probabilities of each event have been assigned on the basis that there has been a 20% 
change in the characteristic about which we are concerned. In the case of wildlife 
diversity, this means that the probability value for the top event is applicable to an 
overall 20% decrease in species in and around the field where potato clone EH92-527-
1 has been grown. If, on the other hand, a threshold value of lower than 20% was 
chosen (e.g. 10% reduction in species diversity), there would be a greater likelihood 
of the hazard being realised and the final probability value would be higher; similarly 
if the threshold were higher than 20%, the probability value would be lower. 
 
 
Assessing Likelihoods, Consequences and Risks 
In the scenario outlined above are described a series of interrelated causal events 
leading to a decrease in species diversity. To be able to attach meaningful 
probabilities to the individual events it has been necessary to apply a threshold value 
to the different stages. The overall probability value, relating to the top level event, is 
then calculated by combining the probability of each lower event using a standard 
metric (e.g. OR and AND gates). This, however, is just one part of the risk equation, 
since risk is generally expressed as a combination of 1. the likelihood of an adverse 
effect, and 2. the severity (or hazard) of that particular effect. In order to complete the 
assessment of risk we need, therefore, to ascertain exactly how severe the decline in 
wildlife diversity is, and for this application we can use a similar scale to the 
probability scale, from 0 (insignificant) to 1 (extreme hazard). This scale, however, 
need not be linear, as there may be instances where a small effect is inconsequential 
but a larger effect crosses a critical threshold and causes severe consequences such as 
environmental instability. Figure 5 represents a simplified hazard severity curve for an 
ecosystem with a critical threshold (or ‘tipping point’) at the 10% level. If this 
hypothetical 10% level is exceeded, then the relationships between the existing 
species break down and the severity in terms of effect on the ecosystem as a whole 
increases markedly. Using figure 5 for the volunteer potato scenario being considered, 
a 20% decline in species diversity can be judged to be moderately severe and is 
assigned a hazard rating of 0.5 (see dashed arrows).  
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Fig. 5 – Hypothetical hazard severity curve for ecosystem species diversity 
 
 
Using this type of approach it is possible to predict (or at least estimate) the likelihood 
of a particular hazard being realised and the severity of that hazard. The next stage, 
therefore, is to calculate the risk posed by these factors. In the case of this scenario, 
both hazard likelihood (probability) and hazard severity are measured on a scale of 0 
to 1. The output therefore also ranges from 0 (zero risk) to 1 (extreme risk). The 
actual equation is: 
 
Risk* = SUM (Probability of Hazard x Expected Severity of Consequence) 
 
*of a 20% decreased wildlife diversity. 
 
The decision as to whether a particular risk is tolerable must then be assessed in light 
of the predefined tolerability criteria defined in Step 2. 
 
 
Assess Uncertainties  
With any type of risk assessment there is likely to be a degree of uncertainty in the 
values assigned to each event. In the case of transgenic crops this uncertainty is 
increased because most GM crops have only been grown experimentally on a 
relatively small scale over a relatively short period of time. Coupled with this, when 
such crops are released into the wider environment they enter a highly complex 
system with a great many interdependent relationships. Determining exactly how the 
crop will affect the environment, and how the crop itself will be affected by the 
environment, is a difficult task. In the case of Scenario 4 it must be acknowledges that 
there are many gaps in the information required for a comprehensive risk assessment, 
especially concerning the interrelationships between different trophic levels, and 
several steps must rely on subjective estimates. Much more data is needed to fill these 
gaps.  
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The release should be categorised as either acceptable or unacceptable when 
compared to the criteria set under Step 2. At present appropriate criteria needs to be 
developed for GM crops. 
 
Identification and Evaluation of Mitigation and Monitoring Methods 
 
Having carried out an assessment of risk for the identified hazard it is appropriate now 
to consider the type and extent of monitoring and mitigation measures that could be 
put in place to negate or reduce that risk. Table 8 shows potential monitoring and 
mitigation measures for the various events leading from increased numbers of 
volunteer potatoes to decreased species diversity. 
 
Table 8 – Potential prevention monitoring and mitigation methods 
 Event  Possible 
prevention 
measures 
Possible 
monitoring 
methods 
Possible 
mitigation 
measures 
A Increased 
numbers of 
smaller potato 
tubers 
Because EH92-
527-1 is a clone 
there is little that 
can be done to 
prevent the 
production of 
smaller tubers. 
Monitoring of 
potato fields after 
harvest should 
detect greater 
numbers of small 
tubers. 
Greater care 
during harvest will 
reduce the number 
of potatoes left in 
the ground. 
B  Higher levels of 
mono- & 
disaccharides in 
tuber 
N/A Sampling  and 
testing may alert 
the notifier of the 
problem and allow 
appropriate 
changes to 
management 
practices. 
The levels of 
mono- & 
disaccharides may 
be influenced by 
environmental 
conditions – 
changing these 
conditions may 
reduce these levels 
C Anhydrous 
properties of 
amylopectin in 
tuber 
The anhydrous properties of EH92-527-1 is likely to be 
fixed, therefore there are no prevention measures; 
Sampling and testing may alert the notifier of the problem 
and allow appropriate changes to management practices. 
D Carbohydrate 
‘antifreeze’ 
effect 
The antifreeze properties of EH92-527-1 is likely to be 
fixed, therefore there are no prevention measures; Further 
laboratory and field testing may help to determine the 
extent of any problem. 
E Less  tissue 
water in tuber 
The quantity of tissue water of EH92-527-1 is likely to be 
fixed, therefore there are no prevention measures; Further 
laboratory and field testing may help to determine the 
extent of any problem. 
F Enhanced frost 
resistance of 
tubers 
Reduce the number of groundkeepers remaining in the soil 
(improved harvesting and cultural methods); Field testing 
and monitoring needs to be carried out under a range of 
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environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
  51
G More tubers left 
in the ground 
after harvest 
Greater care 
harvesting 
Post-harvest 
sampling to 
determine 
groundkeeper 
numbers 
Improved cultural 
methods to 
remove ‘rouge’ 
tubers 
H More  potato 
groundkeepers 
survive in the 
soil leading to 
increased 
numbers of 
potato 
volunteers in 
subsequent 
crops 
Improved 
harvesting and 
cultural methods 
to ensure as few 
groundkeepers 
remain in the 
soil 
Farmland potato 
volunteer surveys 
Spot-spraying of 
volunteers to 
avoid total weed 
eradication 
I Increased 
herbicide 
application 
Use methods of 
controlling 
volunteers other 
than herbicides 
Farmer pesticide-
use surveys 
Increase wildlife-
friendly habitats 
J Decrease  in 
numbers of 
broad-leaved 
weeds 
Restrictions on 
herbicide 
applications 
Arable weed 
surveys 
Increase wildlife-
friendly habitats 
 Decreased 
species 
diversity 
Increase 
wildlife-friendly 
habitats 
Farmland surveys 
of invertebrates, 
birds, mammals. 
Diversity action 
plans may help 
wildlife to recover 
 
 
An increase in potato volunteers leading to an increase in herbicide use is one of 
theoretical consequences of the cultivation of potato clone EH92-527-1. To carry out 
a full risk assessment it is necessary to investigate each of the potential hazards that 
have been highlighted and determine the level of risk for each one. Once the full 
range of hazards has been assessed the resulting risk values could then be integrated 
into an overall risk for EH92-527-1. Based on this overall risk the decision as to 
whether commercialisation could go ahead would be made. Any such decision should 
take into account the possible prevention, monitoring or mitigation measures 
presented above 
 
 
 
6.4. Case Study 4 
 
This case study is of a generic nature and is concerned with potential long-term and 
cumulative effects of maize cultivation. For the sake of argument it will be applied to 
MON 810, although it could readily be applied to any other GM maize line. 
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Organism: maize line MON 810; 
Trait: insect resistance employing the CryIA(b) insect-control protein; 
Scope: for use as any other maize, including cultivation; 
Current status: consent issued August 1998. 
 
 
Background information 
This particular case study is concerned with risks that are based primarily on 
theoretical hazards rather than observational data. The subject of the assessment is 
MON 810 maize, although the majority of the hazards discussed could apply equally 
well to other genetically modified organisms.  
 
1.  Framing The Question: 
In the case of the risk assessment of genetically modified maize the following 
general question can be posed: 
“What are the risks associated with the commercialisation of GM maize; are these 
risks acceptable?” 
 
In order to focus more precisely on the nature of the applied risk assessment the 
above question is defined in terms of the following criteria:  
 
a.  The decision context: in this instance we will assume that question has been 
posed by the regulator who wishes to assess the risk of any potential 
deleterious effects from long-term cultivation and determine possible 
monitoring and mitigation measures. 
b.  The geographic scale of the decision to be made: in terms of geographic scale, 
the assessment is concerned with all EU Member States where insect-protected 
maize is likely to be grown. 
c.  The type of risk being considered: in terms of the nature of the risk, the 
assessment is concerned with deleterious effects on the environment, human 
and animal health.  
d.  Measures of risk: for this example risk is assessed relative to cultivation of 
conventional maize, with the stipulation that any effects on human health, 
animal health and the environment will be no greater than the effects posed by 
analogous conventional varieties grown in the same environment.  
e.  The timescales under investigation: the assessment is concerned with potential 
risks that extend throughout the duration of the consent period, and possibly 
beyond.  
 
2.  Defining Tolerability Criteria: 
The following tolerability criteria may be considered applicable: 
•  Benchmarks and standards: the degree of risk should be no greater than 
that posed by the unmodified crop, unless it can be demonstrated that there 
are distinct benefits that offset the risk (see below).  Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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•  Formal requirements: the principle of As Low As Reasonably Possible 
(ALARP) may be deemed appropriate, although consideration would need 
to be given to the concept of ‘reasonable’. Stakeholder meetings may be 
the most appropriate way of defining what this concept.  
•  Benefits versus risks: to receive a favourable risk assessment, where a risk 
is identified there must be an obvious and comparable benefit (or benefits) 
which offset that risk. Such benefits may be economic (e.g. the insect resistance 
properties allow the production of maize in areas where it was previously 
economically unviable); environmental (e.g. reduction in pesticide use) or health-
related (reduction in worker-exposure to pesticides).  
•  Level of confidence: confidence levels will inevitably be difficult to 
determine in the case of long-term effects. However the risk assessment 
process is likely to help determine what needs monitoring, as well as the 
spatial scale and the geographical extent of monitoring. Once more data 
becomes available the level of confidence is likely to increase. 
•  Ethical considerations: moral judgements can be very disparate and may 
vary with time. To attempt to reach a consensus it may be necessary to 
canvass the opinions of a wide range of interested parties. 
 
 
3.  Hazard Identification: 
The toolbox catalogue in appendix 5 provides a number of tools and techniques 
that can be used for hazard identification, from simple checklists to more 
specialized methods such as Holistic Holographic Analysis. In this instance we 
have chosen to look at the outputs from the brainstorming session of 31/10/05. In 
particular we are interested in the ‘blue sky’ scenarios that were identified, which 
although being somewhat outside the main consensus of scientific opinion, could 
conceivably occur due to the long term and widespread cultivation of GM crops. 
Due to their speculative nature such scenarios are likely to be useful in testing the 
applicability of the framework to more hypothesis-based risks, rather than simply 
relying on evidence-based risk assessment that may be limiting in terms of long-
term cumulative effects. The main exploratory scenarios put forward are outlined 
below: 
•  ‘Genetic meltdown’ which describes a genomic crisis occurring due to an 
extraordinarily high rate of mutation (a phenomenon known to occur in viruses 
and perhaps in other organisms). The concept behind this theory is that 
although mutation contributes to variability and variability drives the success 
of a population in the face of a changing environment, most mutations are 
deleterious. Therefore, when a high mutation rate gives rise to a great many 
deleterious mutations it will eventually cause the population go extinct.   
•  ‘Silent spread’ of recessive genes/dormant traits refers to genes or traits 
that are not overtly expressed in the crop (thus their effects are not detected 
during the assessment process), but remain concealed in the genome until 
triggered by genetic recombination or some other external event (such as 
altered environmental conditions).  
•  Compromised human and animal therapy due to the use of antibiotic-
resistance marker genes in plants. In this scenario antibiotic resistance genes in 
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stomach) leading to increased resistance to antibiotics in human and animal 
pathogens (note, the nptII gene was not integrated in the case of MON 810). 
Whilst this is a long-established theory there remain wide differences of 
opinion as to the likelihood of it occurring, and the potential consequences if it 
did happen.  
•  Increased  Fusarium  infection of wheat may occur due to the increased 
cultivation of maize, grown more widely due to its GM-induced advantages. 
Maize is known to harbour Fusarium which can then be passed on to nearby 
wheat crops, thus creating disease problems for wheat growers. Evidence 
suggests that this scenario is unlikely to happen in the case of insect resistant 
maize (secondary infections are reduced due to lower rates of pest attack) but 
it may occur with other traits such as herbicide tolerance. 
 
In order to broaden the scope of any potential positive and negative effects in 
relation to human health, animal health and the environment the theme-based 
approach was applied to the above scenarios. The results are shown in table 9, 
below. 
 
 
Table 9 - Potential consequences if the hazard/or hazards are realised. 
  Potential effect 
Theme  Positive effect (benefit)  Negative effect (harm) 
Human 
health 
Potential production of beneficial 
compounds due to rearrangement of 
genes during transformation process. 
Potential production of deleterious 
compounds (e.g. pollen allergens) 
due to rearrangement of genes during 
transformation process; 
Potential loss of simple antibiotics  
Animal 
health 
Reduced fungal infection resulting in 
less mycotoxins 
Potential production of deleterious 
(e.g. toxic) compounds due to 
rearrangement of genes during 
transformation process; 
Potential loss of simple antibiotics  
Quality of life  Economic benefits of low-input maize 
production 
Potential allergenic effects of pollen 
may afflict some people. 
Agricultural 
sustainability 
Increase productivity for maize 
growers in areas with endemic corn 
borer populations 
May decrease agronomic resilience 
due to monoculture of maize; 
Fusarium infection may lead to yield 
reduction in wheat 
Environment 
for wildlife 
Reduction in use of pesticides will 
benefit non-pest species 
Maize monoculture may lead to less 
species diversity 
Air quality  None envisaged.  None envisaged. 
Water quality  Less pesticide runoff  Potential Cry protein leachates in soil 
Land use 
and soils 
Allows wider range of cropping  Cry proteins may harm soil organisms 
and cause detrimental effects on 
fauna/structure 
Greener 
business 
Reduction in use of pesticides  Possible detrimental effects on non-
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  Potential effect 
Theme  Positive effect (benefit)  Negative effect (harm) 
Sustainable 
resource use 
Less energy and resources will need 
to be expended to control insect pests 
‘Genetic meltdown’ may lead to loss 
of maize varieties/germplasm;  
Cry toxicity may lead to decline in 
non-target/beneficial organisms. 
Limit and 
adapt to 
climate 
change 
Secondary effect of energy use (see 
above). 
None envisaged. 
Regulatory 
effectiveness  
None envisaged.  If the problems outlined in the above 
scenarios occur it could divert funds 
from elsewhere. 
 
 
To demonstrate the applicability of the risk assessment methodology in terms of 
theoretical risks, a specific scenario must be selected from the list of hypothetical 
hazards. In this case it has been decided to examine more closely the risk of the 
‘silent spread’ of recessive genes/dormant traits leading to unintended effects in 
maize volunteers. 
 
 
 
 
 
Scenario 5: ‘Silent spread’ of recessive genes/dormant traits  
 
In this ‘blue sky’ scenario we have chosen to assess the risk to the environment 
posed by a deleterious recessive gene unintentionally produced in the maize 
genome during insertion of the transgene. As we now have a more specific risk to 
assess it is appropriate to revisit the initial question and revise it appropriately. In 
this case the following specific question is posed concerning the 
commercialisation of maize line MON 810: 
 
“What are the risks that a deleterious recessive gene will result harmful effect on 
the environment?” 
 
It should be noted that the question could equally apply to harmful effects on 
human and animal health, but for the purpose of this assessment we are restricting 
its scope to the environment.  Having rephrased question it may be appropriate to 
look again at how it is framed.  
 
4.  Hazard Analysis 
To gain a better understanding of the factors that may lead to the perceived 
hazard, and to understand the relationships between the contributing factors, 
graphical analysis has been employed. Figure 6 is a cause/consequence diagram 
showing the different interrelated events that are required to combine for the 
hazard to be realised. ‘Best estimate’ probability values have been assigned to Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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each event to demonstrate how the likelihood values might be derived, however, 
because the chosen scenario is a theoretical concept there are very little scientific 
data to support these values. 
 
 
Figure 6: Cause-consequence diagram showing how the genetic modification process 
may lead to unexpected detrimental effects over time. 
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The cause/consequence diagram in figure 6 explores the likelihood that transgene 
insertion into the plant genome will lead to a functional deleterious mutation. It is 
based on the premise that, in addition to ‘perfect’ transgene integrations, several 
rearrangements of the construct and of the target site can occur. Termed 
‘insertional mutagenesis’ this disruption of gene sequences can have deleterious 
effects on gene function and lead either to gene silencing or the expression of 
unintended novel genes. Agrobacterium-mediated integration in particular can 
result in complex integration patterns, including directed and inverted repeats 
(Krizkova and Hrouda, 1998), and the presence of such rearrangements is often 
associated with instability in transgene expression (e.g. Kumar and Fladung, 
2000). At present, even given a known nucleotide sequence, it is inherently 
impossible to predict the fate and the site of the integration of a particular 
transgene construct into the plant genome. The events listed B), C) and D) 
describe some of the factors which can result in sequence disruption. 
 
A) Disruption of endogenous plant DNA – Probability: 0.01 
Reasoning: A possible consequence of the random integration of transgenes in the 
plant DNA is the disruption of endogenous gene function due to the insertional 
mutagenesis process. At the site of insertion in the plant DNA chromosomal 
rearrangements linked to the T-DNA insertion are possible, including inversions 
and translocations. T-DNA integration into genes can cause mutations due to loss 
of gene function. This can result in phenomena such as gene silencing and the 
production of novel sequences. Little information exists on the likelihood of 
endogenous DNA disruption but extrapolating from similar   
 
B)  Insertion of extraneous DNA sequences  – Probability: 0.01 
Reasoning: The presence of backbone sequences (i.e. sequences belonging to 
bacterial plasmid outside the left and right borders) is often observed (De Buck et 
al., 2000), especially in the case of Agrobacterium-mediated transformation 
(Kononov et al., 1997). The genomic context of inserted transgenes has been 
investigated in some plant species and sequencing of flanking regions of T-DNA 
inserts has highlighted the recurring presence of motifs that flank transgenes, 
including retroelements, microsatellite sequences and tandem repeats (Cellini et 
al, 2004). Investigations in a limited number of species suggest the frequency of 
transfer of these non T-DNA sequences ranges between 0 to 31%. Here we have 
employed a cautious probability value of 0.01. 
 
C) Rearrangement of transgene construct/target site – Probability: 0.01 
Reasoning: Insertion of trangenes into plant chromosomal DNA can result in 
either single copy or repeated or multiple insertions, as well as inversion and 
translocations. Multiple insertions can occur in linked or unlinked sites and filler 
DNA of plant origin is often found between DNA repeats.  
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Reasoning: The various probabilities of disruption of endogenous DNA, 
extraneous DNA sequences and rearrangement of sequences are added together to 
obtain the overall probability of a deleterious mutation in the plant genome. 
 
E)  Deleterious mutation possesses functionality  – Probability: 0.01 
Reasoning: In the vast majority of cases the unintended rearrangement of DNA 
sequences will not lead to functional alleles. However in a very few instances it 
can be expected that the functional alleles will be produced and these will be 
expressed to some degree. This expression may be in the form of altered 
phenotype, altered plant response or altered composition, and such alteration may 
be detrimental or beneficial for the plant. Such unintended effects may result 
from conventional plant breeding, however the probability that they will arise due 
to the genetic modification process is thought to be greater. 
 
F)  Deleterious mutation is recessive  – Probability: 0.25 
Reasoning: In order for the effects of the deleterious mutation to go unnoticed 
during the production of hybrid seed it is necessary that the allele is recessive. 
 
G) Unintentional functional recessive allele in P1  – Probability: 0.0008 
Reasoning: Events D, E and F combine to give a probability for the occurrence of 
a deleterious functional allele in parent 1 that is recessive. 
 
H) No detection of subtle unintended effect during screening – Probability: 0.01 
Reasoning: During the development of a new transgenic plant variety assessments 
are carried out in the laboratory, glasshouse, and small field trial. Characteristics 
assessed include plant vigour, growth habit, yield, pest and disease resistance, 
composition and quality. During this evaluation process a large number of 
transformants/clones that do not perform to expectation will be discarded, thus 
the process will result in the elimination of major unintended effects. Subtle 
effects, however, that are less easily screened for, may remain undetected 
(Cellini, et al, 2004) due to the limitations of the screening process. The 
probability of detection depends on the subtly of the unintended effect.   
 
I)  P1 parental breeding stock with deleterious allele – Probability: 0.0000008 
Reasoning: Without detection of the unintended characteristic during small-scale 
screening the transformants are liable to be accepted as parent material for 
breeding. Currently most commercial varieties of maize are sold as hybrid seed, 
which will involve crossing the transformant with another maize line before 
larger-scale trials are conducted. 
 
J)  Dominant P2 allele masks recessive P1 allele – Probability: 0.75 
Reasoning: If the deleterious allele is recessive in the transformed P1 line and the 
P2 parent possesses a dominant allele then the unintended effects will be masked 
and expression will not take place. 
 
K) Production of F1 hybrid with recessive deleterious allele –  Probability: 
0.0000006 
Reasoning: F1 hybrid seed production will result in the deleterious effect not 
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L)  No detection of unintended effect during extensive trials due to ‘silent’ gene – 
Probability: 0.1 
Reasoning: Due to the virtually complete homozygosity of the parental lines, F1 
hybrids will have a very high level of heterozygosity. As a result any recessive 
alleles will be masked by dominant alleles with the result that unintended effects 
are not expressed in the hybrid.  
 
M) Widespread commercialisation of crop – Probability: 0.00000006 
Reasoning: With the absence of expression of the recessive alleles (and hence 
absence of the unintended effect) widespread commercialisation will be free to 
commence. This may result in large areas planted with the crop.   
 
N) Production of volunteers with homozygous recessive deleterious alleles – 
Probability:  
Reasoning: Maize volunteers are known occur in fields and by roadsides in the 
year following cultivation (e.g. Eastham & Sweet, 2002), although they are 
generally considered to be a minor weed problem due to the low germination rate 
and low viability. If the induced mutation increases the fitness of the volunteer 
plant (for example by enhancing its cold tolerance of reducing its susceptibility to 
pests) then more volunteers are likely to survive.  
 
O) Manifestation of unintended effect – Probability:  
Reasoning: Volunteers maize plants that are homozygous for the recessive allele 
will express the deleterious unintended effect in accordance with Mendelian 
ratios. This will result in expression of the unintended effect in the volunteer 
plants. It is also possible that the subtle unintended effects of the mutation could 
be enhanced by external stimuli, such as environmental conditions (global 
warming, for example) or attack by pests or diseases. It is also possible that 
crossing between different maize lines may enhance the expression of unintended 
genes. If the unintended effect confers a competitive advantage on the maize 
volunteers (e.g. enhanced frost resistance or insect resistance) they may be more 
difficult to control. If the mutation causes production of a toxin then there could 
be detrimental effects on insects that feed on the plant. 
 
 
5.  Assessing Likelihoods, Consequences and Risks 
As stated, due to the hypothetical nature of the scenario outlined above it is 
difficult to ascribe substantiated likelihood values to the various events that are 
necessary to realise the hazard. The values that have been assigned may not be 
precise but nevertheless the exercise of applying the framework to this type of 
scenario is useful in that it clearly illustrates the steps that are needed to reach the 
top level event. Simply setting out these steps in a logical way provides a good 
basic indication of how probable an event is and provide the necessary incentive 
to obtain data in the areas where it is lacking. 
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In the case of this particular scenario many more investigations need to be 
conducted to determine the likelihood of insertional mutagenesis taking place. 
 
 
7.  Compare Risk Against Criteria 
The release should be categorised as either acceptable or unacceptable when 
compared to the criteria set under Step 2. At present appropriate criteria needs to 
be developed for GM crops. 
 
 
 
 
 
 
8.  Identification and Evaluation of Mitigation and Monitoring Methods 
 
Having carried out an assessment of risk for the identified hazard it is appropriate 
to consider the type and extent of monitoring and mitigation measures that could 
be put in place to negate or reduce that risk. Table 10 shows potential monitoring 
and mitigation measures for the various events resulting from insertional 
mutagenesis and the production of volunteer plants which exhibit unintended 
effects. 
 
Table 10 – Potential prevention monitoring and mitigation methods 
Event Possible  monitoring 
methods 
Possible mitigation 
measures 
Deleterious 
mutation due 
to transgene 
insertion 
Profiling techniques such as 
genomics, proteomics and 
metabolomics could be used 
to help predict when to 
expect an expression of the 
recessive gene. Microarrays 
may help in early detection. 
Historic data from 
analogous cases may also 
help in prediction. 
Detection would allow 
plants with unintended 
effects to be discarded at the 
early stages of the 
assessment process; 
Methods to enhance the 
targeting of T_DNA are 
currently being developed. 
No detection 
of subtle 
unintended 
effect during 
initial 
screening 
More rigorous screening 
methods may help to detect 
cultivars with subtle 
unintended characteristics. 
Such screening methods 
may include challenging the 
plants with different 
environmental conditions 
and pest stimuli. 
Plants that do not perform 
as expected would be 
removed from the breeding 
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No detection 
of subtle 
unintended 
effect during 
extensive 
trials due to 
silent gene 
Silent genes are, by 
definition, not easy to 
detect. Generic surveillance 
monitoring of the 
environment or of the final 
products may help. 
Product recall and a 
cessation in sales may be 
required if unintended 
effects are severe. A 
programme could be 
implemented to control 
maize volunteers. 
 
MON 810 maize has been cultivated in the EU for a number of years and as yet 
none of the detrimental effects discussed above are known to have materialised. 
However, it may be that the plants have not yet encountered the appropriate 
stimuli, or there has not been sufficient length of time for any effects to manifest 
themselves. The production of maize volunteers exhibiting an unintended effect 
due to insertional mutagenesis is one of a number of hazards that can be 
hypothesized for GM organisms in general. Such effects are not merely theoretical 
– such unexpected effects have been documented for various GM lines, including 
glyphosate resistant soybean exhibiting splitting stems and yield reduction at high 
temperature; glucose oxidase expressing wheat exhibiting phytotoxicity; and 
glycinin expressing potato with increased glycoalkaloid content (for a full review 
see Cellini et al 2004). To complete a full and comprehensive risk assessment it is 
necessary to assess the likelihood and consequences of each hazards and 
determine the overall level of risk. Based on this overall risk the decision as to 
whether the risk is tolerable would be made. 
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IX.ii   
 7.1 Introduction 
 
This Appendix outlines areas of future work that could help to close the research gaps 
identified within the study.  For each suggested work package (WP) we have outlined: 
 
•  Rationale:  why the work is needed 
•  Objectives 
•  Scope: limits and boundaries 
•  Tasks:  what needs to be done to achieve the objectives  
•  Outputs:  envisaged deliverables and benefits 
•  Indicative timescale:  elapsed time 
•  Indicative cost:  
•  Dependence on or interaction with other WPs 
 
The Work Packages have been grouped under three main themes: 
 
•  Scientific Basis for risk assessment (Section A7.2)  
•  Tools and Techniques for risk assessment (Section A7.3) 
•  Risk assessment as  tool for Deliberation and Decision-making (Section A7.4) 
 
This categorisation is purely for ease of reference.  There will be interactions between 
the themes and WPs.   
 
The costs given are intended only to give a broad idea of the likely range. The scope 
and depth of each WP can be adapted to reflect the EC’s priorities, and any overlaps 
with other research in the environmental risk field.   The costs indicated are costs to 
the EC (or other research sponsor).  Costs to regulators or industry in implementing 
any resulting guidance have not been estimated, as the implications for them cannot 
be foreseen at this stage, and costs will depend on many factors - the specific national 
context, what releases come forward, how regulatory costs are charged and so forth.    Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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7.2. Scientific Basis for Risk Assessment 
 
WP1: Obtaining Baseline Data 
Rationale:  There is a need for good baseline data if monitoring is to be able to detect 
changes 
Objectives:  To advise on what baseline data should be collected 
Scope: The main scientific question is what baseline data should be gathered, i.e. 
what are the best indicators of long term/ cumulative changes?   As well as this 
scientific question, there are institutional and other practical aspects of 
implementation to be considered.  For example, who should carry out the baselining, 
and would it relate to ecological baselining for other purposes?   These issues could 
also be considered, at a high level, to provide guidance 
Tasks:  This WP would build on existing national research regarding indicators for 
short term effects, extending it to the consideration of long term and cumulative 
effects, and to the EU as a whole.   
Outputs:  Research report, giving guidance on what baseline data should be 
collected, and outlining how institutional and practical issues and how they could be 
addressed.  
Indicative timescale:  I year 
Indicative cost:  50000 Euro 
Dependence on / interaction with other WPs:  Outputs from WP3 would inform the 
choice of indicators.  There are also some common areas with WP6.  
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WP2: Ranking the Risks of Generic Crop-Trait combinations  
Rationale:  It could be more cost-effective, for society as a whole, if some risk 
assessment work were to be done at a higher level than the release-specific ERAs.  If 
certain crop-trait combinations (or other types of scenario) could be ranked in broad 
order of inherent risk.  This would help both regulator and industry to ensure 
proportionate levels of depth and detail in risk assessments.  It might also lead 
regulators to issue guidance indicating any broad classes of combinations that would 
be unlikely to be authorised, preventing wasted effort by all parties.  
Objectives:  To establish whether certain crop-trait combinations are inherently 
riskier than others 
Scope:   the study should consider the range of releases for which applications can 
foreseeably be expected. 
Tasks:   
•  Define the scenarios to be considered – a set of crop-trait combinations spanning the 
likely range of releases  
•  Apply the risk assessment framework, at a high level, to each scenario 
•  Rank the scenarios in order of risk, and identify what characteristics contribute most  to 
this ranking 
•  Develop guidance – how can knowledge of what scenarios or characteristics are most 
risky be used to help ensure a proportionate and effective regulatory process?  
Outputs:  Research report describing the risk assessments of each scenario, and 
interpreting the findings to provide guidance to regulators 
Indicative timescale:  6 months 
Indicative cost: 40000 Euro 
Dependence on / interaction with other WPs:  This study could inform the choice 
of priority crop/ trait combinations to be studied under WP3.  Or, conversely, outputs 
from WP3 could inform this study, by helping to identify combinations for which the 
risks of introgression and spread were greatest.   
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WP3:  Introgression into and Ecology of Wild Relatives 
Rationale:  Currently, the mechanisms, and hence likelihood, of introgression into 
wild relatives, are not understood in sufficient detail for robust risk assessment.   
Neither is there, in general, a good enough understanding of the ecology of wild 
relatives, and hence of how undesirable traits might spread in the environment.  
Objectives:  To improve the understanding of mechanisms of introgression or 
ecology of wild relatives in sufficient detail for risk assessment. 
Scope:   In order to keep the study within manageable bounds, it would probably be 
necessary to identify some priority crop – trait - wild relative combinations for which 
the mechanisms of introgression and spread were to be studied.   
Tasks:     
•  Identify priority crop – trait - wild relatives combinations to be studied 
•  Desk study/ literature review to establish the state of knowledge about 
mechanisms of introgression and spread.   
•  Explore potential for, and apply  where appropriate, novel approaches,  For 
example, what is the potential to learn from natural analogues, using historic 
or palaeontological evidence about the spread and impacts of new or 
introduced species? 
•  Laboratory and field experiments to establish effects of traits on fitness, 
factors affecting establishment in various niches, etc 
•  Analysis and synthesis of information from desk and experimental studies – 
possibly incorporation into a model. 
 
Outputs:  Research report updating the understanding of mechanisms of introgression 
or ecology of wild relatives.   
Indicative timescale:  3 – 4 years 
Indicative cost:  1 Million Euro 
Dependence on / interaction with other WPs: WP 2 could inform the initial choice 
of priority crop/ trait combinations.  Conversely, or at a later point, outputs from WP3 
could inform WP2, by providing data on more specific crop-trait combinations with a 
high risk of introgression and spread.     
The ecological part of the work could be related to other ecological studies, outside 
the GM field. 
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7.3 Tools and Techniques for Risk Assessment  
 
WP4: Improved hazard identification for long term and cumulative effects 
Rationale: In the workshop and case studies, we found it difficult to identify hazards 
that were different in kind from those that can occur in the short term.   In most 
cases, the hazards identified were the same as the short term ones, although the 
degree of risk associated with the hazard could be greater.  Typically, given a longer 
time or more widespread planting of a crop, the likelihood and extent of undesirable 
effects may increase.   
Nevertheless, some genuinely different hazards were identified.   These tend to arise 
from rather subtle and complex combinations of factors, which would only be 
manifested in the long term or with widespread releases and plantings.   The process 
of identifying long term and cumulative risks could be made more efficient and 
effective if standard hazard-identification techniques (brainstorming, failure 
analyses, HHA etc) could be enhanced to focus more quickly on such genuinely long 
term and cumulative effects.  
Objectives:  To develop hazard-identification techniques that focus on genuinely long 
term and cumulative effects. 
Scope:    
Tasks:   
•  Identify existing methods that could be adapted (brainstorming, failure 
analyses, HHA etc) 
•  Develop novel, improved methods 
•  Test, refine and demonstrate the improved methods in a case study comparison 
with traditional methods 
Outputs:   Research report describing the study, the improved methods and guidance 
on their application. 
Indicative timescale:  6 months 
Indicative cost:   50000 Euro 
Dependence on / interaction with other WPs:   WP3 could provide input regarding 
specific potential mechanisms that hazard identification would need to consider. 
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WP5:  Tolerability Criteria 
Rationale: The absence of explicit criteria in the Directive for judging whether a risk 
is tolerable, and the apparent variations in practice between Competent Authorities, 
point to a need to develop some more explicit guidance on criteria that will encourage 
well-founded, consistent and fair decisions.   As well as defining criteria against 
which to judge the outputs of assessment, decisions about tolerability affect the level 
of assessment required.  The more stringent the criteria, the more effort will need to 
go into demonstrating how they will be satisfied. 
Objectives:  To develop justifiable criteria for tolerable risk, and guidance on their 
application. 
Scope:  The main questions and areas for further development are as follows: 
•  What benchmarks or standards can be adopted?  For example tolerable levels 
of risk could be defined by reference to a comparison with the risks from the 
unmodified crop in the current environment, or against the risks from the 
current crop allowing for normal bounds of variability and mutation in that 
crop and its environment.   
•  How is the precautionary principle to be interpreted?  Is there a need for a 
formal requirement to minimise risks, such as the As Low As Reasonably 
Practicable (ALARP) principle?  Should there be a ‘bias in favour of safety’?   
•  Should the assessment take account of benefits as well as risks?   
•  Given the large and to some extent irreducible uncertainty in assessing long 
term and cumulative effects, what level of confidence in the assessment is 
required in order to make a decision?   What are the appropriate rules for 
decision-making under uncertainty?   
•  How should tolerability criteria take account of ethical considerations such as 
environmental and social justice, the bounds of discourse, value judgements 
about the weight given to various benefits and risks, and issues of 
responsibility and choice arising from the potential for decisions taken now to 
affect future generations? 
Tasks:   
•  Review the international literature on risk tolerability 
•  Consult with stakeholders in the GM crops domain and more widely 
•  Develop a range of potential criteria 
•  Illustrate how the criteria could be applied in practice, for example by means 
of case studies 
 
Outputs:   Research report describing the justification for the proposed criteria, 
providing guidance on their use and comments on advantages and disadvantages  
Indicative timescale: 4 to 6 months 
Indicative cost: 30000 to 50000 Euro 
Dependence on / interaction with other WPs:  Social and ethical aspects of risk will 
need to be considered in WP5.  Dependent on timing, WP5 and WP7 could inform 
each other. 
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WP6: Tracking, Combining and Monitoring Cumulative Risks  
Rationale:  In considering cumulative risks, the EC will need mechanisms to track 
and combine the risk assessments from multiple, and in some cases apparently 
unrelated, releases.     
Objectives: To explore the scientific and institutional issues involved in tracking 
multiple release assessments and consents and to develop guidance. 
Scope:  The study would consider both scientific aspects (how to identify any 
potential for cumulative risk) and institutional (processes and procedures, IT issues)  
Tasks:   
•  Desk studies and interviews to identify current procedures for tracking 
applications and releases 
•  Analysis of findings 
•  Development (in consultation with EC) of guidance  
Outputs:   Review of issues and guidance on implementing a programme for tracking 
and combining risks 
Indicative timescale:  3 months 
Indicative cost:   30000 to 50000 Euros (dependent on state of evolution and 
complexity of current processes)  
Dependence on / interaction with other WPs: 
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IX.iii   
7.4. Risk assessment as a tool for Deliberation and Decision-making 
 
WP7: Stakeholder Engagement in Risk Assessment 
 
Rationale: In other controversial debates about risk and the environment, there has 
been a growing realisation of the importance of considering social and ethical aspects. 
Stakeholder participation in framing the question and defining methods is being given 
serious consideration and has occurred in some cases, in addition to the more 
traditional model, in which stakeholders review and challenge assessment results and 
assertions.   Risk assessment should be developed and used as a structured framework 
for discourse and decision-making under irreducible uncertainty, rather than as a 
technical and scientific exercise alone.  Deliberative processes have been used in other 
domains, and this experience could potentially be adapted and applied to the GM 
domain. 
Objectives:  Explore how deliberative processes have been used in other risk 
domains, and how this experience could be applied to the GM domain. 
Scope:  
Tasks: 
•  Collate literature and gather experience on deliberative processes 
•  Identify/ adapt  approaches that could be appropriate in the GM crops domain 
•  (Optional) Conduct a trial application, linked to one or more current 
applications.  The practicalities of conducting such a trial would require 
further discussion with EC 
•  Develop guidance 
Outputs:  Research report, reviewing how deliberative processes have been used in 
other risk domains, and guidance on how this experience could be applied to the GM 
domain. 
Indicative timescale: 2 months (significantly longer a if trial application were to be 
carried out) 
Indicative cost:  10000 Euro (more  if a trial application were to be carried out) 
Dependence on / interaction with other WPs:  Social and ethical aspects of risk will 
need to be considered in WP5.  Dependent on timing, WP5 and WP7 could inform 
each other.  
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8.1.  C/NL/98/11 Roundup Ready oilseed rape, event GT73 (Monsanto – updated 
version July 2003). 
 
Trait: Tolerance to the herbicide glyphosate (‘Roundup Ready’). 
Scope: The notification covers the importation and storage of GT73 oilseed rape and 
its use as feed as well as in the processing for feed, and its industrial uses as or in 
products. 
Current status: European Commission decision 31 August 2005
12; consent not yet 
issued. 
Note: Originally submitted in 1998 under Directive 90/220/EC, which did not require 
elucidation of monitoring plans, these have been added in subsequent submissions to 
the lead competent authority. 
 
IX.iii.1.2 Proposals  for  case-specific monitoring 
The notifier claims that the results of the environmental risk assessment show 
effectively zero overall risk arising from the placing on the market of GT73, therefore 
case-specific monitoring is not considered applicable to the placing on the market of 
this product. It should be noted that several Member States commented that the 
prevention of seed spillage and the consequences of it happening have not been 
sufficiently taken into account, and more information is needed (see comment on this 
below). 
 
IX.iii.1.3  Proposals for general surveillance 
The notifier will ensure that awareness of the GM crop is made widely available by 
providing key information, for example: 
•  The notifier will provide international traders with the necessary information 
to comply with statutory requirements relating to the placing on the market of 
the crop; 
•  Product briefings to selected networks; 
•  Technical literature (e.g. product-specific information, company contact 
details). 
 
Further information and relevant legislation will be available from a number of 
sources, including industry and government websites, official registers and 
government publications. 
 
Surveillance information will be collected from 1) feedback from selected networks, 
and 2) reported potential adverse effects and other relevant information received via 
direct contacts with the notifier. Where unanticipated adverse effects are confirmed 
they will be investigated to establish if there is a correlation between the observed 
effect and the GM crop, and if so appropriate remedial action will be carried out. 
 
European Commission document 2005/637/EC
13 addressed concerns regarding 
potential for spillage of GT73 oilseed rapeseeds by advising: “specific technical 
guidelines should be added to the decision to place GT73 oilseed rape on the market 
                                                 
12 Document number 2005/635/EC.  OJ L228 pp 11-13 03/09/2005. 
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to prevent any damage to the environment in case of accidental spillage of the 
product.” 
 
Summary 
•  Short-term risks: consistent with other authorisations for import and processing. 
•  Long-term cumulative: key risks are associated with unmitigated spillage of 
GT73 rapeseed along roadsides, railways, waterways, leading to establishment of 
localised feral populations of GT73 and possibly gene transfer into sexually 
compatible species.  Risks of reduced biodiversity in areas where this persists, 
and possible economic risks to commercial oilseed rape crops. 
•  Consent holder will be required to monitor spillage, and to encourage reporting 
of unexpected adverse effects as part of the general surveillance plan.  How 
effectively this will work in practice away from the port environments is yet to be 
tested.  Monitoring will only operate for the duration of the release. 
 
 
IX.iii.1.3.1 Detailed  assessment 
Human toxicity and allergenicity 
GT73 oilseed rape is modified for tolerance to glyphosate through the introduction of 
two genes, which encode CP4 EPSPS and GOX proteins.  This was the first 
assessment of GOX for European market introduction.  There are no antibiotic 
sequences in GT73 OSR.  In the scientific assessment the notifier states that CP4 
EPSPS protein has been demonstrated to be functionally similar to the EPSPS 
proteins typically present in food and feed derived from plant and microbial sources; 
there are reported to be no indications of toxicity from studies undertaken with mice 
and these studies are proposed to support the safety of CP4 EPSPS protein.  The GOX 
enzyme has been extensively characterised and degrades glyphosate via a well-known 
degradation pathway.  The notifier states that a number of studies have been 
undertaken that establish that the GOX protein and its enzymatic activity rapidly 
degrade in gastric and intestinal models, indicating that it will also degrade readily in 
the mammalian digestive tract.  The notifier presents results of compositional analyses 
of GT73 OSR, in terms of protein and oil content, fatty acid profile, glucosinolate 
content and profile and proximate analysis and concluded that GT73 is substantially 
equivalent to the parental conventional variety.  Both EPSPS and GOX proteins are 
heat and pH labile and are rapidly degraded on exposure to simulated digestive tract 
fluids, and are considered unlikely to have allergenic potential.  EPSPS and GOX 
show no significant homology on the DNA level with known toxins and allergens.  
Acute toxicity studies did not point to any effects caused by expression of the 
proteins.  It was concluded there are no reasons to assume that the CP4 EPSPS and 
GOX protein will have a toxic or allergenic effect upon incidental consumption or as 
use of feed of GT73, nor that the degradation products of the catalytic activity of the 
proteins will have a toxic effect. 
 
Safety assessments have been in the form of standard short-term assessments, which 
are effective in uncovering acute toxicity but less valuable in determining chronic 
toxicity. The same theory applies in the case of allergenicity, where certain 
individuals (e.g. workers in contact with grain dust or animals being fed the meal) are 
more sensitive to certain compounds.  Such predispositions may only become 
apparent over time, and sensitisation may increase with increased exposure to the Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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compound. It would seem prudent, therefore, to have a system of monitoring in place 
to confirm the results of the risk assessment in the longer term.  Questions on this 
could be considered for inclusion as part of general surveillance monitoring. 
 
In their assessment of GT73, EFSA noted recent reports that the GOX protein shares a 
6-amino acid sequence present in a 9-amino acid epitope from the major shrimp 
allergen tropomyosin, which binds IgE in sera of shrimp allergic patients (Kleter and 
Peijnenburg, 2002)
14; another publication describes the 9-mer peptide as potentially 
cross-sensitising (Ivanciuc et al., 2002)
3.  Given the presence of similar sequences in 
various other allergens EFSA concluded that since the presence of the GOX protein in 
GT73 derived oil meant for human consumption cannot be excluded, the relevance of 
such a finding should be assessed according to existing guidelines. 
 
There are no potential risks from allergy to oilseed rape pollen as the crop will not 
deliberately be cultivated. 
 
IX.iii.1.3.1.1.1 Potential  to compromise human therapy 
As there will be no direct consumption of oilseed rape meal by humans no direct or 
indirect effects were noted that might compromise human therapy.  There are no 
antibiotic sequences in GT73 OSR. 
 
IX.iii.2 Potential beneficial effect to humans 
The crop will not be cultivated in Europe therefore any potential benefits, e.g. of 
reduced herbicide application will not be realised. 
 
Animal toxicity and allergenicity 
There will be no direct exposure of animals to the modified oilseed rape plants as the 
authorisation is not for cultivation.  There are no antibiotic sequences in GT73 OSR.  
Animals will be exposed to the denatured EPSPS and GOX proteins in animal feed at 
low concentration.  Feeding studies were carried out on rats, rainbow trout, quail, 
chickens for fattening and lamb (extrapolations were made to pigs and cows) and the 
scientific assessment found no evidence of acute toxicity from the CP4 EPSPS and 
GOX proteins.  Note the comments above regarding relatively short-term feeding 
studies that do not identify longer-term/cumulative chronic effects. 
 
Compromised animal therapy 
The scientific assessment did not identify any risks.  Some concerns have been raised 
over the possible effects on human and animal health of the possible presence of 
residues of glyphosate and its metabolites.  The assessment of these risks is covered 
within the framework of a different EU directive 91/414/EEC concerning placing of 
plant protection products on the market. 
 
Potential beneficial effect to animals 
None are identified.  An indirect effect of the availability of GT73 may be noted as a 
result of cheaper supply of rapemeal for inclusion in animal feed, this may lead to 
improved diet of otherwise poorly fed animals which may have concomitant health 
and welfare benefits. 
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IX.iii.3  
Disease to plants: 
As the crop will not be authorised for cultivation in Europe there should be no impacts 
on plant disease levels.  Even if localised populations of plants containing the GT73 
transgene are allowed to establish and persist over a long period as a result of spillage, 
there is not reported to be any alteration in the susceptibility of GT73 to pests or 
diseases. 
 
Target organisms (incl. predators and parasitoids) 
The crop will not be authorised for cultivation in Europe and it is not modified for 
insect resistance, therefore there are no target organisms.  If localised populations of 
plants containing the GT73 transgene are allowed to establish and persist over a long 
period as a result of spillage, we are not aware of any reports suggesting that herbicide 
tolerance leads to altered palatability for herbivores, which may result in 
direct/indirect effects. 
 
Effects on non-target organisms 
The crop will not be authorised for cultivation in Europe and it is not modified for 
insect resistance, therefore there are no non-target organisms.  The safety assessment 
states that analyses of seeds and derived factions (oil and meal) show that the 
chemical composition is not changed relative to the parental conventional variety.  
Direct or indirect effects on other organisms in the environment as a result of either 
feeding on spilled seed, or herbivory of plant populations that may establish following 
spillage has not been considered in the short-or long-term. 
 
Effects of gene-transfer (incl. to soil organisms) and Potential for 
increased weediness 
The crop will not be authorised for cultivation in Europe so potential for gene flow 
leading to hybridisation and gene transfer is not a major consideration in the ERA.  
However, should GT73 be grown illegally or inadvertently (e.g. due to spillage or 
adventitious presence), there is potential for gene transfer from Brassica napus to 
B.rapa, B. juncea and B.campestris, and to other crops of B.napus.  Field trials have 
demonstrated that GT73 and its progeny are unlikely to be more persistent in the 
natural environment than the parental conventional variety.  Possession of the 
herbicide resistant transgene will only result in a selective advantage for sexually 
compatible species in situations where glyphosate is in use; this is most likely to be 
semi-managed environments e.g. roadsides, railway lines, waterways, and in managed 
agricultural environments.  In these situations, if alternative treatments were not 
employed to remove or control the spilled GT73 OSR seed or relatives containing the 
herbicide resistance transgene, it is possible that this may have direct impacts on the 
biodiversity of local plant communities and possible direct economic impacts on 
nearby conventional oilseed rape crops.  Localised events such as these, if unnoticed 
in the short term could have more serious indirect effects on local natural 
communities if allowed to continue over the long-term and on a cumulative basis.  
The proposed monitoring programme recognises the potential for spillage, as does the 
European Commission.  Currently much imported rapeseed arrives at European ports 
and is crushed in the vicinity of the port then transported as the oil.  However, with 
the expansion of the EU member states it is not inconceivable that a number of Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
environment:  risk assessment methodologies 
Reference:  No 07-0402/2005/414455/MAR/B4 
 
5 
different commodity transport scenarios will arise, increasing the possibility for 
spillage and the longer-term consequences that this may bring. 
 
Altered susceptibility to pathogens facilitating the dissemination of infectious diseases 
and/or new reservoirs or vectors 
The crop will not be authorised for cultivation in Europe and it is not modified for 
pathogen resistance.  There is no evidence that GT73 OSR has altered susceptibility to 
pests or diseases. 
 
Horizontal gene transfer 
As the crop is not authorised for cultivation, the conditions for horizontal gene flow 
should not arise.  Both CP4S EPSPS and GOX proteins are derived from soil dwelling 
bacteria; while horizontal gene flow is considered theoretically possible, the safety 
assessment cites a number of studies have concluded that it is negligible (e.g. Smalla 
et al 2000, Simonet 2000).  The safety assessment also states that there are reports of 
long term persistence of transgenes in soil, but no transfer to soil bacteria has been 
detected (e.g. Gebhard and Smalla 1999).  Even if localised populations of plants 
containing the GT73 transgene are allowed to establish and persist over a long period, 
there is little evidence to suggest that this should specifically be monitored. 
 
Effects on biogeochemistry, particularly carbon and nitrogen recycling through 
changes in soil decomposition 
As the crop is not authorised for cultivation there should be no effects on 
biogeochemistry, assuming that monitoring and remediation of spillages of GT73 is 
effective.  Even if localised populations of plants containing the GT73 transgene are 
allowed to establish and persist over a long period, both CP4 EPSPS and GOX 
proteins are derived from soil dwelling bacteria and do not demonstrate any known 
toxicity. 
 
 
 
 
8.2.  C/FR/96/05/10 - Bt11 maize (field or sweet maize) (Syngenta Seeds SAS) 
 
Trait: Resistance to corn borers Ostrinia nubilalis and Sesamia nonagrioides using 
the Cry1Ab gene. 
Scope:   For use as any other maize, including cultivation in the EU.  Bt11 also 
possesses herbicide tolerance but the scope of the notification has been limited to use 
without the application of glufosinate ammonium herbicides. 
Current status: pending authorisation. 
 
Case-specific monitoring 
Based on the environmental risk assessment the notifier concluded that no case-
specific monitoring was necessary; however, in order to delay insect resistance to 
Bt11, an Insect Resistance Management plan would accompany Bt11.  The 
monitoring plan was divided into four parts:  
•  Maintenance of refuges (20% in the case of holdings with over 5 ha of maize); 
•  Monitoring of Bt resistance;  
•  Action plan in the event of resistance being detected;  Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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•  Training for producers.  
Some Member States have commented that case-specific monitoring should also be 
undertaken to consider the impact of insect resistance on non-target insects  
 
General surveillance 
The proposed general surveillance plan includes an assessment of the impact of Bt11 
on non-target arthropods and the impact of tolerance to the herbicide, but its 
implementation in practice has still to be finalized.   
 
The original proposal for general surveillance was revised in May 2004.  The revised 
proposal includes more detailed plans for surveillance ‘modules’ operating within 
existing surveillance ‘nodes’ in agriculture, the environment (agro-environment and 
wider environment) and the supply chain for living Bt11 maize grains.  A detailed 
farmer questionnaire has been developed to collect relevant information from farmers 
relating to environmental and agronomic aspects of the GM crop (questions 
specifically cover agricultural practices, general observations of the crop and corn 
borer infestation).  Farmer data will be collected from a structured subset of farmers 
within a representative geographical area and participant numbers will be sufficiently 
large to allow for meaningful data analysis.  The exact network will be defined in 
advance of commercialisation of Bt11 maize in specific regions, Syngenta will 
coordinate and report the monitoring; all data will be compiled in a  ‘general 
surveillance database‘.  It still remains to be seen exactly how this general 
surveillance monitoring will work in practice and how the various networks involved 
will be compelled to participate. 
 
Summary 
•  Short-term risks: currently proposals will only identify development of resistance 
in target organisms.  Will not identify any indirect effects on non-target 
populations.  Farmer questionnaire will provide information regarding on-farm 
effects. 
•  Long-term cumulative risks: key risks are likely to be associated with target and 
non-target organisms; on-farm monitoring may extend for 1 year beyond the life 
of the consent in the form of farmer questionnaire. 
 
IX.iii.3.1 Detailed  assessment 
 
Human toxicity and allergenicity 
The scientific assessment of Bt11 maize included examination of the inserted DNA, 
the nature of the donor organisms and the characteristics and safety of the newly 
expressed proteins produced by the transgenic plants. In addition, a comparative 
analysis of agronomic traits and composition was undertaken and the safety of the 
product as a whole was evaluated with respect to toxicology and allergenicity. 
Following this assessment the notifier concluded that expression of the Cry1Ab 
protein would not lead to increased toxicity or pathogenicity of the recipient organism 
and consequently case-specific monitoring was not warranted.  
 
It should be borne in mind that the safety assessments of Bt11 have been in the form 
of standard short-term assessments, which are effective in uncovering acute toxicity 
but less valuable in determining chronic toxicity. The same theory applies in the case Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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of allergenicity, where certain individuals (be they workers in contact with grain dust, 
or cows being fed the product) are more sensitive to certain compounds.  Such 
predispositions may only become apparent over time, and sensitisation may increase 
with increased exposure to the compound. It would seem prudent, therefore, to have a 
system of monitoring in place to confirm the results of the risk assessment in the 
longer term.  Questions on this could be considered for inclusion in the stewardship 
and farmer questionnaire schemes that Syngenta has developed as part of general 
surveillance monitoring. 
 
Potential to compromise human therapy 
There is no evidence that intact gene transfer to micro-organisms in the human gastro-
intestinal tract can occur.  If gene transfer were to occur the ERA considers that the 
Cry1Ab and PAT proteins would not be expressed because of the lack of bacterial 
promoters in Bt11. Furthermore, if expression of these proteins were to occur they 
would not confer any disadvantage and would not compromise therapy to human 
disease. 
 
Potential beneficial effect to humans 
Due to a reduction in secondary infections of maize plants by fungal pathogens due to 
the use of Bt11, the ERA considers there will be an increase in grain quality and a 
reduction in the levels of mycotoxins. 
 
Animal toxicity and allergenicity 
A large number of studies have been performed comparing the composition of Bt11 
maize and conventional maize.  Several feeding studies have also been conducted 
using various parts of the Bt11 plant, including studies employing poultry and milking 
cows, and whilst these have shown no detrimental effects it should be noted that the 
duration of most of these was no more than 14 days.  Additionally, although Bt11 has 
been used for animal feed in the USA for several years, very few scientifically 
rigorous long-term feeding studies have been conducted, thus there is a scarcity of 
data on long-term animal exposure to Cry proteins (including any potential effects on 
gut micro-organisms) and on the nutritional or anti-nutritional properties of Bt11. In 
addition, despite numerous backcrosses, there is always the possibility that either the 
insect resistance trait or the herbicide tolerant trait could become unstable in the plant 
genome, leading to the production of novel proteins with unforeseen effects. 
 
Compromised animal therapy 
In the case of cattle fed with Bt11 there is evidence for the transfer of small fragments 
of predominantly non-recombinant DNA (<200 bp) in some tissues, indicating that 
transfer can occur from plant material to animal tissue. However the ERA concluded 
that there is no reason to expect such transfer to cause adverse effects, and no case-
specific monitoring was proposed for this occurrence. 
 
Potential beneficial effect to animals 
Maize kernels from Bt-expressing crops have been found to have a lower level of 
Fusarium infection compared to kernels from conventional crops, and this is 
accompanied by a reduction in the content of the mycotoxin fumonisin, which can 
cause a variety of toxic effects in animals.  
 Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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Disease to plants 
Pathogenicity - detailed open reading frame analysis of the inserted DNA has found 
no evidence for proteins other than those for Cry1AB and PAT. Two components 
used to generate the transformation event are derived from plant pathogenic 
sequences, tNos derived from Agrobacterium tumefaciens and p35s derived from 
Cauliflower Mosaic virus, and whilst there has been a debate on the safety of using 
sequences derived from plant pathogens, the consensus of opinion is that they pose 
very little risk. 
 
Target organisms (incl. predators and parasitoids) 
Based on information from a number of countries currently growing Bt maize, the 
ERA concluded that a risk to beneficial arthropods and non-target species could not 
be identified and case-specific monitoring would not reveal any unanticipated effects. 
However, in order to delay insect resistance to Bt11, an Insect Resistance 
Management Plan (IRM) has been proposed by the notifier. This management plan 
will be based on non-Bt maize insect refugia, high dose expression of the Cry protein, 
and effective monitoring. The plan consists of the following elements:  
•  Maintenance of refuges (20% in the case of holdings with over 5 ha of maize); 
•  Monitoring of Bt resistance;  
•  Action plan in the event of resistance being detected;  
•  Training for producers.  
In its advice of UK Advisory Committee on Releases to the Environment (ACRE) 
considered the IRM strategy and the monitoring of resistance to be adequate, however 
the Committee did state that it may be appropriate to consider the impact of the insect 
resistance trait not only on the primary targets Ostrinia nubilalis and  Sesamia 
nonagrioides,  but also on other potential maize or grass feeding Lepidoptera that 
might be affected.  Such species could include Agrotis ipsilon (Noctuidae), 
Helicoverpa spp. (Noctuidae), Mythimna unipunctata (Noctuidae) and Peridroma 
saucia, all of which are minor pests of maize and thus can be seen as secondary target 
organisms rather than non-target organisms.  In the long term and/or with cumulative 
exposure of these organisms to Bt11 maize  
 
Effects on non-target organisms (Lepidopteran & non-Lepidopteran) 
The ERA notes that butterflies and the majority of moths do not feed directly on 
maize plants, therefore the only potential route of exposure to the Cry1Ab protein 
would be by feeding on plants covered by maize pollen. The notifier points to a 
number of recent scientific studies that support the conclusion that butterfly larvae 
and maize pollen are unlikely to coincide, either temporally or spatially, and thus 
butterflies are unlikely to be significantly exposed to Bt pollen. In the case of non-
lepidopteran insects the ERA acknowledges that some studies have found detrimental 
effects of Bt-maize on lacewings and forest gypsy months, but points to a large body 
of literature and field experimentation that indicates that any exposure which did 
occur will not have a significant adverse impact.  Studies commissioned by Monsanto 
Company have looked at the toxicity of purified Bt proteins on honey bees (larvae and 
adults), lacewing larvae, parasitic hymenoptera and ladybirds, and have concluded 
that the protein is not toxic at concentrations present in the insect-protected maize 
plants and grain.  The ERA points out that field studies and laboratory trials involving Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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non-target insect populations and soil organisms have been undertaken, but to date 
none have shown any adverse effects of Bt maize. 
 
Regarding soil binding of the Bt-protein, the ERA notes that there is some 
discrepancy in the literature as to whether binding to soil particles affects insecticidal 
activity and whether such binding decreases the rate of bacterial degradation. 
Ledipopteran larvae are rare in the soil, although they do sometimes occur there. 
Studies conducted using earthworms, collembola, carabid beetles, the general 
arthropod soil fauna and soil micro-organisms have not shown toxicity of the Cry1Ab 
protein. The notifier highlights the fact that there are no indigenous species in the EU 
that rely exclusively on maize pests for survival, either as symbionts, predators or 
pathogens, thus it is unlikely that the reduction in numbers of target organisms will 
affect the population levels of these non-target organisms. Nevertheless, it must be 
remembered that the majority of observational studies on non-target organisms have 
been conducted in the USA which has a very different invertebrate fauna to the EU, 
and those field trials and laboratory studies that have been conducted in Europe have 
been on a relatively small scale compared to the scale that can be envisaged if Bt11 is 
commercialised. 
 
For consideration of longer term and/or cumulative effects, it would seem prudent, 
therefore, to test the assumptions made in the ERA concerning non-target organisms, 
particularly with respect to impacts on the wider food web.  In addition, rather than 
confining monitoring just to insects, there may be justification to monitor a wider 
range of non-target organisms, from soil-borne nematodes (which include useful 
indicator species) at the lower trophic level, to organisms that are nearer the top of the 
food chain, such as birds. Interestingly, even badgers are known to feed on maize, 
knocking over plants and feeding on the grain in dry summers when slugs and snails 
are in short supply. 
 
Effects of gene-transfer (incl. to soil organisms)  
Due to the lack of wild or weedy relatives of maize in Europe there is no opportunity 
for the transfer of the herbicide tolerance trait to wild relatives, however 
dissemination of pollen to other cultivated maize plants could occur, leading to cross-
pollination. Theoretically there is then a degree of risk that the transgene could be 
passed to maize crops grown for seed, and thus become established in the maize 
genetic pool. However the majority of seed-producing companies are known to screen 
their seed for GM elements to detect and prevent adventitious GM presence.  In 
addition, co-existence arrangements should minimise the risk of this occurring.  With 
respect to the risk of gene transfer to soil micro-organisms, the ERA states that there 
is no reported evidence to suggest that intact gene transfer occurs from plants to 
micro-organisms under natural field conditions, however see the comment above with 
respect to monitoring non-target organisms. 
 
Potential for increased weediness 
Under current agricultural practices, maize volunteers are not considered to be an 
agronomic problem and where they do occur they are easily controlled by herbicide 
application or mechanical means.  Maize is winter hardy only in parts of Southern 
Europe.  The ERA acknowledges that expression of insect resistance may give a 
selective advantage to maize growing outside the managed agricultural environment, Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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but states that maize is incapable of surviving without human intervention.  Similarly, 
expression of the pat gene may result in a selective advantage for maize plants 
sprayed with glufosinate ammonium herbicides, but again the risk of maize surviving 
outside the agricultural environment is remote.  The ERA concludes, therefore, that 
the introduction of Bt11 will not result in increased persistence of maize volunteers 
and therefore has not proposed a case-specific monitoring plan for these factors. 
 
Altered susceptibility to pathogens facilitating the dissemination of infectious diseases 
and/or new reservoirs or vectors 
The ERA does not envisage that the use of Bt11 maize will result in altered 
susceptibility to pathogens facilitating the dissemination of infectious diseases and/or 
providing new reservoirs or vectors. The ERA did however conclude that Bt11 may 
lead to reduced Fusarium infection in the maize due to a reduction in corn borer 
damage which can lead to secondary fungal infections. No case-specific monitoring 
has been proposed for altered susceptibility to pathogens, or how, in the longer-term 
or on a cumulative basis, this may affect the incidence of fungal diseases on 
conventional maize.  The farmer questionnaire developed for use in the general 
surveillance monitoring programme asks farmers to comment on disease incidence on 
the modified crop, in comparison to conventional maize cultivation. 
 
Horizontal gene transfer 
In addressing the possibility of horizontal gene transfer the ERA points out that no 
bacterial antibiotic genes have been used in the production of Bt11 maize. In addition, 
both the Cry1Ab protein and the PAT protein were derived from soil micro-
organisms, thus the proteins are pre-existing and ubiquitous in soil. Transfer of 
genetic material between plants and soil micro-organisms is theoretically possible, but 
the ERA contends that if the transfer of the Cry1Ab gene or pat gene were to occur 
and resulted in successful gene expression it would not compromise prophylactic or 
therapeutic medical, veterinary, or plant protection treatments. No case-specific 
monitoring is therefore proposed for horizontal gene transfer, it is unlikely that the 
general surveillance monitoring plan would identify such effects if they occurred. 
 
Development of insect resistance to Bt maize containing Cry1Ab 
To date one species of insect, the Diamondback moth (Plutella xylostella (L.)), has 
been documented as showing resistance to Bt in the field, although over 10 species 
have been shown capable of evolving resistance, although not under field conditions.  
In the case of European Corn Borer, monitoring of Bt maize has been carried out in 
the USA since 1996, when it was first commercialised, and in Spain since 2000, and 
as yet there have been no reports of a decrease in susceptibility of ECB to Cry1Ab. 
Studies suggest that ECB larvae demonstrate incomplete dominance inheritance to 
preparations containing Bt proteins, and it has therefore been predicted that any ECB 
resistance genes for Bt11 maize would be at least partially recessive, making 
resistance more unlikely.  Furthermore, studies of Bt-tolerant insects have shown 
reduced or neutral fitness associated with resistance, thus if ECB were to develop 
resistance to Bt11 maize it seems unlikely that the fitness would be altered such that 
damage to crop and non-crop environments is increased.  However, where there is a 
high concentration of Bt11 maize being cultivated, the cumulative effects may lead to 
a different behaviour from that predicted. 
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If resistance to Bt11 were to occur in ECB or other insects feeding on maize, a 
number of consequences can be envisaged, including the possibility of compromised 
organic Bt pesticides, potential food chain effects (for example, would Bt-resistance 
result in a build-up of Cry proteins in the resistant insect causing toxicity to insect 
predators?), and agri-environment effects (e.g. higher use of ‘conventional’ 
pesticides). To prevent the build up of resistance to the Bt protein the notifier has 
devised an Insect Resistance Management Plan (see above). No timescale is specified 
for the duration of the IRM plan, although it seems reasonable to suppose it will be 
implemented for the life of the consent.  Also, whilst refuges of 20% non-modified 
maize appear to be a requirement for all fields over 5ha, it is not clear how many 
fields will be exempted because they are below this size, and furthermore it is not 
clear whether monitoring will include all fields (unlikely) or just a few fields. 
 
Effects on biogeochemistry, particularly carbon and nitrogen recycling through 
changes in soil decomposition 
The ERA concluded that any effects on biogeochemical processes as a result of the 
use of Bt11 are likely to be the same as those effects resulting from the cultivation of 
conventional maize. No indication could be found that either protein breakdown or 
foliar decay would be altered in the Bt11 plant. Additionally, it was stated that it is 
highly unlikely that soil-dwelling non-lepidopteran species will be adversely affected 
by Bt11 maize, thus indirectly affecting biogeochemical processes. No mention is 
made in the ERA concerning potential differences in the management practices for 
Bt11 compared to conventional maize, which could lead to changes in soil structure, 
decomposition rates and/or carbon and nitrogen cycling. Such practices could include, 
for example, low till cultivation, altered herbicide regimes and altered organic and 
chemical nutrient inputs.  The farmer questionnaire does ask questions regarding 
cultivation techniques, but these are not (currently) directed at associated observations 
of changes in soil structure etc.  Some work has been conducted on the effects of Cry 
proteins on certain soil-borne species and taxonomic groups, but it may also be 
legitimate to question the potential effects of these compounds on the wider soil 
environment, including bacteria and fungi (including mycorrhiza) involved in nutrient 
cycling, in particular in the long term and under cumulative conditions. 
 
 
 
 
 
 
 
 
 
8.3. C/SE/96/3501 Potato line EH92-527-1 (Amylogene HB) 
 
Trait: Modified starch content. 
Scope: Cultivation of potato clone EH92-527-1 and use for the extraction of 
starch for industrial uses, and the use of the by-products of starch extraction in 
animal feed. 
Current status: Pending. 
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Case-specific monitoring  
The case-specific monitoring will focus on (1) any significant detrimental changes in 
the composition of the tubers and (2) a change in the presence of the bleomycin 
resistant protein associated with ORF4. Monitoring will comprise verification of the 
following assumptions of the risk assessment: 
•  the genes of interest remain stably inserted, 
•  the ORF 4 is not expressed at the protein level, and 
•  the starch composition and the glycoalkaloid content are stable. 
 
The assessment report of the Swedish Competent Authority states that the notifier has 
developed methods and accounted for sampling and analysis. The suggested case-
specific monitoring will continue for five years, after which the monitoring plan will 
be evaluated and may be extended or altered.  The Swedish Board of Agriculture 
(SBA) concluded that in particular it is important to study how the glycoalkaloid 
content may vary depending on the place of cultivation or weather conditions. In 
addition, the SBA state there is very little reason to expect that the possible expression 
of a protein from ORF4 would result in negative health effects in animals that will eat 
the by-products of the potato. The SBA conclude that it is reasonable that monitoring 
is designed to fulfil the most important criterion in this context, that is to detect and 
avoid the unlikely scenario that ORF 4 causes a protein to occur in a significant share 
of the potatoes. 
 
IX.iii.3.2 General  surveillance 
The general surveillance plan considers areas related to (1) growth characteristics of 
the plant (including time to flowering, abortion of flowers, and time to maturity), (2) 
general characteristics of the plants (including height, shape and colour of the foliage, 
size and shape of the plant), (3) susceptibility to disease and pests and (4) any changes 
in animals within and in proximity to the fields.  Farmers who cultivate and/or use by-
products of EH92-527-1 in feed will be required to note all possible unexpected 
effects.  The notifier will supply the appropriate forms for this purpose.  General 
surveillance will also monitor the spread of potatoes outside the field. Management of 
volunteer potatoes will be carried out according to standard agricultural practice.  The 
general surveillance plan will run throughout the whole 10-year period of the consent. 
The base-line information consists of data that the notifier has gathered during 
previous years of cultivation and analysis.  A general surveillance questionnaire to all 
growers and handlers of the potatoes has not been proposed. 
 
IX.iii.3.2.1.1.1 Sampling  plan 
The applicant has a strategy for introduction of EH92 potatoes and has developed a 
clear plan for areas of production of seed potatoes and a sampling strategy at sites of 
production.  Sampling strategies must ensure homogeneity and will be undertaken 
according to European (CEN) standards, further advice will be taken from the 
‘Ecological Monitoring and Assessment Network’, and e.g. ISTA and the EC’s Joint 
Research Centre. 
. 
EH92 post market monitoring sampling plan: 
Object Parameters 
Seed potatoes (80 pooled samples)   PCR- identity 
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Production potatoes (20 locations, 4 pooled 
samples each) 
Starch composition 
Glycoalkaloid level 
Carbohydrates 
Protein 
Seed potato production sites (5 per year)  Plant characteristics 
Susceptibility to pests and disease 
Production sites (20 new sites per year, 
cumulative) 
Persistence in field 
Persistence outside of the managed field 
Production sites (all sites, verification by the 
growers) 
Plant characteristics 
 
Summary 
•  The scope of the notification includes cultivation and use for industrial purposes, 
and feeding of the by-products of processing to cattle.  It is not intended for 
direct human consumption, but it cannot be completely excluded that humans 
will consume the potatoes.  The post market monitoring plan includes a case-
specific element to confirm the stability of the inserted genes (nptII and non-
functional ORF 4) and to ensure that the content of starches and glycoalkaloids 
remain stable, general surveillance will include monitoring growth characteristics 
and pests and disease susceptibility.  The notification has received favourable 
assessments for being very thorough and for the applicant’s commitment to post 
market monitoring. 
•  The biological characteristics of the potato and the relatively benign nature of the 
trait make it difficult to anticipate long term or cumulative effects arising as a 
result of cultivation of this crop; the comprehensive post market plan is designed 
to identify any unanticipated effects of cultivation in the short term.  Use of a 
farmer questionnaire may be advisable to identify any changes in management 
practice associated with cultivation of EH92, such as altered use of herbicides or 
pesticides. 
•  The main risks possibly lie in the co-mingling of EH92 with food potatoes, for 
which it is not authorised, however the strict Identify Preservation scheme should 
ensure against this and enable rapid management if co-mingling should occur. 
•  Longer-term cumulative impacts may lie in economic benefits, for example 
farmers may be able to secure long-term production contacts, or the increased 
supply of high quality raw materials may boost local industries with knock-on 
benefits to the local economy.  There may also be potential benefits from the 
slight reduction in glycoalkaloid levels, which may improve the quality of EH92 
pulp for cattle. 
 
IX.iii.3.2.2 Detailed  considerations 
IX.iii.3.3 Human  toxicity and allergenicity 
EH92-527-1 potato (hereafter referred to as EH92) is modified by incorporation of the 
gbss  gene (granule bound starch synthase) in antisense orientation to reduce the 
expression of the endogenous gbss gene.  This has the effect of reducing the level of 
amylose starch and increasing the level of amylopectin, which is desirable for 
industrial uses.  The potatoes also contain the nptII selective marker gene, which 
confers resistance to the antibiotic kanamycin.  The environmental risk assessment 
(ERA) states that these two traits have a long history of safe use; the nptII gene is 
considered to belong to a class of antibiotic resistance genes that us acceptable for 
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and handling.  The antisense gbss sequence has not revealed any indication of 
toxicology or allergenicity; this sequence does not produce a new protein but merely 
blocks the activity of a native enzyme, allowing the level of native amylopectin to 
increase.  Other sources of amylopectin are known, and it has been found to be safe 
for human digestion.  Amylopectin is, however, digested more readily than amylose 
and this could result in undesirable effects, for example in diabetics who could 
experience a swifter increase in blood sugar levels as a result of consumption of EH92 
potatoes rather than normal food potatoes, over a prolonged period that this could 
affect insulin levels in these people.  This would be a clear long-term cumulative 
effect of the release of these potatoes, if they were to become incorporated into the 
market for routine use a food item.  Effective operation of the proposed Identify 
Preservation system will be essential to ensure that EH92 potatoes are not co-mingled 
with food potatoes. 
 
Significant differences are reported in levels of sugar (elevated), glycoalkaloids 
(reduced) and vitamin C (elevated) in EH92 potatoes relative to the conventional 
parent (‘Prevalent’), although these are within the normal variation for potatoes.   
Reduced levels of potentially toxic anti-nutritional glycoalkaloids and increased levels 
of vitamin C would be advantageous rather than a drawback.  No changes in other 
compositional parameters were reported and the observed levels were demonstrated to 
be stable over several generations; these factors are, however, influenced by 
environmental factors. 
 
Potato is not known to be a major allergenic crop; EFSA considered that over-
expression of an endogenous protein that is not know to be allergenic would be 
unlikely to alter the overall allergenicity of the whole plant.  Furthermore, there have 
been no adverse reports due to handling of the EH92 potatoes in glasshouse, field and 
processing activities during nine years of experimental trials. 
 
No case-specific post market monitoring is proposed in connection with potential 
human toxicity or allergenicity effects and this has been accepted during the 
assessment process and is accepted by EFSA.  Effective operation of the Identity 
Preservation system will be important to ensure EH92 potatoes do not enter the food 
chain.   
 
IX.iii.3.4  Potential to compromise human therapy 
EH92 expresses the nptII protein, but this is considered safe for use.  There will be no 
direct consumption of EH92 potatoes by humans so no direct or indirect effects on 
human therapy are anticipated.  If diabetic persons were to inadvertently consume 
EH92 potatoes over an extended period of time this may compromise treatment of the 
condition. 
 
IX.iii.3.5  Potential beneficial effects to humans 
There will be no direct consumption of EH92 potatoes by humans so no direct or 
indirect beneficial effects to human are anticipated, although reduced levels of 
glycoalkaloids and increased vitamin C would be considered beneficial in potato for 
food use. 
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IX.iii.3.6  Animal toxicity and allergenicity 
Pulp produced as a by-product of starch extraction will be fed to animals; the main 
use of the pulp is as cattle feed in the autumn and as a nutritional supplement during 
periods of grazing and when stabled.  The pulp is not reported to deviate in 
composition from conventionally produced starch potatoes and a pulp feeding study 
with heifers (8 weeks) confirmed that no significant changes had occurred that 
affected feed quality, and no significant differences in weight gain were detected 
when fed with pulp from EH92 or a conventional variety.  Analysis of the pulp 
revealed that intact nptII was not detected in fruit juice and fruit water, but it was 
detected in the pulp itself, horizontal gene transfer in the gut could lead to 
development of kanamycin resistant bacterial populations in the gut.  However, 
kanamycin resistant bacteria are naturally abundant e.g. in soil, and the risk of 
increased kanamycin resistant bacteria as a result of feeding potato pulp was 
considered negligible.  The antisense protein was found to degrade very quickly in 
experiments simulating ruminant fluid. 
 
The risk assessment concludes that there are no significant risks to animal toxicity and 
allergenicity.  It is worth noting that feeding trials were conducted over a short time 
period and would identify any acute effects, whereas longer-term cumulative effects 
would not be identified.  Given that the composition of the pulp does not differ from 
that for conventional varieties, except in benefiting from a reduced level of 
glycoalkaloid, chronic toxicity or allergenic effects due to the genetic modification is 
considered unlikely.  Monitoring for any unanticipated effects of feeding the pulp 
could be done during the life of the consent as part of the general surveillance 
programme, e.g. as a questionnaire to farmers that utilise the pulp. 
 
IX.iii.3.7  Compromised animal therapy 
Kanamycin is not widely used in animal therapy so the release should not compromise 
animal therapy. 
 
IX.iii.3.8  Potential beneficial effects to animals 
Reduced levels of glycoalkaloids reduce the potential for toxic or anti-nutritional 
effects as a result of consumption of the pulp. 
 
Diseases to plants 
Official variety trials in Sweden, demonstrated that, in comparison with the parent 
variety ‘Prevalent’, EH92 did not demonstrate increased or reduced susceptibility or 
resistance to late blight (Phytophthora  infestans), potato early blight (Alternaria 
solani) Erwinia rots, other bacterial diseases, potato cyst nematodes (Glodobera spp.), 
aphids or leafhoppers.  Starch potatoes are currently only grown in countries that have 
been allocated a cultivation quota, this has a historical basis and all countries are 
located in Northern Europe; the environmental risk assessment is based on the 
assumption that EH92 will only be grown in these areas. The diseases listed are 
representative of those found in these regions.  It should be considered that, consistent 
with development of a free market economy for agriculture in Europe, the quota 
system might be abolished in the future, this would widen the area in which EH92 
would be considered for cultivation by farmers, particularly with current drives 
towards use of biodegradable packaging goods etc.  If this were to occur, a review of 
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reported to vary with different climatic conditions, in turn this may alter susceptibility 
to diseases, particularly if being cultivated outside of the northern European region.  
This shift in potential cultivation patterns would be an effect observed in the long-
term, possibly as a result of long-term cultivation of EH92 in northern Europe with 
good results; it would be an economic market-driven effect. 
 
Target organisms (incl. predators and parasitoids) 
There are no target organisms for EH92 potatoes. 
 
IX.iii.3.9  Effects on non-target organisms 
A number of organisms, some pathogenic, feed on potato foliage; EH92 has not 
shown greater or reduced susceptibility to attack by aphids or leafhoppers than the 
parent variety, nor is any evidence presented to suggest that EH92 is eaten by larvae, 
worms or snails to any greater or lesser extent.  Research has shown (e.g. Johnston, 
K.A., 1989) that potatoes with very low levels of glycoalkaloids are more appetizing 
to larvae and snails, however any effect of reduced glycoalkaloid levels has not been 
observed in EH92.  There is no difference in EH92 and the parental variety in terms of 
susceptibility and resistance to potato cyst nematodes.  Animals such as birds or 
rodents feeding on tubers left on the surface of the soil should not suffer adverse 
effects as compositional analysis shows the tubers to be essentially equivalent to the 
conventional parent.  Long-term cumulative effects are, therefore, unlikely to be 
different from the conventional variety. 
 
As already discussed, assessments of EH92 have been made on the assumption that it 
will only be cultivated in northern Europe.  It is possible that exposure to a different 
suite of pests (e.g. as might be found in more southerly parts of Europe) would 
identify altered susceptibility to predation from non-target organisms, either as a 
result of a different suite of pests or due to climate-induced compositional changes.  
These would not be long-term cumulative effects, rather the result of changes to the 
basis on which EH92 was risk-assessed. 
 
IX.iii.3.10  Effects of gene transfer (including to soil organisms) and 
potential for increased weediness 
Horizontal transfer of nptII to soil bacteria is proposed to be negligible due to the 
inherently high levels of bacteria in the soil that already contain kanamycin resistant 
populations.  It should be borne in mind that the tuber itself contains the nptII gene, a 
proportion of which will be left in the ground following harvest (‘groundkeepers’) and 
rot in situ, releasing the gene into the soil.  In intensive potato growing areas this 
could significantly contribute to the pool of kanamycin resistant bacteria in the soil. 
 
The potato has a low competitive ability in Europe outside arable land, particularly in 
northern Europe.  It is mostly propagated vegetatively by tubers, but some varieties 
can form seeds; groundskeepers are easily destroyed by chemical treatment or by 
tilling, and are out-competed by the following crop in the rotation.  The potato’s wild 
relatives in Europe are S.nigrum and S.dulcamara,  very low frequency genetic 
exchange has been reported with S.nigrum under artificial, forced conditions.  Natural 
exchange of genetic material is only possible with other varieties of potato (Solanum 
tuberosum).  EH92 (and its conventional parent) is reported to produce very little 
pollen, any pollen that is produced can only spread a short distance; the tendency to Cumulative long-term effects of genetically modified (GM) crops on human/animal health and the 
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shed flowers prematurely further weakens the competitive ability of EH92.  In 
southern Europe, potatoes can occur as a weed outside of agricultural situation, if 
EH92 were to be cultivated in southern Europe, the possibility of gene transfer to wild 
relatives would be increased slightly, but effective incompatibility barriers make the 
occurrence of hybrids very unlikely.  The likelihood of successful natural transfer 
between EH92 and other potato crops is considered very low, in addition it would 
confer no competitive benefit therefore hybrids would be unlikely to persist.  There is 
no herbicide tolerance trait in EH92 so it will not present groundkeeper/weed 
management problems, in addition EH92 has not been found to possess increased 
frost tolerance relative to its parent.  Its agronomic characteristics are reported to be 
essential unchanged from the parent variety.  Given the biological characteristics of 
EH92, it is difficult to speculate what adverse long-term cumulative impacts could 
occur as a result of its cultivation.  Farmers may derive long-term economic benefits 
by establishing contracts for provision of starch to industrial markets.  This should not 
have a negative effect on the market for food potatoes, as production will be market-
driven. 
 
IX.iii.3.11 Biogeochemical  processes 
Potatoes are not known to play a prominent role in the cycle of chemical elements 
such as nitrogen fixation by the association of legumes with Rhizobium.  The 
agronomic equivalence with the parental line means that any effects that would be 
seen would be similar to the conventional equivalent, and therefore not a candidate for 
monitoring.  The slightly altered composition of the EH92 relative to the parent may 
lead to slightly altered decomposition in the soil, but this is not considered to likely to 
have any significant effects on soil processes. 
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